0001019687-15-003959.txt : 20151110 0001019687-15-003959.hdr.sgml : 20151110 20151109163108 ACCESSION NUMBER: 0001019687-15-003959 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151109 DATE AS OF CHANGE: 20151109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 151216086 BUSINESS ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 10-Q 1 radnet_10q-093015.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-33307

RadNet, Inc.

(Exact name of registrant as specified in charter)

Delaware	13-3326724
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)

1510 Cotner Avenue
Los Angeles, California	90025
(Address of principal executive offices)	(Zip Code)

(310) 478-7808

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer o	Accelerated filer x	Non-accelerated filer o	Smaller reporting company o
		(do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

The number of shares of the registrant’s common stock outstanding on November 5, 2015 was 46,120,671 shares.

RADNET, INC.

Table of Contents

	Page

PART I – FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements (unaudited)	3

Condensed Consolidated Balance Sheets at September 30, 2015 and December 31, 2014	3

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2015 and 2014	4

Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2015 and 2014	5

Condensed Consolidated Statement of Stockholders’ Equity for the Nine Months Ended September 30, 2015	6

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2015 and 2014	7

Notes to Condensed Consolidated Financial Statements	9

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	22

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	39

ITEM 4. Controls and Procedures	39

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings	40

ITEM 1A. Risk Factors	40

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	40

ITEM 3. Defaults Upon Senior Securities	40

ITEM 4. Mine Safety Disclosures	40

ITEM 5. Other Information	40

ITEM 6. Exhibits	40

SIGNATURES	41

INDEX TO EXHIBITS	42

PART I – FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements (unaudited)

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

	September 30,			December 31,
	2015			2014
	(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	36,054		$	307
Accounts receivable, net		159,205			148,235
Current portion of deferred tax assets		17,246			17,246
Due from affiliates		2,604			1,561
Prepaid expenses and other current assets		41,194			24,671
Total current assets		256,303			192,020
PROPERTY AND EQUIPMENT, NET		232,477			223,127
OTHER ASSETS
Goodwill		201,450			200,304
Other intangible assets		45,225			47,624
Deferred financing costs, net of current portion		4,294			6,122
Investment in joint ventures		32,434			32,123
Deferred tax assets, net of current portion		32,584			35,334
Deposits and other		4,108			4,026
Total assets	$	808,875		$	740,680
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Accounts payable, accrued expenses and other	$	95,058		$	97,816
Due to affiliates		5,664			6,289
Deferred revenue		1,323			1,964
Current portion of notes payable		23,391			19,468
Current portion of deferred rent		2,299			2,100
Current portion of obligations under capital leases		8,761			5,637
Total current liabilities		136,496			133,274
LONG-TERM LIABILITIES
Deferred rent, net of current portion		26,299			20,965
Line of credit		–			15,300
Notes payable, net of current portion		606,744			551,059
Obligations under capital lease, net of current portion		7,422			6,143
Other non-current liabilities		5,577			6,241
Total liabilities		782,538			732,982
EQUITY
RadNet, Inc. stockholders' equity:
Common stock - $.0001 par value, 200,000,000 shares authorized; 44,495,235 and 42,825,676 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively		4			4
Paid-in-capital		188,310			177,750
Accumulated other comprehensive loss		(146	)		(112	)
Accumulated deficit		(165,452	)		(172,280	)
Total RadNet, Inc.'s stockholders' equity		22,716			5,362
Noncontrolling interests		3,621			2,336
Total equity		26,337			7,698
Total liabilities and equity	$	808,875		$	740,680

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
NET REVENUE
Service fee revenue, net of contractual allowances and discounts	$	192,904		$	171,098		$	546,337		$	498,536
Provision for bad debts		(9,433	)		(7,532	)		(25,295	)		(21,945	)
Net service fee revenue		183,471			163,566			521,042			476,591
Revenue under capitation arrangements		24,895			20,493			72,880			55,426
Total net revenue		208,366			184,059			593,922			532,017
OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization		175,631			153,000			520,348			445,838
Depreciation and amortization		14,601			14,423			43,836			45,193
Loss on sale and disposal of equipment		738			1,289			774			1,581
Severance costs		167			112			297			976
Total operating expenses		191,137			168,824			565,255			493,588

INCOME FROM OPERATIONS		17,229			15,235			28,667			38,429

OTHER INCOME AND EXPENSES
Interest expense		10,546			10,395			30,965			32,503
Meaningful use incentive		–			–			(3,270	)		(1,762	)
Equity in earnings of joint ventures		(1,992	)		(2,009	)		(6,301	)		(4,722	)
Gain on sale of imaging centers		(4,823	)		–			(4,823	)		–
Loss on early extinguishment of Senior Notes		–			–			–			15,927
Other expenses		8			6			418			4
Total other expenses		3,739			8,392			16,989			41,950

INCOME (LOSS) BEFORE INCOME TAXES		13,490			6,843			11,678			(3,521	)
(Provision for) benefit from income taxes		(5,199	)		(2,334	)		(4,300	)		911

NET INCOME (LOSS)		8,291			4,509			7,378			(2,610	)
Net income attributable to noncontrolling interests		304			58			550			219

NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	7,987		$	4,451		$	6,828		$	(2,829	)

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	0.18		$	0.11		$	0.16		$	(0.07	)

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	0.18		$	0.10		$	0.15		$	(0.07	)

WEIGHTED AVERAGE SHARES OUTSTANDING
Basic		43,637,022			41,644,606			43,247,002			40,734,083
Diluted		44,751,936			44,033,580			44,704,323			40,734,083

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(IN THOUSANDS)

(unaudited)

	Three Months Ended September 30,					Nine Months Ended September 30,
	2015		2014			2015			2014
NET INCOME (LOSS)	$	8,291	$	4,509		$	7,378		$	(2,610	)
Foreign currency translation adjustments		7		(1	)		(34	)		(38	)

COMPREHENSIVE INCOME (LOSS)		8,298		4,508			7,344			(2,648	)
Less comprehensive income attributable to non-controlling interests		304		58			550			219

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	7,994	$	4,450		$	6,794		$	(2,867	)

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

												Accumulated Other			Total Radnet,			Non-
		Common Stock					Paid-in		Accumulated			Comprehensive			Inc.'s			controlling			Total
		Shares			Amount		Capital		Deficit			Loss			Equity			Interests			Equity
BALANCE - JANUARY 1, 2015			42,825,676		$	4	$	177,750	$	(172,280	)	$	(112	)	$	5,362		$	2,336		$	7,698
	Issuance of common stock upon exercise of options		814,662			–		594		–			–			594			–			594
	Stock-based compensation		–			–		6,309		–			–			6,309			–			6,309
	Issuance of restricted stock and other awards		884,423			–		–		–			–			–			–			–
	Forfeiture of restricted stock		(29,526	)		–		–		–			–			–
	Sale of noncontrolling interest		–			–		3,657		–			–			3,657			1,348			5,005
	Distributions paid to noncontrolling interests		–			–		–		–			–			–			(613	)		(613	)
	Change in cumulative foreign currency translation adjustment		–			–		–		–			(34	)		(34	)		–			(34	)
	Net income		–			–		–		6,828			–			6,828			550			7,378
BALANCE - SEPTEMBER 30, 2015			44,495,235		$	4	$	188,310	$	(165,452	)	$	(146	)	$	22,716		$	3,621		$	26,337

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(unaudited)

	Nine Months Ended September 30,
	2015			2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	7,378		$	(2,610	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		43,836			45,193
Provision for bad debts		25,295			21,945
Equity in earnings of joint ventures		(6,301	)		(4,722	)
Distributions from joint ventures		6,255			7,358
Amortization and write off of deferred financing costs and loan discount		4,000			4,444
Loss on sale and disposal of equipment		774			1,581
Loss on early extinguishment of Senior Notes		–			15,927
Gain on sale of imaging centers		(4,823	)		–
Stock-based compensation		6,477			2,069
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable		(32,485	)		(42,887	)
Other current assets		(15,628	)		(4,754	)
Other assets		(1,254	)		(72	)
Deferred taxes		2,750			(2,461	)
Deferred rent		6,034			653
Deferred revenue		(641	)		604
Accounts payable , accrued expenses and other		(1,602	)		(8,225	)
Net cash provided by operating activities		40,065			34,043

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities		(41,237	)		(9,428	)
Purchase of noncontrolling interests		–			(196	)
Purchase of property and equipment		(38,736	)		(33,895	)
Proceeds from sale of equipment		648			766
Proceeds from sale of imaging facilities		35,500			–
Proceeds from sale of internal use software		443			–
Equity contributions in existing and purchase of interest in joint ventures		(265	)		(1,161	)
Net cash used in investing activities		(43,647	)		(43,914	)

CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on notes and leases payable		(6,645	)		(16,733	)
Proceeds from borrowings		74,401			210,000
Payments on Term Loan Debt/Senior Notes		(17,548	)		(211,344	)
Deferred financing costs		(531	)		(6,650	)
Net (payments) proceeds on revolving credit facility		(15,300	)		25,100
Distributions paid to noncontrolling interests		(613	)		(148	)
Proceeds from sale of non-controlling interests		5,005			–
Proceeds from issuance of common stock upon exercise of options/warrants		594			1,546
Net cash provided by financing activities		39,363			1,771

EFFECT OF EXCHANGE RATE CHANGES ON CASH		(34	)		(38	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		35,747			(8,138	)
CASH AND CASH EQUIVALENTS, beginning of period		307			8,412
CASH AND CASH EQUIVALENTS, end of period	$	36,054		$	274

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	$	26,543		$	32,389

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(unaudited)

Supplemental Schedule of Non-Cash Investing and Financing Activities

We acquired equipment and certain leasehold improvements for approximately $15.7 million and $16.6 million during the nine months ended September 30, 2015 and 2014, respectively, which were not paid for as of September 30, 2015 and 2014, respectively, and accordingly are recorded in our consolidated balance sheets under accounts payable, accrued expenses and other.

During the nine months ended September 30, 2015, we added capital lease debt of approximately $7.8 million

Detail of non-cash investing activities related to acquisitions can be found in Note 2.

RADNET, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2015 we operated directly or indirectly through joint ventures, 280 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, and Chairman of our Board of Directors. Dr. Berger owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

We contract with seven medical groups which provide professional medical services at all of our facilities in Manhattan and Brooklyn, New York. These contracts are similar to our contract with BRMG. Four of these groups are owned by John V Crues, III, M.D., RadNet’s Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Berger owns a controlling interest in two of these medical groups which provide professional medical services at one of our Manhattan facilities.

RadNet provides non-medical, technical and administrative services to BRMG and the seven medical groups mentioned above (“NY Groups”) for which it receives a management fee, pursuant to the related management agreements. Through these management agreements we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the NY Groups and we determine the annual budget of BRMG and the NY Groups. BRMG and the NY Groups both have insignificant operating assets and liabilities, and de minimis equity. These management agreements are designed such that all net cash flows of both BRMG and the NY Groups are transferred to us.

We have determined that BRMG and the NY Groups are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. These VIE’s on a combined basis recognized $29.4 million and $23.6 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2015 and 2014, respectively, and $29.4 million and $23.6 million of operating expenses for the three months ended September 30, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $106.7 million and $98.0 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2015 and 2014, respectively, of which $77.3 million and $74.4 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2015 and 2014, respectively.

These VIE’s on a combined basis recognized $83.1 million and $65.6 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2015 and 2014, respectively, and $83.1 million and $65.6 million of operating expenses for the nine months ended September 30, 2015 and 2014, respectively. RadNet recognized in its condensed consolidated statement of operations $320.6 million and $279.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2015 and 2014, respectively, of which $237.5 million and $213.9 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2015 and 2014, respectively.

The cash flows of these VIE’s are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2015 and December 31, 2014, we have included approximately $77.7 million and $79.7 million, respectively, of accounts receivable and approximately $8.6 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to these VIE’s combined.

The creditors of each of these VIE’s do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of any of these VIE’s. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

At all of our centers, aside from certain centers in California and centers in New York City where we contract with BRMG and the NY Groups for the provision of professional medical services, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-NY Groups) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014, filed on March 16, 2015, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Commercial insurance	$	114,827		$	109,472		$	331,670		$	314,300
Medicare		40,840			41,203			120,039			118,627
Medicaid		6,117			6,248			17,582			18,214
Workers' compensation/personal injury		7,712			7,821			23,287			22,708
Other		23,408			6,354			53,759			24,687
Service fee revenue, net of contractual allowances and discounts		192,904			171,098			546,337			498,536
Provision for bad debts		(9,433	)		(7,532	)		(25,295	)		(21,945	)
Net service fee revenue		183,471			163,566			521,042			476,591
Revenue under capitation arrangements		24,895			20,493			72,880			55,426
Total net revenue	$	208,366		$	184,059		$	593,922		$	532,017

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over at least an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a front desk patient tracking system or Radiology Information System (“RIS”) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the nine months ended September 30, 2015, and 2014, respectively, relating to this incentive.

Software Development Costs

Costs related to the research and development of new software products and enhancements to existing software products all for resale to our customers are expensed as incurred.

We utilize a variety of computerized information systems in the day to day operation of our diagnostic imaging facilities. One such system is our RIS. We have historically utilized third party RIS software solutions and pay monthly fees to outside third party software vendors for the use of this software. We have developed our own RIS solution from the ground up through our wholly owned subsidiary, Radnet Management Information Systems (“RMIS”) deployed this system in the beginning of the first quarter in 2015.

By following the accounting guidance under ASC 350-40, Accounting for the Costs of Computer Software Developed for Internal Use, the costs incurred by RMIS toward the development of this RIS system, which began on August 1, 2010 and continued until December 2014, were capitalized and will be amortized over its useful life which we determined to be 5 years. Total costs capitalized were approximately $6.4 million. We began recording monthly amortization of $107,000 per month for our use of this software in January 2015.

During the nine months ended September 30, 2015, we entered into an agreement to license our RIS system to an outside customer. As of September 30, 2015, we received approximately $443,000 in respect to this licensing agreement. In accordance with ASC 350-40, we recorded the receipt of these funds against the capitalized software costs explained above. We intend to record any future proceeds in the same manner until the carrying value of our capitalized software costs are brought to zero. As of September 30, 2015, the net carrying value of our capitalized software costs was approximately $5.0 million. We continue to record amortization expense of $107,000 per month for our internal use of this software and will continue to do so until the net carrying value of the capitalized software costs are brought to zero.

Liquidity and Capital Resources

We had cash and cash equivalents of $36.1 million and accounts receivable of $159.2 million at September 30, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $119.8 million and $58.7 million at September 30, 2015 and December 31, 2014, respectively. We had net income attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2015 and 2014 of $8.0 million and $4.5 million respectively, and net income attributable to RadNet, Inc common stockholders for the nine months ended September 30, 2015 of $6.8 million and net loss of $2.8 million in 2014. We had stockholders’ equity of $22.7 million and $5.4 million at September 30, 2015 and December 31, 2014, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2015 is $626.9 million of senior secured term loan debt (net of unamortized discounts of $10.3 million), broken down by loan agreement as follows (in thousands):

	As of September 30, 2015
	Face Value		Discount			Total Carrying Value
First Lien Term Loans	$	384,176	$	(7,440	)	$	376,736
2015 Incremental First	$	73,026	$	(528	)	$	72,498
Second Lien Term Loans	$	180,000	$	(2,344	)	$	177,656
Total	$	637,202	$	(10,312	)	$	626,890

Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.

As of September 30, 2015, we were in compliance with all financial covenants under our Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan, and the Second Lien Credit Agreement, each as defined below.

2015 Incremental First Lien Term Loan:

On April 30, 2015, we entered into a joinder agreement to our existing Credit Agreement (the "2015 Incremental First Lien Term Loan Joinder") to provide for the borrowing of $75.0 million of incremental first lien term loans (“2015 Incremental First Lien Term Loans”). The 2015 Incremental First Lien Term Loans are treated as part of the same class as the existing tranche B term loans currently outstanding under the Credit Agreement. We used the proceeds from the 2015 Incremental First Lien Term Loans to repay all of the borrowings outstanding under the first lien revolving loan facility and to pay approximately $1.1 million of fees and expenses associated with the transaction.

Interest. The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is approximately $987,000, beginning in June 2015. The scheduled quarterly amortization for all of the term loans under the Credit Agreement, including the 2015 First Lien Term Loans, was increased to approximately $6.2 million, beginning in June 2015.

Maturity Date. The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.

2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Credit Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012 (the "Original Credit Agreement"), by that certain first amendment dated April 3, 2013 (the “2013 Amendment”), and subsequently by entering into a second amendment dated on March 25, 2014 (the “2014 Amendment”) ( the Original Credit Agreement, as amended by the 2013 Amendment and the 2014 Amendment is collectively referred to herein as the "Credit Agreement") to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Guarantees and Collateral. The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of our tangible and intangible assets, including, but not limited to, pledges of equity interests of RadNet Management and all of our current and future domestic subsidiaries.

Restrictive Covenants. In addition to certain covenants, the Credit Agreement places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Second Lien Credit and Guaranty Agreement. RadNet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by RadNet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the outstanding Senior Notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2015 was 0.53%. The rate paid on the Second Lien Credit Agreement at September 30, 2015 was 8%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.

Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents being false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Revolving Credit Facility

The $101.25 million revolving credit line established in the Credit Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Credit Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Credit Agreement.

The revolving credit line bears interest based on types of borrowings as follows: (i) unpaid principal at the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 4.25% per annum or the Base Rate (as defined in the Credit Agreement) plus 3.25% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance. The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “Senior Notes”). All payments of the Senior Notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The Senior Notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among RadNet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the Senior Notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

We completed the retirement of our $200 million in Senior Notes on April 24, 2014 and following such retirement we completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding Senior Notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all Senior Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the Senior Notes, representing 96.73% of the outstanding Senior Notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of Senior Notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of Senior Notes. In addition, all Senior Notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional Senior Notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption of all of our remaining outstanding Senior Notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the Senior Notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the Senior Notes being redeemed (or $1,051.88 per $1,000 in principal amount of the Senior Notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no Senior Notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

NOTE 2 – FACILITY ACQUISITIONS AND DISPOSITIONS

Acquisitions

On September 1, 2015 we completed our acquisition of Murray Hill Radiology and Mammography, P.C. and Murray Hill MRI Holding, LLC, consisting of a single multi-modality imaging center located in Manhattan, New York for a cash consideration of $5.8 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $1.6 million of fixed assets, $95,000 of prepaid assets and $4.1 million of goodwill were recorded.

On August 3, 2015 we completed our acquisition of Hanford Imaging, LP, consisting of a single multi-modality imaging center located in Hanford, CA for cash consideration of $1.0 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $345,000 of fixed asset and $655,000 of goodwill were recorded.

On June 1, 2015 we completed our acquisition of Healthcare Radiology and Diagnostic systems, PLLC, consisting of a single multi-modality imaging center located in the Bronx, NY area for cash consideration of $425,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of net assets and approximately $134,500 of fixed assets and $290,500 of leasehold improvements were recorded.

On May 1, 2015 we completed our acquisition of California Radiology consisting of six multi-modality imaging centers located in Los Angeles, California for cash consideration of $4.2 million. The facilities provide MRI, PET/CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $217,000 of equipment, $1.7 million of leasehold improvements, $34,000 in other assets, $100,000 of other intangible assets relating to a covenant not to compete contract and $2.1 million of goodwill were recorded with respect to this transaction.

On April 15, 2015 we completed our acquisition of New York Radiology Partners, consisting of eleven multi-modality imaging centers located in Manhattan, New York for cash consideration of $29.8 million and a note to seller of $1.5 million. The facilities provide a full range of radiology services including MRI, PET/CT, Mammography, Ultrasound, X-ray and other related services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities. In total, RadNet acquired assets of $34.5 million, assumed equipment debt of $2.3 million, and assumed current liabilities of $891,000. Asset amounts acquired were $4.6 million in equipment, $12.0 million in leasehold improvements, $12.9 million in goodwill, $600,000 of other intangible assets, and $4.4 million of accounts receivable and other current assets. Current liabilities assumed related to accounts payable, payroll and other related short term obligations. Our preliminary fair value determination will be made final with the help of an outside valuation expert which we expect to have completed by the end of our fourth quarter of 2015.

Dispositions

On August 3, 2015 we sold a 25% non-controlling interest in one of our wholly owned entities, Baltimore County Radiology, LLC (“BCR”) to Lifebridge Health for $5.0 million. On the date of sale, the net book value of this 25% interest was $1.3 million. In accordance with ASC 810-10-45-23, the proceeds in excess of this net book value amounting to $3.7 million was recorded to equity. In addition to the proceeds already received, RadNet has the opportunity to receive approximately $1.2 million in additional proceeds if certain operating performance targets of BCR are achieved within the next 12 months. Any additional amounts received under these contingent performance provisions will be recorded to equity accordingly.

On September 30, 2015 we completed a sale of 10 wholly owned imaging centers from our New Jersey reporting unit, New Jersey Imaging Partners. This sale was made to one of our non-consolidated joint ventures for which we hold a 49% non-controlling interest, New Jersey Imaging Networks, for approximately $35.5 million. We recorded a gain of $4.8 million in the third quarter with respect to this transaction.

NOTE 3 – NEW ACCOUNTING STANDARDS

In September 2015, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2015-16 (“ASU 2015-16”), Business Combinations, (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement to retrospectively apply adjustments made to provisional amounts recognized in a business combination. An entity will now recognize any adjustments in the reporting period in which the amounts are determined, calculated as if the accounting had been completed at the acquisition date. Disclosure is required for the portion of adjustments recorded in current-period earnings that would have been recorded in previous reporting periods had they been recognized as of the acquisition date. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In August 2015, the FASB issued ASU No. 2015-15 (“ASU 2015-15”), Interest – Imputation of Interest, (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. ASU 2015-15 provides additional guidance to the presentation of debt issuance costs discussed originally in ASU No. 2015-03, which was issued in April 2015 and described below. ASU 2015-15 noted that ASU 2015-03 did not address the debt issue costs in regards to line-of-credit arrangements, which by their nature have fluctuating balances. ASU 2015-15 permits debt issuance costs specifically related to line-of-credit arrangements to be presented as an asset with subsequent amortization to interest expense ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the arrangement. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In April 2015, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2015-03 (“ASU 2015-03”), Interest – Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In February 2015, the FASB issued ASU No. 2015-02 (“ASU 2015-02”), Consolidation – Amendments to the Consolidation Analysis, (Topic 810). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In May 2014, the FASB issued ASU No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers, (Topic 606). ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update was effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016, which has recently been extended to December 31, 2017. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

NOTE 4 – EARNINGS PER SHARE

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2014
Net income (loss) attributable to RadNet, Inc.'s common stockholders	$	7,987	$	4,451	$	6,828	$	(2,829	)

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period		43,637,022		41,644,606		43,247,002		40,734,083
Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders	$	0.18	$	0.11	$	0.16	$	(0.07	)

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period		43,637,022		41,644,606		43,247,002		40,734,083
Add nonvested restricted stock subject only to service vesting		437,689		1,001,190		484,810		–
Add additional shares issuable upon exercise of stock options and warrants		677,225		1,387,784		972,511		–
Weighted average number of common shares used in calculating diluted net income per share		44,751,936		44,033,580		44,704,323		40,734,083
Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders	$	0.18	$	0.10	$	0.15	$	(0.07	)

For the nine months ended September 30, 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

NOTE 5 – INVESTMENT IN JOINT VENTURES

We have ten unconsolidated joint ventures where our ownership interests range from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2015 (in thousands):

Balance as of December 31, 2014	$	32,123
Equity in earnings in these joint ventures		6,301
Distribution of earnings		(6,255	)
Equity contributions in existing joint ventures		265
Balance as of September 30, 2015	$	32,434

We earned management service fees from the centers underlying these joint ventures of approximately $2.6 million and $2.3 million for the three months ended September 30, 2015 and 2014, respectively, and $6.4 million and $6.9 million for the nine months ended September 30, 2015 and 2014, respectively.

The following table is a summary of key financial data for these joint ventures as of September 30, 2015 (in thousands) and for the nine months ended September 30, 2015 and 2014 (in thousands):

Balance Sheet Data:	September 30, 2015
Current assets	$	17,551
Noncurrent assets		87,527
Current liabilities		(5,044	)
Noncurrent liabilities		(42,245	)
Total net assets	$	57,789

Book value of RadNet joint venture interests	$	27,463
Cost in excess of book value of acquired joint venture interests		4,971
Total value of Radnet joint venture interests	$	32,434

Total book value of other joint venture partner interests	$	30,326

Income statement data for the nine months ended September 30,	2015		2014
Net revenue	$	85,305	$	73,859
Net income	$	13,489	$	9,801

NOTE 6 – STOCK-BASED COMPENSATION

Equity Incentive Plans

Options

We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we amended and restated as of April 20, 2015 (the “Restated Plan”). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 11, 2015. As of September 30, 2015, we have reserved for issuance under the Restated Plan 12,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over two to five years and expire five to ten years from the date of grant.

As of September 30, 2015, we had outstanding options to acquire 965,009 shares of our Common Stock, of which options to acquire 921,676 shares were exercisable. During the nine months ended September 30, 2015, we did not grant any stock options under our Restated Plan.

The following summarizes all of our stock option transactions during the nine months ended September 30, 2015:

				Weighted Average		Weighted Average Remaining
				Exercise price		Contractual		Aggregate
Outstanding Options				Per Common		Life		Intrinsic
Under the 2006 Plan	Shares			Share		(in years)		Value
Balance, December 31, 2014		2,092,509		$	3.58
Granted		–			–
Exercised		(1,102,500	)		2.69
Canceled, forfeited or expired		(25,000	)		2.22
Balance, September 30, 2015		965,009			4.62		1.07	$	1,783,778
Exercisable at September 30, 2015		921,676			4.74		0.98		1,631,678

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the holder had all holders exercised their options on September 30, 2015. Total intrinsic value of options exercised during the nine months ended September 30, 2015 and 2014 was approximately $6.1 million and $5.9 million, respectively. As of September 30, 2015, total unrecognized stock-based compensation expense related to non-vested options was $21,000, which is expected to be recognized over a weighted average period of approximately 1.1 years.

Restricted Stock Awards

The Restated Plan permits the issuance of restricted stock awards (“RSA’s”). As of September 30, 2015, we have issued a total of 3,461,208 RSA’s, of which 2,623,314 RSA’s have previously vested, 29,526 RSA’s were forfeited and 808,369 RSA’s remained unvested at September 30, 2015.

The following summarizes all unvested RSA activities during the nine months ended September 30, 2015:

				Weighted- Average
				Remaining		Weighted-
				Contractual		Average
	RSA’s			Term (Years)		Fair Value
RSA's outstanding at December 31, 2014		942,023				$	1.96
Changes during the period
Granted		744,423				$	8.60
Vested		(848,552	)			$	4.55
Forfeited		(29,526	)			$	5.59
RSA's unvested at September 30, 2015		808,369			0.71	$	5.22

We determine the fair value of all RSA’s based on the closing price of our common stock on the date of award.

In sum, of the 12,000,000 shares of common stock reserved for issuance under the Restated Plan, at September 30, 2015, we had 3,431,683 RSA’s, net of 29,526 RSA’s forfeited (of which 808,369 shares were subject to further vesting), outstanding options to acquire 965,009 shares, and 3,924,567 shares of common stock available for future awards. We had previously granted options and other awards to acquire 3,678,741 shares which have been issued.

NOTE 7 – FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

	As of September 30, 2015
	Level 1		Level 2		Level 3		Total Fair Value		Total Face Value
First Lien Term Loans	$	–	$	383,216	$	–	$	383,216	$	384,176
2015 Incremental First				72,843				72,843		73,026
Second Lien Term Loans				172,800	$	–		172,800		180,000

	As of December 31, 2014
	Level 1		Level 2		Level 3		Total		Total Face Value
First Lien Term Loans	$	–	$	394,753	$	–	$	394,753	$	399,750
Second Lien Term Loans		–		178,200		–		178,200		180,000

The carrying value of our revolving credit facility at December 31, 2014 of $15.3 million approximated its fair value. There was no revolving credit facility balance at September 30, 2015.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

NOTE 8 – SUBSEQUENT EVENTS

On October 16, 2015, Radnet purchased substantially all of the assets of Diagnostic Imaging Group, LLC (“DIG”), for approximately $56.7 million in cash and 1.5 million shares of RadNet common stock. The purchase agreement also provides for the possibility of earn-out payments based on future revenues over the 60 months following the closing of the transaction. The acquisition adds 17 new locations to our existing portfolio of imaging centers in the New York City area.

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information appearing elsewhere in this quarterly report.

Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.

In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “assumption” or the negative of these terms or other comparable terminology. Statements in this quarterly report concerning our ability to successfully acquire and integrate new operations, to grow our business, our expectations for further trends in revenue or expenses, our future cost saving efforts, our increased business from new equipment or operations and our ability to finance our operations and repay our outstanding indebtedness, including our increased amortization payments, are forward-looking statements.

The factors included in “Risk Factors,” in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended or supplemented by the information, in Part II – Item 1A below, among others, could cause our actual results to differ materially from those expressed in, or implied by, the forward-looking statements. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements. These forward-looking statements speak only as of the date when they are made. Except as required under the federal securities laws or by the rules and regulations of the Securities and Exchange Commission, we do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of those statements. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this quarterly report.

Overview

We seek to develop leading positions in regional markets in order to leverage operational efficiencies. Our scale and density within selected geographies provides close, long-term relationships with key payors, radiology groups and referring physicians. Each of our facility managers is responsible for managing relationships with local physicians and payors, meeting our standards of patient service and maintaining profitability. We provide corporate training programs, standardized policies and procedures and sharing of best practices among the physicians in our regional networks.

We derive substantially all of our revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our facilities. For the nine months ended September 30, 2015 and 2014, we performed 4,183,494 and 3,570,949 diagnostic imaging procedures, respectively, and generated total net revenue of $593.9 million and $532.0 million, respectively.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc., all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

The creditors of each of these VIE’s do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of any of these VIE’s. However, because of the relationship, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

At all of our centers, aside from certain centers in California and certain centers in New York City where we contract with BRMG and the NY Groups for the provision of professional medical services, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-NY Groups) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when securing medical care will result in significant out-of-pocket expenditures.

Critical Accounting Policies

The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company’s financial condition and results of operations and require management’s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. In Note 2 to our consolidated financial statements in our annual report on Form 10-K for the year ended December 31, 2014, as amended, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management’s judgments and estimates are described below.

Use of Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These estimates and assumptions affect various matters, including:

our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements;

our disclosure of contingent assets and liabilities at the dates of the financial statements; and

our reported amounts of net revenue and expenses in our consolidated statements of operations during the reporting periods.

These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could differ materially from these estimates.

During the period covered in this report, there were no material changes to the critical accounting estimates we use, and have described in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and NY Groups centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Commercial insurance	$	114,827		$	109,472		$	331,670		$	314,300
Medicare		40,840			41,203			120,039			118,627
Medicaid		6,117			6,248			17,582			18,214
Workers' compensation/personal injury		7,712			7,821			23,287			22,708
Other		23,408			6,354			53,759			24,687
Service fee revenue, net of contractual allowances and discounts		192,904			171,098			546,337			498,536
Provision for bad debts		(9,433	)		(7,532	)		(25,295	)		(21,945	)
Net service fee revenue		183,471			163,566			521,042			476,591
Revenue under capitation arrangements		24,895			20,493			72,880			55,426
Total net revenue	$	208,366		$	184,059		$	593,922		$	532,017

Accounts Receivable

Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Depreciation and Amortization of Long-Lived Assets

We depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives or the lease term of the facility for which these assets are associated.

Deferred Tax Assets

Valuation of Goodwill and Indefinite Lived Intangibles

Goodwill at September 30, 2015 totaled $201.5 million. Indefinite Lived Intangible Assets at September 30, 2015 totaled $6.8 million and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. Management evaluates goodwill and trade name intangibles, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable. Impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit is estimated using a combination of the income or discounted cash flows approach and the market approach, which uses comparable market data. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount of impairment loss, if any. Impairment of trade name intangibles is tested at the subsidiary level by comparing the subsidiary’s trade name carrying amount to its respective fair value. We tested both goodwill and trade name intangibles for impairment on October 1, 2014, noting no impairment, and have not identified any indicators of impairment through September 30, 2015.

Long-Lived Assets

We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment whenever indicators of impairment exist. The accounting standards require that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset’s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. No indicators of impairment were identified with respect to our long-lived assets as of September 30, 2015.

Software Development Costs

Costs related to the research and development of new software products and enhancements to existing software products all for resale to our customers are expensed as incurred.

We utilize a variety of computerized information systems in the day to day operation of our diagnostic imaging facilities. One such system is our front desk patient tracking system or Radiology Information System (“RIS”). We have historically utilized third party RIS software solutions and pay monthly fees to outside third party software vendors for the use of this software. We have developed our own RIS solution from the ground up through our wholly owned subsidiary, Radnet Management Information Systems (“RMIS”) deployed this system in the beginning of the first quarter in 2015.

New Accounting Standards

In September 2015, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2015-16 (“ASU 2015-16”), Business Combinations, (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement to retrospectively apply adjustments made to provisional amounts recognized in a business combination. An entity will now recognize any adjustments in the reporting period in which the amounts are determined, calculated as if the accounting had been completed at the acquisition date. Disclosure is required for the portion of adjustments recorded in current-period earnings that would have been recorded in previous reporting periods had they been recognized as of the acquisition date. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In April 2015, the FASB issued ASU No. 2015-03 (“ASU 2015-03”), Interest – Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

Industry Updates

On April 16, 2015, the President signed into law the Medicare Access and CHIP Reauthorization Act (H.R. 2), which provides for sweeping changes to how Medicare pays physicians, as well as averts the 21% reduction to Medicare payments under the Medicare Physician Fee Schedule that was scheduled to take effect on April 1, 2016. H.R. 2, among other things, repealed the Sustainable Growth Rate (“SGR”) formula enacted in 1997 and freezes payment rates at their current levels until rates increase by 0.5% for services furnished during the last 6 months of calendar year 2015. For services paid under the physician fee schedule and furnished during calendar years 2016 through 2019, Medicare’s payment rates will increase by 0.5% per year. Fees will remain at the 2019 level through 2025, but high performing providers participating in alternative payment models will have the opportunity for additional payments. Such payments will be based upon quality, resource use, clinical practice improvement activities and meaningful use of electronic health record technology.

Results of Operations

The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to revenue, net of contractual allowances and discounts and inclusive of revenue under capitation contracts.

RADNET, INC. AND SUBSIDIARIES

(unaudited)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2014
NET REVENUE
Service fee revenue, net of contractual allowances and discounts		88.6%		89.3%		88.2%		90.0%
Provision for bad debts		-4.3%		-3.9%		-4.1%		-4.0%
Net service fee revenue		84.2%		85.4%		84.1%		86.0%
Revenue under capitation arrangements		11.4%		10.7%		11.8%		10.0%
Total net revenue		95.7%		96.1%		95.9%		96.0%

OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization		80.6%		79.9%		84.0%		80.5%
Depreciation and amortization		6.7%		7.5%		7.1%		8.2%
Loss on sale and disposal of equipment		0.3%		0.7%		0.1%		0.3%
Severance costs		0.1%		0.1%		0.0%		0.2%
Total operating expenses		87.8%		88.1%		91.3%		89.1%

INCOME FROM OPERATIONS		7.9%		8.0%		4.6%		6.9%

OTHER INCOME AND EXPENSES
Interest expense		4.8%		5.4%		5.0%		5.9%
Meaningful use incentive		0.0%		0.0%		-0.5%		-0.3%
Equity in earnings of joint ventures		-0.9%		-1.0%		-1.0%		-0.9%
Gain on sale of imaging centers		-2.2%		0.0%		-0.8%		0.0%
Loss on early extinguishment of Senior Notes		0.0%		0.0%		0.0%		2.9%
Other expenses		0.0%		0.0%		0.1%		0.0%
Total other expenses		1.7%		4.4%		2.8%		7.6%

INCOME (LOSS) BEFORE INCOME TAXES		6.2%		3.6%		1.8%		-0.6%
(Provision for) Benefit From income taxes		-2.4%		-1.2%		-0.7%		0.2%

NET INCOME (LOSS)		3.8%		2.4%		1.1%		-0.5%
Net income attributable to noncontrolling interests		0.1%		0.0%		0.1%		0.0%

NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC.COMMON STOCKHOLDERS		3.7%		2.3%		1.0%		-0.5%

Three Months Ended September 30, 2015 Compared to the Three Months Ended September 30, 2014

Service Fee Revenue

Service fee revenue for the three months ended September 30, 2015 was $192.9 million compared to $171.1 million for the three months ended September 30, 2014, an increase of $21.8 million, or 12.7%.

Service fee revenue, including only those centers which were in operation throughout the third quarters of both 2015 and 2014 experienced an increase of $6.8 million or 4.0%, as a result of increased procedure volumes. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, service fee revenue from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $15.8 million. For the three months ended September 30, 2014, service fee revenue from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $736,000.

Provision for Bad Debts

Provision for bad debts increased $1.9 million, or 25.2%, to approximately $9.4 million, or 4.9% of service fee revenue, for the three months ended September 30, 2015 compared to $7.5 million, or 4.4% of service fee revenue, for the three months ended September 30, 2014.

Revenue Under Capitation Arrangements

Revenue under capitation arrangements for the three months ended September 30, 2015 was $24.9 million compared to $20.5 million for the three months ended September 30, 2014, an increase of $4.4 million or 21.5%.

Revenue under capitation arrangements, including only those centers which were in operation throughout the third quarters of both 2015 and 2014 increased $3.9 million, or 19.0%. This 19.0% increase is due to both new and expanded contractual relationships with private insurers. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, revenue under capitation arrangements from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $504,000.

Operating Expenses

Cost of operations for the three months ended September 30, 2015 increased approximately $22.6 million, or 14.8%, from $153.0 million for the three months ended September 30, 2014 to $175.6 million for the three months ended September 30, 2015. The following table sets forth our cost of operations and total operating expenses for the three months ended September 30, 2015 and 2014 (in thousands):

	Three Months Ended September 30,
	2015		2014

Salaries and professional reading fees, excluding stock-based compensation	$	95,131	$	84,422
Stock-based compensation		906		432
Building and equipment rental		18,129		16,088
Medical supplies		10,809		10,314
Other operating expenses *		50,656		41,744
Cost of operations		175,631		153,000

Depreciation and amortization		14,601		14,423
Loss on sale and disposal of equipment		738		1,289
Severance costs		167		112
Total operating expenses	$	191,137	$	168,824

* Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, utilities, marketing, travel and other expenses.

Salaries and professional reading fees, excluding stock-based compensation and severance

Salaries and professional reading fees increased $10.7 million, or 12.7%, to $95.1 million for the three months ended September 30, 2015 compared to $84.4 million for the three months ended September 30, 2014.

Salaries and professional reading fees, including only those centers which were in operation throughout the third quarters of both 2015 and 2014, increased $5.0 million, or 5.9%. The 5.9% increase is due to higher procedure volumes as compared to the same period in the prior year. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, salaries and professional reading fees from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $6.1 million. For the three months ended September 30, 2014, salaries and professional reading fees from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $344,000.

Stock-based compensation

Stock-based compensation increased $474,000, or 109.7%, to approximately $906,000 for the three months ended September 30, 2015 compared to $432,000 for the three months ended September 30, 2014. This increase was driven by the higher fair value of RSA’s awarded and vested in the third quarter of 2015 as compared to RSA’s awarded and vested in the prior year’s third quarter.

Building and equipment rental

Building and equipment rental expenses increased $2.0 million or 12.7%, to $18.1 million for the three months ended September 30, 2015 compared to $16.1 million for the three months ended September 30, 2014.

Building and equipment rental expenses, including only those centers which were in operation throughout the third quarters of both 2015 and 2014, increased $291,000, or 1.8%. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, building and equipment rental expenses from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $1.8 million. For the three months ended September 30, 2014, building and equipment rental expenses from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $91,000.

Medical supplies

Medical supplies expense increased $495,000, or 4.8%, to $10.8 million for the three months ended September 30, 2015 compared to $10.3 million for the three months ended September 30, 2014.

Medical supplies expenses, including only those centers which were in operation throughout the third quarters of both 2015 and 2014, decreased $585,000, or 5.8%. This 5.8% decrease is attributable to rebates received from suppliers. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, medical supplies expenses from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $1.3 million. For the three months ended September 30, 2014, medical supplies expenses from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $172,000.

Other operating expenses

Other operating expenses increased $8.9 million, or 21.4%, to $50.6 million for the three months ended September 30, 2015 compared to $41.7 million for the three months ended September 30, 2014.

Other operating expenses, including only those centers which were in operation throughout the third quarters of both 2015 and 2014, increased $6.1 million, or 14.6%. This 14.6% increase relates to added staffing and related expenses to support the increase in capitation revenue in the quarterly period ending September 30, 2015 over the same period ending September 30, 2014. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, other operating expense from centers that were acquired or divested subsequent July 1, 2014 and excluded from the above comparison was $2.9 million. For the three months ended September 30, 2014, other operating expenses from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $97,000.

Depreciation and amortization

Depreciation and amortization decreased $178,000, or 1.2%, to $14.6 million for the three months ended September 30, 2015 compared to $14.4 million for the three months ended September 30, 2014.

Depreciation and amortization, including only those centers which were in operation throughout the third quarters of both 2015 and 2014, decreased $815,000, or 5.7%. The decrease is primarily due to several of our assets completing their depreciation schedules subsequent to the end of our first quarter of 2015. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2014. For the three months ended September 30, 2015, depreciation expense from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $1.1 million. For the three months ended September 30, 2014, depreciation expense from centers that were acquired or divested subsequent to July 1, 2014 and excluded from the above comparison was $64,000.

Loss on sale and disposal of equipment

We recorded a loss on sale of equipment of approximately $738,000 for the three months ended September 30, 2015 and approximately $1.3 million for the three months ended September 30, 2014.

Interest expense

Interest expense for the three months ended September 30, 2015 increased approximately $151,000, or 1.5%, to $10.5 million for the three months ended September 30, 2015 compared to $10.4 million for the three months ended September 30, 2014. Interest expense for each of the three months ended September 30, 2015 and 2014 included $1.4 million of combined non-cash amortization of deferred loan costs, discount on issuance of debt, and unfavorable contracts. Excluding these non-cash amounts for each period, interest expense increased approximately $70,000 for the three months ended September 30, 2015 compared to the three months ended September 30, 2014. This increase was primarily due to interest expense stemming from the 2015 Incremental First Lien Term Loans transaction. See “Liquidity and Capital Resources” section below.

Equity in earnings from unconsolidated joint ventures

We recognized equity in earnings from unconsolidated joint ventures of $2.0 million for each of the three months ended September 30, 2015 and September 30, 2014, respectively.

Gain on Sale of Imaging Center

We recognized a gain on the sale of 10 wholly owned imaging centers to the New Jersey Imaging Networks in the amount of $4.8 million for the three months ending September 30, 2015. See Note 2 in the Notes to Financial Statements above for further information.

Provision for income taxes

We had an income tax expense for the three months ended September 30, 2015 of $5.2 million or 38.5% of income before income taxes, compared to the three months ended September 30, 2014 with income tax expense of $2.3 million or 34.1% of income before income taxes. The increase primarily relates to projected taxes stemming from the gain on the sale of the New Jersey Imaging centers.

Nine Months Ended September 30, 2015 Compared to the Nine Months Ended September 30, 2014

Service Fee Revenue

Service fee revenue for the nine months ended September 30, 2015 was $546.3 million compared to $498.5 million for the nine months ended September 30, 2014, an increase of $47.8 million, or 9.6%.

Service fee revenue, including only those centers which were in operation throughout the first three quarters of both 2015 and 2014 increased $18.4 million or 3.8%, as business ramp ups and improved weather conditions led to increased procedure volumes. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, service fee revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $39.2 million. For the nine months ended September 30, 2014, service fee revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $9.8 million.

Provision for Bad Debts

Provision for bad debts increased $3.4 million, or 15.3%, to approximately $25.3 million, or 4.6% of service fee revenue, for the nine months ended September 30, 2015 compared to $21.9 million, or 4.4% of service fee revenue, for the nine months ended September 30, 2014.

Revenue Under Capitation Arrangements

Revenue under capitation arrangements for the nine months ended September 30, 2015 was $72.9 million compared to $55.4 million for the nine months ended September 30, 2014, an increase of $17.5 million or 31.5%.

Revenue under capitation arrangements, including only those centers which were in operation throughout the first three quarters of both 2015 and 2014 increased $14.6 million, or 26.8%. This 26.8% increase was mainly due to expanded contractual relationships with private insurers. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, revenue under capitation arrangements from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $4.0 million. For the nine months ended September 30, 2014, capitation revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $1.1 million.

Operating Expenses

Cost of operations for the nine months ended September 30, 2015 increased approximately $74.5 million, or 16.7 %, from $445.8 million for the nine months ended September 30, 2014 to $520.3 million for the nine months ended September 30, 2015. The following table sets forth our cost of operations and total operating expenses for the nine months ended September 30, 2015 and 2014 (in thousands):

	Nine Months Ended September 30,
	2015		2014

Salaries and professional reading fees, excluding stock-based compensation	$	278,243	$	244,479
Stock-based compensation		6,475		2,068
Building and equipment rental		52,852		47,374
Medical supplies		36,330		30,620
Other operating expenses *		146,448		121,297
Cost of operations		520,348		445,838

Depreciation and amortization		43,836		45,193
Loss on sale and disposal of equipment		774		1,581
Severance costs		297		976
Total operating expenses	$	565,255	$	493,588

* Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, utilities, marketing, travel and other expenses.

Salaries and professional reading fees, excluding stock-based compensation and severance

Salaries and professional reading fees increased $33.8 million, or 13.8%, to $278.2 million for the nine months ended September 30, 2015 compared to $244.5 million for the nine months ended September 30, 2014.

Salaries and professional reading fees, including only those centers which were in operation throughout the first three quarters of both 2015 and 2014, increased $17.7 million, or 7.4%. The 7.4% increase is congruent with the rise in total procedure volumes over the same period in the prior year. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $22.1 million. For the nine months ended September 30, 2014, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was approximately $6.0 million.

Stock-based compensation

Stock-based compensation increased $4.4 million, or 213.0%, to approximately $6.5 million for the nine months ended September 30, 2015 compared to $2.1 million for the nine months ended September 30, 2014. This increase was driven by the higher fair value of RSA’s awarded and vested in 2015 as compared to RSA’s awarded and vested in the prior year.

Building and equipment rental

Building and equipment rental expenses increased $5.5 million or 11.6%, to $52.9 million for the nine months ended September 30, 2015 compared to $47.4 million for the nine months ended September 30, 2014.

Building and equipment rental expenses, including only those centers which were in operation throughout the first and third quarters of both 2015 and 2014, increased $1.6 million, or 3.4%. This 3.4% increase is mainly related to additional radiology equipment operating leases in support of operations. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $4.6 million. For the nine months ended September 30, 2014, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was approximately $759,000.

Medical supplies

Medical supplies expense increased $5.7 million, or 18.6%, to $36.3 million for the nine months ended September 30, 2015 compared to $30.6 million for the nine months ended September 30, 2014.

Medical supplies expenses, including only those centers which were in operation throughout the first nine months of both 2015 and 2014, increased $2.5 million, or 8.1%. This 8.1% rise is primarily attributable to both increased purchases stemming from higher procedure volumes along with supplier price increases. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, medical supplies expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $3.5 million. For the nine months ended September 30, 2014, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $265,000.

Other operating expenses

Other operating expenses increased $25.2 million, or 20.7%, to $146.4 million for the nine months ended September 30, 2015 compared to $121.3 million for the nine months ended September 30, 2014.

Other operating expenses, including only those centers which were in operation throughout the first nine months of both 2015 and 2014, increased $16.3 million, or 13.7%. This 13.7% increase is primarily attributable to added staffing and related expenses to support the increase in capitation and fee for service revenue. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, other operating expense from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $10.9 million. For the nine months ended September 30, 2014, other operating expense from centers that were acquired or divested subsequent to January 1, 2014 was $2.0 million.

Depreciation and amortization

Depreciation and amortization decreased $1.4 million, or 3.0%, to $43.8 million for the nine months ended September 30, 2015 compared to $45.2 million for the nine months ended September 30, 2014.

Depreciation and amortization, including only those centers which were in operation throughout the first nine months of both 2015 and 2014, decreased $4.1 million, or 9.2%. The decrease is primarily due to several of our assets completing their depreciation schedules subsequent to the end of our first quarter of 2015. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the nine months ended September 30, 2015, depreciation expense from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $3.3 million. For the nine months ended September 30, 2014, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $616,000.

Loss on sale and disposal of equipment

We recorded a loss on sale of equipment of approximately $774,000 for the nine months ended September 30, 2015 and approximately $1.6 million for the nine months ended September 30, 2014.

Interest expense

Interest expense for the nine months ended September 30, 2015 decreased approximately $1.5 million, or 4.7%, to $31.0 million for the nine months ended September 30, 2015 compared to $32.5 million for the nine months ended September 30, 2014. Interest expense for the nine months ended September 30, 2015 included $4.0 million of combined non-cash amortization of deferred loan costs and discount on issuance of debt. Interest expense for the nine months ended September 30, 2014 included $4.4 million of non-cash amortization and write-off of deferred loan costs due to refinance and discount on issuance of debt. Excluding these non-cash amounts for each period, interest expense decreased approximately $1.1 million for the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014. This decrease was primarily due to a reduction in interest expense stemming from the redemption of the $200 million senior notes in exchange for the First and Second Lien Term Loans. See “Liquidity and Capital Resources” below for more details on our debt refinancing.

Meaningful use incentive

For the nine months ended September 30, 2015 and September 30, 2014, we recognized other income from meaningful use incentive in the amount of $3.3 million and $1.8 million, respectively. These amounts were earned under a Medicare program to promote the use of electronic health record technology. See Note 1 to the condensed consolidated financial statements contained herein for more detail regarding this meaningful use incentive.

Equity in earnings from unconsolidated joint ventures

For the nine months ended September 30, 2015 we recognized equity in earnings from unconsolidated joint ventures of $6.3 million versus $4.7 million for the nine months ended September 30, 2014, an increase of $1.6 million or 33.4%.

Gain on Sale of Imaging Center

Loss on early extinguishment of Senior Notes

For the nine months ended September 30, 2014, we recognized a $15.9 million loss on early extinguishment of debt through our tender offer for our senior notes. Completion of the tender was conditioned on the closing of the amendment to the First Lien and Second Lien Credit and Guaranty Agreement. See “Liquidity and Capital Resources” below and Note 1 to the condensed consolidated financial statements contained herein for more details on our debt refinancing. There was no comparable loss for the nine months ended September 30, 2015.

Provision for income taxes

We had tax expense for the nine months ended September 30, 2015 of $4.3 million or 36.8% of income before income taxes, compared to a tax benefit for the nine months ended September 30, 2014 of $911,000 or 25.9% of loss before income taxes. The difference primarily relates to the negative impact for loss on debt extinguishment incurred during 2014 and a positive impact due to the gain on sale of the New Jersey imaging centers in 2015.

Adjusted EBITDA

We use both GAAP and non-GAAP metrics to measure our financial results. One non-GAAP measure we believe assists us is Adjusted EBITDA. We believe that, in addition to GAAP metrics, Adjusted EBITDA assists us in measuring our cash generated from operations and the ability to service our debt obligations. We believe this information is useful to investors and other interested parties because we are highly leveraged and our Adjusted EBITDA metric removes non-cash and certain other charges that occur in the affected period and provide a basis for measuring the Company's financial condition against other quarters.

. We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.

Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

Adjusted EBITDA is most comparable to the GAAP financial measure, net income (loss) attributable to RadNet, Inc. common stockholders. The following is a reconciliation of GAAP net income (loss) attributable to RadNet, Inc. common stockholders to Adjusted EBITDA for the nine months ended September 30, 2015 and 2014, respectively:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2015			2014		2015			2014


Net income (loss) attributable to RadNet, Inc. common stockholders	$	7,987		$	4,451	$	6,828		$	(2,829	)
Plus provision for (benefit from) income taxes		5,199			2,334		4,300			(911	)
Plus other expenses (income)		8			6		418			4
Plus loss on early extinguishment of Senior Notes		–			–		–			15,927
Plus interest expense		10,546			10,395		30,965			32,503
Plus severance costs		167			112		297			976
Plus loss on sale and disposal of equipment		738			1,289		774			1,581
Less gain on sale of imaging center		(4,823	)		–		(4,823	)		–
Plus depreciation and amortization		14,601			14,423		43,836			45,193
Plus non-cash employee stock-based compensation		906			432		6,477			2,069
Adjusted EBITDA	$	35,329		$	33,442	$	89,072		$	94,513

Liquidity and Capital Resources

Under the 2014 Amendment to the Credit Agreement and the 2015 Incremental First Lien Term Loans explained in further detail below, the scheduled annual amortization payments on total First Lien Term Loans increased from 1% per annum to 5.3% per annum. As a result, scheduled amortization increased by $20.8 million from pre-amendment terms. This $20.8 million additional cash obligation will be partially offset by annual interest savings of approximately $5.0 million under the terms of the Second Lien Term Loan as compared to that under the retired Senior Notes. We expect to fund this approximately $15.8 million net increase in amortization payments from cash provided by operating activities. Cash flows from operating activities were $40.1 million for the nine months ended September 30, 2015 and $34.0 million for the nine months ended September 30, 2014.

	As of September 30, 2015
	Face Value		Discount			Total Carrying Value
First Lien Term Loans	$	384,176	$	(7,440	)	$	376,736
2015 Incremental First	$	73,026	$	(528	)	$	72,498
Second Lien Term Loans	$	180,000	$	(2,344	)	$	177,656
Total	$	637,202	$	(10,312	)	$	626,890

Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.

2015 Incremental First Lien Term Loan:

2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

The 2014 Amendment provides for the following:

Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

The Second Lien Credit Agreement provides for the following:

Revolving Credit Facility

Senior Notes

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Exchange Risk. We sell our services exclusively in the United States and receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.

We maintain research and development facilities in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. A hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Hungarian Forint would have resulted in an annual increase of approximately $32,000 in operating expenses.

Interest Rate Sensitivity. We pay interest on various types of debt instruments to our suppliers, investors and lending institutions. The agreements entail either fixed or variable interest rates. Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities, which allows elections of either adjusted eurodollar or prime rates of interest. Under the Credit Agreement’s election facilities’, borrowed funds bear a 1.00% floor or 6 month Adjusted Eurodollar Rate plus an applicable margin of 3.25% for all first lien tranche B term loans, including both 2014 First Lien Term and 2015 First Lien Incremental Loans. Under the Second Lien Credit Agreement’s election facilities’, borrowed funds bear a 1.00% floor or 6 month Adjusted Eurodollar Rate plus an applicable margin of 7%. At September 30, 2015, we had $457.2 million outstanding subject to an Adjusted Eurodollar election on all first lien tranche B term loans under the Credit Agreement and $180.0 million on the Second Lien Term Loans. As the Adjusted Eurodollar Rate floor exceeds the current spot rate of 6 month Adjusted Eurodollar, the spot rate would have to increase more than 47 basis points before an additional interest expense would be accrued. An increase of 147 basis points would be necessary to realize a hypothetical 1% increase in the borrowing rate and an annual increase of $6.4 million of interest expense under our first and second lien term loans. At September 30, 2015, an additional $6.2 million in debt instruments is tied to the prime rate. A hypothetical 1% increase in the prime rate for 2014-2015 would have resulted in an annual increase in interest expense of approximately $62,000.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that we are able to collect the information we are required to disclose in the reports we file with the SEC, and to process, summarize and disclose this information within the time periods specified in the rules of the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports that we file or submit to the SEC is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has conducted an evaluation of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report for their intended purposes.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the nine months ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings

We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We do not believe that the outcome of any of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.

ITEM 1A. Risk Factors

For information about risks and uncertainties related to our business, please see the risk factors set forth in Part I, Item 1A, of our annual report on Form 10-K for the year ended December 31, 2014, as supplemented and amended by the risk factors in Part II, Item 1A of our quarterly report on Form 10-Q for the quarter ended March 31, 2015. Those risks are not the only risks relevant to our business; we may face additional risks and uncertainties not currently known to us or that we currently deem to be immaterial as of the date of this report on Form 10-Q.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

Reference is made to the Exhibit Index immediately following the signature page of this report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RADNET, INC.
	(Registrant)

Date: November 9, 2015	By:	/s/ Howard G. Berger, M.D.
		Howard G. Berger, M.D., President and Chief Executive Officer (Principal Executive Officer)


Date: November 9, 2015	By:	/s/ Mark D. Stolper
		Mark D. Stolper, Chief Financial Officer (Principal Financial and Accounting Officer)

INDEX TO EXHIBITS

Exhibit Number		Description

10.1*		Asset Purchase Agreement dated as of October 1, 2015 among Mid Rockland Imaging Partners, Inc. Diagnotic Imaging Group LLC, Diagnostic Imaging Group Holdings, LLC, New Primecare, LLC, and Flushing Medical Arts Building, Inc. (incorporated by reference to Exhibit 2.1 of our Current Report on Form 8-K filed with the SEC on October 20, 2015).

10.1*		RadNet, Inc. 2006 Equity Incentive Plan (Amended and Restated as of April 20, 2015) (incorporated by reference to Appendix A to RadNet, Inc.’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 30, 2015).

31.1		Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Howard G. Berger, M.D pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**		Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS***		XBRL Instance Document

101.SCH***		XBRL Schema Document

101.CAL***		XBRL Calculation Linkbase Document

101.LAB***		XBRL Label Linkbase Document

101.PRE***		XBRL Presentation Linkbase Document

101.DEF***		XBRL Definition Linkbase Document

*	Indicates management contract or compensatory plan.

**	This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

***	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, and are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

EX-31.1 2 radnet_10q-ex3101.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard G. Berger, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d –15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 9, 2015

/s/ Howard G. Berger, M.D.

Howard G. Berger, M.D.

President, Chief Executive Officer and Chairman of the Board of Directors

(Principal Executive Officer)

EX-31.2 3 radnet_10q-ex3102.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark D. Stolper, certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 9, 2015

/s/ Mark D. Stolper

Mark D. Stolper

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 radnet_10q-ex3201.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2015, as filed with the Securities and Exchange Commission on November 9, 2015 (the “Report”), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.

/s/ Howard G. Berger, M.D.

Howard G. Berger, M.D.

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

November 9, 2015

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 radnet_10q-ex3202.htm CERTIFICATION

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2015, as filed with the Securities and Exchange Commission on November 9, 2015 (the “Report”), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

/s/ Mark D. Stolper

Mark D. Stolper

Chief Financial Officer

(Principal Financial Officer)

November 9, 2015

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 6 rdnt-20150930.xml XBRL INSTANCE FILE 0000790526 2015-01-01 2015-09-30 0000790526 2015-09-30 0000790526 2014-12-31 0000790526 2014-01-01 2014-09-30 0000790526 us-gaap:RestrictedStockMember 2015-09-30 0000790526 2013-12-31 0000790526 2014-09-30 0000790526 2015-11-05 0000790526 us-gaap:CommonStockMember 2015-01-01 2015-09-30 0000790526 us-gaap:CommonStockMember 2014-12-31 0000790526 us-gaap:CommonStockMember 2015-09-30 0000790526 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-09-30 0000790526 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000790526 us-gaap:AdditionalPaidInCapitalMember 2015-09-30 0000790526 us-gaap:RetainedEarningsMember 2015-01-01 2015-09-30 0000790526 us-gaap:RetainedEarningsMember 2014-12-31 0000790526 us-gaap:RetainedEarningsMember 2015-09-30 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-09-30 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-09-30 0000790526 rdnt:TotalRadnetMember 2015-01-01 2015-09-30 0000790526 rdnt:TotalRadnetMember 2014-12-31 0000790526 rdnt:TotalRadnetMember 2015-09-30 0000790526 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-09-30 0000790526 us-gaap:NoncontrollingInterestMember 2014-12-31 0000790526 us-gaap:NoncontrollingInterestMember 2015-09-30 0000790526 rdnt:FirstLienTermLoanMember 2015-09-30 0000790526 rdnt:SecondLienTermLoanMember 2015-09-30 0000790526 us-gaap:ShortTermDebtMember 2015-09-30 0000790526 us-gaap:RestrictedStockMember 2014-12-31 0000790526 us-gaap:RestrictedStockMember 2015-01-01 2015-09-30 0000790526 2015-07-01 2015-09-30 0000790526 2014-07-01 2014-09-30 0000790526 rdnt:Incremental2015FirstMember 2015-09-30 0000790526 rdnt:Incremental2015FirstMember 2015-01-01 2015-09-30 0000790526 rdnt:SecondLienTermLoanMember 2015-01-01 2015-09-30 0000790526 rdnt:FirstLienTermLoanMember 2015-01-01 2015-09-30 0000790526 us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-09-30 0000790526 us-gaap:RevolvingCreditFacilityMember 2015-09-30 0000790526 rdnt:NYRPMember 2015-01-01 2015-09-30 0000790526 rdnt:NYRPMember 2015-09-30 0000790526 rdnt:CaliforniaRadiologyMember 2015-01-01 2015-09-30 0000790526 rdnt:CaliforniaRadiologyMember 2015-09-30 0000790526 rdnt:HealthcareRadiologyMember 2015-01-01 2015-09-30 0000790526 rdnt:HealthcareRadiologyMember 2015-09-30 0000790526 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0000790526 us-gaap:EmployeeStockOptionMember 2015-09-30 0000790526 us-gaap:EmployeeStockOptionMember 2014-12-31 0000790526 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0000790526 us-gaap:FairValueInputsLevel1Member rdnt:FirstLienTermLoansMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel1Member rdnt:FirstLienTermLoansMember 2014-12-31 0000790526 us-gaap:FairValueInputsLevel2Member rdnt:FirstLienTermLoansMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel2Member rdnt:FirstLienTermLoansMember 2014-12-31 0000790526 us-gaap:FairValueInputsLevel3Member rdnt:FirstLienTermLoansMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel3Member rdnt:FirstLienTermLoansMember 2014-12-31 0000790526 rdnt:TotalFairValueMember rdnt:FirstLienTermLoansMember 2015-09-30 0000790526 rdnt:TotalFairValueMember rdnt:FirstLienTermLoansMember 2014-12-31 0000790526 rdnt:FirstLienTermLoanMember 2014-12-31 0000790526 rdnt:SecondLienTermLoanMember 2014-12-31 0000790526 us-gaap:FairValueInputsLevel1Member rdnt:Incremental2015FirstMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel2Member rdnt:Incremental2015FirstMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel3Member rdnt:Incremental2015FirstMember 2015-09-30 0000790526 rdnt:TotalFairValueMember rdnt:Incremental2015FirstMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel1Member rdnt:SecondLienTermLoanMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel1Member rdnt:SecondLienTermLoanMember 2014-12-31 0000790526 us-gaap:FairValueInputsLevel2Member rdnt:SecondLienTermLoanMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel2Member rdnt:SecondLienTermLoanMember 2014-12-31 0000790526 us-gaap:FairValueInputsLevel3Member rdnt:SecondLienTermLoanMember 2015-09-30 0000790526 us-gaap:FairValueInputsLevel3Member rdnt:SecondLienTermLoanMember 2014-12-31 0000790526 rdnt:TotalFairValueMember rdnt:SecondLienTermLoanMember 2015-09-30 0000790526 rdnt:TotalFairValueMember rdnt:SecondLienTermLoanMember 2014-12-31 0000790526 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2015-01-01 2015-09-30 0000790526 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2015-09-30 0000790526 rdnt:MurrayHillRadiologyMember 2015-01-01 2015-09-30 0000790526 rdnt:MurrayHillRadiologyMember 2015-09-30 0000790526 rdnt:HanfordImagingMember 2015-01-01 2015-09-30 0000790526 rdnt:HanfordImagingMember 2015-09-30 0000790526 rdnt:BaltimoreCountyRadiologyMember 2015-01-01 2015-09-30 0000790526 rdnt:NewJerseyImagingPartnersMember 2015-01-01 2015-09-30 0000790526 rdnt:EquityPlanMember 2015-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares RadNet, Inc. 0000790526 10-Q 2015-09-30 false --12-31 No No Yes Accelerated Filer Q3 2015

7378000

-2610000

6828000

550000

8291000

4509000

22716000

5362000

814662

1102500

6400000

6900000

2600000

2300000

46120671

-165452000

-172280000

-146000

-112000

188310000

177750000

4000

0.0001

.0001

200000000

44495235

42825676

44495235

42825676

44495235

594000

6309000

884423

-613000

-34000

626900000

57789000

42245000

5044000

87527000

17551000

4971000

27463000

30326000

13489000

9801000

85305000 73859000

15300000

32434000

32123000

2604000

1561000

232477000

223127000

256303000

192020000

41194000

24671000

17246000

159205000

148235000

808875000

740680000

4108000

4026000

32584000

35334000

4294000

6122000

45225000

47624000

201450000

200304000

12900000

2100000

4100000

655000

136496000

133274000

8761000

5637000

2299000

2100000

23391000

19468000

1323000

1964000

5664000

6289000

95058000

97816000

782538000

732982000

5577000

6241000

7422000

6143000

606744000

551059000

15300000

26299000

20965000

808875000

740680000

3621000

2336000

26337000

7698000

4000

177750000

188310000

-172280000

-165452000

-112000

-146000

5362000

22716000

2336000

3621000

384176000

180000000

637202000

73026000

399750000

180000000

7440000

2344000

10312000

528000

376736000

177656000

626890000

72498000

83100000

65600000

29400000

23600000

83100000

65600000

29400000

23600000

237500000

213900000

77300000

74400000

320600000

279600000

106700000

98000000

77700000

79700000

8600000

9000000

119800000 58700000

808369

942023

744423

848552

P8M16D

5.22

1.96

8.60

4.55

36054000

307000

8412000

274000

-34000

-38000

7000

-1000

7344000

-2648000

8298000

4508000

550000

219000

304000

58000

6794000

-2867000

7994000

4450000

25295000

21945000

6255000

7358000

4000000

4444000

6477000

2069000

32485000

42887000

15628000

4754000

1254000

72000

-2750000

2461000

-6034000

-653000

-641000

604000

-1603000

-8225000

40065000

34043000

41237000

9428000

38736000

33895000

648000

766000

265000

1161000

-43647000

-43914000

6645000

16733000

74401000

210000000

17548000

211344000

531000

6650000

-15300000

25100000

613000

148000

594000

1546000

39363000

1771000

-34000

-38000

35747000

-8138000

26543000

32389000

15700000 16600000

1100000

The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at June 30, 2015 was 0.44%. The rate paid on the Second Lien Credit Agreement at June 30, 2015 was 8%.

The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%

The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.

The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.

The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.

30000000

180000000

75000000

101250000

The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is $987,000, beginning in June 2015.

There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

29800000

4200000

425000

5800000

1000000

1500000

34500000

2300000

891000

4600000

217000

12000000

1700000

290000

600000

100000

4400000

34000

134000

1600000

345000

484810

437689

1001190

972511

677225

1387784

265000

965009

2092509

25000

921676

4.62

3.58

2.69

2.22

4.74

P1Y25D

P11M23D

1783778

1631678

6100000

5900000

21000

P1Y1M6D

3461208

2623314

3678741

383216000

394753000

383216000

394753000

72843000

172800000

178200000

172800000

178200000

520348000

445838000

175631000

153000000

43836000

45193000

14601000

14423000

-774000

-1581000

-738000

-1289000

297000

976000

167000

112000

565255000

493588000

191137000

168824000

28667000

38429000

17229000

15235000

30965000

32503000

10546000

10395000

-3270000

-1762000

6301000

4722000

1992000

2009000

-15927000

-418000

-4000

-8000

-6000

16989000

41950000

3739000

8392000

11678000

-3521000

13490000

6843000

4300000

-911000

5199000

2334000

550000

219000

304000

58000

6828000

-2829000

7987000

4451000

.16

-.07

.18

.11

.15

-.07

.18

.10

43247002

40734083

43637022

41644606

44704323

40734083

44751936

44033580

29526

5005000

3657000

1348000

4823000

196000

35500000

443000

5005000

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: left; padding-left: 10pt; text-indent: -10pt">Commercial insurance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">114,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">109,472</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">331,670</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">314,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Medicare</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,203</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">120,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-indent: -10pt">Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,248</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,214</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Workers' compensation/personal injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,712</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,821</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,708</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,408</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,354</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,759</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,687</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">192,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">546,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Provision for bad debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,433</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,532</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,295</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,945</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Net service fee revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,471</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,566</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521,042</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">476,591</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Revenue under capitation arrangements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,895</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,493</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">72,880</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,426</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total net revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">208,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">184,059</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">593,922</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">532,017</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1pt solid">As of September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Face Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Discount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Carrying Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 39%; text-align: left">First Lien Term Loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">384,176</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(7,440</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">376,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2015 Incremental First</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">73,026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(528</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">72,498</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Second Lien Term Loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">180,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,344</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">177,656</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">637,202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,312</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626,890</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Significant Accounting Policies   During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report.

Revenues   Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.    Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: left; padding-left: 10pt; text-indent: -10pt">Commercial insurance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">114,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">109,472</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">331,670</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">314,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Medicare</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,203</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">120,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-indent: -10pt">Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,248</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,214</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Workers' compensation/personal injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,712</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,821</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,708</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,408</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,354</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,759</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,687</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">192,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">546,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Provision for bad debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,433</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,532</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,295</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,945</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Net service fee revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,471</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,566</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521,042</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">476,591</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Revenue under capitation arrangements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,895</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,493</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">72,880</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,426</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total net revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">208,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">184,059</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">593,922</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">532,017</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Provision for Bad Debts   We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over at least an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets   Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs   Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Acquisitions   On September 1, 2015 we completed our acquisition of Murray Hill Radiology and Mammography, P.C. and Murray Hill MRI Holding, LLC, consisting of a single multi-modality imaging center located in Manhattan, New York for a cash consideration of $5.8 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $1.6 million of fixed assets, $95,000 of prepaid assets and $4.1 million of goodwill were recorded.   On August 3, 2015 we completed our acquisition of Hanford Imaging, LP, consisting of a single multi-modality imaging center located in Hanford, CA for cash consideration of $1.0 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $345,000 of fixed asset and $655,000 of goodwill were recorded.   On June 1, 2015 we completed our acquisition of Healthcare Radiology and Diagnostic systems, PLLC, consisting of a single multi-modality imaging center located in the Bronx, NY area for cash consideration of $425,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of net assets and approximately $134,500 of fixed assets and $290,500 of leasehold improvements were recorded.   On May 1, 2015 we completed our acquisition of California Radiology consisting of six multi-modality imaging centers located in Los Angeles, California for cash consideration of $4.2 million. The facilities provide MRI, PET/CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $217,000 of equipment, $1.7 million of leasehold improvements, $34,000 in other assets, $100,000 of other intangible assets relating to a covenant not to compete contract and $2.1 million of goodwill were recorded with respect to this transaction.   On April 15, 2015 we completed our acquisition of New York Radiology Partners, consisting of eleven multi-modality imaging centers located in Manhattan, New York for cash consideration of $29.8 million and a note to seller of $1.5 million. The facilities provide a full range of radiology services including MRI, PET/CT, Mammography, Ultrasound, X-ray and other related services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities. In total, RadNet acquired assets of $34.5 million, assumed equipment debt of $2.3 million, and assumed current liabilities of $891,000. Asset amounts acquired were $4.6 million in equipment, $12.0 million in leasehold improvements, $12.9 million in goodwill, $600,000 of other intangible assets, and $4.4 million of accounts receivable and other current assets. Current liabilities assumed related to accounts payable, payroll and other related short term obligations. Our preliminary fair value determination will be made final with the help of an outside valuation expert which we expect to have completed by the end of our fourth quarter of 2015.   Dispositions   On August 3, 2015 we sold a 25% non-controlling interest in one of our wholly owned entities, Baltimore County Radiology, LLC (BCR) to Lifebridge Health for $5.0 million. On the date of sale, the net book value of this 25% interest was $1.3 million. In accordance with ASC 810-10-45-23, the proceeds in excess of this net book value amounting to $3.7 million was recorded to equity. In addition to the proceeds already received, RadNet has the opportunity to receive approximately $1.2 million in additional proceeds if certain operating performance targets of BCR are achieved within the next 12 months. Any additional amounts received under these contingent performance provisions will be recorded to equity accordingly.   On September 30, 2015 we completed a sale of 10 wholly owned imaging centers from our New Jersey reporting unit, New Jersey Imaging Partners. This sale was made to one of our non-consolidated joint ventures for which we hold a 49% non-controlling interest, New Jersey Imaging Networks, for approximately $35.5 million. We recorded a gain of $4.8 million in the third quarter with respect to this transaction.

In September 2015, the Financial Accounting Standards Board (the FASB) issued Accounting Standards Update (ASU) No. 2015-16 (ASU 2015-16), Business Combinations, (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement to retrospectively apply adjustments made to provisional amounts recognized in a business combination. An entity will now recognize any adjustments in the reporting period in which the amounts are determined, calculated as if the accounting had been completed at the acquisition date. Disclosure is required for the portion of adjustments recorded in current-period earnings that would have been recorded in previous reporting periods had they been recognized as of the acquisition date. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In August 2015, the FASB issued ASU No. 2015-15 (ASU 2015-15), Interest Imputation of Interest, (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. ASU 2015-15 provides additional guidance to the presentation of debt issuance costs discussed originally in ASU No. 2015-03, which was issued in April 2015 and described below. ASU 2015-15 noted that ASU 2015-03 did not address the debt issue costs in regards to line-of-credit arrangements, which by their nature have fluctuating balances. ASU 2015-15 permits debt issuance costs specifically related to line-of-credit arrangements to be presented as an asset with subsequent amortization to interest expense ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the arrangement. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In April 2015, the Financial Accounting Standards Board (the FASB) issued ASU No. 2015-03 (ASU 2015-03), Interest Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In February 2015, the FASB issued ASU No. 2015-02 (ASU 2015-02), Consolidation Amendments to the Consolidation Analysis, (Topic 810). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In May 2014, the FASB issued ASU No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers, (Topic 606). ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update was effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016, which has recently been extended to December 31, 2017. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid">September 30,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid">September 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: left; padding-left: 10pt; text-indent: -10pt">Net income (loss) attributable to RadNet, Inc.'s common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">7,987</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,451</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(2,829</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">43,637,022</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,644,606</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">43,247,002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,734,083</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.11</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.16</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,637,022</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,644,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,247,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,734,083</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Add nonvested restricted stock subject only to service vesting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">437,689</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,001,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">484,810</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Add additional shares issuable upon exercise of stock options and warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">677,225</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,387,784</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">972,511</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares used in calculating diluted net income per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,751,936</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,033,580</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,704,323</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,734,083</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.10</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.15</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>   For the nine months ended September 30, 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid">September 30,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid">September 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: left; padding-left: 10pt; text-indent: -10pt">Net income (loss) attributable to RadNet, Inc.'s common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">7,987</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,451</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(2,829</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">43,637,022</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,644,606</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">43,247,002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,734,083</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.11</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.16</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,637,022</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,644,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,247,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,734,083</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Add nonvested restricted stock subject only to service vesting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">437,689</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,001,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">484,810</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Add additional shares issuable upon exercise of stock options and warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">677,225</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,387,784</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">972,511</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares used in calculating diluted net income per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,751,936</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,033,580</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,704,323</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,734,083</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.10</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.15</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

We have ten unconsolidated joint ventures where our ownership interests range from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.  Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.  Our investment in these joint ventures is accounted for under the equity method.   The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2015 (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 43%; padding-left: 10pt; text-indent: -10pt">Balance as of December 31, 2014</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">32,123</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Equity in earnings in these joint ventures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,301</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-indent: -10pt">Distribution of earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,255</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt; text-indent: -10pt">Equity contributions in existing joint ventures</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">265</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-indent: -10pt">Balance as of September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,434</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   We earned management service fees from the centers underlying these joint ventures of approximately $2.6 million and $2.3 million for the three months ended September 30, 2015 and 2014, respectively, and $6.4 million and $6.9 million for the nine months ended September 30, 2015 and 2014, respectively.    The following table is a summary of key financial data for these joint ventures as of September 30, 2015 (in thousands) and for the nine months ended September 30, 2015 and 2014 (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>Balance Sheet Data:</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 63%; text-align: left">Current assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">17,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noncurrent assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,527</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,044</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Noncurrent liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(42,245</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt">Total net assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">57,789</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Book value of RadNet joint venture interests</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">27,463</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Cost in excess of book value of acquired joint venture interests</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,971</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 40pt; text-indent: -10pt">Total value of Radnet joint venture interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,434</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 40pt; text-indent: -10pt">Total book value of other joint venture partner interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>Income statement data for the nine months ended September 30,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt; width: 46%">Net revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">85,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">73,859</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt">Net income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,801</td><td style="text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 43%; padding-left: 10pt; text-indent: -10pt">Balance as of December 31, 2014</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">32,123</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Equity in earnings in these joint ventures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,301</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-indent: -10pt">Distribution of earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,255</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt; text-indent: -10pt">Equity contributions in existing joint ventures</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">265</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-indent: -10pt">Balance as of September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,434</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

The following table is a summary of key financial data for these joint ventures as of September 30, 2015 (in thousands) and for the nine months ended September 30, 2015 and 2014 (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>Balance Sheet Data:</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 63%; text-align: left">Current assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">17,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noncurrent assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,527</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,044</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Noncurrent liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(42,245</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt">Total net assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">57,789</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Book value of RadNet joint venture interests</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">27,463</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Cost in excess of book value of acquired joint venture interests</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,971</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 40pt; text-indent: -10pt">Total value of Radnet joint venture interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,434</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 40pt; text-indent: -10pt">Total book value of other joint venture partner interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>Income statement data for the nine months ended September 30,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt; width: 46%">Net revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">85,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">73,859</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt; text-indent: -10pt">Net income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,801</td><td style="text-align: left"> </td></tr> </table>

Equity Incentive Plans   Options   We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we amended and restated as of April 20, 2015 (the Restated Plan). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 11, 2015. As of September 30, 2015, we have reserved for issuance under the Restated Plan 12,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over two to five years and expire five to ten years from the date of grant.   As of September 30, 2015, we had outstanding options to acquire 965,009 shares of our Common Stock, of which options to acquire 921,676 shares were exercisable. During the nine months ended September 30, 2015, we did not grant any stock options under our Restated Plan.   The following summarizes all of our stock option transactions during the nine months ended September 30, 2015:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average Remaining</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Exercise price</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Aggregate</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Outstanding Options</td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Per Common</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Life</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Intrinsic </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; border-bottom: Black 1pt solid">Under the 2006 Plan</td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Share</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">(in years)</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 31%">Balance, December 31, 2014</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">2,092,509</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,102,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Canceled, forfeited or expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">2.22</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance, September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">965,009</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">4.62</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">1.07</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">1,783,778</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">921,676</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">4.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">0.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,631,678</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the holder had all holders exercised their options on September 30, 2015. Total intrinsic value of options exercised during the nine months ended September 30, 2015 and 2014 was approximately $6.1 million and $5.9 million, respectively. As of September 30, 2015, total unrecognized stock-based compensation expense related to non-vested options was $21,000, which is expected to be recognized over a weighted average period of approximately 1.1 years.    Restricted Stock Awards   The Restated Plan permits the issuance of restricted stock awards (RSAs). As of September 30, 2015, we have issued a total of 3,461,208 RSAs, of which 2,623,314 RSAs have previously vested, 29,526 RSAs were forfeited and 808,369 RSAs remained unvested at September 30, 2015.   The following summarizes all unvested RSA activities during the nine months ended September 30, 2015:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted- Average</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Remaining</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted-</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Average</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">RSAs</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Term (Years)</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">RSA's outstanding at December 31, 2014</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">942,023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">     1.96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Changes during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 30pt; text-indent: -10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">744,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 30pt; text-indent: -10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(848,552</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.55</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 30pt; text-indent: -10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(29,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">5.59</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">RSA's unvested at September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">808,369</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.71</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.22</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>    We determine the fair value of all RSAs based on the closing price of our common stock on the date of award.   In sum, of the 12,000,000 shares of common stock reserved for issuance under the Restated Plan, at September 30, 2015, we had 3,431,683 RSAs, net of 29,526 RSAs forfeited (of which 808,369 shares were subject to further vesting), outstanding options to acquire 965,009 shares, and 3,924,567 shares of common stock available for future awards. We had previously granted options and other awards to acquire 3,678,741 shares which have been issued.

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average Remaining</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Exercise price</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Aggregate</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Outstanding Options</td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Per Common</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Life</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Intrinsic </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; border-bottom: Black 1pt solid">Under the 2006 Plan</td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Share</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">(in years)</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 31%">Balance, December 31, 2014</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">2,092,509</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,102,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Canceled, forfeited or expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">2.22</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance, September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">965,009</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">4.62</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">1.07</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">1,783,778</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">921,676</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">4.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">0.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">1,631,678</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted- Average</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Remaining</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted-</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Average</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">RSAs</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Term (Years)</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">RSA's outstanding at December 31, 2014</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">942,023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">     1.96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Changes during the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 30pt; text-indent: -10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">744,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 30pt; text-indent: -10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(848,552</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.55</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 30pt; text-indent: -10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(29,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">5.59</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">RSA's unvested at September 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">808,369</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.71</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.22</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

FAIR VALUE MEASUREMENTS Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:   Level 1Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.   Level 2Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.   Level 3Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.    The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="18" style="text-align: center; border-bottom: Black 1pt solid">As of September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Face Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: left">First Lien Term Loans</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">383,216</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">383,216</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">384,176</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2015 Incremental First</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,843</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,843</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,026</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Second Lien Term Loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="18" style="text-align: center; border-bottom: Black 1pt solid">As of December 31, 2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Face Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: left">First Lien Term Loans</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">394,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">394,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">399,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Second Lien Term Loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">178,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">178,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td></tr> </table>   The carrying value of our revolving credit facility at December 31, 2014 of $15.3 million approximated its fair value. There was no revolving credit facility balance at September 30, 2015.   We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="18" style="text-align: center; border-bottom: Black 1pt solid">As of September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Face Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: left">First Lien Term Loans</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">383,216</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">383,216</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">384,176</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2015 Incremental First</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,843</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,843</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,026</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Second Lien Term Loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="18" style="text-align: center; border-bottom: Black 1pt solid">As of December 31, 2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Face Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: left">First Lien Term Loans</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">394,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">394,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">399,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Second Lien Term Loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">178,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">178,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td></tr> </table>

On October 16, 2015, Radnet purchased substantially all of the assets of Diagnostic Imaging Group, LLC (DIG), for approximately $56.7 million in cash and 1.5 million shares of RadNet common stock. The purchase agreement also provides for the possibility of earn-out payments based on future revenues over the 60 months following the closing of the transaction. The acquisition adds 17 new locations to our existing portfolio of imaging centers in the New York City area.

593922000

532017000

208366000

184059000

72880000

55426000

24895000

20493000

521042000

476591000

183471000

163566000

25295000

21945000

9433000

7532000

546337000

498536000

192904000

171098000

53759000

24687000

23408000

6354000

23287000 22708000 7712000 7821000 17582000 18214000 6117000 6248000 120039000 118627000 40840000 41203000

331670000

314300000

114827000

109472000

443000000

5000000

10300000

95000

5000000

35500000

3700000

4800000

29526

5.59

808369

12000000

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2015 we operated directly or indirectly through joint ventures, 280 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York.  Our operations comprise a single segment for financial reporting purposes.   The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or Radnet Management) and Beverly Radiology Medical Group III, a professional partnership (BRMG).  The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (DIS), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as RadNet, we, us, our or the Company in this report.   Accounting Standards Codification (ASC) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (VIE). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIEs economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIEs variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.   Howard G. Berger, M.D. is our President and Chief Executive Officer, and Chairman of our Board of Directors. Dr. Berger owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with Californias prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.     We contract with seven medical groups which provide professional medical services at all of our facilities in Manhattan and Brooklyn, New York. These contracts are similar to our contract with BRMG. Four of these groups are owned by John V Crues, III, M.D., RadNets Medical Director, a member of our Board of Directors and a 1% owner of BRMG.  Dr. Berger owns a controlling interest in two of these medical groups which provide professional medical services at one of our Manhattan facilities.    RadNet provides non-medical, technical and administrative services to BRMG and the seven medical groups mentioned above (NY Groups) for which it receives a management fee, pursuant to the related management agreements. Through these management agreements we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the NY Groups and we determine the annual budget of BRMG and the NY Groups. BRMG and the NY Groups both have insignificant operating assets and liabilities, and de minimis equity. These management agreements are designed such that all net cash flows of both BRMG and the NY Groups are transferred to us.   We have determined that BRMG and the NY Groups are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity.  These VIEs on a combined basis recognized $29.4 million and $23.6 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2015 and 2014, respectively, and $29.4 million and $23.6 million of operating expenses for the three months ended September 30, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $106.7 million and $98.0 million of total billed net service fee revenue relating to these VIEs for the three months ended September 30, 2015 and 2014, respectively, of which $77.3 million and $74.4 million was for management services provided to these VIEs relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2015 and 2014, respectively.    These VIEs on a combined basis recognized $83.1 million and $65.6 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2015 and 2014, respectively, and $83.1 million and $65.6 million of operating expenses for the nine months ended September 30, 2015 and 2014, respectively. RadNet recognized in its condensed consolidated statement of operations $320.6 million and $279.6 million of total billed net service fee revenue relating to these VIEs for the nine months ended September 30, 2015 and 2014, respectively, of which $237.5 million and $213.9 million was for management services provided to these VIEs relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2015 and 2014, respectively.   The cash flows of these VIEs are included in the accompanying consolidated statements of cash flows.  All intercompany balances and transactions have been eliminated in consolidation.  In our consolidated balance sheets at September 30, 2015 and December 31, 2014, we have included approximately $77.7 million and $79.7 million, respectively, of accounts receivable and approximately $8.6 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to these VIEs combined.   The creditors of each of these VIEs do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of any of these VIEs. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.   At all of our centers, aside from certain centers in California and centers in New York City where we contract with BRMG and the NY Groups for the provision of professional medical services, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice groups professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.  We have no financial controlling interest in the independent (non-BRMG or non-NY Groups) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014, filed on March 16, 2015, as amended.   Significant Accounting Policies   During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report.   Revenues   Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.    Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: left; padding-left: 10pt; text-indent: -10pt">Commercial insurance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">114,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">109,472</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">331,670</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">314,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Medicare</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,203</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">120,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-indent: -10pt">Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,248</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,214</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Workers' compensation/personal injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,712</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,821</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,708</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,408</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,354</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,759</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,687</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">192,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">546,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Provision for bad debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,433</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,532</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,295</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,945</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt">Net service fee revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,471</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,566</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521,042</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">476,591</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Revenue under capitation arrangements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,895</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,493</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">72,880</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,426</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Total net revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">208,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">184,059</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">593,922</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">532,017</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Provision for Bad Debts   We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over at least an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.   Deferred Tax Assets   Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.   Deferred Financing Costs   Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.    Meaningful Use Incentive   Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a front desk patient tracking system or Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the nine months ended September 30, 2015, and 2014, respectively, relating to this incentive.   Software Development Costs   Costs related to the research and development of new software products and enhancements to existing software products all for resale to our customers are expensed as incurred.   We utilize a variety of computerized information systems in the day to day operation of our diagnostic imaging facilities. One such system is our RIS. We have historically utilized third party RIS software solutions and pay monthly fees to outside third party software vendors for the use of this software. We have developed our own RIS solution from the ground up through our wholly owned subsidiary, Radnet Management Information Systems (RMIS) deployed this system in the beginning of the first quarter in 2015.   By following the accounting guidance under ASC 350-40, Accounting for the Costs of Computer Software Developed for Internal Use, the costs incurred by RMIS toward the development of this RIS system, which began on August 1, 2010 and continued until December 2014, were capitalized and will be amortized over its useful life which we determined to be 5 years. Total costs capitalized were approximately $6.4 million. We began recording monthly amortization of $107,000 per month for our use of this software in January 2015.   During the nine months ended September 30, 2015, we entered into an agreement to license our RIS system to an outside customer. As of September 30, 2015, we received approximately $443,000 in respect to this licensing agreement. In accordance with ASC 350-40, we recorded the receipt of these funds against the capitalized software costs explained above. We intend to record any future proceeds in the same manner until the carrying value of our capitalized software costs are brought to zero. As of September 30, 2015, the net carrying value of our capitalized software costs was approximately $5.0 million. We continue to record amortization expense of $107,000 per month for our internal use of this software and will continue to do so until the net carrying value of the capitalized software costs are brought to zero.    Liquidity and Capital Resources   We had cash and cash equivalents of $36.1 million and accounts receivable of $159.2 million at September 30, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $119.8 million and $58.7 million at September 30, 2015 and December 31, 2014, respectively. We had net income attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2015 and 2014 of $8.0 million and $4.5 million respectively, and net income attributable to RadNet, Inc common stockholders for the nine months ended September 30, 2015 of $6.8 million and net loss of $2.8 million in 2014.  We had stockholders equity of $22.7 million and $5.4 million at September 30, 2015 and December 31, 2014, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.    Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at September 30, 2015 is $626.9 million of senior secured term loan debt (net of unamortized discounts of $10.3 million), broken down by loan agreement as follows (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1pt solid">As of September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Face Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Discount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Carrying Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 39%; text-align: left">First Lien Term Loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">384,176</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(7,440</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">376,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2015 Incremental First</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">73,026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(528</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">72,498</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Second Lien Term Loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">180,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,344</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">177,656</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">637,202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,312</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626,890</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.   As of September 30, 2015, we were in compliance with all financial covenants under our Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan, and the Second Lien Credit Agreement, each as defined below.   2015 Incremental First Lien Term Loan:   On April 30, 2015, we entered into a joinder agreement to our existing Credit Agreement (the "2015 Incremental First Lien Term Loan Joinder") to provide for the borrowing of $75.0 million of incremental first lien term loans (2015 Incremental First Lien Term Loans). The 2015 Incremental First Lien Term Loans are treated as part of the same class as the existing tranche B term loans currently outstanding under the Credit Agreement. We used the proceeds from the 2015 Incremental First Lien Term Loans to repay all of the borrowings outstanding under the first lien revolving loan facility and to pay approximately $1.1 million of fees and expenses associated with the transaction.   Interest. The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.   Payments. The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is approximately $987,000, beginning in June 2015. The scheduled quarterly amortization for all of the term loans under the Credit Agreement, including the 2015 First Lien Term Loans, was increased to approximately $6.2 million, beginning in June 2015.   Maturity Date. The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.    2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Credit Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012 (the "Original Credit Agreement"), by that certain first amendment dated April 3, 2013 (the 2013 Amendment), and subsequently by entering into a second amendment dated on March 25, 2014 (the 2014 Amendment) ( the Original Credit Agreement, as amended by the 2013 Amendment and the 2014 Amendment is collectively referred to herein as the "Credit Agreement") to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.   Payments. The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.   Guarantees and Collateral. The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of our tangible and intangible assets, including, but not limited to, pledges of equity interests of RadNet Management and all of our current and future domestic subsidiaries.   Restrictive Covenants. In addition to certain covenants, the Credit Agreement places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Second Lien Credit and Guaranty Agreement. RadNet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by RadNet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the outstanding Senior Notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.    The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2015 was 0.53%. The rate paid on the Second Lien Credit Agreement at September 30, 2015 was 8%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.   Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.   Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents being false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Revolving Credit Facility   The $101.25 million revolving credit line established in the Credit Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Credit Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Credit Agreement.   The revolving credit line bears interest based on types of borrowings as follows: (i) unpaid principal at the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 4.25% per annum or the Base Rate (as defined in the Credit Agreement) plus 3.25% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance. The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.  Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the Senior Notes). All payments of the Senior Notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries. The Senior Notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among RadNet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the Senior Notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   We completed the retirement of our $200 million in Senior Notes on April 24, 2014 and following such retirement we completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding Senior Notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all Senior Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the Senior Notes, representing 96.73% of the outstanding Senior Notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of Senior Notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of Senior Notes. In addition, all Senior Notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional Senior Notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.    Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption of all of our remaining outstanding Senior Notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the Senior Notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the Senior Notes being redeemed (or $1,051.88 per $1,000 in principal amount of the Senior Notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no Senior Notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

Meaningful Use Incentive   Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a front desk patient tracking system or Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the nine months ended September 30, 2015, and 2014, respectively, relating to this incentive.

Liquidity and Capital Resources   We had cash and cash equivalents of $36.1 million and accounts receivable of $159.2 million at September 30, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $119.8 million and $58.7 million at September 30, 2015 and December 31, 2014, respectively. We had net income attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2015 and 2014 of $8.0 million and $4.5 million respectively, and net income attributable to RadNet, Inc common stockholders for the nine months ended September 30, 2015 of $6.8 million and net loss of $2.8 million in 2014.  We had stockholders equity of $22.7 million and $5.4 million at September 30, 2015 and December 31, 2014, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.    Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at September 30, 2015 is $626.9 million of senior secured term loan debt (net of unamortized discounts of $10.3 million), broken down by loan agreement as follows (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1pt solid">As of September 30, 2015</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Face Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Discount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Carrying Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 39%; text-align: left">First Lien Term Loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">384,176</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(7,440</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">376,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2015 Incremental First</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">73,026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(528</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">72,498</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Second Lien Term Loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">180,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,344</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">177,656</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">637,202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,312</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626,890</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.   As of September 30, 2015, we were in compliance with all financial covenants under our Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan, and the Second Lien Credit Agreement, each as defined below.   2015 Incremental First Lien Term Loan:   On April 30, 2015, we entered into a joinder agreement to our existing Credit Agreement (the "2015 Incremental First Lien Term Loan Joinder") to provide for the borrowing of $75.0 million of incremental first lien term loans (2015 Incremental First Lien Term Loans). The 2015 Incremental First Lien Term Loans are treated as part of the same class as the existing tranche B term loans currently outstanding under the Credit Agreement. We used the proceeds from the 2015 Incremental First Lien Term Loans to repay all of the borrowings outstanding under the first lien revolving loan facility and to pay approximately $1.1 million of fees and expenses associated with the transaction.   Interest. The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.   Payments. The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is approximately $987,000, beginning in June 2015. The scheduled quarterly amortization for all of the term loans under the Credit Agreement, including the 2015 First Lien Term Loans, was increased to approximately $6.2 million, beginning in June 2015.   Maturity Date. The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.    2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Credit Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012 (the "Original Credit Agreement"), by that certain first amendment dated April 3, 2013 (the 2013 Amendment), and subsequently by entering into a second amendment dated on March 25, 2014 (the 2014 Amendment) ( the Original Credit Agreement, as amended by the 2013 Amendment and the 2014 Amendment is collectively referred to herein as the "Credit Agreement") to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.   Payments. The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.   Guarantees and Collateral. The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of our tangible and intangible assets, including, but not limited to, pledges of equity interests of RadNet Management and all of our current and future domestic subsidiaries.   Restrictive Covenants. In addition to certain covenants, the Credit Agreement places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Second Lien Credit and Guaranty Agreement. RadNet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by RadNet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the outstanding Senior Notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.    The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2015 was 0.53%. The rate paid on the Second Lien Credit Agreement at September 30, 2015 was 8%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.   Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.   Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents being false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Revolving Credit Facility   The $101.25 million revolving credit line established in the Credit Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Credit Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Credit Agreement.   The revolving credit line bears interest based on types of borrowings as follows: (i) unpaid principal at the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 4.25% per annum or the Base Rate (as defined in the Credit Agreement) plus 3.25% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance. The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.   Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the Senior Notes). All payments of the Senior Notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries. The Senior Notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among RadNet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the Senior Notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   We completed the retirement of our $200 million in Senior Notes on April 24, 2014 and following such retirement we completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding Senior Notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all Senior Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the Senior Notes, representing 96.73% of the outstanding Senior Notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of Senior Notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of Senior Notes. In addition, all Senior Notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional Senior Notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.    Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption of all of our remaining outstanding Senior Notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the Senior Notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the Senior Notes being redeemed (or $1,051.88 per $1,000 in principal amount of the Senior Notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no Senior Notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

EX-101.SCH 7 rdnt-20150930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 2. FACILITY ACQUISITIONS AND DISPOSITIONS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 3. NEW ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 4. EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 5. INVESTMENT IN JOINT VENTURES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 6. STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 7. FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 8. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 4. EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 6. STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 1. NATURE OF BUSINESS (Details - Notes payable) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 2. FACILITY ACQUISITIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 4. EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 6. STOCK-BASED COMPENSATION (Details - RSU's) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 6. STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 rdnt-20150930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 rdnt-20150930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 rdnt-20150930_lab.xml XBRL LABEL FILE RestrictedStockMember AwardType [Axis] Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive Income / Loss Total Radnet Inc Equity Noncontrolling Interest First Lien Term Loan Short-term Debt, Type [Axis] Second Lien Term Loans Short-term Debt [Member] 2015 Incremental First Revolving Credit Facility Credit Facility [Axis] New York Radiology Partners Business Acquisition [Axis] California Radiology Healthcare Radiology Stock Options Level 1 FairValueByFairValueHierarchyLeve [Axis] First Lien Term Loans Financial Instrument [Axis] Level 2 Level 3 Total Fair Value Software Development Costs Property, Plant and Equipment, Type [Axis] Murray Hill Radiology Hanford Imaging Baltimore County Radiology Investments by Category [Axis] New Jersey Imaging Partners 2006 Equity Incentive Plan Plan Name [Axis] Document and Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer Is Entity a Voluntary Filer Is Entity's Reporting Status Current Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable, net Current portion of deferred tax assets Due from affiliates Prepaid expenses and other current assets Total current assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Goodwill Other intangible assets Deferred financing costs, net of current portion Investment in joint ventures Deferred tax assets, net of current portion Deposits and other Total assets LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other Due to affiliates Deferred revenue Current portion of notes payable Current portion of deferred rent Current portion of obligations under capital leases Total current liabilities LONG-TERM LIABILITIES Deferred rent, net of current portion Line of credit Notes payable, net of current portion Obligations under capital lease, net of current portion Other non-current liabilities Total liabilities STOCKHOLDERS' (DEFICIT) EQUITY Common stock - $.0001 par value, 200,000,000 shares authorized; 44,495,235, and 42,825,676 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively Paid-in-capital Accumulated other comprehensive loss Accumulated deficit Total RadNet, Inc.'s stockholders' deficit Noncontrolling interests Total equity Total liabilities and equity Common stock - par value (in Dollars per share) Common stock - shares authorized Common stock - shares issued Common stock - shares outstanding Income Statement [Abstract] NET REVENUE Service fee revenue, net of contractual allowances and discounts Provision for bad debts Net service fee revenue Revenue under capitation arrangements Total net revenue OPERATING EXPENSES Cost of operations, excluding depreciation and amortization Depreciation and amortization Loss on sale and disposal of equipment Severance costs Total operating expenses INCOME FROM OPERATIONS OTHER INCOME AND EXPENSES Interest expense Meaningful use incentive Equity in earnings of joint ventures Gain on sale of imaging centers Loss on early extinguishment of Senior Notes Other expenses Total other expenses INCOME (LOSS) BEFORE INCOME TAXES (Provision for) Benefit from income taxes NET INCOME (LOSS) Net income attributable to noncontrolling interests NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS WEIGHTED AVERAGE SHARES OUTSTANDING: Basic WEIGHTED AVERAGE SHARES OUTSTANDING: Diluted Statement of Comprehensive Income [Abstract] NET INCOME (LOSS) Foreign currency translation adjustments COMPREHENSIVE INCOME (LOSS) Less comprehensive income attributable to non-controlling interests COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Issuance of common stock upon exercise of options, shares issued Issuance of common stock upon exercise of options, value Stock-based compensation Issuance of restricted stock and other awards, shares Issuance of restricted stock and other awards, value Forfeiture of restricted stock Sale of noncontrolling interest Distributions paid to noncontrolling interest Change in cumulative foreign currency translation adjustment Net income Ending balance, shares Ending balance, value Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net income (loss) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Provision for bad debts Distributions from joint ventures Amortization and write off of deferred financing costs and loan discount Stock-based compensation Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: Accounts receivable Other current assets Other assets Deferred taxes Deferred rent Deferred revenue Accounts payable, accrued expenses and other Net cash provided by operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of imaging facilities Purchase of noncontrolling interests Purchase of property and equipment Proceeds from sale of equipment Proceeds from sale of imaging facilities Proceeds from sale of internal use software Equity contributions in existing and purchase of interest in joint ventures Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Principal payments on notes and leases payable Proceeds from borrowings Payments on Term Loan Debt/Senior Notes Deferred financing costs Net proceeds on revolving credit facility Distributions paid to noncontrolling interests Proceeds from sale of non-controlling interests Proceeds from issuance of common stock upon exercise of options/warrants Net cash provided by financing activities EFFECT OF EXCHANGE RATE CHANGES ON CASH NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for interest SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Purchase of equipment and leasehold improvements not yet paid for EX-101.PRE 11 rdnt-20150930_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`$*':4>0&ZUDM`$``(L6```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CIZ4/`9O2;8O4_H";3(A%'%NV"?#WM0-4;916 MT!)I-GEPQW-O,LY9,'G;:;"#K2PK.XT*Y_0#(38M0'(;*PV55W)E)'?^UBR) MYNF*+X&PT6A,4E4YJ-S0A1[1;/)2@S$B@\'C7@B]IQ'7NA0I=T)5I*ZR5M>A MRG.10J;2M?1+8N>MXM2[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?' M5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7. MU49V[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997 M'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_ MV/P"4$L#!!0````(`$*':4=+^1`9A`$``(,5```:````>&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'/%V$MN@S`0QO&K1!R@9L9Y*\FJFVS;7L`B$T`)#]FN MVMR^E$5%'QYU$>G;@`!I_-_PD^5=&_+MDUQ=K+LV5'4?9N_-M0W;X?T^JV+L MM\:$HI+&A8>NEW;X>NY\X^+PZ$O3N^+B2C&^O\)50B,9CQ1@_#`L/G6R__6;X[G^M"'KOBM9$V_E%AOA;(3#J( MTT$,";+I(`L)FJ>#YI"@13IH`0E:IH.6D*!5.F@%"5JG@]:0H$TZ:`,)HER1 M,<C-&; M%;T9HSC-&;ZOH;3%Z6T5OB]';*GI;T%F)=EB"T=LJ>EN,WG:B=ZBIW&S"WBERW+I6$.!I<&>Y4L3UAR7AZ*:M:T4K'+,DMC*M,B MM^9IS`M1K"7"KS'+IL9'0,V`RH3%+SR5;]:@P;13-8;$-&,.:%EKF@G6H/XF M:XQ3;$N:OQG-:I;FSR(JP\*EDK59QQM-]0WE+`'1H^J'9(VY>X,^LXKK;&C^ MQ)(V]O/FWHL5XZ+J=&CJ`_@<+-CGF]J,)FG^M*`I%]9T)R<[%LN"OX]I)_M. M*2GB:NAB%<+YA(8>J6!5>*WM*$]I+C4DTM^P-+5&MLG6<58*R:V'@C^+#6-2 M3(U#L@[;V':7R/UE1][0W8C36 M6MWO2R":)PCG$JXC\O)&"H;7MN00.8'O8I]@%T%$@IGGVB$L;NR9[3L8]>", MNG!("%]S[/?@7/3@7/;@?%5RACKR[3!:8A3#XF!-E^90/QB))CZNC6 M=KR9%_Y"MG,?><0+/5"L::ZGY(Q`!S\`W`DB/_3\[]6Q?-=>NFJ-L8ZPO?0! M2-`"+Q&YLY=8B;S0D>>O,`G!_A!"]"/P(%C!"MI25[_403YP?IY#D[5=\P48 M9U==*/%?JXZ])5K9LPBC.;8)E*[TU.6OH'QT0_!]5!T)K_X)/.G^4#WETQSU ME)5NHK.0/L)C_Z6[K<-O76VMQ#I:6Y^ONP6FV8%SYC))TTRH?R!.ZXR[/1R- M5)?QO)^MQWQ,]34XS;GJP>EQ#US6G3,:]N"H[\&I^P:&=^>,CN[!IY?MAU>K M0>%M8\Z'$4]=_ M3Y9U+0,NNW&K:[^/7\=)*1P3UL.3MPX\*@A7>UV;P(2;9QM$QP@)8@.:AU&L M,#&YLEYSC*%?$\?%EJ^!C(MB1C0@EQPY.0!SUQ.SJI2""0\_P4O1XM_-U M@DE!H`8-!@.A(TJRZL5LC6U,209]54;'-0^XL%*M%,C;=BC[G8J=$;P.1SG( MOGWZ^Z>'E"%95[D/JJ]JFF;43%)=')B2M\7C."3G-*\^)F26=L>LV*XOTPV9F_P;#NAOBWCD\&TW9180T7[C9I M9%IN^DP@"4%XY5!9&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW`A(5M>5`TR`` M6'!VULS2`Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5`9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E`L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+` M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH`1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_`5!+`P04```` M"`!"AVE'UAJ/>DT"``!\"@``#0```'AL+W-T>6QER85D2.FI++RZDAAE MM=G$J#?S_;G'$.$P#GG#%DS5(!4-5Q&\&"#@]M^)#$?PZ>SKGT:HVR_`C9-O MDXG_='Z[BY_9A7,(',>/+(+!_!)Z+R>=^OK9RVQ7=^CGKZ3_'_D.]96A]KH4 MQ6$N^)BI&71`'-;/8(6H]@^,>RJHD$#IJ]`:+,(1P\[C#E&22&+`'#%"UPZ> M&<#>7N?'"!?2QG81=N-,_3&2+)((^MWS\G#)R&X'5<>\RWN-@?.Q]RQ#X%1T9LZ$9TY MEH%-JK?)YK@W:8_C!6T^!-"[4571]7=*"LZP$^N@A>AFA^B#/?1QB'I64`I) MGK6_*814`UA"L,)2D703^2M1M<2MZBK8:_-]"H\]\GMJ.GW61C6Z!#\Z/4<' MM]!]PQ(L%_;#^'I)%U>'K\R^G7!'YL=6S1$23I`&PO=V]R:V)O;VLN>&ULE9;1.G]N$"DH$D3.F,@Y76M\2DV-#IHX)%T52V&4LD;;_^KDQRNS2*ISPA MR?;Q[NH@[SLS>:R;[_=U_9W\*'5E)LTTV%F[G_3[9K.3I3"]>B\KN+:MFU)8 MF#;?^O5VJS8RKC>'4E:VSP:#<;^16EA55V:G]B9XHIF_H9E](T5A=E+:4A]A MI5!5\/Z=F6R5EFO9&``3L=^GHI33X(<.B!;&\D)964R#(4SK1WFRT!SVUP>E MW60T&`5]!WM.]:XAF[J01UB^4^;+TX6`%'(K#MKF$.SS>Z&NVVM MY*/!0+=`Q,:J!YF+^VDP"(@XV/I&:2N;6%CYH:D/>U5]`U9`MJHQ-G/IMG>6 MJE*E^N7BAIG9U8\?ZT;]JBLK=+9I:JW;I]R%]B%X@_E_!6*T:G-RHQ7W2[<3 MTV`\`."#,NI>:65_3H-VK*7+I/]'*FWY?X](U1;G>8N)J`K"*PL4DE3'S8/2 MN!C@YJ1H7]Q,%`R:I*#'4F'0;)'&/,UX3&"4+>9)'.4PN8[F43KC!($8`K%S M02$"A0@4_C4HR^'GEJ<(-$2@X;F@$0*-$&AT+FB,0&,$&I\+ND"@"P2Z>`FB M/9)&^6K)R>*&7*^R).591J+4U3M+,@2Z1*#+ER#6(S?1+)DG^5<2S3ZODBS) M$XBM9<4)`ETAT-5+4`@1\2_`F"U6:9ZD'UQ6:1PM8QP-'6`;!R\QPQ[AT3*% MYS-RQY=0C2;KF60ZJY#`D_RX2&*QA!N4ZB04+33U&CWN0 MPV+VZ1^H:;MEMW>P>9&K#\9@G:G'YPM7XF1)UM%\Q?'UG\]CA:G'X4YC*':88HFIQ^)N%+:88HVIQV/O=I,W<))J M:=YB$O:8>D3NW'=ZA5'89.I1N6/?76CX2,0Z,X_.K^]]FR1&8;&91^S.JC.& M42HI M0>P5P[(SC^R=7C$L.\.R,X_LW:A+C,*VLW-M9]AVAFUGY]H>2_S=QK:''ML[ M42'%*&Q[Z+&]&X5M#['MHXAM#X=/C=WO7@[: M657)PG6ZIGT-M(H;U_["S_'C-!RY@\K-;Z$EG@:N;X46]:#U#-86U;P6;7=W M)#\WO.__`U!+`P04````"`!"AVE'ZYQIR&<"``"_"```&````'AL+W=O]@7?#MGCL>>89S?&7\7%:72^VB;3FS]2LI^$P2BK&A+ MQ`OK::=6SHRW1*HAOP2BYY2<#*EM`AR&:="2NO.+W,R]\B)G5]G4'7WEGKBV M+>'_]K1A]ZV/_,?$6WVII)X(BCR8>*>ZI9VH6>=Q>M[Z.[0YH%1##.)W3>]B MUO?TYH^,O>O!S]/6#_4>:$-+J4T0U=SH@3:-MJ24_XY&GYJ:..\_K'\W[JKM M'XF@!];\J4^R4KL-?>]$S^3:R#=V_T%''Q)ML&2-,%^OO`K)V@?%]UKR,;1U M9]K[L!*CD083\$C`$P&MOB1$(R%Z$F+CZ;`SX]P"R$"QK4&+M\F-+`H`D ML(3^/T`I%;H64CNI`$RVH+*0N,BU8%\YA%E2`;-WA[!K86VKN!@<+JC`*8PB MUP*R50`,7E"!,QVYB8PCZU\T8N:Y&*<(AVFV$,D(3GKD9CVV`^T3)ATP2Y$& M)SURA@5B]:RB^FC@JO9-=.#H5AFIUJ]0Z;>O.$%WE/+O07 MX9>Z$]Z1256U3-TY,R:IVDSXHERNU&MB&C3T+'4W4WT^U-=A(%G_>"Y,;Y;B M/U!+`P04````"`!"AVE':8WRQK8$``"S%P``&````'AL+W=O_OM*LN-U9H;;B_7A=\B7%/EPR-6Y[;[U^ZH:%M^;^M@_+O?#<'K(LGZ[ MKYJR_]R>JN/XSW/;->4P/G8O67_JJG(W!S5UAL;XK"D/Q^5Z-;_[TJU7[>M0 M'X[5EV[1OS9-V?U;5'5[?ES"\OW%U\/+?IA>9.M5=HO;'9KJV!_:XZ*KGA^7 MO\##QLZ26?'7H3KW=_>+R?Q3VWZ;'O[8/2[-Y*&JJ^TP%5&.E[=J4]7U5-)8 M\S_70G_4.07>W[^7_MOQ?>V'MGD/62Z:\OOE>CC.U_/EGVBN87H`7@/P%@#VIP%T#2`6 MD%VWZM1S*]:IKSXON\C%.Y?3-X8'&GMM.+Z>.&MO4C_]-BO7J;8UAE;U- MY5PEQ;T$+Y*/BHVBB#=)-M9_,X&J";R+ITM\KL>3&D]W\7:.)\,:<9$<9TFX M2+QQEC5$49F@.[&J$RN=`'-B[^IPLP1>B'FQ8M:T!O^B:0(G`?=25"=!.F$55($48D%R+D5J1K[ M)"2\1-5+E%[80"BBK,5Y,JSS-E(&XZA"H[O)53>Y=,-&0I%+-X0V,&9L%!D2 M8&(N3:#5V&0$%RA50H)N(%L4.=Y`>C5@G>&0TW2&[@;H1TASE.4/+61`B4E$?.A*S MTR=&(.G$\D_3K:")-G$D<#/)!]]Z.0C23[/R4<*T6(DX%-3TX407*IG=/*1 MS"(]SR))YH>?0)P+J"I(?6F=HB0IRG.7@B0>/X%WEB\A&U48$%-Y).DD)4E2 MSTE*RL8<`X@NDC)'/M5%.DQ)PM1SF)*$Y%@-7\H5U9@.)5)2JX/42I!Z#E(K M$8F>B+-+D06?)[(NJY/42I)Z3E)[S\B0WH4H.G47DMT=KY[*E^K/LGLY'/O% M4SL,;3.?M3ZW[5"-99K/XYS=5^7N]E!7S\-T&\;[[G*F?'D8VM/[$?GMG'[] M'U!+`P04````"`!"AVE'>U4\I>,!``!F!0``&````'AL+W=OU%I=5>M-=.&`):&U/; M"=NWKVT(98FU6B[PZ?]GOK%EYX.0KZH!T,$;9YTZA(W6_1XA=6Z`4[41/71F MI1:24VV&\H)4+X%6SL09(AAGB-.V"XO@""?4A_!+MR\PJG.!7"X-:]`/+?A+BU0Y^ M5(<06P1@<-8V`C7-#4I@S`8RB?],,?^GM,9E_Q[]FZO6T)^H@E*PWVVE&P.+ MPZ""FEZ9?A'#=YA*2&W`LV#*_8/S56G![Y8PX/1M;-O.M<.XDFTGF]]`)@.9 M#5'RH2&>#/'*@$8R5]=7JFF12S$$\5I4>QFR7(Y)\AB!>"+/RQ\V^QWQ][_?'"GXS^:%7$ M*.F<9.(,Q7LE*3R3B)TF$,FC/UZ1)`N2=-PL/'TKF,\HWS&E7J;TD2E9 M,:4/F9(D>4I)G*Z0/$*R(VFVS?Q$F9R1:)3IFGR7R"/U$:'$E>GJ!GU1> MVDX%)Z'-[7+WHQ9"@PF*-Z;.QCQZ\X!!K6UW:_IR?`?&@1;]_56;G];B'U!+ M`P04````"`!"AVE'CS/KC9(%``!"'```&````'AL+W=O25Y#C[ M[5<"3'#W4YR+`?G7/?-F1O-ZI/E+W7QK'ZNJF_S8;??MS?2QZYZN9[/V]K': ME>V'^JG:]_^YKYM=V?4_FX=9^]14Y=TA:+>=L3%AMBLW^^EB?KCVJ5G,Z^=N MN]E7GYI)^[S;EDOYLMH>_D]OGMJMWKR'3R:[\5._3)KC=#^5PZJB:]_/ MS>UP<9B*?M3:_G\#L9A_7\0PGWT?\IR0Y27"1R2^1=8:H3,QZ]L_=X)1)Y:L MPOEM`RM-Q"3Z\&Z2XI=)WG33PK&R%_'V&)]QO(/Q[B+>'>*3$6-]1/8')!X' M,G,V3@P'P"*9+(=$8]X%:\7L%1IS.7D;L#8/M7FMC80V?]&,/R!7V5DKI`$J M>BNF<@TH]IR]4(8PRLYC90$J"UJ9Z,TRJ&8H61?%`*P`%JP/XGY;:\PS&2=7 ML\9<##Z/W'@1:HM:FYB/953-L$MRH%>`,BZ+7&M-14[R'B@TY;WCD=68H*ZD M=8E;:)E`CY.5D['2&"5G?!;*-.:SS2SG#&"6#46L+4-M6>U":60]#PZ)MGRC M1T?M^4;KCCY8N:01YZTQ8D[7@/-LK!,[5@$XYWRR(_LTC9@::851*B3=, M$H@PQW)E`\S99(.4!S!/%_?)6W70+3\2:W5)JF-]J]DDM6F(.,FEC5)%)X6! M5#Z-[$6$[96LUI6E+@OVT"AU`8BD@P"(LW1&`.4XLA,1-GW2KI^EZY/3'#9R_M$7#]INW3V-V&K9^T]V?I_:2=F")SE@(!YMEZJ4]C MG()F3Z8DV.#\*L=.,UP*S) M04T_P-B;L=T(6RUIK\W2:TG[GI'*WD76`+FR'&7Y@#"*86S.L,E2UJJ\5)5! M0SG+HPO"^G.ZVF8!%JSTHP)A+O*(.L85`.L*(,L*@+437[DDC6\%,#EOOY>I M^&6FMZJPZ[-V?;FA+UD;L%R)[R/K]Y$"(.0SCU1ZC)V>M=/+,]Z2M?-*GP>( M/',`Q)$LSA`TH@<[/&N'S]+A65NNC58:!:"2E;?>&E`4LBPJ"H`YRGYL]6&? M9^WS),O@)0,#MT[6`RN`A>1DS8F2]<60FC6-7=G^1#FB#GL\:X\GN3\5F?MQ/+.F<%*.?57@^H M:/7$:>J*`XTM2UQ\L"X^R,CJ@U&]()\Y`N`I$F6F?22*5O<35B=35")&\Z"VH$ M%X=G'&H:$6EL?_R4Y1;.:7JYLH9$))8ZNWA!LJN:A\.KJ79R6S_ON^,Y[WSU M_/KKX^'ME[B^I.L5@>MKNBZ.+[=^IE_,G\J'ZN^R>=CLV\G7NNOJW>'%S'U= M=U4OP'SHW>RQ*N_./[;5?3=\C?WWYOB*Z_BCJY]>W]B=7QLN_@=02P,$%``` M``@`0H=I1Q87?8^*`@``N@@``!@```!X;"]W;W)K!U-0.<-W(:5#5VFDRK+W0-"$77E&U M.I=<+CAIXLR\8]7@EE6DM2@^;>UG;[./)6(`_*IPSQ9C2VH_$/(N)S^.6]N5 M$G"-"RXC(/&XXAS7M0PD$O^>8MY32N)R?(O^;7`KU!\0PSFIWZHC+X58U[:. M^(0N-7\E_7<\60AEP(+4;/BUB@OCI+E1;*M!'^.S:H=G/[Z)W8EF)H")`&;" MG,=,\">"?R<$7Q*"B1#\;X9P(H1*!F?T/E1NASA*$TIZBXZ[W2%YJ+Q-*/:F MD(MR*T35F'@G$6ER33TO3)RK##1ALB4&#!@('R$['>+-"$<(F%4`DXH,:'3P MF"#7$3!6-/PSR/[+(`\R?6.Q_`7?GXH5F0,$Q@#!(D`P!G`5D=F(:0<,'#`Q M6'M*.710$+IKI2`Z"/IJU?8Z:`4BSS6["HVN0MV5IQR0+%RD"4M0!Q!Q96SN)D;3,]#3V1602XM'V^5>75NN\]`WNS* M>N9MNRJ]_!ITJ$S_HGHN6J9=2!<]).A(YP(X5B(=Y_$_Z84'Q+S MI,8G+H=0C.G86\<))]WM2V'^7$G_`E!+`P04````"`!"AVE'M^)Q+SL#``"% M#0``&````'AL+W=OGW3^4>R5 M*KVO-,F*B;\OR\-3$!3KO4JCXE$?5&;^V>H\C4KSF.^"XI"K:%,;I4F`PY`' M:11G_G1<7;_%N7U8O@NDXZ.PV M<:JR(M:9EZOMQ/^!GE:(5DA-_([5J>C=>U7P[UI_5`\_-Q,_K&)0B5J7E8O( M7#[57"5)YY/GEY4X&'J"IT]"1-N:RKEU5UF$06YK^*F(X_IPBC` M\0H@7FM29L)-HJ2TMR$-="2H(P$=:R>:24?G`8\8OK*T1Z#."-"Q2G\^G$A,WO22I(+L3!D\*"JDP'45T)@6'8P+328/XZ(O4U_0PW#N=+F M$!".->SG%AH(V:6UO`=:?0,-(X9["P*:"[%6TP*YW85++.V0[Z%>`(K9K6$% M0(*(*YLP@GL9`IH9M9L9(HX0I=2L+7*M#N$M'P%[/G4../U-'VZ=`(*D),CN MG0#W@#BC#-O%!H&4VZES*8P%F?'0[13OZ)\ M%V>%]ZY+/GN[+ M:_H?4$L#!!0````(`$*':4>GSH;68P4``#`<```8````>&PO=V]R:W-H965T M&UL=9E!<^(X$(7_"L6=P>IN27:*4!78VMH];-74'';/#G$2 M:@"SMA-F__W:0(C3_70!;)ZDI[;TJ64M3G7SLWVMJF[R:[\[M/?3UZX[WLWG M[>:UVI?MM_I8'?I_GNMF7W;]9?,R;X]-53Z="^UW<\JR,-^7V\-TN3C?^]XL M%_5;M]L>JN_-I'W;[\OFOU6UJT_W4S?]N/%C^_+:#3?FR\7\5NYINZ\.[;8^ M3)KJ^7[ZX.[6/ALD9\7?V^K4CGY/!O./=?USN/CSZ7Z:#1ZJ7;7IABK*_NN] M6E>[W5!3W_*_UTH_VQP*CG]_U/[[N;N]_<>RK=;U[I_M4_?:N\VFDZ?JN7S; M=3_JTQ_5M0]^J'!3[]KSYV3SUG;U_J/(=+(O?UV^MX?S]^GR3YY=B^$"="U` MMP*W=G`!OA;@SP)R[NG%V;E?OY5=N5PT]6G27![&L1R>N;OC/G*;X>80J+Y/ M;?_?H%@NWI=.:#%_'RJZ:E9C#5TT-\6\K_W6!*$F5F2*JP;65A%SW`+#3O"H M/%\[P;@"@17(J`*Y5B`J"A?-X:R)%Y,\LGGIB17-*+@,>_'0BP>=\;B"`"L( MIC-Y5'T)(YO^+!'..:C.`)5W12*P$7J)UHM37J)IA3P57GD!*E>DXI)#+[GQ MHEM9Y::56>!,.5X#E40B[*6`7@HPX%3X5X5I)I#7<;&BR#XQ>0:>(01DP(P> M,5?1E\&099ER@U0RFDE?[22(Y.R8R;4;9[L=19NQ(N?S!+H<9->#(SMH3&C( MM&/B8B7.%Q037C#E'%LO>LQ<-5_'9DZL_5A9@E$.`],!8C)K,V)'L,2HO5@5 M9:%(V,',=`B:J5F`J>DL-IT4ND<6B3,FR?6L1#JA/$\]<`Q/9^GI?*8M63+. MG`^D5R:DD^A3PB`E"U+1("7+R%D0O>`!5<@2(X
M,$T)T=3,!T!)SJ-)C:&.\R+UP#!.">%4KSED.1GT/%X#40RI^&"8$H!IT*L- M64RR]R8/!+)$?L&8I`Q(&O1"PRC;U+0`HI05C%&V&'5!+S(,.$H&%$CE7&J1 M84Q2MB1U02\R#!@I''1:O\:ZPB7@SHG]-]B`AU05&'\,$DH=OQ7;5'$6@I@P M`YD+D1-`9DQ3!C0-FJ9L*1E%S(X1R,AEX_W35T>8I@QH&C1-&:&RS_,T,9". MG./4;HTQ51E0-6BJ,J"E9Q,DH`K!IV*$DL^;L&,A=C`O2"J2H@1=4O.58"-OQF,P%% MJ6&3>$,*^!PUG\6"EWTTBPZ0S7*7-(3Q+`#/4>-9+'V@GCW77U?OS M0<]S77=5[S+[UH_MUZI\NEWLJN=N^!G[W\WE0.MRT=7'C_.YVR'A\G]02P,$ M%`````@`0H=I1]].Z@VA`0``L0,``!@```!X;"]W;W)K-9]H5I(0TMBY1[L66!@U?2P(LE;M!:V']G4#B>Z([>$J^R[7Q, ML+)@"Z^6&HR3:(B%YD2?=L=S'A$)\%O"Z%9K$KU?$-]B\+,^T2Q:``65CPHB M3%=X!J6B4"C\=];\*!F)Z_5-_7OJ-KB_"`?/J/[(VG?!;$9)#8T8E'_%\0?, M+1RB8(7*I9%4@_.H;Q1*M'B?9FG2/$X[C]E,VR;PF<#O"&PJE&Q^$UZ4A<61 MV.EH>Q%O<'?DX2"JF(Q]!XLN[$5$65S+W2,OV#4*S9CS&L,GS()@07TIP;=* MG/DG.M^F[S<=[E?T_>QPORV0;PKD*X%\%LCO6MS"'.Z*L-69:K!M>CJ.5#@8 M/QW>DEU>YQ-/=_(!+XM>M/!+V%8:1R[HP\VFNVD0/00KV<.!DB[\GR50T/BX M_!K6=GI24^"QOWV0Y9>6_P%02P,$%`````@`0H=I1S6Q([FD`0``L0,``!@` M``!X;"]W;W)K=\?&7-5!UJX.^S!A)T&K18^A+9EKK<@ZD32BO$L>V!:2$/+(N5>;%G@X)4T M\&*)&[06]N\9%(XGNJ.WQ*ML.Q\3K"S8PJNE!N,D&F*A.=&GW?&<1T0"_)(P MNM6:1.\7Q+<8_*A/-(L60$'EHX((TQ6>0:DH%`K_F34_2D;B>GU3_Y:Z#>XO MPL$SJM^R]ETPFU%20R,&Y5]Q_`YS"_=1L$+ETDBJP7G4-PHE6KQ/LS1I'J>= MG,^T;0*?"7PA'+)D?"J4;'X57I2%Q9'8Z6A[$6]P=^3A(*J8C'T'BR[L1419 M7,O=X:%@UR@T8\YK#)\P"X(%]:4$WRIQYO_1^39]O^EPOZ+O9X>/VP+YID"^ M$LAG@<.G%KP#7A:]:.&GL*TT MCES0AYM-=],@>@A6LKM[2KKP?Y9`0>/C\C&L[?2DIL!C?_L@RR\M_P%02P,$ M%`````@`0H=I1]$@7R"C`0``L0,``!D```!X;"]W;W)K&UL=5/;;N,@$/T5Q`<4AZ27C1Q+3:NJ?5BIZL/N,[''-BHP+N"X^_<+ MV'&MKO<%F.&<,V>XY`/:=]<">/*IE7$'VGK?[1ES90M:N"OLP(2=&JT6/H2V M8:ZS(*I$THKQ++MA6DA#BSSE7FV18^^5-/!JB>NU%O;/$10.![JAE\2;;%H? M$ZS(V3XCO,7BI#C2+%D!!Z:." M"-,9'D"I*!0*?TR:7R4C<;F^J#^E;H/[DW#P@.JWK'P;S&:45%"+7ODW')YA M:N$Z"I:H7!I)V3N/^D*A1(O/<98FS<.X-CH63S47A1 MY!8'8L>C[42\PAX,H8S+V'2RZL!<117XN-C^RG)VCT(0Y+C%\Q,P(%M3G M$GRMQ)'_0^?K].VJP^V"OIT<_J?^;E5@MQ#830+\6XMKF.VW(FQQIAILDYZ. M(R7VQH^'-V?GUWG/TYU\P8N\$PW\%+:1QI$3^G"SZ6YJ1`_!2G9U34D;_L\< M**A]7-Z&M1V?U!AX["X?9/ZEQ5]02P,$%`````@`0H=I1TYM%'2C`0``L0,` M`!D```!X;"]W;W)K&UL;5/;;MP@$/T5Q`<$+^M- MVI774C95U3Y4BO+0/K/VV$8!Q@6\3O^^@+V.E?@%F.&<,V>X%"/:5]/*F ME7$GVGG?'QES50=:N#OLP82=!JT6/H2V9:ZW(.I$THKQ++MG6DA#RR+EGFU9 MX."5-/!LB1NT%O;?&12.)[JCM\2+;#L?$ZPLV,*KI0;C)!IBH3G1Q]WQG$=$ M`OR6,+K5FD3O%\37&/RL3S2+%D!!Y:.""-,5GD"I*!0*_YTUWTM&XGI]4_^> MN@WN+\+!$ZH_LO9=,)M14D,C!N5?`\ZAN%$BW>IEF: M-(_3SCZ;:=L$/A/X0OB2"&PJE&Q^$UZ4A<61V.EH>Q%O<'?DX2"JF(Q]!XLN M[$5$65S+W=>\8-:?Z'R;OM]TN%_1][/#P[9` MOBF0KP3R6>#^0XM;F(SN0$D7_L\2*&A\7#Z$M9V>U!1X[&\?9/FEY7]0 M2P,$%`````@`0H=I1_%I'C2D`0``L0,``!D```!X;"]W;W)K&UL;5/;;N,@$/T5Q`<4AR3=-G(L-5VM=A]6JOK0/A-[;*,"XP4< MMW]?P(YK=?T"S'#.F3-<\@'MFVL!/'G7RK@C;;WO#HRYL@4MW`UV8,).C58+ M'T+;,-=9$%4B:<5XEMTR+:2A19YR3[;(L?=*&GBRQ/5:"_MQ`H7#D6[H-?$L MF];'!"MR-O,JJ<$XB898J(_T87,X[2(B`5XD#&ZQ)M'[&?$M!G^J(\VB!5!0 M^J@@PG2!1U`J"H7"_R;-KY*1N%Q?U7^E;H/[LW#PB.I55KX-9C-**JA%K_PS M#K]A:F$?!4M4+HVD[)U'?:50HL7[.$N3YF'/1=B+>X.;`PT&4,1G[#A9=V(N((K\4F_N[G%VBT(0Y+3%\Q,P( M%M3G$GRMQ(G_1^?K].VJP^V"OIT&PO=V]R:W-H965T<^GVG;!#X3^$+XGB7C4Z%D\X?PHBPLCL1.1]N+>(.[(P\'4<5D M[#M8=&$O(LKB6O*,%^P:A6;,>8WA";-;$"RH+R7X5HDS_T+GV_3]IL/]BKZ? M'>ZW!?)-@7PED,\"^:<6MS"'3T78ZDPUV#8]'4@I7L[D!)%_[/$BAH?%S>A[6=GM04>.QO'V3Y MI>5_4$L#!!0````(`$*':4<&PO=V]R:W-H965T MVF?6'MLH MP#B`U^G?%[#7L5*_`#.<<^8,EV)$^^8Z`$\^M#+N2#OO^P-CKNI`"W>#/9BP MTZ#5PH?0MLSU%D2=2%HQGF5W3`MI:%FDW(LM"QR\D@9>+'&#UL+^/8'"\4AW M])IXE6WG8X*5!5MXM=1@G$1#+#1'^K@[G/*(2(#?$D:W6I/H_8SX%H.?]9%F MT0(HJ'Q4$&&ZP!,H%85"X?=9\[-D)*[75_7GU&UP?Q8.GE#]D;7O@MF,DAH: M,2C_BN,/F%NXC8(5*I=&4@W.H[Y2*-'B8YJE2?,X[>SSF;9-X#.!+X2'+!F? M"B6;WX4796%Q)'8ZVE[$&]P=>#B(*B9CW\&B"WL141:7DF=W!;M$H1ES6F-X MPNP6!`OJ2PF^5>+$_Z/S;?I^T^%^1=_/#N^W!?)-@7PED,\"#U]:W,)\^U*$ MKPU[%2]P68X9PS9[@4 M(]H7UP%X\JJ5<4?:>=\?&'-5!UJX&^S!A)T&K18^A+9EKK<@ZD32BO$L^\*T MD(:61%$6%D=BIZ/M1;S!_,## M050Q&?L.%EW8BXBRN)0\SPIVB4(SYK3&\(3)%P0+ZDL)OE7BQ/^A\VWZ;M/A M;D7?S0[_4W^_*;!?">QG`?ZIQ2W,[E,1MCI3#;9-3\>1"@?CI\-;LLOKO./I M3C[@9=&+%GX)VTKCR!E]N-ET-PVBAV`EN[FEI`O_9PD4-#XNOX:UG9[4%'CL MKQ]D^:7E.U!+`P04````"`!"AVE')RX@90T"``#C!@``&0```'AL+W=O!GP))"L*R;$4D;]JT+,+%5)^8J)=?_ M#B!4OTMI>I]X:RZU]1.D+,C$.S426M.H-M%PWJ5[^GR@S$,"XG<#O9GU$Q_\ M4:EW/_AYVJ69CP$$5-9+<-?\H^NGIB?/^7?U[V*X+_\@-O"CQ MISG9VD6;I`F*]1DA0AL(Q,$PS+<9(V:K!$!&IE@F`=)W:`F M&T0@CTPPS`(WV:(F6T0@3CR&>9!X?[NQ&Y0A$G'J4="#W-,'-Y4B$G'V,5#^ M(/T4O:Y[RA")^`=`0?$?0&9%2(*^A%IKDDI=6SM4FVEVJN?[4,[))[PL.GZ! M7UQ?FM8D1V5=*0S%[*R4!1=+]N3N5>U>G&D@X&Q]=^WZ>JC!P\"J[OZD3.]: M^1]02P,$%`````@`0H=I1]9Y24"M`0``%@0``!D```!X;"]W;W)K&UL;51?;ZL@%/\JQ`\P++;;TEB3=GY1_Q.Z=>E/W,`CRC=1V=:%31-2011-F*WHVN=]G<8%M5&"[$MC.+6ZO6HQA=G&37=1D%Q&X MO3*)8>ZN3.CJX!3H)MQ/0TH<.CN=T%)=GL`#"P?_`R_RGC?PG^M&=(:&PO=V]R:W-H965TFT:78?-FGZL/O,Z%5)@6L!Q^Z_7T#'FM87 MX%[..?=#\COH7@5WU,TF`!)%0N*'`_7>`1 MI`Q"OO#[K/E9,A#7ZZOZ<^S6NS]S"X\H_XK:==YLFI`:&CY(]XKC3YA;V`?! M"J6-(ZD&ZU!=*0E1_&.:A8[S..WDV4S;)K"9P!;"71J-3X6BS2?N>%D8'(F9 MCK;GX0:S`_,'485DZ-M;M'XO(,KB4K+\KJ"7(#1C3FL,BYAL05"OOI1@6R5. M[!N=;=/S38?YBIY/U>_WVP*[38'=2F`W"]Q^:?$[AN7W7XK0U9DJ,&U\.I94 M.&@W'=Z275[G`XMW\@DOBYZW\)N;5FA+SNC\S<:[:1`=>"OIS3XAG?\_2R"A M<6'YPZ_-]*2FP&%__2#++RW_`U!+`P04````"`!"AVE',)DH++0!```5!``` M&0```'AL+W=OO_?FC<>F&-&\V@[`D3M-]IT"CN_-*TU/8&>!U)2E*6IO=4<:&3LHBQ9U,6 M.#@I-#P;8@>EN/EW`HGC,`(I@Y!/_'?6?$\9B.OY5?U[ MK-:[/W,+3RC_B-IUWFR:D!H:/DCW@N,/F$N(#BN4-GY)-5B'ZDI)B.)OTRAT M',=I9W\_T[8);":PA?`UC<:G1-'F-^YX61@A@]F!^8.H0C#4[2U: MOQ<097$I69X6]!*$9LQIC6$1DRT(ZM67%&PKQ8E]H+-M^F[3X6Y%WTW9'QZV M!?)-@7PED$>!/+NI\".$Y9_4N-_,L=\08#=)MC"[FR1TU3<%IHW7TY(*!^VF M!BW1Y04\LMCW=WA9]+R%7]RT0EMR1N=O3^Q_@^C`6TGOO)?.O]%E(:%Q8?K% MS\UT;:>%P_[Z")<_0?D?4$L#!!0````(`$*':4>R1/6IL`$``!8$```9```` M>&PO=V]R:W-H965T0'*`YQFBIR+#5= M5=W#2E4/[9G8XQ\5&"_@N/OV"]AQK91+@.'[&P/)1]2?I@6PY$L*98Y):VU_ MH-24+4AN[K`'Y79JU));M]0--;T&7@62%)2EZ3V5O%-)D8?:JRYR'*SH%+QJ M8@8IN?YW`H'C,=DDU\);U[36%VB1TX57=1*4Z5`1#?4Q>=P<3CN/"(#W#D:S MFA.?_8SXZ1>_JV.2^@@@H+1>@;OA`D\@A!=RQG]GS6]+3US/K^K/H5N7_LP- M/*'XZ"K;NK!I0BJH^2#L&XXO,+<0$I8H3/@EY6`LRBLE(9)_36.GPCA.._ML MIL4);":PA?"0AN"348CYBUM>Y!I'HJ=/VW-_@IL#^6+"8Q8G]H+,X?1M-N%W1MQ,]W<8%LJA`MA+( MYA9W-RW&,/=QDUW49!<1V-^8Q#`/-R9T=7`2=!/NIR$E#LI.)[14ER?PR,+! M?\.+O.<-_.&ZZ90A9[3N^H0+4"-:<%'2.Y>E=8]T60BHK9_NW5Q/]W9:6.RO MKW#Y*RC^`U!+`P04````"`!"AVE'5WO0K*8!``"Q`P``&0```'AL+W=O=\?&7-5!UJX M.^S!A)T&K18^A+9EKK<@ZD32BO$LNV=:2$/+(N5>;%G@X)4T\&*)&[06]N\9 M%(XGNJ.WQ*ML.Q\3K"S8PJNE!N,D&F*A.=&GW?&<1T0"_)(PNM6:1.\7Q+<8 M_*A/-(L60$'EHX((TQ6>0:DH%`K_F34_2D;B>GU3_Y:Z#>XOPL$SJM^R]ETP MFU%20R,&Y5]Q_`YS"X"7:/0 MC#FO,3QA=@N"!?6E!-\J<>;_T?DV?;_I<+^B[R=Z]K`MD&\*Y"N!?!9X_-3B M!N:0?2K"5F>JP;;IZ3A2X6#\='A+=GF=3SS=R0>\+'K1PD]A6VDC.FBMZJLV_O9H>N.=W'<;@ZFRMO/]FAJ]V5GFRKOW&NS MC]MC8_)M;U25,2,DB:N\J&>+>=_VV"SF]M2516T>FZ@]557>_%Z:TI[O9W3V MWO!4[`^=;X@7\_ABMRTJ4[>%K:/&[.YG#_1N3;E'>N)'8<[MY#GRR3];^^)? MOFWO9\3G8$JSZ;R+W-U>36;*TGMRD7^-3C]B>L/I\[OW+[UXL67;7Z/-J>UL]6XRBZK\;;@7=7\_#U\T M&JUUWSRQF+\NF*3S^-4[&IGEE&$]H]0UL@J1#R>Q M2^"2!<.R6++`G%T'R$)":9##/YVL_^KD*DV.=A:?V/-!I>:X`X$Z$!,'8NQM MD.1R8.J>44,0*C0#/9XA&$F%`MY6(<8Y310!/8-@5'!"<'$2%2<1<1R(DY,X MLF<$T0)DDR$4903X6H64@PA/@30$HSJ9].>5M`25EB#2!)"6!'$22N&H(1`3 M<"*'$%52P\F,4)I1@@;LS!%=:6!+@U6SC(- M)T7*4@)2SA!,N>T#3L00DR+A'`Y9B(E42Y[@VGS=Q@H1"=4%A8@$D3ZE@H.- M(<,P)3G<&C',;<MEH&&79QA&1`HK`((IIN&B6".8 ME(+=FI]X[:<\5`=+P,A,RR@CFL-QR1".NBH(]XP5PLF4IRP8/X3CC%"XN\23 M4V%EFGU_'F^CC3W5W7"BN;1>SOP/S)\J0?N2WF44:5_Y?X3^%/KA?C$_YGOS M/6_V1=U&S[9S9]G^-+JSMC,N??+9E>B#^XNYO)1FU_E'Y9Z;X5P_O'3V^/Z; M&PO=V]R:W-H M965TQ]-W:JM7VK=;8)`'4K> M,/4D.MZ:.RBW/O*O"Z_5N=1V(2CRX!9WK!K>JDJTGN2GK?\9;7:(6LB`^%GQ M7LW&GA6_%^+-3KX?MWYH-?":'[1-P]X7=M,AOGWE/0?IPVW)L1L=LS]&& MF)T[V$6[4:8F9>Y91)&_%SBF>?!N$TV8YSD&CYA[Q`Y`I#=(8`3<5&!0!9[% M1Y.*E00$3$"`!-FBC!'3#A@Z8$@:(9HL:@%@64;C$)83@7(B5TX2+N1$,YYX MP'RB4;1"$X,T,4"#%C2Q0T-H0DD"\R0@3P+P8#@!!1/0!]I#':&4A'A%9PK2 MI`]L>^IN>[QV6#.0)7M@US.W&!QE*S3V.0-9,P2(R$J*%7>C!S9^`LW%HC0T MOZ7)D>.,!>Y>$FQU!'C=:=($NNL2)E&TP@0_$Q#P4'`:A8A;/*5)O'+N$.QW M!!E^32WL9028V6V5Z^:$4!RNF!'!=D:0GYT6)&X+4$C0&A5L?`0XW^T!=0Y6 M@I,T6QZL8/92Z]B9_V#R7+7*VPMMWH_#&^XDA.8F9_AD=JHTWRVW2:5^UEYS*LNL_G^A"GU^FK#)QXU?^?[0FAO^?.9?X[9Y MJ:HFUY57J]W3Y)E-UR(TD![Q;Z[.S=5_GR__),$0A@/X$,"O`=<\ M.$`,`>(S(/PR(!P"PD`B(K0#_,EG]5"^S-IO/:GWVZDM]'#-3 MAFP:=XNY,3?-VG73W'3_&<1\]C[G<33SW\U``V9QB^$]1LHQ9$DA[(KP.P)7 M%ARQ6'`2SL<)7BA")A:'NX.L[@^R!H,D6(F`\RENXL-A/F-K/B^8JL?("R8- M@\!2#%`BME%+BDH$LU$KBHJCV[%&PD(H+`3"K"I8A#=I(JR'P`6COA[1]GZ`39CAMS8[ON,FJA$DN[!QH2PVS)JMUW#MS,!'V2N1!S[(`<^F-B2 M(,CU3(]=BP/72KB=!X&$(P^V(@ZL*`GM/`@4.?)@A^'`82+'RP''FYZ#34^* MCM.'6K-?R0J%I!3&L#$A;"$<6`BM!02*'7FP?W#@'[06$$@Z\F!CX,@87.6$ MC8$_8@R<[GB6H$5*Z'Y-OE@E;`T<6`-=)01RO;MB9Q!HT]NK!$&.QB6P,PBT MZ>T=BT"I8]X$=@8!-GWJ,#'A>)]'CQ5V-0CP0!`P'I&7];NX,25L(@*8"*D& M!$KM#NG?G!*5JM[W!WJ-M]&GJC4''#=WKX>&S]R<,EGW%VSZPL#])9NN+D>" MG\//9\=LKWYD]3ZO&N]5MZTN^].IG=:MZK@'WSJ_.:AL>[THU*XU/V7WN[X< M#%XN6GW\..>\'K;._P)02P,$%`````@`0H=I1SK?B4*H`P``\Q$``!D```!X M;"]W;W)K&ULC9C;;J-($(9?!?D!ANXJ\"%R+"59 MC68O5HKF8O>:V&T;#=!>P''F[:UV76ALOZ$#>GVF6[WJDL8C)F'I=9 M7LTVZ_[><[U9^W-;Y)5[KJ/F7)99_?O1%?YR/[.S]QL_\\.Q[6[$FW4\^NWR MTE5-[JNH=OO[V8.]>TI,9]);_)N[2W-S'G7)OWC_J[OX>W<_,UT.KG#;M@N1 MA<.K>W)%T44*RO]?@WYH=HZWY^_1O_?##>F_9(U[\L5_^:X]AFS-+-JY?78N MVI_^\L-=QY!V`;>^:/K?:'MN6E^^N\RB,GL;CGG5'R_#/PMS=<,.='6@T6'4 MP0Y\=>`/AZ0?Z9!9/ZZ_LC;;K&M_B>KA89RR[IG;.PZ5VW8WNT*%,37AO\YB MLW[=T(K7\6L7Z&KS>&M#O8T=+>(0?90@)/%(PIT^"SP!BR568#@(OO%/>G]> M3L8PF%2]R6*0,#9)S2039&;8)#B;!&:3B&QHI01(88`4!$@GXTEO$DU[F]08 M@U7F4&4.5.83E;E0X86FLH`J"Z"RP`&6,,#R"\58RC335,MS!6567ZC&2L@D M2TVE6SL0;@;H*'/=*L1:$&(U1=;*^:'G"KE]L"2Q,F8J1$+(SE4AC*\%_!H[ M%6(A=#,//LM@+JT$4RP35YM/S]BJP\'X6LDO&U)"8#8M@E,\8TFG5=<`B_&T MDD_PC!>2KT2K/:;82HQE[27&\U23P11;B3$;5IH5)I00H=/27XT^31-24B6, M,4F,9>5)8FQ9Z26$*29$<3+5D1332IE)A"$F!+%6$@PHH8*PV6<(8$\!XBA=)BDE=V@AC3`!C\8`DQKH, MQI@DQC:=-@22[5A#@S'J+%%GHSQAQA3S5YHQ2XI#T]=JPIAC1AR+MUS0C=47 M(59>IA'(8DBR&X>6H"IAWADT9#M=`EGR3JP*8=X9\&ZG\XDE[\N5LM%AS#LC MWJ?K"DO>$_6-B3'OC-KV=&%A";PE]06!,?'\A<;-@/C0/C0AS#R#UBUFG41> MK5R"F4\`\W:R'WU,;MO[L`U,$B$4W^RQ2U_0/\\WZE!WO%MV.GW>_6]]ZT+R9AO85X>7;8;+PJW;[O313BO MAV\2PT7K3^^?6,;O/)L_4$L#!!0````(`$*':4?%J\`4!0,```X,```9```` M>&PO=V]R:W-H965T5`!-G6;NY&$F\?;MO5TCK]*R;E_:@E/'>JK)N MY_[!F.,L"-K-055Y^Z"/JK9O=KJIVJR5)],6=3JJ?':4U7ES=^%*O5Y[E/_LO"SV!^,6PBR-!CMMD6EZK;0M=>H MW=Q_I+,UY0[2(7X5ZMQ>C3T7_+/6+V[R?3OWB8M!E6IC'$5N'Z]JJM6NKR=[$U!QLM\;VMVN6GTOS4YV]JT!`ZPHTN MV^[7VYQ:HZN+B>]5^5O_+.KN>>[?Q&0PPPW88,!&@]$/;L`'`_YN(.X:B,%` M?-9#.!B$P$/0:^\RM\I-GJ6-/GM-7^YC[G85G86V-ANWZ$IAL];:=PZ1I:\9 MISP-7AW1@%E<8UB'D?(C9#6%T!$1V`#&*!@6Q8)-S-E'!\LI0L8@AO^2K.^2 M?`B3H\GB5_:\5YF$.(%`"<05@1BR+4"V>TS=860?9!*#?"^G("%""A(R!44Q M`UE;3T%?6,P27%6(J@HG:>'T1EHBE"!"TA*!M$17<8:]8AYQ21C<*0B01D)$ M!#"N,$8F)"%PVR!`(KD@,<=%2E2D1$2"LBZF&`K#7F(8^#EB&%AX#'.C[#$J M*$;*?N-S2E""Y!-E3Z:Y%S*D"8=IP8"$\S`F(#&@'>+;N[D+`3 MEB`R$WC$$F0SRB@&N"6"HX10FD"5&&$L8@IP:P1';LB[<8'0J3Q&H#PZ\1)) MR5@(Y4UQE,=2Q@+*FP(3R4)*H;PI[I8\]&9ZI`R11Z$\]ME=BB+1;8IS8OL4 M0][?J/CM1CDBE4&I4]#TB,)`L#0K%`2/7M0=/*6"JV:G4LV^:S-;;Z-/M>F/ MIG%U;&4?F6N6P/J"SI8465^YUK=KKM[IL_28[]6/O-D7=>L]:V-;M*[)VFEM ME(V=/-A[\6";\W%2JIUQ0VG'3=^N]A.CCY?N>_P+D/T#4$L#!!0````(`$*' M:4Z+40(``%4'```9````>&PO=V]R:W-H965TU>UBIZF%[=H@34#&FMA.Z_WYM0P@QWG8OL3V\ M-_-F/!EG'67OO,18.)^D;OC*+85HEY['BQ(3Q!]IBQOYY4@904(>V/FF;:]L#RC9U%7#7YA#C\3@MB?-:YIMW(#]VIXK4ZE4`8O MS[R1=Z@(;GA%&X?AX\I]"I:[5"$TX'>%.S[9.TK[GM)W=?AY6+F^DH!K7`CE M`XKI4C&?AC\'D+J8C3_=7[L\Y6JM\CCC>T?JL.HI1B?=@SWZM&KUV_9?4'VAV`A@(8"2,<>R$<""$ M-T+T)2$:"-'_1H`#`1H1O#YW7;DM$BC/&.TTVA,,F""R9W<@.6`6AN`I"&I0'/J!4?JYIR@!P)Y4;$TJMB05&U+B MF92'&$`C]5T\T_*0A/`?G9!8Q206,>9_(IF)`3&T!TFM05)+$*/IUZFE6Z+0 M[*GO4+T8;S(T"&8G/:ZY4]!S(_J&'ZWCB_`$U-`Q[.M@N0DL]JU\0?J!?W.? M9RTZX5^(G:J&.WLJY*C3P^I(JZ>4;]QXJ/%1J&TB]ZP?^_U!T/;Z MB(TO:?X74$L#!!0````(`$*':4?&#V8+F0(``/T(```9````>&PO=V]R:W-H M965TNK)0%U-7K7SI M(GUI&M']7O&MGJ2K51)P^K^!DOMY@YD][B M5R6O>C:.7/"O2KVYR??]*D8N!EG+G7$NA'V\RXVL:^?)DO^,3C^93C@?W[Q_ M[=.UX;\*+3>J_EWMSJ&?^\LW"'!2V:W>N<6W<[:3=#VG;,HB_>2DKQ(WIVCT68]MR&]#9XL$NM] M0A`(L2:!G-P#-J$%S^Y-MH"3#`Z"@GG2F9X.>5($.V"@`S9SP$8'V-NHP:;M M;?BP43Q-'VQ6"F)2`.-MUSJ=8=+>)N,IX3!F`6(6`(9ZF$6`^9(BQF`,!S$< MP#`/PT,,(X2E,"<#.1G`23U.%G!2SK,2H$N) M`!#W;R4*2"SG#PX;?G#[,0#*?!`.0)0P_W_(9$R"@H!Z1 M,"!$R>(!"2X(F(8DAGP2#:]:2I%WM#9W9D/JG&;I@[.%X0*#PPJ#P]2!$D-9 MEOL!A69YAORSD9@8=;Y] M;$Q?/.4_4$L#!!0````(`$*':4?/FO.N^@$``&\%```9````>&PO=V]R:W-H M965T0E$BT'?#8D2E#@>6M$<=VX:6)LKSQ-6"=)W<`K=T1'*>9_ M,B"LW[F^>S6\U64EM0&E"1IYYYI"(VK6.!R*G?OL;X^11AC`KQIZ,=D[.O83 M8^_Z\..\]P^UKMU@W ME;]=J;?)M5$_A:J:4'<:D2:7-(S\!%VTT(#)IIC`8.+X'G)XA-Q$D`I@C")8 MBB(+'NC!O8/](R+^-HOAGR+'+T7NP@P7BQ5.^*'-Q9D M9C&-P<0VC;7GSX] MJ>:OU/0;#P0*J;>QVG,[$.Q!LO8ZWL89F_X%4$L#!!0````(`$*':4>/QE!V MPP(``*4*```9````>&PO=V]R:W-H965TYAI:J'W;.;.`DJX!0[3??MUS:$(GM\"=C,_-_8S@]3 MW\3X)L^=T;0=[O4U/RG1.@Q/PG("7A*RPA4\@ M6^9WIEA3C^(6C=/>7I@Y0O2`]4;LS:19MRY1ZFM%X0W-'#("/8Z M`LQ.7`^BM=M1.I-PZ(Q@LR/`[<2U(B(^*=_0$`GV/`),3UPK(NIM7KXI`B]: M!%L>%?X_EP;,C&`W(\C.WJX`033P44&PFQ%D9V]/@*#0WF/8S!@P,\T"$K"9 M,6!FZGH,K\U<3%_9HLR*(N!G#/L9`U:EQ&5AGT4S_9YS6CY>++=DHSV MXCJHJ5]89I>.[-$V9,E7>%-?V(G_9N.I'63T*I1N9FP[N> M<1ET_*C,;:'OQZF+F@9*7.Y-X=*9-O\!4$L#!!0````(`$*':4?HA)*M40(` M`(@'```9````>&PO=V]R:W-H965T<8F,Y/?N7B5 M%6/*^6B;3N[=2JE^Y_NRK%A+I<=[UNF3"Q>19'SFVKJCCT+1][:EHI_1];P^]Y%[F/CI;Y6RFSX1>Y/=N>Z99VL M>><(=MF[![0[HM!(K.)/S>YR-G=,\"?.7\WBUWGO!B8&UK!2&1=4#^_LB36- M\:3);Z/33Z8QG,\?WG_8Z^KP3U2R)][\K<^JTM$&KG-F%WIKU`N__V3C'8AQ M6/)&VE^GO$G%VX>)Z[3T8QCKSH[WX20)1C/8`(\&>#((K8$_@&R8WZFB12[X MW1'#V_;4?$*TP_HA2K-I[JU#E/K,*(K\O0CC./??C:-1%K[Q," M0X@C7IF'<0([",$8PYF#:'20+F(<-)W5$*O)(AS@$.9$("<".-F"$ZTX211% M6QP"'B90/ZL4K9,7&U#D$[);YT:2N*T.S6=`[:5]E->Y#V]LM]47.M. M.B>N=+VV%??"N6(ZF,#3"5WIMC@M&G919IKHN1@:Q;!0O'_TO:GY%O\!4$L# M!!0````(`$*':4&PO=V]R:W-H965T6_J5N[<4JGNV?-D4;*&RB?>L5:_N7#1 M4*6GXNK)3C!ZMD%-[6'?C[R&5JV;9W;M1>09OZFZ:MF+<.2M::CX=V`U[WX2<6;1XCK-/1]>%:M??;#FYB,87`` M'@/P%(#QEP%D#"!3``ILIH,SF]"=X[8MB,CIH]1\]$?[G"+)H/I7.2 M^IU!Y-D])XF?>7=#-&(.@3U8BT$H$6`D65J*5"M[X7C&H$0,:X4(#PD2P2`**)`!!#!.D($$*$"0+ ME^GZ^`01PO[&.357!U1M/B"5+LO-7VGA"!."@@VMC9(6[FK1'GLN5PMUTEE:R.?2J4YYGI1_GV2FSDN7NY<#+^G^H)L#WFKA M7>VV:2Z+*E6%4\K=TOW"']<8-))6\2N5YVJP=IK@7Y5Z:W9^;)Z?]K-H;#]<7[MS;=.OS7I))KE?U.M_I01\M<9RMW MR2G3+^K\7?8Y^(W#CC#41O(*X& M'$<-H#>`.P.OBZS-ZVNBD]6B5&>G[&[&,6GN.7^$NG*;YF!3J#JGJC[7*%:+ M]Q7$L/#>&T>]YFFH$:U&W"K6A"*Z2KPZ@&L4@HQ"#.RQL_1C<%8.0Q7'H,SHD@GIYHPS.%`)N0:B\:YLHC5G_N M2?A4=QN2A4INA`0Q6ES02'$QHS`T5!R(*/S[PH"1L%&3,#"E','D7&GNN`D>Q*'%!@L-D^#3RR$L_M$P5XA`\/O^0.EB#'W+8T_0<`H*SMCB M@L9*X(S"T%@)LU$1A?'-/B$BM.5+TR=,^M#V5!4T6B*Z+TPO&GM@C$IN`Z%1!1-5 M9);1"2S#Y(QI$FBT@.I81CEP@32<:,*)S+>X MH+'"&>,DTECAE'$2S5EQI%>@Y<^<21\RR[R(-%HX8UY$&BV<,B_B<%X,[;V" MU!&]PAO\\3\F>_DS*?=I43FO2FN5MV\!=DII6?MD#W6.!YELKSN9W.EF&=;K MLGO;T>UH=;R\O+F^05K]`U!+`P04````"`!"AVE'E5ZD=9X!``"N`P``&0`` M`'AL+W=OPXWK3J!#.8:D3[ZGH`3]ZU,FY/ M>^^''6.NZ4$+]X`#F+#3H=7"A]2>F!LLB#:1M&(YYY^8%M+0NDJU9UM7>/9* M&GBVQ)VU%O;W(R@<]S2CU\*+//4^%EA=L8772@W&233$0K>G7[+=H8B(!/@I M872KF$3O1\37F'QO]Y1'"Z"@\5%!A.4"!U`J"H6#WV;-OT=&XCJ^JC^E;H/[ MHW!P0/5+MKX/9CDE+73BK/P+CM]@;J&,@@TJE[ZD.3N/^DJA1(OW:94FK>.T ML\UGVGU"/A/RA9!M_DLH9D)Q0V"3L]375^%%75D';BEVBT(QY7&/RA,D_(@YW$)\7"`L&%A?Y71?YBE],_)6+ M#P+%78%B);!)`F5YT\4$,0FR31!^T\6_B*PL.+_QP5:C'<0)?@A[DL:1(_IP M2VG.':*'H,@?2DKZ\'B61$'G8[@-L9W^IRGQ.%Q?Q_)$ZS]02P,$%`````@` M0H=I1]%Q[EX,;```&78!`!0```!X;"]S:&%R9613=')I;F=S+GAM;.V]:6\C MU[4H^OGN7U$PVB\24*(YBJ1S3@"UI+;E=$L=2=U.<'$_E,B25&FR2F&1K59P M?D42W/=__,O>&O=0`T6U'=S[@`/8+8FLVL/::Z]Y^(^R7$=?EHN\_,]O[M?K MA^^_^ZZ+K[K=[N'WRV3 M+/\FVN39WS;I<;')U__YS;`[^>8/_U%F?_B/]1].BMEFF>;K*,GGT6F^SM9/ MT5G.8V9%'AU$Y7VR2LO_^&[]A__X#M_A]Z;1NR)?WY?PSCR=5[^]2A\ZT:`; M1_UN;U3]\KSXW(FZH^8OGUE/]7%YXC*]R\KU*H'WSI-E6GWJ,IF?I^L8!IIU M6D8XACE7R0(>F:=?HC^F3ZT+NWYZJ$W0ZQ[\J?6%]^DJ*W`S\^@D6=?>55B9 M__$_F@!R!&/,:9PWB^2N^NUMLBAK(QYO5BMZ(2MGL*6_I,FJ=?:#@U[_8-"K M?GQ6*O"3Z.=TL3CXE!>/>725)F61I_/HK"PWZ:I^LMO&^5@L`/V2U1,L;%%_ MV3[ZNQ+.\Z%8K;/\+KI:)^M-&TPCV:S%+Z' M;^?-BU&L*)9+N`17ZV+V*8ZNZ"9$%YMUN0;TA.6UGKF`7H[^#7Q<6^B?!L^] M30?7^.[QQ?G)Z?G5Z4D$OUU=O#T[.;J&/UX?O3TZ/SZ-KGX\/;V^@KO[X>HD MVGNU'[V*LCRZOB\V):R[-MI).@,,[-&%'-:F^G!Y>7I^'1U=7<&8M6^3\IZN MZ@Q_2?^VR3XG"]A";0Z`.!*?,EJELQ0>NEFD<92GM1-5W*7S!]`7M]$\O4WA MPWFT3KY$25FF]=%/-FETNRJ647)[FRTR.-?:(^]7Z4.2S:/T"Y#-$HX15UVL M[P%+9C)G\]C7Q1K.8OLS[R\OWI]>7O\E.CH_B4[_].'L_3N`61R=GUY7'[VX M_O'TL@6:/Q3%_#%;+&KOT#(SN#SY70:0:X."`NHVRY-\AM=G5I3KD@"-D)R% MP*W=P/QS6JX)`P%=_EK`A-%G^&O30/]/ZH>RZS0G<+G+;.V=0#/(FS>I^/CV M[.CUV=NSZ[/3&A@MKCTD3XQHR6RVVJ1-A]^$2>MB"Q[9C:]2@,VFE?AZ")P7 M,(XNYB4(WT3R&IXO;A;9';''$AC]'#$Z><@0A`N@U_4MA!@-V[R!O:ZS^H-O M+\Y_.+@^O7RW#=HG_FIWQ8&W69[28_!B5MOCN0^P78>\V`Z%G8>ANY87^<$. M`&)(;GG@ZOKB^(\_7KP].;V\^EVT=W+ZYNSX['J?:,3U7VIGR^RF1'8#U/M5 MI]OM]@`.JPBHZB9%`MV-N_R_R&51LEG?%ZOL[^G\]]%P&`^GH[@_`.$*,7S8 MCR?]47PX/M2G,^3;=T46.L[X'$'F0`.P9]P\W<+#<+XKM">XLER*SW<"MAO&A1E$V%PO`A/)W;6^>%_D,Y-A5L5@@'(#BI;"]-B:`_&U=VW,- M"0APS<_NQKCWWB>(>??I.@,Y8!]1(?JN11!'`2DEF@VX_88)/TH>2&*1/OS/ MHQN4C&?K__4,MEDTB_:`^I\`1)(57$(X(YIXO_KZJXC0\YE1:UBZV_.,I[L] M6[3+8RW@OKJ&'\BAKZ*+-Q&R[J/K,WA@9XEIL+/V4Y.G0"2(+D\_GIY_.*V_ MM_J*/`]I*&):L0/&Z(QQLN3>XAY91!?CG/T2G?WZ/1U47 M,4&$(2[W@`([DO<8^/ALL2'*-4^!?`#&\TH`&LD2Z?K?&[7%DY<\_!9H4838 MEJ#`Q7`&P06V`XO!V_VP;&#/5[#-%9X-BU[-\)"MP/)5(*F)8N?'%^].HS>7 M%^\\_&R6)>59$CU;8'@F=$WGJW[_+DUR6,[M9A%MRA10?P9;`X)<4XN(J.'5 M`-4$WR@1&-LEQ1\2>%SA"$]GR^2.1-,4%U67.03L,,'B"=:+8-IDY;V2N*LT MSP";241HYMUM,!78;WU&8+GW]N+J:C]Z??KFXO)4`7Q]]."2P:OI#EP MFC5K(P#'8IFBB%R?">E`,%O3M90!DO5ZE=ULUB@.H72:[\BU:G-$1]?7EV>O M/UP?O7X+&[J(+H].X*$8G^H`C7SW[N(\\F66ZHBOCZ[.CJ/ZN("BP+R.`%B_ M=@9@*[U)TX^["#&&?[R]/?X3G MSCY:S-^5+0:RR'$@V9TQ)K=+(V^*59K=Y2*>SYXB-.>5"Z'5\[]N6#-M,(4T M++CY1KU-@;2$`F?[!3O8Z89MF?U7X]-SYX7'%>H7K%7`<4VC)-732B?STF\1$D31?ZS/#I^7N0_:1;"_4>8A#?BSG?1VP;UP,K^*&3` MD]%IH^!=$?25(3:.5B-Z*3`LY'8@0RV0M\=6K%U'6XUG#6^RB/W+-4[2W01S.\GU/&D_0JD$J_/?;T86DN^UB[Y&G6A#&/ZZR M-2+H;6#BJYAJZ16JVM&O1)A[BV<3*7\LK-#6.51OYX!:5R)^2>P5\!M M71(THH?-:G8/UYN1%P$"^ZU!H\&:WRR+;S>;\S//&+,;I>>3;2;2\Z;S;CKE MYW#U[/SCZ=4SN/I>`>:I-K?)K,4>Z#^]JQ3OOP,[@GV@.TU,3(U**.@DLS2= M"YZJXO7"QW?83/-[N`\4#%"3+(O;-=#X-D62]F]O%:J57^">T2'!_AY\T*H& M^ZQGPIZ^7'#X#]T:+SOY-V?G1^?'SYS\"BA-]@`[?4B>F!;!56=C/]TP,KZW MV?U#X-T4JU7QB`IUW:+JQKY.5TL0@H`ZG*0WZ^^VJ<)MOJ`F:#WH4F"*5?JY M6'RFQ\DTK\=?]X>_A'_NB#H[B]WAZ]E+A9OO'LEFU0R-&N5P$&S'G],W;TZ/ M22(__?/QCT?GH)D!ESN-^'?@G>?$.UL4],O3HZM3]`[P;_OP&;-:M.G0+RC9 M?SQZBWRX$76;'HRC&RM^(ND@7_0+WDY13&M[[^K#^_=O23`X>AN=G%T=@\[S M`91H7TB`;;RYN'Q'MJO:O`1EQ)KY9H4K!%8@4Y&ULDWR"N:].O[Q].3#6YKU M_.+\@&;VB#9L:Z>+[-$92R3=%48?`E!#1`DVL_E8!+[=HVK]B:1B)]'WYD,S2__SF`5>Q^IQ^\X>?4[TO9IXE=SG0 MF6QF^8>8EI&\J]$6OLG1MX$R?9'3U=6G]]Y=GNW'I%N@#0-HRK*X6R4/]R"Q M'5_#-^0[7N&]7L*]1PBX1\S>^U-\)M_,%A@[`3(-Z)LYR,#+9*D/Q=%F`8`I M08"9QY&WX%4RSXI%<0+3;$J0!![>/*TEE7*NBK1S3GRH$YT MY'G0C%6U'U.1.]!W!:+7;+T`202QV_ZUOE\5F[O["E.#]R?=JJD4!,,9#96A MMKW(`//R+(FC=\GJ"61]V,V;1;$"3(G-"2P1^6X/T4_P<@H;O[POYJ!. MEPNR?L'>!77O1 M'JS@EW_6OOWE7_NTI]=H@5\\F4M[G.\0#6#.'P#2#]'9V5D,VX+#NTT)@8B! MK]8Y`.D^>XCV?OGGZ\MW/\!PE:U$S5LQWE:215G8_=16&)WQ#N*FK_SO:-W9 ME\:GY]&98(6XB\K8\&-ZYO:!][(K'<>A0LLC[/%U-Z(VDQS`+_\$B@\`BDVR M6$2/0"`1K1\Q,*SS!S);@1)Z#_KU70J@3!`6,"%OYREZS-;W4;(/LY>;6S1_X6FS M(%O55L@`DY.QM`ME@!^:Q>I,T#;B>06'!Z1&G2`='UMZ\S MBC^A+];0-4>LW6(;@`BZ-BE\U%%()CPL6P%L)X-S,]4JW4\N*TTY@WP,EBSP;=N M"_0HX\@[SH9@S8KE,ST`#J"S1U5MF=SE= MP1S9(\A=B;R(:/&/,D);3[$$Z@3X177Q)ZJ]]P",H]0U.C0OTK!2R)8LI]`2EF*'&,EZH0OAJ5^LD9GL5&)T002HX1P M(-FT\D=RMTKY-SJYC9Q,NGQ8%$]P)O>`OG"Y030L5AY"T<.((L6F%.D8-I\^ MH-\)8^SL:X8,.OHG,QVRW;4AC0@Y<>Y!55R']% M&`XDM,?"V*7_.L`7N;T"#M0^!>3-6J9BT+8J`P&W3V?W.8U)FYJ#H$+Y4\3_ M[#1P"H3M?.GPBP:$09Z144Y0VS2- MT7Z`5EPK2:F1I8E'D9&!Z:S`LNDAN.GF/H$E4;0@11)(&"JRRL](^0![/;B` M7#&C4*Z#9?()ST[7($LJ\KN"/*LP6(ZQ))[!1+#!PLK"@!C?HZ]/D!";.9W[&+KOGE3LOG++W3YH!+>&)HU25H:BY!BF0$B,&)+X%LL$Q".D,K'/%V ML9A%"O[LGFD_04\-YK>@0!`4:&6Z:A.NFM0G]"LZW7[#S)JV8D&$[\$$+7O' M45"?B^4[QZA:]!%^$+D,[#;-22Q[#'5+QC@)N=7@P-@T^U7)3HSTEV"A(B=# M4*1FY.#(Z6^(S=PD)=D=9@6ST^@,L\LSXO&]4)8?Y/YE6ZQ3=KK^5-440P>$N8*#NS230:<7'N7A*,3*K[\T. MLOI?>UG,JT&_ZZV8[_UX&FYB)^1X]K;@?@.D,5]U6?J#<6=467!OT)F^]+J8 MK[TN.T/D-]BXN",LMW6BI*P;6:`X'ZRQ%ATJ9`#G"(`F+"!^YH9E`SV)K?*J MAI*5S-*]P"#FVSX#2_P&FMT4>`1+1"]`&-[2<-^)34`YI8-/;'-:\FU>LQ=:QDVZ@2 M`R)6.\Y%#:2R4-)T1ZK44,Z>0C)`%S$J@5118%Z0;N#O(D$(R?/[41%@IEFA&0KI/>.4ZLL/6 M*:]&/*QH0J'YT!`P2U=H)K#>U]"&1B*E^T;UVNB8G#X$U\>T08-M$&AA1"/F M+TDEX4BO=@W0W0#?B@O'DM\=H`Q=M=#Y-CGGYA8-+LMI=L""Q(>Y,WV$]D8T MOOB*)K/P]7VVFI-)Y,F;0>U59;-B:[=C7&P`'#!^6NH5(T+TL$I=N$-#C('S MQ,<4&`G8WO"4'!??I89%&JR50D=^NP'4$"V>5<7MYZ,;(4K'-\`SASS*,54/ MR5=5T2!37Y(>T=[ZZ0$1`&C;L!L]I?[%W$ MCRT#(SE(N1+<3"/6A`:XA3$Q-4BX,0/TU!-O8KTXCKI=$ER*P6/.Y^KOE&H]2*7'?@01NDS.%`K2#K$ M5$X.,(=E<_XT[J\=;A;??F8_);DNMH#74`P'T62,)8\MB-BH=UL1059IMKQ! M`B]:>ED6,\_Y4K\;;8@O6&;PDF4*G@`8+YPH2FX1W>$X-[,U!_PTR^$:-LA6 M`+;6Y(7G<6RUI-VG`5';0S,.D=>"D_`8&L6TK=&FOAK<(+7`Q8V818@NR*Q MBHZ&P52N5QN1UP#6;PH@/5BPB*2YR\T"\>N@VZ-HC?1N(PD+5P=_CJKX*-*% M!K@D)">Z6E%XJV^+8LTAL'F*[!=-,;?L,B*'J$9$?.A<=9R+QL#"4?B;J\@D MTC?&URZ$3I'?)%TWG\GOT1/)DH9@1_$`%*^P?KNE%T6$Z_8RRM3_@(=!0:BP M'T1ZC%TG2YKW:+BIA(G20R4>+T2WY4V4.E`#H$N@F,_*XSBD:YK,GNO&0`@#DE,B05!#0 M,5^"S.4]B9@WZ*A*5'_XZR;GF!N+R<\/Q'R%16G&0L)>XBFY^'SDJHH%EH.! MD"O@O3!P$_YH.0YN2^#>4`;C-ELP.WF7K(#M]`[Y/-@+MZ37.M&59YOUXHW> MPS9F*!J<5(-?#4FUJK_9:"6YAMX9`YE$K61%5%)R0D1+]0W"_GW221^)X;/9 M0@SD#PL"#@IB[=")`NC<DWM:7UXFD-$$9-550,"^HH!`K+:`;DU.(+WD2F5T)/YZS?J!N M;_$OLJM1_(ZP[&69+CZ#4,EB!XJ6<)TX(KW$1-,,%-]YL"HT(9"D@2%E<;1` M[<5;Z:WG>:=-.+H$ZDS)_A4)1RM4^#">,Y,N4F"?#Q61F#&NR7PA)+]TJ0Y4 M4J*0F]FHK(22NW&V(6NFNGEJM?$CEB*9EB`CGI5ISD*3^!-2MTM?>4;D8,%3 MKY5()\;)ID$8&-8QJ/BB_%B`!H],#=)6]*"(6KL%JU(B4$TC4$N:GOS0[,T* ME^[[Y1QG\1U6MT(C/9N5T("F$S%6X!/7?+!RNUXG\B;+`@.8"-AVJCB4_F<+ MH$$MGD0@:661Y^D"]/^B^/0I31_P*,0*HG3)G8Q>`';7<-`G,LY@0MT[Q6-3 MJ`[3"[*CE.D,$0ZI(HO/#U8R(;O5;)71)QXZD-*7YII`HL,CFE)N*N\+B/(Z MPU#H6'00FZ0$N%)(B*8+R.HTD2*XC*M4!DZ;$A\8U9G@.%UI976IN>@P1$4H MH@BDEB7A/AP569KF6@G/&TO#)D!#/R`-W3#)0I)L/U,RIL+=;3HG:Q&^2AP6 MU-4T)_ZQMU'%4V(35FS9XC\R@LG=*EF6^[%<+91PD'NER0+T7&`V.9':Y1)3 M5T-4T8T)8&2(&@L!)6R<,!<+=95 M24LPH>>&/O8^#X?*\G`AH3_5N.@D[T@?,)Q-?:#,!J@`D_(GY#QI>@`$[$#I M"3U$&B;%GC-R<7B[5_MG7FQNUEC=12V29H^G=19N>!+HU+K@R^QN'YG45AF& M^>[[E#;`K5FAFV?W,NE]9/`4M,1%V#<>[PM6]>1P"#XD]P"XY!"]^(9U#4G5 M].&*$)G`;!E$I?D8$%N2GR!@#](`P@"2STFV(/OMEO06 ME%N0->$\D8ZK*$G2:V/%)"N\;*^K%(6N,-72F6QH/+01-[@$P(8F5#^JHW&- M+4%]/O@X3<1WLIG6RQ@[J4KI9%,QJHH?$9^LN4BV:3T&!9;-$I'8`XP+:.:2 M'GOTN62H[W]OKFDROX97=(ZS^I]4'#/!7X;60%J7_LF$)O_[H!]74< MCWM]^'?2[T7]0=R?C*-^/QYW)X:3LN&S87<"$PQ&PV@TB,>C:=0?QH>3L6DK M4]:."Z&0'?6F_7C:'<*Z>W%W.HE&0YAF,(Z&TTD\&AP:6U+)A*BR!^`;#*+] M:`\V/.CC+_U1W)^.Z+=>/!W";Z:EG!F`![8T[H&B-HA'AX?1"-[H#OO1<'P8 MCZ8](_?0;+^'`(/)%`\\'DX'T;@?3R;=:#2*A_U#0\5#C%?L#,ZWWYW$`Y@- M3G\RC+L`Q5?1:#J(IWW$`]A%W(5S#"NUO4[FE.!;1BZSCIP$&$VG0+41HDVN M*\]O11 M(YM8$'-LCSTQ0AG0S8HDZ8ZS4=9`7![67K93,";S6#NGL5)>R^`:&0X'P>?) M]T$4O(;)FI]'KH,&(<0[=/B5$C1@/.&2',_DR'QBL>`)+6B2PR5JN:_R*1)4 MQXRVCDG6`Q";<%CE3'*8@NPPGN2*>+++>@4,!-4"Q&?0)6>N>`:)SY1*@@9@ M]1RL-R`;D&SBQBO4W#S#Z%U@##<;D-]9^=F"!Q0P3:8XQ.56++A6;Q'M!>EG MEF]@>R"2\6K%0&B79=RR:CMEG`<4ECN8D5!9H#FO$]F2`-?)%]!B*;+MS%:H M4]>IR4J7?8N!CG=Z5.L@#NX)-"7`7TX#X>LCNN41XY5,">=G(]82T&"SLA$T#?7)65Q#`@O;RVZ=V3A&7"#ZQP*G^,WQ34D_ M(G2.C;LG5OC4;+M8KZ6%-Z,:$V.TM/U\GV(`$$8OH*L0A"FX-HOL4TKYQ@D5 MJ>!K,P^JK$18?!R_--YP&!N-Q%V8H27G(I&NQ&GG\9,Z0/`!#$ARW*/..=Z@ MYR9U2_+1P,N:LF.0(GB[H90E>%1RE/!,?1,&#H*R*WD_R3"1WDE*AHTWQ:\T MR8]S#YI7@<2G&905^-N;]L:6CCBFZC[\+ZY;OS`<7"O/>S5)Y?1IS9BI=K!` M`96#XJQ'>I'=6KN\YY;#`D)*U+P(%K:EN5NI#C5#N25\&SN1JP5J/I14?(UK M@3IW0GE-`#*<>[A'Z')R2%8B!"U/EER#$B>S!/?B(MR67'S5Z5U@`R; M;(%*.)"I'%&I_&0G0>F8E,KRJ00"ANY*E^GA-UZYXN_W?OGG)>5:NT4!.J_Q M.0Z2IEQ.=`A0+;5T[IU?A.>'42PVHYFLET1[Y6-X'H;7Q:`M7B'JK)*8AXS7 MHN+6CDD*4.I]CKXU80"'CFGJE/K#D9T; M^Y"S23M466Y0/`0YIQ1"M\8D18DR!X&1*<$<2;E?^%83)@/@4+5;C/9>HWF" M'S&"T(`OG'XJD_'9H8RE#LV;)VLDB]U*%1PD'F#`"1DZBBBEI-3'-/WDO#D) MDDC)/LQD1_`Z*#WFZ*,6(GF$R6)(M/1L^$33R%?YL2R_( MP1![;BX*[&P:AFK['I/,CP^2.4;N M)LI%64XF:1>NI?2\;2D&/482;>!,D03ZLGHHUBI*6=ETNA89`VNY0Q`*70BF M)D@IVS.5J,-!9Q!&!_8Z$_N!9^W=Q<`1MT:_JJ7?$'Z0^TR@T8FNY+J9$X]P M^:Q'#'C&)MF4*7DO67AU[Y#WZ]&C.:L")5NQRN;W*`'8\GNV:%?#XX#FMY2G M2S6>V$-C9G`[X5Q7C($B>,X13V$O6#%N3G!62I*0R)^NG]C"0+*IFGL4)$'G]8S_>66!T_HNTBUPQ/2Q;Q+:`%':.Y*LY6BEX]7N@\B((CNJH` M*8O%QKG[44FB\X=W-1Y=PXG\(>SKH$?-,>S3B]=B0N216#^/A@XR954`(X]X M+;P$=Q$P[`?9YH.E'?A\L<<:YZ2]7XNZQ1@\O$$ MI:E88%\!K8:[N>)(.;H%G>CUDV_,`Y+C.8[N-AG'NC!!0DHS`$HSA"OD^=H5 M9E;V.A8,LKC2/R09,^Z!:.ZJO&U(^_9QEK@9,M\*B,9>XM-$&G#%(>,LA`%K+ M$ST8H!6)<&_+TTF@*C$W21W&,UZT&+$H(*M]&>0,(K0GX/P]714U:'O'BKC' MV6XOG`=%WLKQC%S4N,W+S?)-ZN_?+Q^JJCE,]JK7'=/1HE_(>2I(/O,++U:I M`]=9R"2L52>;%_"`!\3F#5;.T^P"R+?9W^!V9D"SJ8J"=.*Y3$M8*:KI%.TG M@4\V`LKK'X;SOAH<5E)JF@R%!)31M--W3S:E$G!-L41+"L%TIGU>@?'6*8>3 M<,I:](L09%0$'HL5"?W:D4AR'_A`>U-/3""Y833QTQ>^MC>/G=\KBNL7.CH$,@V=1,LJHW"56Q>YD^<(EW880IPN M]J+@9(%7?>]+YD/N*/UI?_F'5O2@M_K5E).1GT/96!YNQT,T4D..BR8H#A') MQ*SF&(01X-VWV9=T?H!7$H/V@'^LGECUD82*,HP+6]HZ:SH@5J-"><`%"C)C MD$!R1!>_!\NC3=6@(G'5H?V174QCMI:(O=7Z`.2.%K%SJWS&>B?5,I861VA$ M;N2VH*T7&;RTQBDA.0>F8E836UV(S-+03[5Z&X`WC/^N% M/NRV:[LF$FA5='P.6&%Q)Q6QJ+:9_=85L34\#`7G4XW:$J-I,10B*"I+ACA5 MA4$/!>EO31=^F:9L$;G`?>>#F<9#^R6%>85T-[8'0QQUGDFM M17+OJ,\#=VQ3I5SE%5O>$%?@.2?L4BMS&<9M;^`0&5R\,CJPR7K$N$1[LT6N M,(PV\VJ?>,'QL2M$X%Q=XDB(S5+RL<0*B#PZ?2K$/2!A]7"_;S5WGOP\0F]I M3^(#K"!P0Y)6F::?@@NHZ$LU/E!,2##8$R-6L=`X.Z@T;=^>ODS-J2K>%6!, MHKVI[(#7AF)L6-/75[%F478K54E0BY-*'"#LH+I,IE/:`T7*6'NRNI."O,9U M8?T]7'9?JJ=)+7VG!!,X[3E(;'000^<(%9S*/*-:U&O.DH!APK*?-IOJZ4&* M>OF+0MB+`X1RE`A3M%RQ5'!>.>L.,%!6\P29UYB@>1>;$G5JO)-L254?A+=0 MC-VPZ\1'@U6B!1FC@M618LNA:GDO>\N05V<:9`\".Z#8#9K.T%*S%B6?G1B. MC#JYWX><%ZA$1&<[P7*$R#\)^RE3)^6`CGY)Y-$.5,NO](0,1N6`%=]X+4@M M@5E\Z4Q8&G/E]1BEDV6U'!VPJ*IE[,9@#7XE]CM0X3D:>I5*8*14+D:9`2I:O!Y2VI`4%"<(O8"\3RU6'_T,OP)F]U<%J46\<] M%'"7>Q+_O83;'2.AA/8&(WD-'A**%^0A%"-*CHB MSV%]U>9-`K+^1R(=)S)SQ,$BQZILT;?F#1E!WH)@X6J]EQ@E-!G&O3%&D>R- MX^&P&V'7C<'X,!X/#CD6Z0RI%2X0KAV/\BH:#^)NGUX:]2?TRK@?#Z<3-#KTU-P*O%D MVD7V:%J+R+,Z4CCIT^]!VJ)ZLP@B6?:.QMC;C-0&AA6@?<;PX'7I$8ACWM>1H@5E.BRI=BS;_)$PTMG7 M#R8$>VSIJ'\J]?')!0&38"-3*H^!V1.=W>9`7G@$MWKAMF]J9BHB\E07T+=6 M43"!VG>KJXKV<-W?M"!@90T_\?#?[!L_L5LT`W>:>(CC45BA)?/&9COA`L>V M%YVLCCNM`DM2D5@2[?:XE"Q*.<:::U.J282=+(ND5`^+`Q12QQE\\-I?HTCD MBZ>`$KL`T2ITV09>IC;EUFMYL-Y]!V130HNSTU",8Y!1\UH\*+O+3)307F41 M1VGDT+S5\ZPVJ,ZD<MR?FFFD%*!@;'4#JV*'`GTO87G>@=5B?%B4_@Q8ZA MD,LCS"U25&V"(`$KOY(]&]3K\Y=9DN0NI(\Y<""5K$[3R$W_YGDTI=H]2[Z,!3P2?_6>=7UW3M=2* M_GTC='_8)-@1(TVY9-@QMO]=H]B(``O];<=*"SM>UP'WH3G]K$:TD_0V M`1!T?&9CCEWI"9GPJ;J/AL?=8;UT5]<4W\&N;].RCX8E7UJ4EQ6\4:3'%0J/ ML<6Z:MR.(C7\)"]!@MIVT#0,8LF"L4DC@[Q$`:JHQTF-F*;"TMDBD;BQ:.VV M9RAE6<%266+4SI"EBC-V6\W(60XD?S;C$HM[V7YT`>HD\LT>,XYQ#)]F^^)A M'33,#I(YJ"*$MW3D"BU$@H.]F_VH!=EM6,M\#H>-\5PP M-\@2R>K).'6#9W(*`:S97[1-I;?@<\FM;8":L\5<,D1F46K19LYH8YIV,^EP M8G7[O:T!C^-\*&[+9KR[T%E5##T*[B32[^G(-OD#)^%H>R()[N2F:3#.Z695 MS*F_=W2)X-AS8H5I0=5]0#O0D8>`5-^2ZP%#_)9:91\-3[6AVK!>AAJ$0S%> MF067F$7;H2,5%$9#MH"4BY`,.^&K[H@]%,#8;QBGVPE7S(O:Y,18&?CI2G4/ M%@W<=I[?38N>@C>;=M@)&A8#MS$LB'&V,/O6O'K:)?::>=7O!N)/KQL-OIM\ MJWK.)E=-AU.<$3-AK`E9/O#8.9%M.ND<3KK?LHSVRS]Y&8:60=7ULHN/?Y2NHQPB!AL*YL4R)>-NX+IV_2(#S5NYC'/>-9+:3[6;.U11>)_FGZ#QA*QPHHRQCD9T`Y=,57G[VMA)]L,1%KD0`DD(5 MAA[Z'[3T@MI[UIF+?D4%(4!8N"C-0_6'+&!)G0AUZHN=T8[YF$;!?`8S6,I; M%@UM)LE]LK+!6)$]!F&+OM%LD29S+R\V7'QMWU+J=+;*;E3'^AZD"$0*6YHJ?]4L1[[A#2B6HV\]U]?(G1%G M<`3NF'=P24$O^!&-NRZ\D7)$_49,[SO'7/3:?_[=Y5GT(Y!!RK5]^_8X-JX^ M!XO/TI$(1?+L`)3NA&6-(#S1[Y5D"R2[\M-2O8+,B&H)MH+`JY'S`#)'L%*` M%4!AE7%T?!U''VPS*=H)=8[RZD%I3`X%^DF]$#8B:_1Q('^X%ITV_KP:9=8+ MZS&2VT\>CZ-7TQ$9<*A`54KWW(MD?S4,-;.[HIB3`9XHH(9X=(A+;>XPA'*P MXX'_F&`HD.U-!`?WWM92^*IS0T%$!@4X'W'Q@^;3ZOG1%+_=:9FO.JVJ+CP8 MV@/Q3HI/XW!DOVL_B>BG39Z:72_>CQ3O3&&0X;WSNCI)H!QP3I[DB#ZW&EYY03=:87G469?ME^8H"OKXVKG$N`1'!`LJ_&K:B36$*PY'Y1@N_:*/#+2!#36--]LMGM5 M8_,"&YC:;$UOM./EM\S-(9/K[Q:B%29$HC-G)\PR6WAH"U;UJS%-"2DKK!HO M%JSBP1&.GL6]Q%")*0I]P)=<-;>&QI(!H@:BQ@>OYR.C;)`>RA5QV_@`L%*N M;HMUO[X&H:6_=I!)AI4B"PI*$%6A^B9%HH&JJ\Z,V([C"C*R'X^"E@:N$*T_ MIXT#">O7OYI,>TR(CY@AJ3=4%T'H"M3AT'B"?7#_^IU`Z&^Y@/3@U']0;P1\ M=?CL%>38L%=^"?2BO5PO#Q(V'>]$QPT@4/!X%2VJU7HI70-K))@&5+FG(K1H M97>V6PD.V0E;@@00-`0OG"G\/ET\L%=>XX&-2\"C9$ MZ>)+'5K@'YA"8ZPI/0MCK$^R4HO4E41V2/8SGNQ'9HDD0HM-6X]F(K"N:$>@ MBJ?2V3$&'14(#N70'2.LO38W).M3\\WC2^P;`AMZF]VF-ZML#A>?Y1JB.&'T M[$4>F/4PRR"VH:Q8=,@/8P42BUNP2T8K#1"A@1LN"(0V-A!:VCX.1P?]01RZ M8X)"PS1%96:^6<)$7@T\KH73^RF4VHNC$G073)DXW\MM1#._<55!]Y MDTMXDJVR6E4B^OZ5]*)WW,9NM0*R<0DY?L^]-:K@3*?@S+A3U.P>@\IL-@\? MQ)=UU.M+7";0&XPUW?616^:" M(\(XH;"&V3W?SN&T_7;ZZS&Z'D`;#%J3DFA5Q67D,V!WS4LB+Y9+]P\>M'5%MS3)WG$19QY>B6<=H>"<8TU=9J6[E!@1WQQ= MO<9T&;%`-K[PX8$H'#6D_8`/GQ?L^S_H'1K^5/\D4V2CH0@-C4+<_:7"]'9N M&,:-/(J"D4=Z/3H\AP0^`JDXLOHZL>CR]/J0Z?)*B<_ MTGM,B<)8QRW7X@7#H<^%0B>QHD2E;MTCY;DB+9&B7Y+'BAP<7Y$B;R[27RJ@ M>!\$.1LNAL&V?O$?-B!1L:UB1:4;GN+6,"YBY@]K7@8GZ^D^4,A(7EP\R@3% MHTQ;\:ASE_VPAYD(^V9+$D3G=V5C'L2K:!Q/)UAJ:A@/1SV,RHHG_0F'7EQ=[1M[GM'1]?7EV>L/UT>OWYY&UQ?1 MY=$)/![C\YW?747PTKN+_Z#PN6ZG.P;8G9R]_7!]>O+O@E[E,IA_(_2.YN@\I&H-%4\9W2V- M1Z?L:E+9.8*=8H)AUB',M!L-)\,8A&2@B3BV\=N6\]HI)):" M;*D"KOA0Z,+3E,6#\]8_4J8#W.O#\3CN]T3830=]^,1G`W,LS/2 MD:<7H_R2Q6PC]IQYMMAH$2M!((3+GW:'<:#_L"' MY`D/]._$Q"[_&#E,I%HIE80GTY+P-&0E4?OD+!8!&OE@=VB@-/>1F+.&,"GX M"NG"P1!,A=X;MU_M]<)!RUQO)'J4:F0PU3JCES%COG7][O0< M+UGTT\49_/(1_OIP>5J3ODY9TG_'E8C.;/D1WM!/)#-_5)FYG:N]8,KHRW+Q M??F0S-+__(;JOJ\^I]_\0>U%ZS2G2FM.<#<5P9T[PTA>MC2/=0VAVI M&28"U#\8=31\]5$ZS1:UF2MSOK"$1"T^_;4$V"<2[59)/,20\G[%CMO>FG.[PDU=4T3[,%);F2*D72?TJ?O`!5%'UU[CJL6@\HQ$`) M_-B9=7GYQ&VH?$6Y(B>PNN\;[#OF.+`$4RY#/!KUS'F1AT;B".2+47]LFDS% M>Z.XBZD0_EO!]\,^R%B(Y*X`J)UPA'++U+P.+)%BLB,H&J6!C@N\BOKC>'@X M,,>\(Y>*GDMM*&R%3Q\5=A/ M.$07!*5#(^4%7<-)'X]V(V*J'1E74W4R`J(SX@27R6A*WXKL!2<\B(<3K+(Z MC2?=7BWTYK##PON3"B0GG4A_"@2C:$$E.\*FK MB_&9^3KEW?DRL#0ID&*2P5>8H$KBJX9'2'S$M@(>FGTM0AM3(LW4\]AWN,I> M'QU4Y*1JMDQ0@CY5'T5;C@K4<2!"V[]@NZD$Y44K5%^\]C\B;;]>O:?*::0*A0^%IRP_)E[Z=@L$$Q,O)5:>2@R\Y>61:LSAW;X3`4<3"AK M4FC(G\?5"::'&'(R]GSTNMF&0P51D.^4(3\WADGCD3+ MKGUP2:D)N!B-C)089+\WPM'='2`/;,-<>(>EE`PMCW(>Z/-#J^T*^]K/S`>+ MW$2H"+&O^!S95`F"@>%^B))"*9)!W"#?PE6>]N-1%[G#H#.:F!_D"OWRO]&@ MH,N?1WN]N-?M4US0?@1BW]04QWRKCS=[[LU-/`S MQ<9AY[`?]5"=!YX%,L(@'H\GN@9V:#=&EBLV#COC8=3M3"?P]B&5DY\X*.-= M%P@RZU;G#`],:256?V1&(/F5V#WEBWM=.#^1=5=E%]3X]2/6G*1L7N"1%,=+ M2"?AYXW>-DUT3`,\B3D*!1NX6*>U,^5D^0%\@#6^TR>]'/M2/8`L"JXCEO4@ MRB#,+*C,$-X-Y1VI/6:V3^B-\]=LP=WA/-T:0*B>!K_GQFN^7#M(MPTEHJJ5 MCUZ-G!)0%>>W%*TB$6Z3>P6XZ9A$5O$[!&AVGA\1@=Y$L1'J;LEEWJ?0$5LV MNZQ7(K;3(2,P2=W@+T;+FI:%N8-TGUW>&0*/<.N(.61-E$#3TS(3/+8<'6.% M6BQ:6*/NZNB7?T@BQ+,B@R9H"#SA:1`R#[%#PR3B@3P.TH\/^X-X`,?*7_$0 M<+$^9YP]R!"%.::@*"9SZAW@%3(T]P#AAQ?#F41@KQ#(NP+\.H M7L.BK^<,!\H)C.4$EDDQ,#XWZ>FN&<4OEQ\-A/*07)IW#KOG(8-B;#">@$W(2^[`S&IDW M]A#VY(CPJU%G-)6E;8>_'AL0YW&/7NSW45:WG7W(_><%!N$=P#AYADK0)4%I MJTWJX?()GANL".-?",$I@J3$Q"A)]WU6B'V94!RW55@3>0PN!S*DR4`OA[;@ M"S'>(?N>O3P*.UDF78J@.LZ*%%!Q1.S'S\A^)I3]V,""S3>&\>APW.IK="6) M"UMMB$F'+03FW6<5Q'U;.NG)1LB-)TL.D$_'XV'/[I"V[9@8DYJ:77R,&2-G ME]''H[7TB7"E1*ZL70Q1$$-\GP$)64/F[7XAK`0HKV<;L@.Q2K8)L'-'0$,EDO,B!;$5'V'6)%CA?[7WFJI>B*6 M#N""$5ZX5..67&Q=D/0<87CN78%I;2:@&_`U:F%<^XNVRB)3%A:!HZCFYK/Y M/GI++_=^^7\1HU2,+".O01G(6=SX89,GFEOZMTU!M8!6W&L*)R47F+U2U*68 MU$VN),.Q3%S6FMKZM31>X.7T=UF.G"W;JJA(O^RE;76&8^)1>^U0UXX&.ZBS$!"2U8M>VC8.KQ3'^4Y6&`X=I:'(W6L22JS"^4Z M5[I:[EBMOE`73ZJE>F@%"#VJS%W:EBDV6)+;T6$RQE.&X12SS>ISZG5?063' MI.2;@DNKW_@`U+)!:/_3LQR\X"SM46UR;U"J[T==N\-Y@\D^V+KN5#F5 M&&HK*-3#IZB<$,RA?TB-(=EP3:[;OM^7;G**KOQ!_<_!=`J_==L63LN=Q)C6 MZOVJU9&N[ZOEAHT<=WOY@$81EG(@1G[5>*<+S:EABL^-KLEUC`I87M1F,G8F M+:/5HAS\[+520=G0;B2H"-I2E3?VFX+%C>'V_%Z#FP29C=L>*]^^&*Q1`[82 MPR)A!5>"[9W&2$72U`1!,<^K["Y,PRBU[[V+!I!H!-54I0$-!5F[JGG`\VWH M"C+]QQ!:405:5B27@G>4`^%G!#3N.JKOVC1&Q06TU\HJZ`I',VS:M*(R;/BB M!R$4D7LP546[22>Z^O#ZZO1/'S`"XO1CD_AWM0&R^[<-CB4%4[;X-YX;[")W M=44..1Y.R\O;DG9<>WZ=4+6OA5^]R,N/\;(:-:B9NB_;9(*3LQ\H?+(6X&Q> MC0Z]4'P*#Q*D][*2/`U!?':AZ?^:0R1HP7Z-.&2\M5HU#P6(>RR!&O&1'V!O M%5>P444X43EL_S3;[^>PJWIY4!3?ZHD"H""/[%J3DB11+)G/2],;4]U"2O!2 M/`U*?6$P.\R1%20L5V(R1%2UB6#'1.'@1M50J]>)SH\PCB:Z>!.]_G!U=GYZ MQ0GH&(AXA9^^OSR]`B0A#UBT]UZ:U._7`K*3M7CB7OM53U]S0Z3;Z#T;,VD[ MU7==&T6SI8.KET<&WP`NPC,P:,&MH?7IO7>79_NQ:Y&V+C3)+-H[OH9O*)5F MA0:U94;1+]XC9N_]*3Z3;V9`*E;<;!HV@WV2O62UC9>LYBW81;7L40H;XO5B M4ZR*N*XQ`2@`?<@?$9GY2*1[%)%,8[+\F=[Q#=U?W,5?(E_:PU*$Z19N!>MS[KT1.C4)8DUU2>1.NI[L()? M_EFO7O(OCH!XC851@`*Y+,UWTG.<:%=T=G8F+;-<3QHOQ(MRI"[?_6#=JBWE M-.U6C+>50"6HUSD[TUHD#5_YWW'+IR^-3]LB`-HHMM3'],QK"3'ZP):<&0%M M)95=GPIG8L*/+4AB@VRCN:-)EC8?(E?&L6*$K=+JTMC$;*%-[FP73996DM+0 MX0.W^.5?,2#"8\H_-R7_!#K[R[^T=-(O_SRFCN=/\!&156JKASC;:4R5,,=4 M9)+)-B<*'"-B76G!*!P]D"2@BA0SDF+#D?:CM333?:CH*JY1!'8 M&NB"B MOI10FYJ'V"RPMRLQ.^#)&/^W0E8U:VC:CAE[;%?3EHE2"5JSHOQ.8YH?16TO M6=(C4_]'P!#2^6QRR2G#"V#^\>R4;I_(TG+E2$2!KX@_VM@)K"*;`'G_:T'% M"S\7ZR!K4LL=T7M!5A=5GJ1.8QG%9'%_R!F6`>J$]F3M7>A>BAI>XNH.,(^E MZ(D8R$C.AI5PKHI8BJ3/&#J\:46?%1YVZ5(26Q,/MP-8SP;F9ZK5.A[<5FYJ M![PLDEZS3MK9<38J4U6V@>+[:*^W+S+9(X?#2$E&)O$6RV5Z!AI`98D!69[- M8/&D36+E,;1KV]KM?LHBE2CK\Z1>M4=4#V[*8G5#[2=HQEA(@Z$`$3^'4SJ$ M(9]$X6[2Y;S39+ ME,UG09FP[]D5D>*TTCO%@Z1.SPOG`N[RJ6L]KWN"8S9^E4W)Z;4RH`?N&B*5 M?D&U^^(1'WYB5X)7SYK('D":-2.FXQ9\AN-PL9`^AT;3%1"*Y4<1SZO8D/LP MH#+<^ONMI&.O*=DXZV&D-AEFZ@I#%FZ2W6G9I1 MT'QT@60:ZX=)CF.&.*:J**?2D6Z$&$W=KD]6.@V2(SHR%>_B:#K]5O'EOII(KHK\^"5F/#JE4@5-B^:U].NZ.0V MB;\O M!R%"&-MEDS*B12YP\^!5@]'O08-E-=)O]N7:9$BX/<)`E1M"=NYU0?Q<6ABH MZ02=/8:M/4!W4,"EF3V<):$9-E[O6R(<3Q-K;KAZ9)I3T"93[!",5)%4!1$) M,'1[-!YB9LRVJ2`F)Q+7;MP`GK MDB?I8YZ;C!IR,$)PB`IVH`AP8)-[,FD58^6J4C2WKS20AER@!4-EYD#I$`G< MO,8$26S>^:GI>U]]B5K4%Y7EJ5ZY]>O">HC.8"'9[K'C$ M7!*L5TCEFX*KY_+1R:KQ7;OIGXK[//H8':\VI+&@9H7$7TLYP$TS"E(EXJ@0 M+E,-BFJF\U)GI\?@I0=Y117R7Q&&`PGML3!VZ;\.\%XQ`P=JGP**04V9BL%@ M(QDHYD[-[`/#3W9/WL70Z&65$; M(![,*M'FEU`[=@L7D"MF5/?B8)E0KR$O5HL$R_RNP(]M/QK/8"+88&%E86`X M]RN,3]&HZYO-_(YC-YI?[K1\SM([!T_EOACJ4L?8BFLJSDWFZH!@>.)+#"V3 MHBC76^`H53MA&E+P9_?B+T3HI5YW*TFAD*M*OLQPU5SM'RBTT^TWI=]851V4 MG$[6LG<W@&%6+/A)+>GLN)G;/\Z"Z)6,9C(OHP2` ML%"1DR$H4G/!W9&P.$2JM7B]L#TLX%7)0NH/7/Z3H>`Z68T$]WA'$V1>V837 MK^PEV)`C99Y9'H=G*J(IM'Z3^95N844'8(@>R-`KOR[;K'$N!:;P6[%A%;K# M:N/`Z21L?\&AN7"XBY0SE@6^!DM<:UJ,7ZIN[9_T;P-UR\E?C<>=@0G6._:K MSMZ46 M`VN^ZK+T!V//F\@+[@V\?,X=KXOYVNNR,T1^@XV+.\)R6R=*RKHY"TE*$8BI M!!TJ9``G/U(C%KB8!!J6#?0DMLJK&O/`X4E!PHN+K)2B?.*>1YUOZ MD94[].$UKH6KC1S7W5;"^X&(5H@^H/&X.<`_WE;QL.+4GE2OQ]2QDFVC2LE# ML=K-5F@^"Z2R4-)T1ZK44,Z>8E&P4[U*(%44F!<4L269>##[JDQ5F[)=-UWK MAS7%O'!_2JW?ZK5!]6V?0++0DK`AXJG65`Q+NT\6MUQ.\:FZ',\TT1A^(@8) MH5\-O2]M'ROG;!-W!QE22(;':>N$-4CK==^KSY\)A11,*S8>&`"G/ MY[OE/6L3B93NF]!9SV4H'M,&#;9!H(41C9B_N.X>KFJK!NAN@&_%]<+A*A8Z MWR;GW-RBP4G?=RHM[<'R,:7WQ%DUFXZY7[U%@WHE&QM=LQ+C8`#A@_ M+?6*$2&BO"E7&J468^`\\;:KX[;2&7B7&A9I,+^"^Z-NI),[:/$N/*3]?%QI MVS,M:.&90[077/60?%45#3+U)>D1[:V?'A`!@+8-NYS`L]^)/GBE'/UK&_LU M)UW75^+'EH%QV0;A2IO2QMAM:^9L<3>`A!LS0$\]\2;6RQ'C4CH3EV+\[%F; M-X4+<[VH,*I+`JV"(%`[JI@9`&$Q5QW-I\RUA+`$(=PAA%'Z#`[4"I(.,963 M`\PI#4YJQT;M<+/X]C/[*K<5$6259LL;)/"B MI5>ZOM7O1AOB"Y89O&29@B<`Q@LGBI);1/KEW+"<&$XU#FT"30&K-!)%&7J MD;>L0E?CQ9Q09C9Y`@BV9B%]:Z2)OP8G>%$C"F8!7G%=5^Z8`S5=X^4W M!9">7O?@3R3-76X6B%\'W$?KTF:@1U<'?XZJ^"C2A0:X)"0GD@_6-H^Y+8HU M]TW*4V2_5*6974;D$-6("&JI8UTTAEM-IW,5F3+7%6DA=$HKR3;"X_=>PV\) M6GT`BE=8O]W2BR+"=7-&A?1.MK7;D0CFN!]$>@SN)$N:]VBX*/!BXVP2 MB5VDUGZ.M7UUQ41A`X%9J%=R1]B>+24N=P>MT$,)K'BK[<^:IJ2UYT^5.5`" MH$N@F\S(XSJG:)C/GNC&0PH`D%,B0U)!0,=\"3*7]U*]S&#U9=$?_KK)9U++ M6S#Y^8$D$XD>8"PD["6>DHO/1ZZJ6&`Y&`BY`MX+`S?ACY;CX+8$[K7@\A@6 ML&!VPNV(>H>:IH=>.*[H48O7O/),M7[)7(G*?.'C?F4$2<8DF5BU/QOK))?8 MPQ`@LJC3K(C&2FJGZ+B^.=F_C3KI(XD+;/00\_K#@D`;FVVPC0+8WF8E\K#M M(/8@2=CL$QO*%4''EY4EBEFWTC.&@JU<)&Y,*37-=-?%1HO2,9)J#/=@L)_W4IO/9\_;<)1 M1,KO)L^.!,(5*O88SXU*5SCP#(0J4,S8VF0X$693NCAN7`V-U1HR$.H,QEFE MK('LYJG5NX`8C@Q"PIMX5J9VJ"^RDDR*?NFK[06U)D"15Z^DR$7&2<5!`!H& MJ%>\8'X40H,OJ`9I*_10+*_=@E5FJ1QX(U!++>BF\0KATGV/H.-IOJOL5JAS MV,2E[42,%34E*"!8N5VO$[:IR9\`VTX5AWK';`'TJ\6'">2P+/(\7<14T^M3 MFC[@48C]16F:.QF]`.PHXG!39-G!A+IWB@2G("&F-63!*=,9(AQ25!;<'ZQ, M1!:SV2JC3SQT('4SS;6<@@[/E>#%O97,@:"OLY)J+[/VH^N$M2T++?-O0\$Z M3:0(+J/?':=>W991G0F.T])65HN;5TM,NZP\38R9:_EL;RP-V,A6\P.R#1@F M64C.[6=*QE2LO$WG9*>BA,$U17Z"H$B\9\^ES+,+7XI(\Q_4E16C_)?E?BQ7 M"V4KY'Q4IM-@L2XBML+)3JC;4M0[(Q<'ULN507(W+S8W:Q`2K2W4[/&T MSK8.3P*=6A=\F=WMXUXL&088[_N4-L"M6:&;9\)'-* M%JYZ;BG9>9>*B:IO8=U]FZIL`>,ECM&Y5?.07U;=/@JJVT=MU>V/F^C9JZ@' M,O2D3Q6PNM-X..YC9B[5LL*L& M%.=Q/.[UX=])OQ?U!W%_,H[Z_7CW%W.HE&0YAF,(Z&TTD\&AR:]XHJ)D25/0#? M8!#M1WNPX0$6L\&29/WIB'[KQ5.J3WK>XOOK36!+XQZHB(-X='@8C;#`T[`? M#<>'\6C:,W(/S?9["#"83/'`X^&4$\0GW6@TBH?]0Z\RJBOCV:=:+YARWIL, MX^X(R[*-IEB=!?$`=A%WX1RKVL_[X+*\3E`O`PCL^%CD4@')JT%5$N0L;$AK MDZ_-0Z%/N;B\$S<\.1VHM78YM\K0(H]G*.$&%P4-IR3BD MI'W_[&095D+<@@.#,=-<80Q-6P"5@H@X]I`G!T'RA%T&R$>UIM1EY%%P&`=, MYA<@EQ[<8-8-$],XS#!T60'$=HX"O=SS/EN]HT;A5%,P9/XXL/I3R"A!JGG4 M4"R6WQRW9->1$!3T"R,EN^/TF?4:.S)[Z5G!F,R:[9S&"HXWGR M-1*]L&&RYN>16:$%"_$./92E1#D83R8E3[E4JB%IX@E-?I)T)MJ\KRDJ$E3' MC+:.*?4$2.Y6AB:'&=F:'I+8N?J6&]` MI""1QHU7J'U\AN'&P$]N-B#VL\ZT!0^XH@YUR[IY:L>":W5OT5ZXA=B&2S7Q M:L6B:9=EW+)J.V65,@!()+HP M+J1L\.F6X$*)WV=5"M"^6*&YV56'M,C0E(6+V&KK,(3*6[>4`D)+ MFU>JB%RN-AO3K9OD0B3)L+WLUEG&8RT0Z6HXH*T9WY0,*[H`L2NIY*1<32B, M]2+7*A\B^49SX,_W6,UKC0$:5-V6FAXNLD\II50G.3>1Q8OFKSV5CG;PI?&& MP_!O5[+',8`L;"#H<:`Z0/`!C+ER_*;.:["O"'(A?=M'`[\41NIKG%*M`!Z5 M-"P\4]]6@H.@D)QSF5!$PCO).K$AM?B5YC%R>D7S*I!<-8,RA'_KQ9-.9#`= M%>_>]3GY%[>K7Q@..Y;GR1:R1!3^NR`-;15S^`X6*$!SN*#UU2^PT*TK:*$. MRT7A*F\'E3R(NMK+K*Y&0UDWTFJBNI=W:8)P1>46BR#9\M[MSYG@.>>_QT9G MJ/WF(`J2-LK5!BY3KU_%T8QK_'5!E&(8U%T#Y%*5,M'UR1K-O%=&?&]-: M0Q)J%:RXE<7M^I'/\W.Z*![$6@'KIZ":/)DGOFT:Y<;"5HI"U-MDU(,1B")U MY2T_V4E0Z"==F5NPH/_7I0Z#*_X>BY-2\KI;%%R>-3['4>>4'(L^$BHO MF*)Q*3AG#`NR*>)DE"5*+Q_#\S"\+@;=$PI19VS%Q&[J1A+&"7#///56DRN` M%J2GP"9R7;1VYDQ!X\ZTF")ANRNOV(`!'(NGN6@:8(#BAO%JVJN(X%!EB5T- M40XKA:RN,>M3PO9!H&6Z,T?&H<#RPKU"X%#C$PR?7R=W^H@1A,96HI3/*Y/Q MV7$[&/80WSQ9VU_L5AHT_,4('K+?%!'5_`'BFGYR#JZ$>2()Z#83F\_32&ED MYJ`VQ83?0?$FQ^)M[!O(,+LNR9:>:X+()SE??[:U+.1@2!@(8./@;4TUY@<, MP#C6MJPSV"J6B\-8DX4Z+S']?CCJ'@RZH:2!#\;<@X#NIA0]1$N[BW]3[M&V M%$,]R3A\PUE8"?1E]5"LL9>KW>/I6F0,G``.02@6))@ZZ'UJJDU2_=I=&&[9 M\QJBOK"B;MP:3JP.#*-]XBTTZOY;O7TG'AUK8G3-WD)]W=1>EW_%RJEMB?%% M(1?AHT?!5@7*\6*ZSN\3VZ<5KX`6'6IXG%LDX43)0@-%S4P;7A(^ MB]`\EV8&6/%J3J>F="DA!2?ELDLB5ZM-S)%?[9"E*=P)L0S\80,3MH12^0&' M%[DFX%HB2X7\SZXZ1E.)G$$979^\T'D0I$A46@%2%HN-B\9`E9"P"=[5=`&- M]O*'L*^#UCC'J%POG([)FD>P_30G.LATKGW*9"V\!'>M,"H+F?"#I42USM\V MR_A)J\08OZ9,C?MQ;>YWS/_F*;DXYK).`28?SPV(D"Q0VG@6K`.H?8?A*2YW M]_HI+)5E/._:W2:;>W6.D6X-@&X-X4)ZP0P*,RL`'@L&1=7+EG+Y9"H8@F3E M`T8A5)I#/)=#$=M@3(V91:)F<]\Q/#.;49UV02F%"S^I6*`WY)GN&=9K7Z%K MP^&`*AUFN9(B;=XLTY-*JJNJM$V/;-MTA>:C1T&9;,"T#VJC0&5]0ZJVGU+. M%?6X9+W">49'8,,Y.*&3\)9C+$1B(#\:#'9>87] MFI9!'C-">P+.W]-5L;44/^`>)R.^<)Z&Y@`C%]1OTZ8S-*IZ^V=5)"CM;ZC> M9'=,1XO.,^?.X=YS@K=-U('+8&02=:R3S0MXP`-B\P8KYVEV`625L;W-_@:W M58LY'TN]Q7OV2ZG4.JIT9FDRM7-ASVNF[)YLK MII-/5ZM(P72F?5XYMZU3#B?AE+60)5N_/(FP]3O7D&8X2+H+(TEOZ@DR)-F, M)G[&RK.Y,%Z05)@B)/-[_5+]]JBFTAZUL3GJUV7V$83\S$K:UM!+SPJD+CJ) MEE56FKAN7>1.+CMN,V^I/.#&;>QFP-/6CVQS-$C15])MO7QK]5*7N.1H>0Y`(W&P*G^2+/Q:;*B& M=J)E@:G^=Q#R6Z_M8K==VS610&M$P.>PT\V=%$&C>S#$I>%=SA(B!YEZC7#'-CO.%=NQ%2UQ!9Y[QRZU,I=AW/8& M#I'!A:B'W1MX;[:N&49.9UZY&R\?(G:U)YRS4%PQL5E*"IZ8-ZE5]%,A#A;) MI(#[?:OE$LA3)O26]B1>U`H"-^3EE6GZ*;B`BKY4U@5%#ZY8GV,C1'7Q::4& M>_HR-65>`,8GVIK(#7AL*;F);A+Z*9:JR6RE$@YJA%%\!`0H5>K()TQXH M1,G:U]4A%Z2RK@OK,>.ZQ%(P3SI*.,6:P&G/0<+A@^!%1ZC@5.89M5.15JYY MI9NH2Z![>I`Z;OZB$/;B$,ILX6*ZNE;L=M6U2U@5B_>*S&O,R;V+38EZ.MY) MMO6J3\9;*`;-V'7BHV$3TO3V%D.YU;%D*^!J13=[RY!79YI7`4H`H-@-&O?0 MEK06PP$[=1P9=;J$#SDO0HR(SG:"Y0B1?Q+V4Z9.MH:WI5^N#^!S5,LO[H4, M1N6`%=]X;>HC$7%\Z4Q8#77EJIWRR;*JCRYL5/\R=NNP56`E%L:R6'`(^RJ5 MB%2IAXTR`YQ[3"7PV.Z-CY`JH97@C-^^AY:)3?5XX;116ZX)8/V9M1^OAE]! M)8%S3;KS$9.=?"E##SV3MM'%8U92/P].S-:,@)9LD"`'O$7L!6+YZK#O-VDF M?W]P6I1.B;X=WN6>!-YOZ9`W&A_%XT-H\XI4TC,"7 M1OT)O3+NQ\/II*T3PRO;=0%>Z<<#;,1,?9S'\>%(XHK@[\/!..YW,6YHK]>- M!SUNYP6G$D^F762/IKTU`ZDCA9,^_<9C;8VMN=26]$RT-,;>9J0V,+R(X;UN MK],?&:NQMYT),0*J4TD)1LL'N(G6GD*64"_M\#/&9:_]1J''O*\C10M*3UE2 MN>#4-D6DLZ\?3`CVV-)1_U3JXY.3),'&+;=<$0537CJ[S8&\D)L'V^V;FNF+ MB#R5@O0M8$&A^NJJN%?E-RT(6%G#3SS\-_O&S^47S<"=)A[B>!06YI%V0O,^R;FN0IAS8%%P<[+_O) M^R1OLYCF(H%1E+2ZJA9`=B3&JU*`^,OW;$JQ>Y02+PUX(OCL/UOKB&$M M\]\W0O>'34*M]5*N$G<,3V-*8+)PO4'1(WBLM+"C01NP>O>AD7XE6"HQO4T` M!!V?V9AC5VU$)GRJ[J/A<7=8+]W5-<6[L'/>M.RC8CVX: M1LQ'+:,-J9I-Y,.Y]*WW]L: M\#B`B>+8;)$#%WRLBJ%'P9U$^CT=V29_X.PGRIC'"'C6`X^T;^#I9E7,\8)C M=`R`8\^)%:8%5?7XW+7H*WFS:(6;@D79R3AGH%[EA08P3Q-E?YY50!VT(RY9U`_&GUXT&WTV^ M53UGDZNFPUGMB)DPUH0L'ZY][732.9QTOV49[9=_\C(,+8-;,2\6SE8@*.JO MU5>=/5S2*CS4R($$Z#ME'6+-6+!L@`5BI>0V<#536SS'Z-T\!3X(R7-D2:7> MU>4?KLL6(08;"N;%,B7C;N`.=PVI`\U;N8QW**P&\"%(-?2<"HJPN8.UT^#8 M%*AG^A`UOKIYTLA$N,U2QZK:L(84!9IK%5=W3N(E[DT@BJ6(2="TCGWWC10S M(-O-G`MHO$[R3]%YPE8X4$99QB([`,E1_**WXN#2(!@J(G=&.^9A&P7P&4X?*6Q8-;0K/ M?;*RX6*1/09AB[[1;)$FI`A$"G.!IHT.]@:@ M'O0HCET\B,WS,IUC4@)=V*I`67>POKA3US7EL=3Z=%V!CC'?+(*D!R_7:"=' M[7_GH/UW#MK_S3EH/HZ3'KT35O^W*6[:K8$2*-'IT>7YV?D/5]'[T\OHZL1V?GQQ?O8)=O+ZZN]HW;]M'U]>79ZP_71Z_?GD;7 M%]'ET0D\'N/SG=]=1?#2.Z"\5]<7QW_\\>+MR>GEE?E9>H8:[1DJ\<&%ZVDO M+2Q]2WNMO,)P$..Y=0'M@;0=#H&4=`_QT_X0PT[Z2/?&`[@ADX'!EHLSDU>A M1@(M3;8M5J(=?MU.;\(_>OR#4+/;Z8X!=B=G;S]W*@A7/Y)#QL5X]C& M;\C&:R?/#_F2J,*.B`K$GVG*XL$II8]$38&0'L*M[H.VWHL'$V!&DV$T!>HP M@K.!>79&.FTW/DL6LXU489EGBXUFNPH".``0\$#_3DSL\H^1P\0J11IU`+\^GEY=O\-VMV?GT4\79_`+MKT%6>JJ MC9(U#@8ULC^'],GS]2( MC=IQKG"*'45%S^!F^)RI^0U7/B`'S*?Z9&*4@FM0V5;K5D+'FN@+M1`O\WP8 M6M5#IT"\(A?C":SN^X:X+',<=ME^16+EJ`?*FYG51?'*QG:)2$A2-.N-=`S&0L$`B.1R8 M8XX!\VH>W]AQ*-=S)L$;H5O?C32,I^.>+,N?/=?9&]Y1])/7;H*5<_Q&^*IT M3`J'`"$&I$?)TG6EZ7T\VBW*3Z4-X^3/R0BNYXB%L[4[=-AA9G8`@@6P1N!O[T_/KY[1SCR*KS69GG:Z:)95'@G-KWUP2?9@ MO(:JCHKAQZ\$='1WMTJQ`HNY\%CJA;"@]]@PC6GR6\R//$-BE*.X08E$AEU, MP%O?8YF6*V8R]`.OE>&ZPR(LR[V*&^@H2/6@XXRZ"-M!9S0Q/Y"Q:`Z\#=F; M+G\.$FSU'CZ:\Z9]5%*!3W;&0V!2H*C!WZ2X M3FJHFB.I?)`31RSISD&N6%(+TPZAUWSD46N MO_TIT,Y#^FK4@?O(2]NHN-9\$A-2(J=P".,>O0AR M8/4$QIWHS='99?3QZ.V'T^C=Z=$5B`*5/T7G;%,O4?4>#NP/4C7;%,L>/D5J)@_N=@.H7?NFT+I^5.8K0T>K^JEORK+6PG6.YZ448' M6@AK'W[]<'42[;U"!`5N>JUR1'4NS]AUIL:N>MHWV[2:/\_FU<_%-MENZ?TI-A]TTUG7+,@N-B'6\0.$@>V/*1FL=9' M*ODNU>>:KT>-+3?B5^VI^V*UYLK\6,PH^I_OZ$[\K]\,TR^\(9\G*]X6?"] MZ=IY,=QUU"%7`;G=JM]]<.&%K8C\-N-R@N+;U(!'CQO7W]`,P!:('[O]:3WP^$H,3*A M2K2V6:4?--<`BGC[SNZIE3`UB835WBZ*@LQ/($=_RPZWUC?;G>/=SFCP;2VE M_KT66%Y1<\99C8&;Y`$I,U;\#UXP*JO.RZKO$\X,T)QF2)T5L\%Z$QL-(0?[R*5.5\^ MOXWBUDI\,SU.@TP]^/$O\J@C'FT#N]8UOI'GU;?^?H0';;WC3O=YI.Z[@70X6D=! M_%"85],QFQ8`CLU/U)+$^Z[SFPUI75F573D]%\ZB\(O$$1"@V%Q`KF7?=F*[ M)[Q*KWI^%BO74URE!V$<*"=*47H(]R4A1A^M\$;3*ST?)V%Y(8[>!FF;DMC) M$D-#W:_GKVR+;O>U5VU;8*_F$ M8S[4UBBC"/Q$4^!D#&*&5`N1A%MIT[<$'I6LB]43O\I2!8=L\^R]Y9)OIJ=;\]*\5B[C03^R%VXYFG"KP;/!@Q0T2W=R.Z1;P[2;CN0W#>JL61[0XGA\]O;L^B_1 MT?&?/IQ=G:&V?_7KU/UDL73JUG;R#&YH\13_B36O=Q#&F M=&I6KC*^NF7L#98Y$$=9'0Y*)IJ^_3'!$DAS76WM:RIF2(%GK6M\B]P7G==: MWE#B],6A5M^2[1#:.N2IZZ?8,HKM)NI*&;8!&HUY$LE:_4H*X+9-`E]OEEBT MS2X'`\W:GFKP9]8>;6FBRZ[`T(VZ8Z"2W*7P!GUG0R]RX!L9TO?MUZH6@O05 M@0NUJ]H<;A3]FH"9FFVJ.7[FA=%'=2)39K/HMPWKJ&G+;0%%ORE\VH)]HIV" M?9I&^VW">[[Z'%\:T%,#>_W9?\/A/AN4([?VX*<@^.,%;-":9$2+:J*@ZZ=Z M=,[V$)<_M(7IM`R_:[!.[76^B"UKWQEZ]2">W2'8$`!T6RWJ4/=JA8$N!\\\ M7@^->>Z-IIB9%\SRDM?8E>$%V!QL?[X6=K,E\*7N#6P/OHEV"+YI7OM7+D9\ M."^/Q6EBFBT>B%U1^&M$X+H_R>N,IPW725=9/#U_%;<&\>A%\T-EFL@Y+I[C M.B20INXD>NA8G4&VZ<04_K?V#BXKJB^KD1;BRC20[;^BY@$U+*/M>Q=VT_:$ M!M_X$3>MHS&XGEM4)/B@_RH((SLJKFLN=%J?X0%=VM0[_4TMJX_:'S`1I6YB#&.^VA_ M4&B/=[/^*WKUW..I!X>&QW>YS!C-\^ MNGGF+O#+=\]<4WY*1-KM#[D0N>W/!>M-`^'DV9MXL!W9T-Q4?76BV-0[;,0F M.[1*P]1$FS"@`9PO>ONN\7YO?X=!_:)7+.!?]%:Z52S<";F_@I\>>_*\S7BM MJC(^UY,.MQ3!6+LLV[B@N\V9I1*-03L?[S([PZN M;9"5NR#MX^X6Y.6>WRWR\'$9P+ZYU MQW4UO+?;`AM>W&VE.R#SR^CF=V6Y_L/_!U!+`0(4`Q0````(`$*':4>0&ZUD MM`$``(L6```3``````````````"``0````!;0V]N=&5N=%]4>7!E&UL M4$L!`A0#%`````@`0H=I1TAU!>[%````*P(```L``````````````(`!Y0$` M`%]R96QS+RYR96QS4$L!`A0#%`````@`0H=I1TOY$!F$`0``@Q4``!H````` M`````````(`!TP(``'AL+U]R96QS+W=O!ELECX!``!I`P``$0`````` M````````@`%H!P``9&]C4')O<',O8V]R92YX;6Q02P$"%`,4````"`!"AVE' MF5R<(Q`&``"<)P``$P``````````````@`'5"```>&PO=&AE;64O=&AE;64Q M+GAM;%!+`0(4`Q0````(`$*':4?6&H]Z30(``'P*```-``````````````"` M`18/``!X;"]S='EL97,N>&UL4$L!`A0#%`````@`0H=I1S.U4^Z1`P``.0P` M``\``````````````(`!CA$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`0H=I1WM5/*7C`0``9@4``!@``````````````(`!U1P``'AL+W=O M/,^N-D@4``$(< M```8``````````````"``>X>``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1[?B<2\[ M`P``A0T``!@``````````````(`!=B<``'AL+W=OGSH;68P4``#`<```8``````````````"` M`>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1S6Q([FD`0``L0,``!@````````` M`````(`!5S(``'AL+W=O&UL4$L!`A0#%`````@`0H=I1TYM%'2C`0``L0,``!D` M`````````````(`!"S8``'AL+W=O-*0!``"Q`P``&0``````````````@`'E-P``>&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1QSE6C:D`0``L0,``!D``````````````(`! MFCL``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`0H=I1]9Y24"M`0``%@0``!D``````````````(`!DT$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1[)$]:FP M`0``%@0``!D``````````````(`!0$<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1_566?IV`@``*0D``!D````` M`````````(`!F4X``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`0H=I1\6KP!0%`P``#@P``!D``````````````(`!B%D` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` M0H=I1\^:\Z[Z`0``;P4``!D``````````````(`!'&(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`0H=I1P^@+6!8`@`` MIP<``!D``````````````(`!SVD``'AL+W=O M;```>&PO=V]R:W-H965T5 M7J1UG@$``*X#```9``````````````"``0EP``!X;"]W;W)K&UL4$L!`A0#%`````@`0H=I1]%Q[EX,;```&78!`!0````````` M`````(`!WG$``'AL+W-H87)E9%-T&UL4$L%!@`````K`"L`GPL` '`!S>```````` ` end XML 13 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

7. FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands

Sep. 30, 2015

Dec. 31, 2014

First Lien Term Loan

FAIR VALUE MEASUREMENTS

Term loans face value $ 384,176 $ 399,750

2015 Incremental First

FAIR VALUE MEASUREMENTS

Term loans face value 73,026

Second Lien Term Loans

FAIR VALUE MEASUREMENTS

Term loans face value 180,000 180,000

Level 1 | First Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0 0

Level 1 | 2015 Incremental First

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0

Level 1 | Second Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0 0

Level 2 | First Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 383,216 394,753

Level 2 | 2015 Incremental First

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 72,843

Level 2 | Second Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 172,800 178,200

Level 3 | First Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0 0

Level 3 | 2015 Incremental First

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0

Level 3 | Second Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 0 0

Total Fair Value | First Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 383,216 394,753

Total Fair Value | 2015 Incremental First

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value 72,843

Total Fair Value | Second Lien Term Loans

FAIR VALUE MEASUREMENTS

Long-Term Debt fair value $ 172,800 $ 178,200

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueInputsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_FirstLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_Incremental2015FirstMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_SecondLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FinancialInstrumentAxis=rdnt_FirstLienTermLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FinancialInstrumentAxis=rdnt_Incremental2015FirstMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FinancialInstrumentAxis=rdnt_SecondLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=rdnt_TotalFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

2. FACILITY ACQUISITIONS (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Goodwill $ 201,450 $ 200,304

Baltimore County Radiology

Proceeds from sale of imaging center 5,000

Gain on sale of imaging center included in equity 3,700

New Jersey Imaging Partners

Proceeds from sale of imaging center 35,500

Gain on sale of imaging center included in equity 4,800

Murray Hill Radiology

Cash consideration paid 5,800

Fixed assets 1,600

Prepaid assets 95

Goodwill 4,100

Hanford Imaging

Cash consideration paid 1,000

Fixed assets 345

Goodwill 655

Healthcare Radiology

Cash consideration paid 425

Fixed assets 134

Leasehold improvements acquired 290

California Radiology

Cash consideration paid 4,200

Equipment acquired 217

Leasehold improvements acquired 1,700

Goodwill 2,100

Other intangible assets 100

Other assets 34

New York Radiology Partners

Cash consideration paid 29,800

Note issued 1,500

Assets acquired 34,500

Assumed equipment debt 2,300

Assumed current liabilities 891

Equipment acquired 4,600

Leasehold improvements acquired 12,000

Goodwill 12,900

Other intangible assets 600

Accounts receivable and other current assets $ 4,400

X

- Definition
Amount of assets acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of property, plant, and equipment recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.13(h))

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_GainLossOnSaleOfEquityInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_GainLossOnInvestmentsByCategoryAxis=rdnt_BaltimoreCountyRadiologyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_GainLossOnInvestmentsByCategoryAxis=rdnt_NewJerseyImagingPartnersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=rdnt_MurrayHillRadiologyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=rdnt_HanfordImagingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=rdnt_HealthcareRadiologyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=rdnt_CaliforniaRadiologyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=rdnt_NYRPMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 16 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

2. FACILITY ACQUISITIONS AND DISPOSITIONS
9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

FACILITY ACQUISITIONS AND DISPOSITIONS

Acquisitions

On September 1, 2015 we completed our acquisition of Murray Hill Radiology and Mammography, P.C. and Murray Hill MRI Holding, LLC, consisting of a single multi-modality imaging center located in Manhattan, New York for a cash consideration of $5.8 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $1.6 million of fixed assets, $95,000 of prepaid assets and $4.1 million of goodwill were recorded.

On August 3, 2015 we completed our acquisition of Hanford Imaging, LP, consisting of a single multi-modality imaging center located in Hanford, CA for cash consideration of $1.0 million. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $345,000 of fixed asset and $655,000 of goodwill were recorded.

On June 1, 2015 we completed our acquisition of Healthcare Radiology and Diagnostic systems, PLLC, consisting of a single multi-modality imaging center located in the Bronx, NY area for cash consideration of $425,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a fair value determination of net assets and approximately $134,500 of fixed assets and $290,500 of leasehold improvements were recorded.

On May 1, 2015 we completed our acquisition of California Radiology consisting of six multi-modality imaging centers located in Los Angeles, California for cash consideration of $4.2 million. The facilities provide MRI, PET/CT, Ultrasound and X-ray services. We have made a fair value determination of the acquired assets and approximately $217,000 of equipment, $1.7 million of leasehold improvements, $34,000 in other assets, $100,000 of other intangible assets relating to a covenant not to compete contract and $2.1 million of goodwill were recorded with respect to this transaction.

On April 15, 2015 we completed our acquisition of New York Radiology Partners, consisting of eleven multi-modality imaging centers located in Manhattan, New York for cash consideration of $29.8 million and a note to seller of $1.5 million. The facilities provide a full range of radiology services including MRI, PET/CT, Mammography, Ultrasound, X-ray and other related services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities. In total, RadNet acquired assets of $34.5 million, assumed equipment debt of $2.3 million, and assumed current liabilities of $891,000. Asset amounts acquired were $4.6 million in equipment, $12.0 million in leasehold improvements, $12.9 million in goodwill, $600,000 of other intangible assets, and $4.4 million of accounts receivable and other current assets. Current liabilities assumed related to accounts payable, payroll and other related short term obligations. Our preliminary fair value determination will be made final with the help of an outside valuation expert which we expect to have completed by the end of our fourth quarter of 2015.

Dispositions

On August 3, 2015 we sold a 25% non-controlling interest in one of our wholly owned entities, Baltimore County Radiology, LLC (“BCR”) to Lifebridge Health for $5.0 million. On the date of sale, the net book value of this 25% interest was $1.3 million. In accordance with ASC 810-10-45-23, the proceeds in excess of this net book value amounting to $3.7 million was recorded to equity. In addition to the proceeds already received, RadNet has the opportunity to receive approximately $1.2 million in additional proceeds if certain operating performance targets of BCR are achieved within the next 12 months. Any additional amounts received under these contingent performance provisions will be recorded to equity accordingly.

On September 30, 2015 we completed a sale of 10 wholly owned imaging centers from our New Jersey reporting unit, New Jersey Imaging Partners. This sale was made to one of our non-consolidated joint ventures for which we hold a 49% non-controlling interest, New Jersey Imaging Networks, for approximately $35.5 million. We recorded a gain of $4.8 million in the third quarter with respect to this transaction.

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 17 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. INVESTMENT IN JOINT VENTURES (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

Management service fees from centers underlying joint ventures $ 2,600 $ 2,300 $ 6,400 $ 6,900

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_ManagementFeesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 18 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Key financial data for joint ventures

Current assets - joint ventures $ 17,551

Noncurrent assets - joint ventures 87,527

Current liabilities - joint ventures (5,044)

Noncurrent liabilities - joint ventures (42,245)

Total net assets -joint ventures 57,789

Book value of Radnet joint venture interests 27,463

Cost in excess of book value of acquired joint venture interests 4,971

Total value of Radnet joint venture interests 32,434 $ 32,123

Total book value of other joint venture partner interests 30,326

Net revenue 85,305 $ 73,859

Net income $ 13,489 $ 9,801

X

- Definition
Key financial data for joint ventures
+ References
No definition available.
+ Details

Name: rdnt_KeyFinancialDataForJointVenturesAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Net revenue from joint ventures
+ References
No definition available.
+ Details

Name: rdnt_NetRevenueFromJointVentures

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total book value of other joint venture partner interests
+ References
No definition available.
+ Details

Name: rdnt_TotalBookValueOfOtherJointVenturePartnerInterests

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents the aggregate cost of investments accounted for under the equity method of accounting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EquityMethodInvestmentAggregateCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of assets reported by an equity method investment of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current assets reported by an equity method investment of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current liabilities reported by an equity method investment of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities reported by an equity method investment of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name: us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 19 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Stock Options
9 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

STOCK BASED COMPENSATION

Begining Balance | shares 2,092,509

Granted | shares 0

Exercised | shares (1,102,500)

Canceled or expired | shares (25,000)

Ending Balance | shares 965,009

Exercisable at the end | shares 921,676

Weighted Average Exercise price Per Common Share

Begining Balance $ 3.58

Granted

Exercised $ 2.69

Canceled or expired 2.22

Ending Balance 4.62

Exercisable at the end $ 4.74

Weighted Average Remaining Contractual Life

Ending Balance 1 year 25 days

Exercisable at the end 11 months 23 days

Aggregate Intrinsic Value

Aggregate value outstanding | $ $ 1,783,778

Aggregate value exercisable | $ $ 1,631,678

X

- Definition
Aggregate Intrinsic Value
+ References
No definition available.
+ Details

Name: rdnt_AggregateIntrinsicValue

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted Average Exercise price Per Common Share
+ References
No definition available.
+ Details

Name: rdnt_WeightedAverageExercisePricePerCommonShareAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted Average Remaining Contractual Life abstract
+ References
No definition available.
+ Details

Name: rdnt_WeightedAverageRemainingContractualLife

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. STOCK-BASED COMPENSATION (Details - RSU's) - RestrictedStockMember
9 Months Ended

Sep. 30, 2015

$ / shares

shares

RSA's outstanding, beginning balance | shares 942,023

RSA's granted | shares 744,423

RSA's vested | shares (848,552)

RSA's forfeited | shares (29,526)

RSA's outstanding, ending balance | shares 808,369

Weighted-Average Remaining Contractual Term 8 months 16 days

Weighted-average fair value, beginning balance $ 1.96

Weighted-average fair value, granted 8.60

Weighted-average fair value, vested 4.55

Weighted-average fair value, forfeited 5.59

Weighted-average fair value, ending balance $ 5.22

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION
9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2015 we operated directly or indirectly through joint ventures, 280 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, and Chairman of our Board of Directors. Dr. Berger owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

We contract with seven medical groups which provide professional medical services at all of our facilities in Manhattan and Brooklyn, New York. These contracts are similar to our contract with BRMG. Four of these groups are owned by John V Crues, III, M.D., RadNet’s Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Berger owns a controlling interest in two of these medical groups which provide professional medical services at one of our Manhattan facilities.

RadNet provides non-medical, technical and administrative services to BRMG and the seven medical groups mentioned above (“NY Groups”) for which it receives a management fee, pursuant to the related management agreements. Through these management agreements we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the NY Groups and we determine the annual budget of BRMG and the NY Groups. BRMG and the NY Groups both have insignificant operating assets and liabilities, and de minimis equity. These management agreements are designed such that all net cash flows of both BRMG and the NY Groups are transferred to us.

We have determined that BRMG and the NY Groups are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. These VIE’s on a combined basis recognized $29.4 million and $23.6 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2015 and 2014, respectively, and $29.4 million and $23.6 million of operating expenses for the three months ended September 30, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $106.7 million and $98.0 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2015 and 2014, respectively, of which $77.3 million and $74.4 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2015 and 2014, respectively.



These VIE’s on a combined basis recognized $83.1 million and $65.6 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2015 and 2014, respectively, and $83.1 million and $65.6 million of operating expenses for the nine months ended September 30, 2015 and 2014, respectively. RadNet recognized in its condensed consolidated statement of operations $320.6 million and $279.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2015 and 2014, respectively, of which $237.5 million and $213.9 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2015 and 2014, respectively.

The cash flows of these VIE’s are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2015 and December 31, 2014, we have included approximately $77.7 million and $79.7 million, respectively, of accounts receivable and approximately $8.6 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to these VIE’s combined.

The creditors of each of these VIE’s do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of any of these VIE’s. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

At all of our centers, aside from certain centers in California and centers in New York City where we contract with BRMG and the NY Groups for the provision of professional medical services, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-NY Groups) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014, filed on March 16, 2015, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.



Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):

Three Months Ended Nine Months Ended

September 30, September 30,

2015 2014 2015 2014

Commercial insurance $ 114,827 $ 109,472 $ 331,670 $ 314,300

Medicare 40,840 41,203 120,039 118,627

Medicaid 6,117 6,248 17,582 18,214

Workers' compensation/personal injury 7,712 7,821 23,287 22,708

Other 23,408 6,354 53,759 24,687

Service fee revenue, net of contractual allowances and discounts 192,904 171,098 546,337 498,536

Provision for bad debts (9,433 ) (7,532 ) (25,295 ) (21,945 )

Net service fee revenue 183,471 163,566 521,042 476,591

Revenue under capitation arrangements 24,895 20,493 72,880 55,426

Total net revenue $ 208,366 $ 184,059 $ 593,922 $ 532,017

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over at least an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.



Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a front desk patient tracking system or Radiology Information System (“RIS”) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the nine months ended September 30, 2015, and 2014, respectively, relating to this incentive.

Software Development Costs

Costs related to the research and development of new software products and enhancements to existing software products all for resale to our customers are expensed as incurred.

We utilize a variety of computerized information systems in the day to day operation of our diagnostic imaging facilities. One such system is our RIS. We have historically utilized third party RIS software solutions and pay monthly fees to outside third party software vendors for the use of this software. We have developed our own RIS solution from the ground up through our wholly owned subsidiary, Radnet Management Information Systems (“RMIS”) deployed this system in the beginning of the first quarter in 2015.

By following the accounting guidance under ASC 350-40, Accounting for the Costs of Computer Software Developed for Internal Use, the costs incurred by RMIS toward the development of this RIS system, which began on August 1, 2010 and continued until December 2014, were capitalized and will be amortized over its useful life which we determined to be 5 years. Total costs capitalized were approximately $6.4 million. We began recording monthly amortization of $107,000 per month for our use of this software in January 2015.

During the nine months ended September 30, 2015, we entered into an agreement to license our RIS system to an outside customer. As of September 30, 2015, we received approximately $443,000 in respect to this licensing agreement. In accordance with ASC 350-40, we recorded the receipt of these funds against the capitalized software costs explained above. We intend to record any future proceeds in the same manner until the carrying value of our capitalized software costs are brought to zero. As of September 30, 2015, the net carrying value of our capitalized software costs was approximately $5.0 million. We continue to record amortization expense of $107,000 per month for our internal use of this software and will continue to do so until the net carrying value of the capitalized software costs are brought to zero.

Liquidity and Capital Resources

We had cash and cash equivalents of $36.1 million and accounts receivable of $159.2 million at September 30, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $119.8 million and $58.7 million at September 30, 2015 and December 31, 2014, respectively. We had net income attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2015 and 2014 of $8.0 million and $4.5 million respectively, and net income attributable to RadNet, Inc common stockholders for the nine months ended September 30, 2015 of $6.8 million and net loss of $2.8 million in 2014. We had stockholders’ equity of $22.7 million and $5.4 million at September 30, 2015 and December 31, 2014, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.



Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2015 is $626.9 million of senior secured term loan debt (net of unamortized discounts of $10.3 million), broken down by loan agreement as follows (in thousands):

As of September 30, 2015

Face Value Discount Total Carrying Value

First Lien Term Loans $ 384,176 $ (7,440 ) $ 376,736

2015 Incremental First $ 73,026 $ (528 ) $ 72,498

Second Lien Term Loans $ 180,000 $ (2,344 ) $ 177,656

Total $ 637,202 $ (10,312 ) $ 626,890

Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.

As of September 30, 2015, we were in compliance with all financial covenants under our Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan, and the Second Lien Credit Agreement, each as defined below.

2015 Incremental First Lien Term Loan:

On April 30, 2015, we entered into a joinder agreement to our existing Credit Agreement (the "2015 Incremental First Lien Term Loan Joinder") to provide for the borrowing of $75.0 million of incremental first lien term loans (“2015 Incremental First Lien Term Loans”). The 2015 Incremental First Lien Term Loans are treated as part of the same class as the existing tranche B term loans currently outstanding under the Credit Agreement. We used the proceeds from the 2015 Incremental First Lien Term Loans to repay all of the borrowings outstanding under the first lien revolving loan facility and to pay approximately $1.1 million of fees and expenses associated with the transaction.

Interest. The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is approximately $987,000, beginning in June 2015. The scheduled quarterly amortization for all of the term loans under the Credit Agreement, including the 2015 First Lien Term Loans, was increased to approximately $6.2 million, beginning in June 2015.

Maturity Date. The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.



2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Credit Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012 (the "Original Credit Agreement"), by that certain first amendment dated April 3, 2013 (the “2013 Amendment”), and subsequently by entering into a second amendment dated on March 25, 2014 (the “2014 Amendment”) ( the Original Credit Agreement, as amended by the 2013 Amendment and the 2014 Amendment is collectively referred to herein as the "Credit Agreement") to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Guarantees and Collateral. The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of our tangible and intangible assets, including, but not limited to, pledges of equity interests of RadNet Management and all of our current and future domestic subsidiaries.

Restrictive Covenants. In addition to certain covenants, the Credit Agreement places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Second Lien Credit and Guaranty Agreement. RadNet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by RadNet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the outstanding Senior Notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.



The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2015 was 0.53%. The rate paid on the Second Lien Credit Agreement at September 30, 2015 was 8%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.

Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents being false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Revolving Credit Facility

The $101.25 million revolving credit line established in the Credit Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Credit Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Credit Agreement.

The revolving credit line bears interest based on types of borrowings as follows: (i) unpaid principal at the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 4.25% per annum or the Base Rate (as defined in the Credit Agreement) plus 3.25% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance. The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “Senior Notes”). All payments of the Senior Notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The Senior Notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among RadNet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the Senior Notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

We completed the retirement of our $200 million in Senior Notes on April 24, 2014 and following such retirement we completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding Senior Notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all Senior Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the Senior Notes, representing 96.73% of the outstanding Senior Notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of Senior Notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of Senior Notes. In addition, all Senior Notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional Senior Notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.



Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption of all of our remaining outstanding Senior Notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the Senior Notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the Senior Notes being redeemed (or $1,051.88 per $1,000 in principal amount of the Senior Notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no Senior Notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 22 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Common stock issued upon exercise of options and other awards 3,678,741

Stock Options

Aggregate intrinsic value $ 6,100 $ 5,900

Unrecognized stock-based compensation expense $ 21

Unrecognized expense weighted average period 1 year 1 month 6 days

RestrictedStockMember

Total shares issued 3,461,208

RSA's previously vested 2,623,314

RSA's unvested 808,369

2006 Equity Incentive Plan

Shares authorized under plan 12,000,000

X

- Definition
Number of shares issued pursuant to the terms of a deferred compensation arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (l)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Unrecognized cost of unvested options awarded to employees as compensation.
+ References
No definition available.
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of options vested.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=rdnt_EquityPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 23 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Sep. 30, 2015

Dec. 31, 2014

CURRENT ASSETS

Cash and cash equivalents $ 36,054 $ 307

Accounts receivable, net 159,205 148,235

Current portion of deferred tax assets 17,246 17,246

Due from affiliates 2,604 1,561

Prepaid expenses and other current assets 41,194 24,671

Total current assets 256,303 192,020

PROPERTY AND EQUIPMENT, NET 232,477 223,127

OTHER ASSETS

Goodwill 201,450 200,304

Other intangible assets 45,225 47,624

Deferred financing costs, net of current portion 4,294 6,122

Investment in joint ventures 32,434 32,123

Deferred tax assets, net of current portion 32,584 35,334

Deposits and other 4,108 4,026

Total assets 808,875 740,680

CURRENT LIABILITIES

Accounts payable, accrued expenses and other 95,058 97,816

Due to affiliates 5,664 6,289

Deferred revenue 1,323 1,964

Current portion of notes payable 23,391 19,468

Current portion of deferred rent 2,299 2,100

Current portion of obligations under capital leases 8,761 5,637

Total current liabilities 136,496 133,274

LONG-TERM LIABILITIES

Deferred rent, net of current portion 26,299 20,965

Line of credit 0 15,300

Notes payable, net of current portion 606,744 551,059

Obligations under capital lease, net of current portion 7,422 6,143

Other non-current liabilities 5,577 6,241

Total liabilities 782,538 732,982

STOCKHOLDERS' (DEFICIT) EQUITY

Common stock - $.0001 par value, 200,000,000 shares authorized; 44,495,235, and 42,825,676 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively 4 4

Paid-in-capital 188,310 177,750

Accumulated other comprehensive loss (146) (112)

Accumulated deficit (165,452) (172,280)

Total RadNet, Inc.'s stockholders' deficit 22,716 5,362

Noncontrolling interests 3,621 2,336

Total equity 26,337 7,698

Total liabilities and equity $ 808,875 $ 740,680

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Net amount of long-term deferred finance costs capitalized at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DeferredFinanceCostsNoncurrentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 25

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DeferredRentCreditCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.26(c))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 25

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707

+ Details

Name: us-gaap_DeferredRentCreditNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31938-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

+ Details

Name: us-gaap_DeferredTaxAssetsGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

+ Details

Name: us-gaap_DeferredTaxAssetsGrossNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DepositsAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 2

-Article 4

+ Details

Name: us-gaap_DueFromRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 12

-Subparagraph 3

-Article 6

+ Details

Name: us-gaap_DueToAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 7

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OtherAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.
+ References
No definition available.
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 9 months ended Sep. 30, 2015 - USD ($)
$ in Thousands

Common Stock

Additional Paid-In Capital

Accumulated Deficit

Accumulated Other Comprehensive Income / Loss

Total Radnet Inc Equity

Noncontrolling Interest

Total

Beginning balance, shares at Dec. 31, 2014 42,825,676

Beginning balance, value at Dec. 31, 2014 $ 4 $ 177,750 $ (172,280) $ (112) $ 5,362 $ 2,336 $ 7,698

Issuance of common stock upon exercise of options, shares issued 814,662

Issuance of common stock upon exercise of options, value 594 594 594

Stock-based compensation 6,309 6,309 6,309

Issuance of restricted stock and other awards, shares 884,423

Forfeiture of restricted stock (29,526)

Sale of noncontrolling interest 3,657 3,657 1,348 5,005

Distributions paid to noncontrolling interest (613) (613)

Change in cumulative foreign currency translation adjustment (34) (34) (34)

Net income 6,828 6,828 550 7,378

Ending balance, shares at Sep. 30, 2015 44,495,235

Ending balance, value at Sep. 30, 2015 $ 4 $ 188,310 $ (165,452) $ (146) $ 22,716 $ 3,621 $ 26,337

X

- Definition
Changes in additional paid in capital related to exercise of share-based payments awards (such as stock options) and the amount of recognized equity-based compensation during the period (such as nonvested shares).
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (c)(2)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569655-111683

+ Details

Name: us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 35

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6939497&loc=d3e30304-110892

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,d)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=rdnt_TotalRadnetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 25 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Commercial Insurance $ 114,827 $ 109,472 $ 331,670 $ 314,300

Medicare 40,840 41,203 120,039 118,627

Medicaid 6,117 6,248 17,582 18,214

Workers Compensation/Personal Injury 7,712 7,821 23,287 22,708

Other 23,408 6,354 53,759 24,687

Service fee revenue, net of contractual allowances and discounts 192,904 171,098 546,337 498,536

Provision for bad debts (9,433) (7,532) (25,295) (21,945)

Net service fee revenue 183,471 163,566 521,042 476,591

Revenue under capitation arrangements 24,895 20,493 72,880 55,426

Total net revenue $ 208,366 $ 184,059 $ 593,922 $ 532,017

X

- Definition
Medicaid insurance revenue
+ References
No definition available.
+ Details

Name: rdnt_HealthCareOrganizationPremiumRevenueMedicaid

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Medicare insurance revenue
+ References
No definition available.
+ Details

Name: rdnt_HealthCareOrganizationPremiumRevenueMedicare

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Workers Compensation/Personal Injury
+ References
No definition available.
+ Details

Name: rdnt_WorkersCompensationpersonalInjury

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized based on fees charged on a per capita basis.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8200-115640

+ Details

Name: us-gaap_HealthCareOrganizationCapitationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized that is not otherwise disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationOtherRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8184-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8195-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51673531&loc=SL9156464-115641

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the provision for bad debts related to patient service revenue.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of insurance premium revenue recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationPremiumRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 26 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

BRMG and B&C Entities revenues $ 29,400 $ 23,600 $ 83,100 $ 65,600

BRMG and B&C Entities operating expenses 29,400 23,600 83,100 65,600

Total billed net service fee revenue 106,700 98,000 320,600 279,600

Management services provided to BRMG and B&C Entities 77,300 74,400 237,500 213,900

BRMG and B&C Entities accounts receivable 77,700 77,700 $ 79,700

BRMG and B&C Entities accounts payable 8,600 8,600 9,000

Meaningful use incentive 0 $ 0 3,270 $ 1,762

Working capital 119,800 119,800 58,700

Senior notes 626,900 626,900

Unamortized discount 10,300 10,300

Line of credit balance outstanding 0 0 $ 15,300

Software Development Costs

Licensing revenue 443,000

Capitalized software costs 5,000 5,000

2015 Incremental First

Line of credit maximum borrowing amount 75,000 75,000

Payments of loan fees $ 1,100

Debt interest rate The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payment frequency The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is $987,000, beginning in June 2015.

Debt maturity date The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.

First Lien Term Loan

Line of credit maximum borrowing amount 30,000 $ 30,000

Debt interest rate The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%

Payment frequency The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Second Lien Term Loans

Line of credit maximum borrowing amount 180,000 $ 180,000

Debt interest rate The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at June 30, 2015 was 0.44%. The rate paid on the Second Lien Credit Agreement at June 30, 2015 was 8%.

Payment frequency There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Debt maturity date The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.

Revolving Credit Facility

Line of credit maximum borrowing amount $ 101,250 $ 101,250

Debt interest rate The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.

X

- Definition
Working capital
+ References
No definition available.
+ Details

Name: rdnt_WorkingCapital

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_CapitalizedComputerSoftwareGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDateDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).
+ References
No definition available.
+ Details

Name: us-gaap_DebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Description of the frequency of the required periodic payments of interest, principal, or both, and the amount, if set, or a description of a formula upon which payment is based.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Incentive fees which are compensation paid to a trading advisor or to any practitioner who achieves investment results above a specified contractual level.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.14)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_NoninterestExpenseRelatedToPerformanceFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of expense between the reporting entity and the Variable Interest Entity (VIE).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income between the reporting entity and the Variable Interest Entity (VIE).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying amount of the consolidated Variable Interest Entity's assets included in the reporting entity's statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of the consolidated Variable Interest Entity's liabilities included in the reporting entity's statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_Incremental2015FirstMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_FirstLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_SecondLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss) $ 7,378 $ (2,610)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Depreciation and amortization 43,836 45,193

Provision for bad debts 25,295 21,945

Equity in earnings of joint ventures (6,301) (4,722)

Distributions from joint ventures 6,255 7,358

Amortization and write off of deferred financing costs and loan discount 4,000 4,444

Loss on sale and disposal of equipment 774 1,581

Loss on early extinguishment of Senior Notes 0 15,927

Gain on sale of imaging centers (4,823) 0

Stock-based compensation 6,477 2,069

Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:

Accounts receivable (32,485) (42,887)

Other current assets (15,628) (4,754)

Other assets (1,254) (72)

Deferred taxes 2,750 (2,461)

Deferred rent 6,034 653

Deferred revenue (641) 604

Accounts payable, accrued expenses and other (1,603) (8,225)

Net cash provided by operating activities 40,065 34,043

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of imaging facilities (41,237) (9,428)

Purchase of noncontrolling interests 0 (196)

Purchase of property and equipment (38,736) (33,895)

Proceeds from sale of equipment 648 766

Proceeds from sale of imaging facilities 35,500 0

Proceeds from sale of internal use software 443 0

Equity contributions in existing and purchase of interest in joint ventures (265) (1,161)

Net cash used in investing activities (43,647) (43,914)

CASH FLOWS FROM FINANCING ACTIVITIES

Principal payments on notes and leases payable (6,645) (16,733)

Proceeds from borrowings 74,401 210,000

Payments on Term Loan Debt/Senior Notes (17,548) (211,344)

Deferred financing costs (531) (6,650)

Net proceeds on revolving credit facility (15,300) 25,100

Distributions paid to noncontrolling interests (613) (148)

Proceeds from sale of non-controlling interests 5,005 0

Proceeds from issuance of common stock upon exercise of options/warrants 594 1,546

Net cash provided by financing activities 39,363 1,771

EFFECT OF EXCHANGE RATE CHANGES ON CASH (34) (38)

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 35,747 (8,138)

CASH AND CASH EQUIVALENTS, beginning of period 307 8,412

CASH AND CASH EQUIVALENTS, end of period 36,054 274

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid during the period for interest 26,543 32,389

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

Purchase of equipment and leasehold improvements not yet paid for $ 15,700 $ 16,600

X

- Definition
Purchase of equipment and leasehold improvements not yet paid for
+ References
No definition available.
+ Details

Name: rdnt_PurchaseOfEquipmentAndLeaseholdImprovementsNotYetPaidFor

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 8

-Article 9

+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2443-110228

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of noncontrolling interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.
+ References
No definition available.
+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleOfProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.
+ References
No definition available.
+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with security instruments that either represent a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes repayments of (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares

Sep. 30, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Common stock - par value (in Dollars per share) $ 0.0001 $ .0001

Common stock - shares authorized 200,000,000 200,000,000

Common stock - shares issued 44,495,235 42,825,676

Common stock - shares outstanding 44,495,235 42,825,676

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables)
9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of service fee revenue

Three Months Ended Nine Months Ended

September 30, September 30,

2015 2014 2015 2014

Commercial insurance $ 114,827 $ 109,472 $ 331,670 $ 314,300

Medicare 40,840 41,203 120,039 118,627

Medicaid 6,117 6,248 17,582 18,214

Workers' compensation/personal injury 7,712 7,821 23,287 22,708

Other 23,408 6,354 53,759 24,687

Service fee revenue, net of contractual allowances and discounts 192,904 171,098 546,337 498,536

Provision for bad debts (9,433 ) (7,532 ) (25,295 ) (21,945 )

Net service fee revenue 183,471 163,566 521,042 476,591

Revenue under capitation arrangements 24,895 20,493 72,880 55,426

Total net revenue $ 208,366 $ 184,059 $ 593,922 $ 532,017

Schedule of loans

As of September 30, 2015

Face Value Discount Total Carrying Value

First Lien Term Loans $ 384,176 $ (7,440 ) $ 376,736

2015 Incremental First $ 73,026 $ (528 ) $ 72,498

Second Lien Term Loans $ 180,000 $ (2,344 ) $ 177,656

Total $ 637,202 $ (10,312 ) $ 626,890

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 320

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969

+ Details

Name: us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - shares
9 Months Ended

Sep. 30, 2015

Nov. 05, 2015

Document and Entity Information

Entity Registrant Name RadNet, Inc.

Entity Central Index Key 0000790526

Document Type 10-Q

Document Period End Date Sep. 30, 2015

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer No

Is Entity a Voluntary Filer No

Is Entity's Reporting Status Current Yes

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 46,120,671

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2015

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Document and Entity Information
+ References
No definition available.
+ Details

Name: rdnt_DocumentAndEntityInformationAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

4. EARNINGS PER SHARE (Tables)
9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Three Months Ended Nine Months Ended

September 30, September 30,

2015 2014 2015 2014

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 7,987 $ 4,451 $ 6,828 $ (2,829 )

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 43,637,022 41,644,606 43,247,002 40,734,083

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.18 $ 0.11 $ 0.16 $ (0.07 )

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 43,637,022 41,644,606 43,247,002 40,734,083

Add nonvested restricted stock subject only to service vesting 437,689 1,001,190 484,810 –

Add additional shares issuable upon exercise of stock options and warrants 677,225 1,387,784 972,511 –

Weighted average number of common shares used in calculating diluted net income per share 44,751,936 44,033,580 44,704,323 40,734,083

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.18 $ 0.10 $ 0.15 $ (0.07 )

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

NET REVENUE

Service fee revenue, net of contractual allowances and discounts $ 192,904 $ 171,098 $ 546,337 $ 498,536

Provision for bad debts (9,433) (7,532) (25,295) (21,945)

Net service fee revenue 183,471 163,566 521,042 476,591

Revenue under capitation arrangements 24,895 20,493 72,880 55,426

Total net revenue 208,366 184,059 593,922 532,017

OPERATING EXPENSES

Cost of operations, excluding depreciation and amortization 175,631 153,000 520,348 445,838

Depreciation and amortization 14,601 14,423 43,836 45,193

Loss on sale and disposal of equipment 738 1,289 774 1,581

Severance costs 167 112 297 976

Total operating expenses 191,137 168,824 565,255 493,588

INCOME FROM OPERATIONS 17,229 15,235 28,667 38,429

OTHER INCOME AND EXPENSES

Interest expense 10,546 10,395 30,965 32,503

Meaningful use incentive 0 0 (3,270) (1,762)

Equity in earnings of joint ventures (1,992) (2,009) (6,301) (4,722)

Gain on sale of imaging centers (4,823) 0 (4,823) 0

Loss on early extinguishment of Senior Notes 0 0 0 15,927

Other expenses 8 6 418 4

Total other expenses 3,739 8,392 16,989 41,950

INCOME (LOSS) BEFORE INCOME TAXES 13,490 6,843 11,678 (3,521)

(Provision for) Benefit from income taxes (5,199) (2,334) (4,300) 911

NET INCOME (LOSS) 8,291 4,509 7,378 (2,610)

Net income attributable to noncontrolling interests 304 58 550 219

NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 7,987 $ 4,451 $ 6,828 $ (2,829)

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ .18 $ .11 $ .16 $ (.07)

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ .18 $ .10 $ .15 $ (.07)

WEIGHTED AVERAGE SHARES OUTSTANDING: Basic 43,637,022 41,644,606 43,247,002 40,734,083

WEIGHTED AVERAGE SHARES OUTSTANDING: Diluted 44,751,936 44,033,580 44,704,323 40,734,083

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2443-110228

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized based on fees charged on a per capita basis.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8200-115640

+ Details

Name: us-gaap_HealthCareOrganizationCapitationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8184-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8195-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51673531&loc=SL9156464-115641

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the provision for bad debts related to patient service revenue.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense for debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Incentive fees which are compensation paid to a trading advisor or to any practitioner who achieves investment results above a specified contractual level.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.14)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_NoninterestExpenseRelatedToPerformanceFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents a sum total of expenses not separately reflected on the income statement for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.7)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. INVESTMENT IN JOINT VENTURES
9 Months Ended

Sep. 30, 2015

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENT IN JOINT VENTURES

We have ten unconsolidated joint ventures where our ownership interests range from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2015 (in thousands):

Balance as of December 31, 2014 $ 32,123

Equity in earnings in these joint ventures 6,301

Distribution of earnings (6,255 )

Equity contributions in existing joint ventures 265

Balance as of September 30, 2015 $ 32,434

We earned management service fees from the centers underlying these joint ventures of approximately $2.6 million and $2.3 million for the three months ended September 30, 2015 and 2014, respectively, and $6.4 million and $6.9 million for the nine months ended September 30, 2015 and 2014, respectively.



The following table is a summary of key financial data for these joint ventures as of September 30, 2015 (in thousands) and for the nine months ended September 30, 2015 and 2014 (in thousands):

Balance Sheet Data: September 30, 2015

Current assets $ 17,551

Noncurrent assets 87,527

Current liabilities (5,044 )

Noncurrent liabilities (42,245 )

Total net assets $ 57,789

Book value of RadNet joint venture interests $ 27,463

Cost in excess of book value of acquired joint venture interests 4,971

Total value of Radnet joint venture interests $ 32,434

Total book value of other joint venture partner interests $ 30,326

Income statement data for the nine months ended September 30, 2015 2014

Net revenue $ 85,305 $ 73,859

Net income $ 13,489 $ 9,801

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=49116238&loc=d3e32847-111569

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=49116238&loc=d3e32787-111569

+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

4. EARNINGS PER SHARE
9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

Three Months Ended Nine Months Ended

September 30, September 30,

2015 2014 2015 2014

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 7,987 $ 4,451 $ 6,828 $ (2,829 )

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 43,637,022 41,644,606 43,247,002 40,734,083

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.18 $ 0.11 $ 0.16 $ (0.07 )

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 43,637,022 41,644,606 43,247,002 40,734,083

Add nonvested restricted stock subject only to service vesting 437,689 1,001,190 484,810 –

Add additional shares issuable upon exercise of stock options and warrants 677,225 1,387,784 972,511 –

Weighted average number of common shares used in calculating diluted net income per share 44,751,936 44,033,580 44,704,323 40,734,083

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.18 $ 0.10 $ 0.15 $ (0.07 )

For the nine months ended September 30, 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS (Details - Notes payable) - USD ($)
$ in Thousands

Sep. 30, 2015

Dec. 31, 2014

First Lien Term Loan

Term loans face value $ 384,176 $ 399,750

Term loans discount (7,440)

Term loan carrying value 376,736

2015 Incremental First

Term loans face value 73,026

Term loans discount (528)

Term loan carrying value 72,498

Second Lien Term Loans

Term loans face value 180,000 $ 180,000

Term loans discount (2,344)

Term loan carrying value 177,656

Short-term Debt [Member]

Term loans face value 637,202

Term loans discount (10,312)

Term loan carrying value $ 626,890

X

- Definition
Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_FirstLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_Incremental2015FirstMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_SecondLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=us-gaap_ShortTermDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. INVESTMENT IN JOINT VENTURES (Tables)
9 Months Ended

Sep. 30, 2015

Equity Method Investments and Joint Ventures [Abstract]

Investment in joint ventures

Balance as of December 31, 2014 $ 32,123

Equity in earnings in these joint ventures 6,301

Distribution of earnings (6,255 )

Equity contributions in existing joint ventures 265

Balance as of September 30, 2015 $ 32,434

Key financial data in joint ventures

The following table is a summary of key financial data for these joint ventures as of September 30, 2015 (in thousands) and for the nine months ended September 30, 2015 and 2014 (in thousands):

Balance Sheet Data: September 30, 2015

Current assets $ 17,551

Noncurrent assets 87,527

Current liabilities (5,044 )

Noncurrent liabilities (42,245 )

Total net assets $ 57,789

Book value of RadNet joint venture interests $ 27,463

Cost in excess of book value of acquired joint venture interests 4,971

Total value of Radnet joint venture interests $ 32,434

Total book value of other joint venture partner interests $ 30,326

Income statement data for the nine months ended September 30, 2015 2014

Net revenue $ 85,305 $ 73,859

Net income $ 13,489 $ 9,801

X

- Definition
Key financial data in joint ventures
+ References
No definition available.
+ Details

Name: rdnt_KeyFinancialDataInJointVenturesTableTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

+ Details

Name: us-gaap_CostMethodInvestmentsDescriptionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

8. SUBSEQUENT EVENTS
9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

On October 16, 2015, Radnet purchased substantially all of the assets of Diagnostic Imaging Group, LLC (“DIG”), for approximately $56.7 million in cash and 1.5 million shares of RadNet common stock. The purchase agreement also provides for the possibility of earn-out payments based on future revenues over the 60 months following the closing of the transaction. The acquisition adds 17 new locations to our existing portfolio of imaging centers in the New York City area.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. STOCK-BASED COMPENSATION
9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

Equity Incentive Plans

Options

We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we amended and restated as of April 20, 2015 (the “Restated Plan”). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 11, 2015. As of September 30, 2015, we have reserved for issuance under the Restated Plan 12,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over two to five years and expire five to ten years from the date of grant.

As of September 30, 2015, we had outstanding options to acquire 965,009 shares of our Common Stock, of which options to acquire 921,676 shares were exercisable. During the nine months ended September 30, 2015, we did not grant any stock options under our Restated Plan.

The following summarizes all of our stock option transactions during the nine months ended September 30, 2015:

Weighted Average Weighted Average Remaining

Exercise price Contractual Aggregate

Outstanding Options Per Common Life Intrinsic

Under the 2006 Plan Shares Share (in years) Value

Balance, December 31, 2014 2,092,509 $ 3.58

Granted – –

Exercised (1,102,500 ) 2.69

Canceled, forfeited or expired (25,000 ) 2.22

Balance, September 30, 2015 965,009 4.62 1.07 $ 1,783,778

Exercisable at September 30, 2015 921,676 4.74 0.98 1,631,678

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the holder had all holders exercised their options on September 30, 2015. Total intrinsic value of options exercised during the nine months ended September 30, 2015 and 2014 was approximately $6.1 million and $5.9 million, respectively. As of September 30, 2015, total unrecognized stock-based compensation expense related to non-vested options was $21,000, which is expected to be recognized over a weighted average period of approximately 1.1 years.



Restricted Stock Awards

The Restated Plan permits the issuance of restricted stock awards (“RSA’s”). As of September 30, 2015, we have issued a total of 3,461,208 RSA’s, of which 2,623,314 RSA’s have previously vested, 29,526 RSA’s were forfeited and 808,369 RSA’s remained unvested at September 30, 2015.

The following summarizes all unvested RSA activities during the nine months ended September 30, 2015:

Weighted-

Average

Remaining Weighted-

Contractual Average

RSA’s Term (Years) Fair Value

RSA's outstanding at December 31, 2014 942,023 $ 1.96

Changes during the period

Granted 744,423 $ 8.60

Vested (848,552 ) $ 4.55

Forfeited (29,526 ) $ 5.59

RSA's unvested at September 30, 2015 808,369 0.71 $ 5.22



We determine the fair value of all RSA’s based on the closing price of our common stock on the date of award.

In sum, of the 12,000,000 shares of common stock reserved for issuance under the Restated Plan, at September 30, 2015, we had 3,431,683 RSA’s, net of 29,526 RSA’s forfeited (of which 808,369 shares were subject to further vesting), outstanding options to acquire 965,009 shares, and 3,924,567 shares of common stock available for future awards. We had previously granted options and other awards to acquire 3,678,741 shares which have been issued.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

7. FAIR VALUE MEASUREMENTS
9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.



The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

As of September 30, 2015

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

First Lien Term Loans $ – $ 383,216 $ – $ 383,216 $ 384,176

2015 Incremental First 72,843 72,843 73,026

Second Lien Term Loans 172,800 $ – 172,800 180,000

As of December 31, 2014

Level 1 Level 2 Level 3 Total Total Face Value

First Lien Term Loans $ – $ 394,753 $ – $ 394,753 $ 399,750

Second Lien Term Loans – 178,200 – 178,200 180,000

The carrying value of our revolving credit facility at December 31, 2014 of $15.3 million approximated its fair value. There was no revolving credit facility balance at September 30, 2015.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies)
9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business and Basis of Presentation

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2015 we operated directly or indirectly through joint ventures, 280 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, and Chairman of our Board of Directors. Dr. Berger owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

We contract with seven medical groups which provide professional medical services at all of our facilities in Manhattan and Brooklyn, New York. These contracts are similar to our contract with BRMG. Four of these groups are owned by John V Crues, III, M.D., RadNet’s Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Berger owns a controlling interest in two of these medical groups which provide professional medical services at one of our Manhattan facilities.

RadNet provides non-medical, technical and administrative services to BRMG and the seven medical groups mentioned above (“NY Groups”) for which it receives a management fee, pursuant to the related management agreements. Through these management agreements we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the NY Groups and we determine the annual budget of BRMG and the NY Groups. BRMG and the NY Groups both have insignificant operating assets and liabilities, and de minimis equity. These management agreements are designed such that all net cash flows of both BRMG and the NY Groups are transferred to us.

We have determined that BRMG and the NY Groups are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. These VIE’s on a combined basis recognized $29.4 million and $23.6 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2015 and 2014, respectively, and $29.4 million and $23.6 million of operating expenses for the three months ended September 30, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $106.7 million and $98.0 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2015 and 2014, respectively, of which $77.3 million and $74.4 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2015 and 2014, respectively.



These VIE’s on a combined basis recognized $83.1 million and $65.6 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2015 and 2014, respectively, and $83.1 million and $65.6 million of operating expenses for the nine months ended September 30, 2015 and 2014, respectively. RadNet recognized in its condensed consolidated statement of operations $320.6 million and $279.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2015 and 2014, respectively, of which $237.5 million and $213.9 million was for management services provided to these VIE’s relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2015 and 2014, respectively.

The cash flows of these VIE’s are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2015 and December 31, 2014, we have included approximately $77.7 million and $79.7 million, respectively, of accounts receivable and approximately $8.6 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to these VIE’s combined.

The creditors of each of these VIE’s do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of any of these VIE’s. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

At all of our centers, aside from certain centers in California and centers in New York City where we contract with BRMG and the NY Groups for the provision of professional medical services, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-NY Groups) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014, filed on March 16, 2015, as amended.

Significant Accounting Policies

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report.

Revenues

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the NY Groups, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the NY Groups as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the NY Groups. As it relates to non-BRMG and NY Groups centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.



Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2015 and 2014 is summarized in the following table (in thousands):

Three Months Ended Nine Months Ended

September 30, September 30,

2015 2014 2015 2014

Commercial insurance $ 114,827 $ 109,472 $ 331,670 $ 314,300

Medicare 40,840 41,203 120,039 118,627

Medicaid 6,117 6,248 17,582 18,214

Workers' compensation/personal injury 7,712 7,821 23,287 22,708

Other 23,408 6,354 53,759 24,687

Service fee revenue, net of contractual allowances and discounts 192,904 171,098 546,337 498,536

Provision for bad debts (9,433 ) (7,532 ) (25,295 ) (21,945 )

Net service fee revenue 183,471 163,566 521,042 476,591

Revenue under capitation arrangements 24,895 20,493 72,880 55,426

Total net revenue $ 208,366 $ 184,059 $ 593,922 $ 532,017

Provision for Bad Debts

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over at least an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a front desk patient tracking system or Radiology Information System (“RIS”) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the nine months ended September 30, 2015, and 2014, respectively, relating to this incentive.

Software Development Costs

Software Development Costs

Costs related to the research and development of new software products and enhancements to existing software products all for resale to our customers are expensed as incurred.

We utilize a variety of computerized information systems in the day to day operation of our diagnostic imaging facilities. One such system is our RIS. We have historically utilized third party RIS software solutions and pay monthly fees to outside third party software vendors for the use of this software. We have developed our own RIS solution from the ground up through our wholly owned subsidiary, Radnet Management Information Systems (“RMIS”) deployed this system in the beginning of the first quarter in 2015.

By following the accounting guidance under ASC 350-40, Accounting for the Costs of Computer Software Developed for Internal Use, the costs incurred by RMIS toward the development of this RIS system, which began on August 1, 2010 and continued until December 2014, were capitalized and will be amortized over its useful life which we determined to be 5 years. Total costs capitalized were approximately $6.4 million. We began recording monthly amortization of $107,000 per month for our use of this software in January 2015.

During the nine months ended September 30, 2015, we entered into an agreement to license our RIS system to an outside customer. As of September 30, 2015, we received approximately $443,000 in respect to this licensing agreement. In accordance with ASC 350-40, we recorded the receipt of these funds against the capitalized software costs explained above. We intend to record any future proceeds in the same manner until the carrying value of our capitalized software costs are brought to zero. As of September 30, 2015, the net carrying value of our capitalized software costs was approximately $5.0 million. We continue to record amortization expense of $107,000 per month for our internal use of this software and will continue to do so until the net carrying value of the capitalized software costs are brought to zero.

Liquidity and Capital Resources

Liquidity and Capital Resources

We had cash and cash equivalents of $36.1 million and accounts receivable of $159.2 million at September 30, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $119.8 million and $58.7 million at September 30, 2015 and December 31, 2014, respectively. We had net income attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2015 and 2014 of $8.0 million and $4.5 million respectively, and net income attributable to RadNet, Inc common stockholders for the nine months ended September 30, 2015 of $6.8 million and net loss of $2.8 million in 2014. We had stockholders’ equity of $22.7 million and $5.4 million at September 30, 2015 and December 31, 2014, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.



Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2015 is $626.9 million of senior secured term loan debt (net of unamortized discounts of $10.3 million), broken down by loan agreement as follows (in thousands):

As of September 30, 2015

Face Value Discount Total Carrying Value

First Lien Term Loans $ 384,176 $ (7,440 ) $ 376,736

2015 Incremental First $ 73,026 $ (528 ) $ 72,498

Second Lien Term Loans $ 180,000 $ (2,344 ) $ 177,656

Total $ 637,202 $ (10,312 ) $ 626,890

Our revolving credit facility had no amounts outstanding as of September 30, 2015 and a total potential borrowing capacity of $101.25 million.

As of September 30, 2015, we were in compliance with all financial covenants under our Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan, and the Second Lien Credit Agreement, each as defined below.

2015 Incremental First Lien Term Loan:

On April 30, 2015, we entered into a joinder agreement to our existing Credit Agreement (the "2015 Incremental First Lien Term Loan Joinder") to provide for the borrowing of $75.0 million of incremental first lien term loans (“2015 Incremental First Lien Term Loans”). The 2015 Incremental First Lien Term Loans are treated as part of the same class as the existing tranche B term loans currently outstanding under the Credit Agreement. We used the proceeds from the 2015 Incremental First Lien Term Loans to repay all of the borrowings outstanding under the first lien revolving loan facility and to pay approximately $1.1 million of fees and expenses associated with the transaction.

Interest. The interest rates payable on the 2015 Incremental First Lien Term Loans are the same rates currently payable on the existing tranche B term loans under the amended Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. As applied to the first lien tranche B term loans, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled quarterly amortization of the 2015 Incremental First Lien Term Loans is approximately $987,000, beginning in June 2015. The scheduled quarterly amortization for all of the term loans under the Credit Agreement, including the 2015 First Lien Term Loans, was increased to approximately $6.2 million, beginning in June 2015.

Maturity Date. The maturity date for the 2015 Incremental First Lien Term Loans shall be on the earlier to occur of (i) October 10, 2018, and (ii) the date on which the 2015 Incremental First Lien Term Loans shall otherwise become due and payable in full under the Credit Agreement, whether by acceleration or otherwise.



2014 Amendment to the Credit Agreement and Second Lien Credit Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Credit Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012 (the "Original Credit Agreement"), by that certain first amendment dated April 3, 2013 (the “2013 Amendment”), and subsequently by entering into a second amendment dated on March 25, 2014 (the “2014 Amendment”) ( the Original Credit Agreement, as amended by the 2013 Amendment and the 2014 Amendment is collectively referred to herein as the "Credit Agreement") to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Credit Agreement, which are (a) the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 3.25% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 2.25% per annum. With respect to all of the term loans under the Credit Agreement, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at September 30, 2015 was 0.53%.

Payments. The scheduled amortization of the term loans under the Credit Agreement increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Annual scheduled amortization payments increased by $16.8 million from pre-2014 Amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Guarantees and Collateral. The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of our tangible and intangible assets, including, but not limited to, pledges of equity interests of RadNet Management and all of our current and future domestic subsidiaries.

Restrictive Covenants. In addition to certain covenants, the Credit Agreement places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Financial Covenants. The Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Credit Agreement, as modified by the 2015 Incremental First Lien Term Loan Joinder, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Second Lien Credit and Guaranty Agreement. RadNet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by RadNet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the outstanding Senior Notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.



The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% per annum or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0% per annum. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2015 was 0.53%. The rate paid on the Second Lien Credit Agreement at September 30, 2015 was 8%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13(a) or events of default per section 8.01 as described below.

Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents being false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Revolving Credit Facility

The $101.25 million revolving credit line established in the Credit Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Credit Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Credit Agreement.

The revolving credit line bears interest based on types of borrowings as follows: (i) unpaid principal at the Adjusted Eurodollar Rate (as defined in the Credit Agreement) plus 4.25% per annum or the Base Rate (as defined in the Credit Agreement) plus 3.25% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance. The Base Rate as defined in the Credit Agreement at September 30, 2015 was 3.25%.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “Senior Notes”). All payments of the Senior Notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The Senior Notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among RadNet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the Senior Notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

We completed the retirement of our $200 million in Senior Notes on April 24, 2014 and following such retirement we completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding Senior Notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all Senior Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the Senior Notes, representing 96.73% of the outstanding Senior Notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of Senior Notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of Senior Notes. In addition, all Senior Notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional Senior Notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.



Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption of all of our remaining outstanding Senior Notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the Senior Notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the Senior Notes being redeemed (or $1,051.88 per $1,000 in principal amount of the Senior Notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no Senior Notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

X

- Definition
Deferred tax assets policy text block
+ References
No definition available.
+ Details

Name: rdnt_DeferredTaxAssetsPolicy

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Liquidity and Capital Resources
+ References
No definition available.
+ Details

Name: rdnt_LiquidityAndCapitalResourcesPolicyTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Meaningful Use Incentive policy text block
+ References
No definition available.
+ Details

Name: rdnt_MeaningfulUseIncentivePolicyTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_DebtPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for assessing the timing and amount of uncollectible revenue recognized as bad debt expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 310

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673446&loc=SL9156395-115594

+ Details

Name: us-gaap_HealthCareOrganizationBadDebtsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Research and Development

-URI http://asc.fasb.org/extlink&oid=6523717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 40

-Section 30

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6389767&loc=d3e17916-109280

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.15)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 50

-Section 25

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286

+ Details

Name: us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

7. FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)
$ in Thousands

Sep. 30, 2015

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Line of credit $ 0 $ 15,300

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Line-of-Credit Arrangement

-URI http://asc.fasb.org/extlink&oid=6517033

+ Details

Name: us-gaap_LinesOfCreditFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 43 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

7. FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

As of September 30, 2015

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

First Lien Term Loans $ – $ 383,216 $ – $ 383,216 $ 384,176

2015 Incremental First 72,843 72,843 73,026

Second Lien Term Loans 172,800 $ – 172,800 180,000

As of December 31, 2014

Level 1 Level 2 Level 3 Total Total Face Value

First Lien Term Loans $ – $ 394,753 $ – $ 394,753 $ 399,750

Second Lien Term Loans – 178,200 – 178,200 180,000

X

- Definition
Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a,b,bb)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2C

-URI http://asc.fasb.org/extlink&oid=36462937&loc=SL7498348-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

4. EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Earnings Per Share [Abstract]

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 7,987 $ 4,451 $ 6,828 $ (2,829)

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 43,637,022 41,644,606 43,247,002 40,734,083

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ .18 $ .11 $ .16 $ (.07)

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 44,751,936 44,033,580 44,704,323 40,734,083

Add nonvested restricted stock subject only to service vesting 437,689 1,001,190 484,810 0

Add additional shares issuable upon exercise of stock options and warrants 677,225 1,387,784 972,511 0

Weighted average number of common shares used in calculating diluted net income per share 44,751,936 44,033,580 44,704,323 40,734,083

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ .18 $ .10 $ .15 $ (.07)

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 55

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2626-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 48

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2538-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingently Issuable Shares

-URI http://asc.fasb.org/extlink&oid=6508586

+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 28A

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1500-109256

+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 45 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Statement of Comprehensive Income [Abstract]

NET INCOME (LOSS) $ 8,291 $ 4,509 $ 7,378 $ (2,610)

Foreign currency translation adjustments 7 (1) (34) (38)

COMPREHENSIVE INCOME (LOSS) 8,298 4,508 7,344 (2,648)

Less comprehensive income attributable to non-controlling interests 304 58 550 219

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 7,994 $ 4,450 $ 6,794 $ (2,867)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613674-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

3. NEW ACCOUNTING STANDARDS
9 Months Ended

Sep. 30, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

NEW ACCOUNTING STANDARDS

In September 2015, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2015-16 (“ASU 2015-16”), Business Combinations, (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement to retrospectively apply adjustments made to provisional amounts recognized in a business combination. An entity will now recognize any adjustments in the reporting period in which the amounts are determined, calculated as if the accounting had been completed at the acquisition date. Disclosure is required for the portion of adjustments recorded in current-period earnings that would have been recorded in previous reporting periods had they been recognized as of the acquisition date. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In August 2015, the FASB issued ASU No. 2015-15 (“ASU 2015-15”), Interest – Imputation of Interest, (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. ASU 2015-15 provides additional guidance to the presentation of debt issuance costs discussed originally in ASU No. 2015-03, which was issued in April 2015 and described below. ASU 2015-15 noted that ASU 2015-03 did not address the debt issue costs in regards to line-of-credit arrangements, which by their nature have fluctuating balances. ASU 2015-15 permits debt issuance costs specifically related to line-of-credit arrangements to be presented as an asset with subsequent amortization to interest expense ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the arrangement. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In April 2015, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2015-03 (“ASU 2015-03”), Interest – Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In February 2015, the FASB issued ASU No. 2015-02 (“ASU 2015-02”), Consolidation – Amendments to the Consolidation Analysis, (Topic 810). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In May 2014, the FASB issued ASU No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers, (Topic 606). ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update was effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016, which has recently been extended to December 31, 2017. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 47 0001019687-15-003959-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-15-003959-xbrl.zip M4$L#!!0````(`.B#:4?`;&"1^-```!E""0`1`!P`$@D>`@@(8F26`_= M52*)_#+Q(9&X$I_^\;YP1F_`#VS/_>F$/^5.1L`U/)I/.1=*H_C\9C@F*_`]?R_&\/TV6Q+V'X>GYV M]N/'CU/7>S-^>/X?P:GID17WZ$6^"99E^8;E@O!WGOOSOX4K@>-E3A>YT_<9 M5.+*".$+Z#?XB.?A?SC]2>#/!>6<5_^74%IHA%&PE,:]<^F?Y/-/[\^^8Y^C M_XY@1;C!^7M@_W224_"'>.KY\S.!X_BS__GZY=%\`0MC;+M!:+@F.,F^%W7S^*GV:NE-Y'P3(9XAAX_&\&J9`2PX?T2$OC4"I5Y%4[>]4"V'L!,$_GWML9?`#?YZ4QQX]%/GO=![-:R,H9?)J]:`>>)/!J MDW[)&]D'43">&\;K\H.9$3S'+ZQ)Q]`+-13,3SE[AZ4!GC58,+K)/T,1+ZTTE@(Y=Q,CK+BDI:BNFY M(7@/1[;UT\F-[RTR;!P?>LG?]?%*_O(SX(9V^+'\=?F[;:$G,QOZJ!@E*!@O M(]GE]->3SZC1JCHG"\JG,_SCE;BS2GFIM%=H>,\JHX`MR`^1M_F\4B!'>SO;5MXI_""B-E3Y@:21KS`FHH M>VND5('-&"EML5*NQ4I[R:I"BY7:M%AI>RWV]P<0A-#EA\!Z##WSCZ]@\0S\ MG5E\940P7X`>1\=3<$S;YY)\IB'KDS>7R.E M"FRT^ZH(.']/W<_O<*2[\-P#9]`U/7]!;@ MJ`A";(^ANR$:TPSTV@]Z[7JL,_!D[WBRJZ[+C(+06_S^Y,&!X$.\9>DHJ(&V M69V7E!ZZH:9N:*#*#JFRHRYEJ/-^U/FN1S:WGHN^\#W'@2.]*?S6!\%Q<"%[ MK"`]> M/#]$*EV!YW"U*S<.+VI4/JYZ?P3P'>NX*KY.YR.I^^?@HZKR\ M8%IQ#($75([3.$'9]^K?D[,7VSC+U+S=8CAW,XP6JRBC'M:!5;67=I9R=M[/ MTS_X,4-Z.V_SF&$:Z4Y=TX^'A(:#'L;1_V&XOJ98MU[K0XU\UJ^U#4S8+1/V MICNL(]`P:-[=H'GOR3/,M`W4:3]R>_.<-]N=7_K`LL,;P[0=:(##8%!1)WP8 MUZ#XP".RG=(#=W;/G?Y$P;>_/=P?1N5?1('M@B"8F']&=A"?L,IU/BL]!S]! M,$P>:'$\+N#2<.R9Y[NV\6!8MN=X\P/I#IJKOE;MP4$0.(B!-+LE37_+5\3X`B%=F[UZ1Q0Z#"C5KT;7Z M#HZ#9`)CH,MQ[%/#]RP-];[[>M]1^N6!`[OFP'YEE,[H/V!!%IC68:CW7J(#9KN&:MN%, MH?/P(Z1BTQ+A@2GK!N(.Q.UW9TWA<86!N*3$%0;B]LCC#L0=B+N7'E<< MB$M*7'$@;H\\[D#<@;B]];CY'#S+&AD(FR?L*E\/9J`CI^DV_>M`TX&F/?:F M&$V'8Q`]2#NQ@WH?SDX=3SJ]W9]3HSO.ED,P3SB0MVW14Y4BPCW4\<^>QK<]')KU94UF(.Y`7"KB M]F5.01B(V^-!60^)VQ>/.Q!W(.Y>>EQQ(&Z/9Q)Z2-R^>-R!N`-Q>^MQ"2;` MCIVPO9C^ZB%->[;O:*#I0-.M>U."#!3);;3&JPUKQOX+6/>^!V6%'_<.A#%Q M+71[U"M2^3#H6JO>Q4?Y"#*E;;;-HOW,83$0;F\)UX/$.6EO^C7R?>/C%]MQ MCBJ%4JW:@^LA&$4,I#GZO%M9!C;#G7F^-5T8<]N='P,)JC0>G`9)LKZ!*D?M M*BX,)[07G@\NO<@-/PZLY_C9L-TO7A#87?C#L=&JV0X#K0AZJ.1^;S1$/`SR($UNC47^ M]!"NXB%U1Y%K)[7[[?&J5'4+8`21#S[;@2<)O'H.W\D*RQX51:#2:LI_?#%\ M$-2*2.T5O]1:!L1W7R/'LM\@9\JV1=_>1@O@&Z%7,>M+80,<8U6I.:%7P/46 MMKM.['J[X'*K"LZ>%ZQ095`+V.?7,3D?P-P.0A^R"[6&44J>!S!KZE]./L.> M^1:$?QM-7?/TTUE=<65QE[!)^&C>W`+OOX(/8GEYUU!;6E[RZPID$001=- M*O;6RQ.@IK2RV.^>`P-*P_^XL1W8\;<4AY520>_$#@_@U?-#&&@\AD88D4O[ M#37^=:65I<9HLK"'6-C$-(!>P1G$)>=&%(JL:0%+5"7%OX&_D2OY++)*_ M5%*].,0L.F'H[U7BEB5EPG(SZ3,[1&$EJ8P1P`?YT,A9/ M/JNBJD'7]>FL7#Z=Y(JDO`X:=E`O"G4/*;'7KN>@+WW,<:*HI_!9V]D3P9)E9399N'F\4K`DZ MSXJ^I;NX&R5+,J<32HYS-[]XC@5=R6@?7[\`W[0`Z>TK:7GJ+A>?&196XFD;A M.36FMS>0-KRD*`*F!A7([:M9G_E\K;H\SPERJ=HZZ?O5<(UY?-3O!H#@`;P! M-R*.S9I=G<05G4FEJ-9XJ/LI1=\H'FJ7)RB;M@^=(Q1$&CRYX''5;!/>W44A MFD6P(!VK_2,/*TY>SW9)X05.4?E"I-H@##<5'C+`.#1:1`Z*0Z_`#,VSM';? M8UZ1);GH0M>+8P.0R,&/>56((XU.`'-O)'LYO,6K#U[0%-<;@"-R;P%0/PD' MZ'>S)^.]@SFE8F=(*7@#N`FMS`M,<5M6O'P%1RF&;4W==.],:[ORFB9BL7F- MB`Y(B"S%JZHJMT*2:_'Q-LO6QI`*TO%BVX@ETKRUV'O#O_/12!Q8\:NP:X]= M'K$![FO\*G<*(?&5F.ID,H)9:;`ZF$Q1)C(F4?CB^6@K&ID1:Y`)7/JG$ATN MJB.JLLVV@RJ)*CO929(D719$N0%0(J4#&&+S2((FR(JJ=`>S-KYA9YZ&Z(86 M%DM#-<"BP=)EY%=&R08:@T%IN5[70ZL>Q\7>K(=U^Y5E;JW2PO MB\V\@HA-V&T`:']LP8+Z1V:QEC/S.S!2X_3=`PA"WS9AD!N_%M\K^+/?8CF@ MS;RJ)DF"2#C/6`NT-'=ENS#X##^R%8DK8/H`&@_I<(56\^WG*+;3DU>]A/%+ M,D'-Q(V,%5XL3G>#^RYFRQ-FQ]/O@%;EYDVK_A? M3M+8ELWT`LS@-_A\3FM^B,7^=$-8^V6256^S?B*+B$E':<1V'=".;/4(7-OS M;[T0!*VGUA2AM+B2*Q:7F*PO?@7ABV>M-M1.YG,?S"'A+KV@_<2\K*I:L1LG MD$8&\#%:+(QX[B1W*AL:=1%;^HMM/-L.C!$ZF%$2!$DF`$^,A(5BZ=X@%OK) MG"1U5J^,AX66DR``87O--%46U,ZJ)2`85EI'K7A5EGE6%4:CW#<71@O.!PP@ MDN=3]Q9T54;251)=&D2386^/4%`E122`N`2R2D)QX7G)>L+=+.XV_NG9;O@= MOAOY(#V#D(5B[?&)G"@DRW3M!./VRW5GL"^MT35>*KN*MQF[5G#G%\)-)H$> M+TI8E]$=V'94I=X"H6LF*B)#2"M\:46TZ%.A` MVML(LE4MAJ)- M!Z^&;5V_H\ED``T31U5=0U^>QQ:'FL1TA41&"4E1\0W?Y)"NP`Q`\UE/QGOR M0CS=W)4AO"I@V]`:Y70&1;AQJA.HB6FB`^[!`S"!_68\.P`VL,Z&DB&KBQ,5 M37*Z8B*SDZ0)8@=,'NWTTG0MMZ?O8\ZX?M MM-^P*\F"(&-1^7IQK""2-4Y5$?#1$#W$SI9"<+$-Q6UDD04K'`P/93Z/';KNB;F4"JS8S7[$UDF M`I%;KN@2315JB**@2I?QTO\P7M&O@[MFQY_'20&=;:"HV M_FZ6TQT5V>E*150[H,JZI`?X+)D:ZSSV%72]LMB$ADL`A!,#DJ+1`EB9JGSLC\Z%8'-_6,$MY!(JK51'AG5R M(_#D+:4[6Z3'8+L@6,EDMVF;ETV4-"TV?'MY^PE;12AV M`'C);223$4<4%2K)9:M,W73.[!XE8?/<29CLLD'NIFY??8>V)V)C5#:`MJF-]LTNFSK5AJ>KVC>[5%WT29%I M8'WRR'ZKW^V<'DGJSG[KC[N+]B>%2\.>?3,%NT/3I;'G9DQQ!9[#U66P-X8) M)@LTZ4W`\QO;#\***WN;U=(D7L5W8U5#8`BU]GKA-9%=*0/6)K%FG'E\@=6) M<*)"R%)-J,FNX*W:%++/C[-Y&@YZ&+.!!*TJEK?CL0>+=4GMN*KK^#AG"U!W MS-5OKK%`[N0O8*&#,^B#>UC/=K1HWL/7R=+)-'TM]D9,FU6G76T(HH0O3.]: MG];>A>=$OLFY[+!RVKH@6)UG")[8H;V&_S_!0A_ M`.!^GUZC\U7II4GQ-AM&AW%%?"=7:SP;58P^4;R,9V;OIV+T&>=U/"5_/Q5K MD;J^/S66'F#K2Q-+X6Q2K5TTL"VHM8OFM9W:VGKC8J56,D5[YZ.$%6RSO0EB M,G+LHF4ENNWI3-T,!5[$3Y;LF\[4;515\6U/^Z8R=?M-Q^H;5_D78#CA"XQ8 MX8MSP[7_BO<.LKQ12!0XW!4U"NV,D+Y)J?IV$5(W`)Y3U&W;D(ZONH9/C%$! MK";WI><&GF-;:.FO.*CJ>$):57%SM@.P.37(-DKI_5"#Q3Y\C2Q>(0*Q87W( M#CK@[8&!/G&BJG][_A_PI[FSU+IN5R=_D7$+:C1%].5]S=5F#!.*:1Q@K+>EKHD<(5TYOMDR[(HM'7EZ<5( MH00_HUO0@ZF;Y&0G35+<:-OU)H51I<3$I)3J;<^LWZ%A@+5ELVJ2)LO"-LQ: M5&][9LTUE'\#>_X"04S>@&_,P0-8&#;:MW>)MD$89A@9#EH":'%7=)7M/]]K M7WGE:ANV;:'C]BH`^K"WN.XQ:'$[NX+1PS(18Y=>[5O]Q6[RJ;`5AI,KNB_& M;]TO-M0&?ZKCEV@=36T4NQ:Z*F'0!S34BG:J<-OO7'M4-<7NJ4]5(YW*^-5N M?;!`^=1P\#)Q+?0_).K-<)"0R7))N=MEJJ+"R=C-IB3RF($D2Y+&X6E8M@E1 M)(&H23Q^.GR[9B3+2]\=(MO;3"IO;N[G33]U=SUOSR#4L]AC+(O%H1F$?M7H MH,U!/4,_KLBRL7%[5`A@Z@54?`MH@\".V.@;I*!(VI;`43<.3="WA8V:J9+, M;0(;]6F3UC?T8MO9.V+:@HHM=B'H>Z8B=0O!DX?V7T7JAB83-S/&&G8^"-;Z M&F)5)ZY5%@>_MF"#%OV2IJ@'9@3ZX%`_1")0]K-X+N8-V^#>]][L`'X,X\LK M+WH.9Y&39?]CLQ]0%O1BPJ4FD5WAM>DTI?;PJN_YVN@E:XH@D]QL27J?6G<- M6ESRA?5QW328)$>6XL'/W2R]-Q$M"^$W]+6UN(3O&FF2V!4=M34E"1MMT:"K MGG-EPU/\\J1J6>T1T3=U3M%;((I/),&7KM*KNJ=N^3H41ILR)0V_LF"]:%9P MZ8DG:)JZ`;C))$CMM:NM+Z>4%>SL(XEH5G#IK:O*^-T0S-#>O0(?4MV=LS2O M0(87D\T.,7TW)&P$;Y;F,@G58)3&Z)#@6,!/Y!/)9@:8WMU*2NF*5)9X+Z'W MGK,RKL*5+J9<(Y<)4/IQHB+C=TTRP\GR@,%8D4@KOV;W>2N<]`?H.-)J)X9) MDCN=C8UYA5M'!A(PFU.)GMY:^=8F%BJAZ^J,X"4>VEG`NOCX%B"OLW+NR8D= ME-4>:F&[$?PM?YA`6T3'!67R;+9H"CX'WE;NEF,]&IK"%( M3F!7<-2&Y'DL&*=!5^/%DR^VTWN.)5&15)*^A1#5YG6D#WXD4>>E#>KX`%[3 M6K^;95=QH"PY\1:T^,37(S`CGUV$JBC8W#H-`M;HZ=N,HHHB,_AYUS4-@@C= MD7HW0U^SV70C21Q^#7B=P&[06BRQ:_:+#E^(9NYPDJ;_UI/Q`O70%4 M*[`3,GJ&R7C:(W)@RP`ANX`E7BY)T_"RZ1YXL28FJ1+9'2!]#X!'SG0`*YU< M245#4$UO!;3+WS MF/6[P,^VFZ$[A5C-KDCX8L=*!*UX^OD_0<2N&ZX2'^=0N8]\R-8`=@S+N2AH MQ?@B4!0H3!>OT+7$!QJ#6R_\#<0EW'@^FY&-7,CGTA;+QA1J,0A76"J4U5[; MT5/7-,5\^<[V-4.78AKCC'7($U)E=%B/^_/3"QC9V5Y6V)^!8/2:W@'KN:,0 M/D6?C')%C.+O1R@C]@BA&:&)'BWXYFL4>A# M$\`?+D8A*LF)2XI04!6_!XN"?[=&Z>!H,O=!#.)OHQ\OMOG_[%U]TX55G@5**Y]JIPXV?53<9*R?;NW?UV-Q,B:701:0'9\G_ZZ!Y`0$A@0 M2-BA=K=6EF"F^]<]W3UOW3/1YPE](YZ-KD#!PQ^7OF=[CD-]@H#!`P'(8XJ% MK8!3\6RVO3=DX2P#H@U4XS4!MTZHZR[G!+3Y9!RUCB%=U>;4S>8&Y!Q06BP< M#F^&GGAS*J!T$,I=4$C%G,&8()3,N?4)RIE)O8QI!'[#&:W7O./9[@%L!\HA,\Y/*85L>UG)X64P';0A.:&G]7-,2=D$=, MK7'!@HG/%Q7.EI>-5^9Q+P23-9*IYU>)4X(9ZN)X'8M0'_ROCTKJ32!B03TZ MX6_(UTGH(5A*!)8E@6K;\`N/1HGH&IJ(1F?E_CT\9OK`08)CAL<@B;UDHH/$ M(H`@ITMXL-@R,&R&C!\)G4R8$Z]'X&!>M9\KV1Q1'4*^Q6Y]MW1SW#D/"H5X M16'F0%0#1:@J3XHPIY/:(BMRA1OB@\&^!)WQ(5+VD\T@84X#)F[[@X%5-#3_ M@`8>282I"W`(@YXNGPKQK@KD&R:;`R1O0[FM_W MGN][#U$"4?@%!%>0]VRO.D!;.XI5J&J9H\;*F'6(I]IE>8PN,E7.M3Z1_5M1 MC78Y^^2S?Y:8Z^/K-$EWY2:)K]J8^P9>87R:94LF8.KC.B.V-XYDZS`:2*&M`SF'&!GJ0 MP_>JXQ5/&*_\I`P'5M)KQ`THVJG@[1P7[00,"!;H&V@@Z"QND0(UH+^HT>(5 M)3T#!?(V9Z01X,!#R($\&M62&PN;RNRFU6[K9.3[98`')0(6_.I[054-^_+G M];=2A3-7J=_+$M(RX1^HPR'D=CF]IC;W'.^NE&/4U6ZQ$96\F%"?563CB=.\ MA^7B"BP[??P-1EDE+HR.Z=1OU`65LB_G%,*!NW)QUIXVUG>:X#>8 MIME/5EFIRHFF9UEIGMPV`8EO0*=^$!=W&T1(S9[N.P#YAT6L0;"LD7)`K-J$ M:?=5EOW0T;,5=5HAN"NHU`PA5,5\WAB)$8SYEW+30NSI?-2L5VR=^B["55.] ME&R!KA\2O)IQL3IZ0=A=NF*SC(?L,[_'/T/JWO'5NPV.V#;-_A-<=!O`NF/X M9>*YDY`!V@$^:PW3H6FJJO'\ MF*TW6#7+-"V]36[3MW&KI9"^9N'2=[].=U7/;BS]3U/4-58I<+NDZM,EMY.3 M4A_G"\=[9"QU8;EL(=X1`M-$^>T\^H\"4+:`Z!X`J?)(-9X50INU+BMM!#>` M5Q/E//,9:1JKC]\7/+X<7K<"]CZZM6F46F"F>;R8/^$!^H/#F"=5&9I-U.W- MH[]%\Y0I91IWS;[Y?%)XUJ$*;(7U6X=-E)^NQE>'X*SC`PK@U`:&U7TX@THF MM32D#9G!-+S?`_[.YS'U5OQR93C'V6[CN>L2)G0^+A6+Y$\I-D66IXUVKY', ME$V.JN M5*TMY.NSV&)$=0D]<3?@D]RZZ35M1MI8R'BDQ]),LYWH:9.'8\6;1:8:(E[[2.0VZ]D#H%:M:<^]_.7IG9BST$;UW!<\="_[YX M&J,.X+FBG?GW8%EWD_#%$VNX8%FQMT`TF_X=\SA%V:?6F\FYR2F;&]FK7,NI M!'J'8.=@&$92_.3Y\5?XG-)L9*1<#2\.`-].3K;S+<2%G'9K/^95N00/=<]M M\.11U(`;G*SR^N(UP]V'21B+M>S*F:8/%55.N9':!#?M5'\7\HB6WY+\K`<" M11VJFJ9DYRT-\[*%%U(807FQ]+$@L-"OZ.'=6EMET;Z$*D`X8>JI#>NZ%&W= M`4YEV?]$N5\ZCEP]?.DN();[S.Z9HT1"S+W[&Y2QL.D+_[N(J\U!=C7Q^7%0 M1@9J$QQHEJ8JFZF9#R^+9C@9Z6:FHM_A9:)U6JO*R*+;'&2.+8H(8?7"LQH/ M[7'0A7&0L:YU<]YTR;[6SMNC6OJQQ:$]$W&4&!3/60R945$ONU67HJ:.<5!C M5-?,,&:JV7001X^:ZG)B9;.,'-T\=4RK:D1-'>.@@GGM^'AHD8-ZXP"7I+Y. MFZSW;:BREBF6M-%)90HJ%PK0=4[-3.&M'4`J^D?N-5,,9Y*!-XP/!"1U%LINX'T5%J,S90U MF3YJD%"]'+PY;)B$ZE9KV`(*%6V3R(U3FH2XNF4-#9M]Z MWY@_]?PY^K)/K"%'=:JI9C:-:5D"FB6]1A1M#M5.D%Y933M`3##9[].&_/OF7EM88>-4%AG!6.DFELS\/8IW/;"_O?=*11MJVEN/X7UR`, MWC.("5GTW"W]SH(K[GI8<":9#YV[]N$B0P6O/A6$`JURT#'PJMM:S5"+XNH? M";SJ,;.F9Y)G_[C@539*P^Q!N*-C!TW&-O$]<]F4-Q/\Z]E:(SF=[4%3]5$_ M4G8-^B9IJCR8#)B!MH]3Q4FFEDEQ7)*F+RQ7(H^ET()MM$?6DPN0#9;4(5+$2Y=.D[$G3!7>68>D[TV6I,O*I MBCO<@ZZ6U&I_PMI1K48`JZM>V2)*JG[]:5H:X/Y6&[3,0C:*N-YD8% MC`D8&4\K5!XE+3#2[L@X("/U1H=NXKG[IQ7KL!*I,4)T6=-@NM,8(X4I,S+9 M2$2"$(B;OTX_>?Z4\7!9(\-)G(:_4G:3D:&F/+.U#T5'X&XEW'/;%H?@J?.-U>5PK]N!W.WA%%EE^? MD2D0@)\7(;GE"%#_I!V9[ M(9]0YY0Z_,Y]1\9>"-'G^FE$1[QA)V_$Q)\Z;!KW?$80@U/N8LG1=^04OXM: M@!>1P.15_'P:\/\#=JSD$3I?G/U+&!W M?WDU7&$ON(GQF##T#+G$7E`1!X M48!^X6X'\'P;^OT`ZX0^W+!%*":+1).E?FP]GJ@% M>G)&XB`C(>F]0R&D`<)(X#G<;DZ/,!(JJSZ'P:L7S5HT>B^:KHJF'S6=%4WW M1DU57PEP`3QWOK=T;9QH>OX[XM^-3U3-DN+_WA3YTW@>JENO8S\:MX[^]8PT MZVUQMP_KH5"'<#=8BIPXY6!/9LNOVU/.;$_;<)3M^Z=J/,F9KGS\$].\&!J=3DK@FN"7__ MQXR'['"3YBMF`UW^$ZZ[;>T[U'BJK6^Z+%EZ275KFYE>&(JDREHOC$X(0U%E M2=9&O32Z(0W%DH9EIQ#==X95)K]M^$5N]_I6V-%04I1.:%LO"Y"%JEN]+#HA M"\64#*OD@D`OC+:%`-0L[,B53ZH#RXX(0Y5,N1.1Y;'F ME*D=XJ:]J4B&6`[;@^[OQVT5[]\?;B>D"AU5+8U>5KEWJL.A$.BEWX+TAY)F ME)P9],)_:<(W-,DT2JY<]])_:=)7=6E8-L0\@O1?Q%+!#?/O^821*6/$CVYJ M2<1EX8H<;RHN;/ET$BZI0ZCC>`]XDBP@U+6)S8,)\!,&?8!>O,`U4J61W(D5 MKEX:9XJI2/*H$_.E7AIGA@XQGM8O)71#&OK(D@QMV`5I''HM(=_7MKBZ\,WW M[GG`/7=%U-3S@1'PK6S\E%_MP\\6P\^3D:1K)0\Q-1I^ONF%?CRAFV#]2N[W M]$)_*4)7#4D=&;W4?S"I*])([YS47\2RPA<&OVXO+?2Q]Q/'8#1)-_L=[HY( M8ZA)QK`3,Z%>&F<&6&M9[T_B=$,:NCF4C%$G+-4/L4H0)U%;D02T,Y],1(I? M/-Q'J.]3]XZ)7(U]3'FTF%+5)>LH$XE^P[(+TI^AV0OJE*EE7R M!FHO_92?#8C>BE3S^%6JVE6US/;YB?$OV#B\%56067M9 M\`54O[R*$QIGI%R0%-\Z;D[\%YMV4Y$[D7?S/$B?Y=U(3TTZF2ZUB?S5+TJ1 MNI&_]1.=K->??Z=./+WJDN;T@L(/%_&9_%X\G13/YFK%!^K[CUBEM)LCZDCY MD;71'ID@/W$_",EGSEQRR_PY^>Q!R%8.S[A[]25F\]3VRN8)\WG%++F><[PT MK+W@=IQGUHVI;!B:&V?//P"2/\HP)OJI+>C4N?G3RR M5I;%&S;Q7+M>?/V23A[LL\K>Q($#Q9(EN6R"_?Z\R0N1^HDJ:?HQ\N'\@#>5 MCBUKQ32EH?&#GRG::W_M@^O9$]Z?&>!CS`4R(LP#4H/!UR[MHW0#V? M@A]TP_.)V)(#1K]!4##A+*AW$F2QN?7T]'F-,S*G_AT'%&7\9^N@K3PPN%L: M7"?>PQ*8Y>Q3+=;()O`>E^H_&%E@DA4[VKZV.;USO0#B$\+G]`[WWN*;R@'A M[L19HCI"_W_N?4IX_0T-19>KX73+S%H\C*YF'&6J#@OGB#9O[;!(ZC\3S`9+57^$,0K>[&?G+XP#X/4@" M&X7W+7D%3K2;&A#0;-$4=\D'&,93SWE'W.`9[.$>'P>,$)) M`(0Y#*1\ARO$(K_.E*-,L32JSQ:>CP.3+)8^2`Y0:EVG]QJ#!0:N0V3>SA@: M-G@S8+:@!OX2$R*A%FO\`S"7T;7%>/0QT#.06F0P`SRS=$UM/-1_15T:W7"4 M<+U_0$Y`D#$P;3$B<:@=>K0125$7+(KZ#;"W)Y>2F! MQL"0F3(Q=.&7!?5#%U1RQA?D9-W?^^NK7U-=[-3)#13(;@0$/2D4J!-X*RBV MF"*7$?/2KI^2WW:1DG#,O^]LP":7T0@6Y,19(8/DT61\)@^1;S$FR0/K89OS MB)#`Q=J*)4]M]I3&]^+R)@5O9">HXY"'F>>@:7IP@>A@.0XX&$\+^R[.3((-Y/<,>J;1@;H-S?O" M4NHFI;3R@>W^?AGL_MY;^NL?T/[B8%C__`&L&G4?4X^`@0UG/(CM6&^[&B!S M':R1FQ#TEOIV)/(/GBWB.7'C.J6JYS M8;#9Z,^19K",T"?!!9Q%-![%K`$U=#*CF"$6A("C.R#!@DT`JB@`P`<`(ABY M?#(C#'O%>(I&B65A:"'2:P(Y1A`L@.YX(&PF/(_CD)+?89R+H]"7\2."B(\1 M=BEY_'[Y,6V9R1\L;7LQARV!1]#AQ#1A\//@0@]S^A>$)=#:O2?DG]`BS-?J M/8P@5B^BK0`.!2D0<8`&/I(Q"!?%!Y]%[S:#9N80XL%K3`1GZQ?)CI?0.E'L M:Q5S4?+/$N(HG%O8@_0 M+0R'*#"-PX752$B1$`$(",W!Z4`8N)J.P:CC8$CCEU/J,CP+".YO>7/P41!, M@J3G(OA'XD[4B`!O#//2R`@`%70<>/X8`MX@$+U+L=465(AY,SX%E#*47,01 MC-TIS/0DLD$E6!T'PG4O1'$*TS!F::JQG95,+MV$/H03W,9**214KF3*GT4U(B(A'O5Y]FR2* M#E9\S6)G*68%PAJ$7O0BF"68/:3:2XM@2]E@K`;!DD73@)GW@"^!N83?B,ON M8*P*(R?,)Z`/NO,WBZ9F:S@CJ^G>0VL>1B784C148LL7_1]O>>"K&6UQTYAX M.+E*/D<,1`:\=[\-D/F;!Z&F37X=0,3NWS$_\LF8D$"5*D1%*@E'?IEB4` M>3+/?O(LB"=\]76,WX9_O"'A`930<-XD:BG4`L0)RN=UG8N+GTV1(M6B09>1 M@YY`@_Y3*=64=(4DC9(S,9/NA@XY>"R#M.*1<`*7@E5*9"E=:4F_ACLMN\"@ MUM(^@'>="/Z)F"&7A"YF\S!>`(E/04*`/`4'&8BXX%=Z&+DNSE,9/D#(UWO]VN22;+W?**QLZ*[9/^+(RE>)1Y0225[:854+XR M3I9"$(E'BX'$C33`:0YB0+]JAC^4_C4=#200@H!BJ.P?P/E*\ZU8RY1HL-(T M&`7#'N@CTI0-OB\Z?/66N2?")C?"A.'J)A#-U@%JAE%"D-I6$CQ M(A"((7XF\"VF.3)T&LR#T2#J1 MK##AEAKK'8E>%0>1D..[FJ;^&4\CYU_.59)3A`8#3*B'*79DA#Q`P+&.EEM3 MNA5#:3.N-ERK?MG`=%I,R?0@05>0Q+)^7G(<2Q[+;_U!IORYM&Q]381P\1XAS0UW M3=W#5%EI*3K7;&%(@JUZ"'0903#U`%3Q`]RTE*(`.:A)-AIO4,^#$#'."YR5 M,0T6.)]YWY%1%!P2K#BZCO'7(_A8!&Q@7IY()M1G6)R),O]NS:`&>>!1A/.! M1KE_+;+U'VBL^3V'#VB#8!L9/J^$"@#UP,'."@A`^G4F83Q+9T&0:<@U\Y``3W%('!1?S!;!BW:GT5>_4:K/G.-%WD1!_T9/;I*44N9.Y$4# M>#L"^`6P,`4FBM#*7VT80`O##UT7_9&YNA=Q-6O<`2:I5,W5ZBSW`D-#;H@1 M0W:V<7Q@(&#D;PW!N7M7`P;37,[&>89.H#Z$#X4%;W/ M66\4_<]9!N.V60BO4L!^,*&=A1>#0:-#4)3@'W0-!-UZO.PJF1C.WCIX]8:8 MK8)PH?1+H:WI@KT@SW6'93:*WP\UU%JPG9R35B6Q&*=W2*UAI]$J\T^_5Q8' M]Y=8$:S)]'U_H;4-A!L$U@-!4#+KP9**96^GW30@9^$[N"AO9BL.W%I4X?Y+ M'"I3".XAK=J=0:.W!'RKT[C8558I"^U!\FKKD]K309R,N*HSF)1QHTWW*Q%VE_+E11X M*Y37)4_"FP,C_0#FR##9!0V()>,'I(G^304KZ\PM=I$IN$S^NOE=EE7#94EU M49A5F[X\]Q;%9\?C!"\&2^Y@V=5=1;U25I;E]L5RX/0&&,Y3'*=BUI7'[\=. M%&=,=ZCU\B05*E`IKWKD%Y5WE[#_%L7RJL@<=V!>GH-R5GN&$Z"A:K`/-N'`9B;&7I_J&NG3%(C7VS*,K^@3##=+K5['%I?0^F7-#5T44 MJT$05DT*8'[Q8TS!&-/DD(K&!A3VDMUEAMLY,Y5SEO&.C5"'MT-CD>#=D9M)^B\1GDG&Q;U8^<(:;^?,.UKV#;)ID/AT7[8P M5E$7FVEUX%UO25YPJPQ\X!G\2ZJ4`RG6>2+DP!,XH8I,_B+7'2]I2:!4/"51 MQXE-%8"R-0_H)Q*8Y$`N\L:!(ZV;<:4V1#DZ+&2,2YU;B;)EA)G17G6UM`J: M0ME9MI@C08"&[C:=A?"2]&7#^8/R`61:JR$AZ2Q49B`)6KH8)>->6[WD8"E3 M-I="5-Y^5)PARKSY3.5@K)Q(\=T2R2H*J++?\3LJ3H%)^G!OLHJ;N;/279=0>B#B>47R94YZ4_`:/%;X?1W(7YDDON[HE M1&NOM2!:Y1(`'F`;\-$$YFR_APU+7[C'$1*,]IPW"K^[;):A$,0KCXVOA&> M+/DSB0AF(]2Q,O"=IO'82)A:Y9UUC"&I3Z8<$'.LI'KLO)CC39`=`,7Y../2 MFVKG?^X%.K!>$3OY9MR11+&18+CVLG`J2G+Q#"]/2$H#8>'/6DB_K!(2K\@> MQ03;:QDO]F-Y9Y6MA(XKZQT(42A)"PD95%CX5>]:2V!/AJOI\+'9&'G`RAG' M7#86;IBH+%PYT%"@`-F18P(A]XR(GRDNS9)<>H!`S>]B$/ZMYOG_IWW$SWF( MG'S>;%%%@[C.V?)TOIS_7V>9\Z4IK>I%//)`*6LU4XIS$L<9/`/'&0FT+?'R M8\+97Y0^JO+._VA\:1295BQGQF-T)GWE>LG`";;"#J6VH-0GD563^"O,U61S M6C)]$^MTO)E1TX.P>_Z?>9KQF"/"?:&(&>><#V0^7MZLK7S,,L70K]DYE7#B8HI4."))AA#FX0^UL$_0P2F7F^D"*V MBE3\F4=<[:`I_.Z/L:9G%YTIDRB:-'PD4[:D))37RES=@CH:^85@``[Y M/]H&P.U)'*@XAU/$."9!R`K^@Y>`(=#J,VXXJ6Y&KZT3J$4]\$-J?%K M,OBA-<&!/K/BIT,*_9UA,\[;,:I[U(D?$?1GH%;?Y"2;R3(DR27+/V^DGVK6 MJTE=9@A',-TP1)B0Y39%%R95$7HS+<142!*+:(*!W$7.C)59AZ2-%&^Y7J1 MXI3$R21(T7#>+%4,X4'"W-2[(P$:`U,UM?L21U*GPF8P'!2RA0Q%@$=($0`L\72=$(.X M!M@3H]R"=E18K@WG,N640ED>&JN@`-O@198ZF5BE5+1R,-%ET5IU1RD=!-HT M&V$($7UK;;5&.>(F#3]U.:SOJD>+M7E8*)+1J)=%?;PR6Z48@>5(/EWRI.:5 M#4I`#A0I/1(8M>E%/*E4A@FB.EI*Q32+0"H2$5=.7?O_U&M";T.'A_%P31#* M!YP2"%1LP`F=Y2V8Z:J%+V+F:TZD)6U<4DO%5X4=&8Z2@1E9BU':@8:["$]Y MLQB+!>G@]7)N.7(W#H')UR39@CY/XR@2H0ND$W__+L1Q2FE7&!),0:G MV'$=/;I1$!YA]&=0ED4UU>VE&5\\^\@!=(ONYO.HQOJ6*CX+$/Z=K M#.8RTA-HY.G?*]VAXBX3X=.M);Y.CJX#)M#E^%4C5R(5^%%!^*[>< M;M"F#%O%L@XM24=*)\FQ,76:2I1S]>]*L;^2Y:5%C93W*^/WY4\%41F8HK`[=5QA8N/>+U(NH7[! M9FC9)`]U\@'!<,9+%SE$\#0HARQFR5F(.;K:30+L=_#25'$E>AO'ZA`XC9T" MX93?($D5`=%OW$[C(M`MD45G11X6')U$JE&\DJT0[LF(L3J#R==M8V\>&!92 M*3.A5%9K,I:K318/Z?1<1'A#(13*.7V"4LEDNAM5<'@W7A!2YLN&)F;*R403 M"]=RU+<5MU.,3@-M7A0V'.GKR">KG\):_*5D14,RJYX:!(9,NY<-$\H9$F;! M3B6<:ZJ3S6,\.AD_24_L(]78%AFX*MQ>K3/2K!1MIS)CD^N MY$=NBI=SQ`:42SY#&6L06M%8A.=BGM'O@33@U?3EK[4^ZATI8KO!G^66GALF M?>+U\&..^MS/N/=''S"B!\KU-PR46[N;W0?&$0-]8+YY2WG%X?KVFX:3QSMUAQX.+2YJ@8O6P.T-MPP(6&0<&AF@/&1T^`GHQ#L=Q$-'?K_%R7>1I/]5]`L) MXN@7KEV0A1,(5!#]F2<+2YH;%QJX@VT'>%LQ<7!<#-LMBXM:X*+=<=M#:UC6 M!!EM=]"LA67Y6#ZE<4.\;VWZ$:L%MSO;H][ORV]MOK\_WDW(+G#L*FFZVQ)W M)3D-&L1X;+8>-4:M-SF12W\)8N-5[TNV'@= M&TJH!S:Z%T.WU^G7`1O'CB6LU[4'C"Y\4M7C&JA2%;DU/Q_-_#R[<+N=+9.8 M]FI^OK1(?SRD#T#Z;7G?8Y'^5)#>[KGMBY[%^C/#>LN]Z-8.ZT\BK/![]:1` M:WO?D0;3<;L#>\-=$VST.VZO7PM/R&+C50^D=;-K,W'J@8WNH._V+FHAJ9Y% ME$"V)=0@;6Q/:&W*1[,IVUUW^"B.A+VPK`/VFV[WXC$B1A;[-<#^H.T.AUM6 MH%KL/S7L]WINM[VEL_#\DA743MO8/7C?QM'7.#.J&G`(RE;AAG78:.^KP_'N M#$%+4\OU4!R\S<..$.RH"8=N9UO?>0V1/)8XM/A_./Y;PZ[;O&_FGL7_R>._ M=]%Q+]KWO$>S^#]]_'?:;G/;NO-'P?^R0?0+M9HO?K7T'V&-6^87SA_7`\SSJWG*<_C M>(9#8-0@(_H[SDCR\[&0`V22!&>F.S=>F-.@H30?3XWOJ:FM`8-1S-]B!P4$ MVW]H67J?QC"I1WB(80$TSUJ2DZ=XUHV<:U2UC=&"A^=DBSF!-?<6@D'`\4@X M*"\4'AY!Y+2&YSQB)XSC[^?H\,DA-CP;CL?D)2(4-SAQ=N*-,QH#=ED:1(L3 M6HV!YM734-24036;9QR?ZSF,Y9E/J1/?\IR<7(XO+`8_X10D\#0\\_6+(!'1?-;@$P)OWR?+6=,5BQ8_3P. M"\*)Y4B':2K2E`9=Q1,^BF+TFN2P;O\5?'P4A#B6G@9E+7#LN\/SX'A`7&GZ MI"*.Y>\[6WV;)O?*P6*XA!HR))$MF0*^'6B`C'"!+=>ZD>5BRG MU`"(43Q;N')")?XV3R*>2UQ\3U)U$(V!)=28M5$.E@G/8MQ`)["!D:!9\DCS M:ZF$1[ZK_:#R"J(U+Q M/12NTMF)#^+PC9B(!,305^_')6!;O6*5\KV4LCI-!X[3X?,\OCZ6)BZ.PPTF MBV>@I-]'I%TS.'.<#ABE0LVZPGXE.>K(/.4II"32>"Q@&"C)-1,@]WWZ)3^' M7QG3:$L>&RXF$^38&UY#SCG\0\Y^@V7X`RY($XG^@"!BB0QOT*)I:=6`I&Z: MAYFC-D8C$ M),A(Y/,@ZD*WZ+E[`FVK"+6@5&OZ[%D\^5QX('EG,:B7 M,/@N0@3`B^AM4B\F_#C%/@A#_".#4'P2C!(REN2%MS:/Y#`^&I1:MM%6#P8? M".!X"FMLU1)[!]H6;33U]C)9W`H>NHWD),P1HY,\PQ'V\"A]CG%L3A_&C^#8 MOHC&%>),87%-`WZ!;M3T3OS3[520Z443C3=`@@J[^EC+N%BKE3:IE&57$164 M=07WJG7>L9P`C%_%J?4%]PPFGRGRI3IF;>5JP4`CL&4XH4<)@(I1M#4P8CWDN?1CC'MC0!7F7Q#^D5"!#6&LCFB:IW*)"Y M.-"A48?L]R%/$O"+_X&6PF?/#^(POE[P4'%O-L-IXO,IF#J?&E<-_JWQ_(?/ M[YU_Q*%/$^]_^^V*31W2Z&DF8RL@!>`GT.$S,/B"\UGL>V1YJE'#/#L'V'Y, M[`_J^X,7@2F3X1GB_"A()&1*658 MZ*5)=N%YD@#49B8+QT)X@3WQHM7H*R!9D/[0K[C.BXN>VVPV*<8$1BQ., MUA?=1LM\]SJ.?;+L;H4QV?[P\XL/1+I'U(&'9;[+_!J^Y72VY+Q_>-$$Q\2_ M9TX`#OKD.@]A'G;](O5A(/9+8IPU;--J-#7;./MC&2;^^["-L\0RG:[F"H-= MF"7Z/?VW6K##25'^/8G<^6<>,7JW52XB,KB?]5J?K]E9( M7ZJ#]D43_ZC"&W@'(::@AC$0#%!SYKKEAD-SPP=`?8M-GJV8X0I(%\@P"CR# M&Z-=*?,*7([RADQ$A:@:="=W.2?)ER4PC&*IU$U^L M@/N*\3Z^VP3/&+X4I1Y=CUAVW3^[7LZ3@%-;6[TMU9=V/PI^_>0E601\N*RH M\&971%LRKS+4UGDZ:QBW?5$X.LPR2(]TFYZ*,,0H)YEUO3O9VR,()CD0)M4Z MX8N)WJ-B;2/<6I(')<>P$`ZNE`RE^VZ251L-17!XP@`%1+*XG]Q(TWPFED+[ M[\$(P%1F%U&'%=3+;^))=;J-'DLM/BY7?TM+'+YQI\-O=)SB.6/=,3C$^*1Y MO8$O#"]:;%9F`\JP0-_ MZM\I[5R9W4&N9M>4KU59$05^U=;Y*PWGJN(HU#$I6D!YJCXZ]Q;X11=_2.(P MU&`LD<\T3D!,`CDX\0B<-B()6.XCY4AL03TD@=4%-X8P0Y;`2%)3$<[YZ@8D M0(8<1U`4MR-X*P/+* M'2O<*X"]?SSO39#.X\<,13YT`W4*2-Y;N5+H@^`QPA\I"BK/:?=^!D45G9.U M!&R."D7%[\DZBX3BF%N0;6#]Q;<12N$H(QGB.J_!C0SH>NX*)<>B4,@4=W3. M5%;.X-7KJ\_J'\-7+U62U&_!1(R2P`=5QSXIZ=D7/3,$\I$=1Q\O$]`6]T)* M4!+DJHWB^'N1GT;V&FY+;^/62U'U=HK/@0I"09?X-"P:X2"9<_GERAFVFN?P M?]W>>;O#2U#2B_#IVEO\P`MFO7N+>B1;,""^3PRB MCJ.TI!>"@^POI(C'RV&I,Z<>W[K$<[Q6SR.9ZB2?6W%9"[<"=Z&6!%E;;&X" MEE"2>0$#$L_)NH&MP`^`CQG=06=`F%)#`R[I8M8;3P,PK]ANEOY]!.3JM&!) MS+K#3+IH8:ZIU*W:E"SSSBB#B3.7KC&;"^$P5];[ MER;Z%H,%2K/*7/>(09%*6LVRV%@VNBG)!(4+0O]/^(U8&)DB2-:N^2<9CM66 MOKI2`%:D%9'-R)``5/E)_:?B#=?1YI@T]0U$DC.OL;S8.P,F[V7OSI?P.\*@PFEJ^.&#'B1'3\4Z63GGRC_V[GT M\8:)")A%B0&1(YT7E=^0"'(.R?,D30MB@;@05!BP-S`[_F?Q02V(M-HJJSZ5 MV8SZV!G)CO3['J8=5`R(RA7U6N/\R/(,4T7`*@<*Y:]*W1E20 MC5,DU)M;4$)1Q6&D'WLN=R*\!'/'9,;V+94QD*]'4&F)&F"NLKBA'._ETTAI M%P#"HGA)XL)+2]&,M##,>$L8LLF9X&%+1<8+[FD"VP4,+R@+\`P]95(7P:P" M`&DKF:^\!&!`$%!BG#=!2?\&S"-.%^@5D>R&\]9+B-#B.1T?P#%'%&:9/-LB M*S/-`%`^53HM.B>,DM*VU?G`QYB_22^W[)* M`/&N93H(O$)"]YQ*Z=RKEL[OE8,E_]P#:-]C9K.."ZHG"H'M.F=?\E'&4KO3 M`TW_\E<"[!,\!UN46:]`#/!8"C(#Q>V'3\"D1.D#F71M^HAF/L3-\ELLPKG)3K//#9YU$NF0$?92,#$($"8DQ` MX)B(/*5DXB2XQE@6,E=4/N1F1Z70H;4JT1"8,7`RJ+D,)!TGP0CC5P*XH@PX MAI=]9FS]ZV8'8/"Y#L?W$]259C.BN9/5B)0"3.)F$.4[,D(G=(8W,6#I@DDYIY8&A_J0"*SRH(@I)()2A*G7^ MDHF_$B4LMW42/:$_+8A'YCTRXC`O6E&M3,K'Q'EOA!Z*RGY$E:@N<#D;XG.*$Z2^)8TF*IT*SZWI&"XH.YX2L:I4C"J M9N%82L9953`$PDDJF2>H4%!*'=#%*$O*2G74[&Q61WQ,#U))C9)(515_2[:P MK,]!=JB2;1C:D-=H.@\;OI1<@[,4-$1#2ZR7ZAX;[ZN-^A^T8<'GQRI=+P2:>"LF3@.S[8]44A*I;$4NF043W,YZ!+<;1.TBOJ*UN4V/K^IU+GZEE, M.YKCTJ$XK+35WVP6%]>R7SW61K@"M@N'@FDK1D MZ#`O]YO]@I?I\PB5C-"1*R6YEF\49;!1MF5`AJ6*5[IPF.`M#I@CLP#=7LQL M`:)*BC0E3,A3D$C2EW8`28I$3+#K`,`,_V(-K6IMU7TK-R]04<.5%8C[O3"- M'0T_74:#@/&"4/#L1@Y#$C0BHD09,*@2'>PKJT73HXGY;I+<-[[:)-_7E9MP ML0L&EW#C+:845'!PF+,ECZO,5,#<`15S$\[&99SIDRI*921?8ZC@R)Y@GQ4! M^_Y3OK]FB42V"G`$Z!,V)?6K'4X^'^S9;N&,N#V+L>(R;!_76LM796]EG/J3 M2+Z`T?^8E8E/[*Y+G2Q2-U@,7J+;*G`=?SZ7@95;@?6M&!VZ`=(`&1+E1*28 M/X*OI=QY93:#YX'O`#7N+;]/@>76M0P]:`O[K:CGE;.YM?S^J*N<:(9P M=IKNMA1VG`.TN#HI7%E)L6_J:]>"^M!KJAVQ6=1(U'0M:NJ*&LLUM45-_;CF MV`,(I??='?Z\VB/_$'-\9:_*LS!.TY<:)B_+DF"4N\C\:-_TI+ M`2`L'%#Q]CO1I6(+/Q^.J)=7.OBD!1TO65IJM_%B[L5PRX$*>]C9KE+)HFW- M6EVWV]MR3JI%6WW0UG>'[:%%VZFA[:P->-MR[-0>MO;RT';!`T;N/9%8^)I] M'HJS[DUY#UG(CBBW"+$(L0AYU@@YMAM]:,WY^O++^ROG][=?G?>_7WW\\-8Y M^^WCER^%`_WI[6?GRS\N/[]U+K]^_?S^]1]?+U__]M;Y^M'Y?/D&7G/QO<9_ M?7'@Y0\??W>^?/UX]7_^\?&W-V\_?[&$?4*$;1%B$6(18A%R0@BIR;3XUOYG MQ7^3N8]%''LE!U*%KF4JI%&CZN>)2M/E#.+M<'74&QOYK+5.T"QVYQ MU8[;[PS<\2TI8!]4$#+[7>[;K_9MQ3P3"F@X[:[V'';RH#G2@%- M=X`=TX>=VE)`?>(::M/M1F__AM5K+PW&&J1H.6_`*.(X5.9`Y38?A\5H:<>/ M<]CBP2_.=H1@)_YJ-EI;WH*N(;+'DJX6^7M!_I:9"Q;Y3Q'Y][2K+?)/'OEG MS49SRURS/6/?9E2H`SXT!=N0J$6(18A%B$7(4T5(?2(/^]&<;][_]L?7MV]L M3H4E;8L0BQ"+$(N0$T+(DW!>OU6WCM+0[#-]XMG3[ZXI#E:@'!HA.V8<6(0< MGD-V2@"P"#DT0G:\CZ^_RJV3`WSIXPB3Z$:D&0TG3K,D&)O)C-R<,=DNV)+Q9I@S<_G#+&E(K4`Z,#1Q'WG);%TV+CUK@HSOL MNL.6Q48]L"$7ZED/][!5`Z!XBX*!8A2:]'%IO@WU3L<.R^*'2,9!RN.X21_S M?`-NOWU+4ZVR>Z:TV9S1/>2,]@<#M]WNW1L#-F7XI-'?5TW4&OY5YT;&G>\Z6`9J?C]H9;A@HL!3Q!"A@TNVZG7=_2/$L!AZ6`YU&< MN8>0U4$J,M^P;61K,I]8<8ZMR7S>R+^G1661_Q20?\^PM47^R2/_1&HR?R$; MHOC5TG^$1QYY^=S'@-X!YCLY/3K"B85@XF73E&#B"<9Z>AE.+:.1V,ZMP/FL M88Y_]L*PE-]KWG,6R4GR$M2[]1*?1E?C>CJ&AT.-)SJ,)^0(6X*AL$Y'8NSE MJ<`W@T2.>W9NXSSTX4^P7!;0!X(;T#M0-9G^:813ODT^+J*>+*2HI] M4U]MYA?:T9*U14W]1DM:U%BNJ3MJZL0,$V)&H18A%B$6(1\E014I_( M@QW(:DG;RAJ+$(L0BY#GBI`GX;S:@:Q'I%\[D+5N"+$#66N&$#N0M68(L0-9 M#ZA][4#6H\@4.Y"U/MBP`UGKA0\[D+5.V)`+V8&L=B"KS1G=%A`[D/59H]\. M9'WF!&`'LCYK].]J,]F2@9I48MJ!K"?#8W8@JZ4`.Y#UV5.`'11G MVH&LVZ/4%N?8FDR+?#N0U2+_GLBW`UF?*_)/I":S&,A:#,&\YVS+Y1&9;__* M@VSQ0633V']/63`SL(K2-T$Z!GLF3^XY%?/19K:NG&J-)K5^$\[4NP%;4$1. M#D9C1,Z`I^S)/^,`7K^![^88FKN="C`BXSQQXML(C,-I,`=3,Q.8HI0ZB1== M"V<":'`ZO9_1O.PU?VXX7Z)DYGP\;\X`SE/ MYC'?T@+,&$O$)V,PB55DT;N.XA0^X@0S[QI_Q=-NTH8AH/1/GY)X(M*4[H4) M.IET!0!DM%YIGQN^[J`Y#E!(<$<+HF7<#J9\56P0]N-5_(&`R*8>'V0P#N:` M/#T0MP1-Y88^`C(#S63RO55\!0#P>`SN4";/%APCP2_UOJD=D3H=H.1277^[2-A>.E2(QOQ%A24XLG>V]GR$CPVD]QSDGG(7-..FVWM6U@]6CS:6I1 MX=1^(-VRD8GB4DV'U[I/0U06I)NQ<&C"K7V.8M_M-+=,MJ@_>>XB6_=+E^#E M<(@63$R4J(HZ+?5M]IK[;KNW9=#D*?8LVI#`L1])J2$B-T42*,E,\2.@>I.= MQ*6]D#O@A5R[7]^LU\>5SONU=E>=IP?$[6S8]$%A4["4NYU[YOH>)6J^/H!J M^*C'<:I/V(-_Q#@I6F+"A\]%WK7`6(L9_W,F`F"@V"<&6E20CZ)DX4+&7U;# M:B!$O/D\B7\$,R\3X<)YT6[TG5D0AFC^8:02?M'1OU!!S6R:"!7((2C6!G/P M$^B'NUA&.A?C++B!95S^=+_1+:_5;URLK+5-S(A@J%[J9`*"IT&'&T.#:3Z# M119(5=_%PID$$2BKP`L=W\L\A=!5(ERGS)8B@40B%52Q'0':L.)]PXK#PX45 MJPRG'2VA+U,A,N<-$%@%2A_=XH?#!!3`J;?U@9M:GG$!)N9&2WPM>`39-OB` M=T?X@^8/#6?)@P$/36^UC=D.@L/:6J2[U)ZN'%&+M*N#"P!L% M89`%]E;BKKAPSVUVMPP+//&X\#W$V-9T9L.Y!PSGGG7;;KO[&"'=@U/V$09> M/?3ZXVNM+4/GL< M=AYZDQ;'WYT;+\PI-9?KT#@PJ0%22;0ZP_@T"79+B7G_V]Z!V^T_F3Z<#TX, M>RAA7L5IQFD-8Y%29'RD2=7L?^V-_\J#1/A+&=];$JLUF`]9D.Q>#.K;]Z<^ MDGRCW=S=J]UL2OI(2?I],8TUJI]A_L1>E8NUG:WM_,0D[JAD8,?95"1+4E=6 MWEGI6P/IVW0[[3K/X:U1]MH#]G/,%!.;*,+X>,^M:-+,RRAKKI2,=%=V60V= MJ)JEE-0R><2B1J*F6SO4G(@MM.[61@N[;G_KC)W?11%33`18/_F6/4-M;M"Z MS(V>VVEN>2%YM-P@B[<[UQITW&%ORYNSIYW3=:3+8U/T<$^^TPP<'/H.H]5Q MNW86T^/BX,(=UK.`^X1]S:(WUO9-K9;;8>&%U.I[(ATG`0VTEM[OU&\82C?[8;A>U&<=BPB>U&8;M1'#PT9[M1V&X4)QY1L]THMB1R MVXWB643;;#>*8ZC>9V\ZV(HZVXWB%+((;3<*VXW"&LRV&T6M:Z-M-XJ:&]4G M=X5MNU%8V]E*7-N-XFE(7]N-PG:C>)J)(K8;A>U&\6Q18[M1V&X4VU@W)Y8; M9+M1G";>;#<*VXVBEG<8MAO%X^/`=J,X1#>*W8MDEKM1%`TK/DZNXME<1*F' M]3B?10@NE8_W5>F7J9>(UUXJ_$_>@@IW:E9SLV_7>VL,*6-I2C'BS^$.`/'ZE*C(\TT.#9P]W?/.RI!W0;1\()8[!0P)>= M<>V5ZB:A2'L.I.W<3H/QU+D5X/),1.)D,=9Y8MEPL'RM]%?G%CY* M`[EOX#>CA1/G:/Z!W)K&H8\#O;V,?N=%4>Z%Y3_-A*#:[SAR_IE'?#O?XMXO MO89SN::LS<7]T5'"QD2"ZV(T*DC3G"J::((XG509TE;;;3:;^/].BN*6/@\F MW0R6)[`:SC>&80Q/X^<`6+=>XA?_@FT+4`G4;8%4=4KG/?;2J7QT M'3`-YPIL8R^(U`K.=>)%^%=Z@0L#5W8`-"!F\S!>X.1T3]Z[$IKA+W_!\0:3 M!2*YH"0&5*W!P.B2^\S[`4=XG8>T@[3A?#&?)ABN1202+PP7#E:4.H!DV,QM MC.M-\/L+X26\:?%C'@!$]%OX*\`E_Z@GO/NP$3QRVNG)##FO,YA+'$+P+'&) M#\R7`0U%/C&:)`04)IS^XEST>\`2%P9+(+=>,5L00;CX2Q8L5>^W6VY_T)?O M$PBW`GXO?HAD'*1H&36*XWR3)T1Y=T>.BTWX@>]$<<9T`[2VJ*1JA%IQ"T%! M;%9K])T(E:V6+'.=,CP$K!^&BF9,K#@9("OUQHPA?S>LV]KB[:^,AD>],EH? ME=_=["P?XPXA]F,O?I]+BB=\'$\'%SM?"'T3:.2!S+H$EO&N1=U/RZ)*HPIL M@QF8VZC!:GYN3P=IIW\ZW&U9M6E*JW>)'P<5;]OB$,T^"L=6-CXZ/*_A; M`BY8[H5U/X^G@XR=#97+Z^M$7'O9*3#,(^G"G<_THQ'R,F\U:GRZ5EO69_&C MX.*34%'6NA_'T\?%;\'D%,3O$\'"SN+\/?:,CM)@[-3]G`ZN(X^7_/R'OH=$ MN/2],]T([XB%.VMTZTK"1VPLR;=GIWBP]8/HJ*A>!S%A]"2/KWX0U9MWSX)( M0T@I#R]/\I#K!U&]T?XO:BCR\'/=^@QK61XD[Z$[K:UK-63C:?=9C/NZ9^5+ M:WG-W1H*NF_S M0FXN%5N]&WQ?CU0$6]Y*I%2,T04I/F*3O$H:\P>AL* MW\6JVXD(,,D^3F3]YQT*\CAA\&?:-?NLC96<6VK>XXV9>5RLUUXVA]N6NGV^_3/-A3EVK9Z^$!F'@\<74< M0JB]P.HV^O%)7$%&I'#=]\T8Q M-2F=8Y_2*./NK1D.^7+@5]A]4W]"#OJB/JQ^,)F(1&`KTY'(;H6(J+T>]I#& M@G9NLT<]-K!Q:G7W1VK)B1\3I:8D]@54#5Y51`0/$&B MVS::L&L#L.'0$+25@\$6@_*]XGO5;06YI>Z:UH)T+EAK4/2M_1',`)OAPGG1 M;[2<61"&V+\0GWO1:URH7[C8;'8NQMA5-5QL:DZ;Z2EN>03'%%]'0#\^H^U\ MA"V^L>FL[@*.%V?P,]()M0/'WII1')UCOU6\69.[1G!?@&F&'6QE,\X@I7?' M\J41?D(OAYU:"0C/N56ML#S9"FL.[!#[-`.W=``MV#\5,)U,V\Q3:*N-34F! M]Q`!W%_WDCL#$Y2/W&>[W=V7QJX1?:STJ":(@.AG@93!NE4TL$!2H,?L\>R< M&>VPOURJ?_1?I:5^V'?WJ*8^TL![AER`-SINM]]RV\VA4_ZXT6NW[?;;';<# MHJK\"'\6%,A-$.>I[,R,U_'M"[?7[B\_3Q-D@;#M=)_;!,9'3^VRW8A.M?>* MYFKFU?,LGA._RG\JE[-9=C?ON2W5<_5\.X/&V>U_CKZ=+9K\SFM%*:=+ID_O M."I"++9SK"6EDUO\*+BPO;EK@XJM='@=3L,*V)I3TND+89H/X5=5L M?R#N_BLMC<#TL@VB&1W+8HW6:A0;?K=K>UU2W_/RO^ MKR]"#EWG.VST#]RZL$9F\'[%[K\H5_4TR>IH?'XV[`[=7F_+%@ZV/::5MD]9 MVG8;O2U+_NLO;1_/WGVGBCNV.TK;>_$@O1>I^.;>&+"]%T]!#]C^?351'+U& M[YY=S$ZD8=]A^_#PK>CF$K_[':]MQ;/'5CRJ3O/^F'CJK4">"2$T&X.6I8+' MH((M%=DAD=^[=X-HVTCF-`K!OPG'%QGV)X@$7BH30!-,^]+-3[`M M-O5I@?]W4AKLCG\L80,[`B78/V<2)T4["C``P0++EOM7N-46FNPQX6,S">PW M->PL-Y,@8"*1X?+5W2&*QA!GNO&$-#L4Z-1`(LU'?XIQAGUF)GD"$";4=@)( M[J5;2J]3_6K@06_\5QXD?"*R\[#\IDMM*#KN1;OK]OJ#=8?DW7A!2/7^>$J3 M/,L!$F[/T7"^\=Z-/AC7?.^G0<`U8@25^^!P6X\"+EB_/QBZ@VY+[Y2V7S0Y MXM8=ZYCDOW_)T_-KSYO_^B9(D?\`NH^3*Z.USV?NZ',5IUE*X^!?(\M^\A8S M[`;U%2CN=0C[_)___;]0I_VW^MR7\53X>0@?*UXR/TM=9#[R)B^Y*\3B*QZ3 M_B(<8X0$_5E,_O;3NR2>(;F<-UOP?UG,/U^<=YH__0_IC\-V5!@>M:-"E6=I MJU:>UW$\'5P0,+O,I%?5F\[IU!A95,FN;+8(VLJZ^RS^9(KT+"E97!P4%V]+ MO5#K?B1/'Q^V*OT4#!7=\+CNQ_1XNG#G,_UH1$RD)U_WT[7:LCZ+'P47GT3B M7%$XKN['\?1Q\5LP.07Q^T2PL+,X?Z^[U=?]G`ZN(^_=_F#G0_\C4A,'$"Z\ M-&DWFWUN^+TC%IY?LXF=3YNN(FR_F!-$]3J(":,G>7SU@ZC>O'L61!K"A>T/ M]%S0;GL&X5=5SZ#M^X7H&=8/ZQ.T?9.B4^PRL[SF3BEM;;=YT79[VTZBMDUF M-J^]8Y.9!Z&NT^AM.=;.8JV&G&?[.]5CM?-D24MO]8X>%>K8"VB+$ M(L3V"+`(J:D;NR70*K7%ZKW-"YVUW%837<\#=_FQ'5CNB``TMJUKM7+U611&O*^K72NCZJ!CNHW!EKF4%G]UQ%^S<5%G/6/Q M=Z>QT,>&<2=E+!1])8O&:P_OE+9K[S7LRY<$XTSX].T_HB!++[&S7/T;L36/ MVHAMSR1_,):U=>RG6K6K^WUR%\_S+)Y3)T_Y3R6LFGLI"U+=NLXW[6I>VM0. M_W/T[6S1'FY>*THY73)]>L=1H9QMSS%+2B>W^%%P8;LZU@856^GP.IR&%;`U MIZ33.8ZGCPO;1+!&R#B=MM-/1L`^OT88:TVMTFB+DSS'^D%4"\Q^%-E#VQ9\[1[+G0>TG/AHMMVF^W. MCL=INV;4!X.U[9IQHDCO0OG"WY4^MQL66*4)/HSO*0W,/KJ9>="U2Q\\3 M5"783G4NDB"V!>6'6\A6SUJ$6(0<%R&/5:R$.P'SOJE]/35K]+RUPVA;V]QJ MFX4&W:[;W=96M_S_K/B_O@@Y=(7(L-$_<-.;&IG!^Q6[_Q*IE;IW+70V[`[= M7F_+XC_;6,E*VZ<@77LNW%[[GO5V MMFO/B>@!V_FE)HJCU^C=L__%B;1Z.6P%-]^*YM$-F>RVB+NF1=S#YM#M;-L" M]%D6D3X30F@V!BU+!8]!!5LJLD,BOW?OUH(G4X*\8\'P77_[X_/;#V]^_?F&XF$9ZL,!EFHHL=;S(=\+`&P5AD`4`6YJ/ M_A3CS,EB9X*9;#>(*&G@4B\9#Q=-`B(KU-1^5 M\N*^R$0R"R+SDPWGNXU7NE$`9>TD2D$GE8CO=.7XJR_2VS#\; M$.,!C$/X;#`)BBUGZ[8%?XL!/H"='HG#,+[%?(2QEXGK.%&PC)#-X$EZ"AX! M)@/^OQ$A;QE^#89?`!@"R0`+C[V(L.2MP=.OM2;23<*J1F#^AN=O).`H_FE1 MFB>!QP-&4Z#NC!=`GHCB///_/G*SVO_(8_VL.@E.DC$RD(^_&"T)JDH!< M@_)3(.C?D6(G0)(!0HU.R!HR;M3Z_$X3S>U=T2QE4@R9<-:AWP,DB<'$(V!& MYF%*6!W?RSS+./MGG,X]&4>S0QX9R$+"B^)L!9\F$IT_4J594Z$^%T0W<8A4 M8:A*@@6_*`T7)D,)I$`7:=]SW9R3`CB%XTGP&WX;'V+X#;@YF MA$_#>`$TQGD"I@_X1$@J0#&C#`4`FTRIX\GW(=YSXFUV\]Y=K6X-8'=YUAQVVWZE94:Q%GF>X)X\XR MW1V.^D_="ARRPS2=X:*I[S[7>YWC%QVUW MV+6UQ_5`AN6.FB'$=D-%QF]L6=M7?+MDE/G3?W7P1XSCR=PL*/7LRLT*X M9@AIH11NUJ(91'VQ<>@ZOUVC,L\5#Y8KGBVE1WI/CWR6]_`DJDCL2=%1/3(5;"K=Z6')IM*= M`I9L*ET]L<2Y618W]<6-S9NS>7,GDDU@4WA.%W>=BZX[Z-G),2>'.,MTIXL[ MRW0GB[@+0-R6<5^;-X>/V$MI>_UV^@AI#<`]J<>%C\6&98^Z(<2R1ZVP86^G M]W8[_9BM=[!IX0*;*U%7'0))=M9)!/9%HM:#B?"#S)EX8^ZK6#5E%^]&7[1Z MC8XS"\(0&W5Y\WD2_Y"->P)L4&>T7(2E$^'<>JD3Q2LK$11ZM9$7>M%85#>R M/IEF3'4&\QMV08O2P*=^=$+WNB2Z\&9@PF/[MPG02CJE/EOT`_;T!&QBDT\7 M4#@6`37B@G]P?[9QGB3P1[,QG/J5V6@.FU(6E(+KRU9@1J^GD1A[N6[=A3T^ M/6S)%2Z<=!HGF9S327^&TX''LULAN#5F#%(MB&3KN*+S5YHEN>Q/"G#1HH[X M,1?8IA:^#[+J/_0.,T3BS+T%]?YR+GT@4/B#%V*ST-ORR3E+IZ::5(V]>8#E M/*'PK=.ZL[)S!P@5N!0AJ;C(+;Y5V+=T$B>S/)1?7(8J M-9=,-5)DHS1JF[>.K8JNOQO;\J[MX"`CYP%U+_8_19("P`*#SP M>QPEZI^OO31(RUV"Z]'X]\FG&AW(ZK#Y1+8WUPD34CVN<&U"T>EAR284G0*6 M;$)1/;%D>W.=-+ILCE'YTL[F&&VQMDUWL+C;9BW;)NA$$6>9[G1Q9YGN9!%G M>W/9WERV\<6S0XCM/E0C9%CNJ!E"+'?4"1FV-Y=-@[9"^-DAQ'8AVF)!VYNK M'GBP7/$\L6&SG^\']U-/F%M_[WHH&K:Y=+8WU^G243TR%6PJW>EAR:;2G0*6 M;"I=/;%D>W/5'3*.,MTIXL[RW0GBSC;F\M> M2MOF0\\.(;;Y4)VP8=FC9@BQ[%$K;-C;Z0?<3E?TN-E;VYKEQCA?\E$J_LI% ME+V]P6Y$Q^]O\U-Y\_5H2/4QNH-7;][_7?UC^.JEBTV4S$Y)X8(`>='K-P:ZR5D0%5VQ6HV>_GTZ]1)! MRP/(OP/(XW@VP]]G@%QJ?Z8WX7C7B:"B$H`_C1U8\";PX65<'[2Y?SCL__4_OHG/1!CW7-.`I M+W,/*+H&%-VMH.C`DX,]0P'['^QT%NWFL-/O[_\L!CN=16O8;?8N=H'B'$+ ML^D54-O'Y-J+9)^W*^K0AC_)-_="+X/V<-@L`;?EZGL$>G?RZG7;_4<&>G=J M[`XO>H]_TKL1;[O9O>@<#NA/$\@(D$QWP1C(5_]3:3I)]0P*3SQ+DY>>_X; M,0(%LA?YV&XUN^TM=K03:$?:[Q>M$]WMSAS6&G:Z@U/=[>YZI=_I M];>1@L?:K?[<9,\\V^ZUMY*<6T-UA$WNS*KMUD7WU#:Y,X=>=#O;:),Z[7%G MOAR@\5N//>Y'8W;[G<[@OCO:,_2[:\"+8:]S;RFY_[/?4:-=M"^:W9I`O[N& M`F5\,3PL]!^QD?=>R;TS6/+6[EYX/Z#NKC*Z_>$VC+E_4'=W?CK=YC:4<)!3 MW8UJP:S:AN.J($W\*/OU6YQ\%TEZ%<_F(DKIV3G\&_NQOX_^S)/%?FRB3EOB M?KM%'P[B[N39'DB<'PO$G`[$W"_U1K4`.[=A6R[.SPJW,E^ MK`,4%YV+^T">B+U"OCN)MX;]]KUH9<^0[TSC8#ETFS4`?&[+%I]"+LLO( M?_M7'LSQEOD#55??P9:28HPM+8&W#+VQ,II>>2:2+_$DNX4C^'L2I^6XT67Z M<7+H+?26-W`7A,L[PLC2>SUBZH_(F\5)AF_CK"2:"[5^2W<1S#(_WKG6,G"O M\S2(1(IF[D@.QOHLQO%UA"^]QV2-8!)@THI,>L';_T3XY>07^!NLYU_QZ"A^ M$FAT#B;$VQ]H/0MXGI#"?]N$PW&>9O'L_WV`;WF+?P1A^-GS@SB,KQ?;(&LI M=OTHNUL^8J"^L1!^BKSW)K@1:19@3L;'B8).8"[1>SFY*WT?74XFL#1/X]J. M=^6AO09A$0#&Q16B>K'3R:V0^0/`?KP3^%W<_A.<-+&0N3V?O"2+X!?;G$"G MUSO<$?S="Z+?0#A\C#`AX>,$15"V>!_A1SEEYWBHI@BSN<\[@3OT;AZ"-G)N M'K2;+YB=]1HSIDQG_Q($4'1-F5BO%\4CGSC%ZA+$O:^^K,<'DA3X.O6BCW/* M@WH7)Q,19"!KHD\\E'!'9?P98$X"'$/X!5/%5LZ#X$K-(WG_^[N?_J=]T6OW MC1R8XVWPZ&>+DP:_R3&(ESP%\>_P\>P-<*'.V-SWL0,9?EIS]+U&[^*()[_5 M]H^'E-]C8C/A_YY3ZYT-BOZ>I#W$1+.CG/#27O9VB/RYCQ/>X&6>3>,$[9$M MK"*&&C/G MAC]HAF\HVS)0-NJ:]@M[SIU^.-3?A,HC)H#\(@=:Y>*F?!^(R;CC,,=&$;#^ M=23P&4!9'-'09?7TV8?/[U^ZF,6,[@_.F)W%UXDWGRZXG-1/@Z%ES@SC,4`U;BPZDP]Z#IYF"5>BH6)KF,`G2AK MQSG[O^?@)F!V=IC'X'R-X_F"LJ]YZ#"-!@;XYFC(^2@K&\ZE,3B:0%&3-G%\ M+_J)](8/?L`X"Q=.G,"1Z']ETR3.KZ?.GW$`!XXIQ_A1>'_87$EKIFQH''8= M.5?@+D[B)`H\U_G@)0M@8-C1NQ`8R/QKYPWJ?X M`NU+)4DWC,(%_=/'/)$[H"1L1$\28$JY@RG=H0`L7U-F.>:23P+$:>"%<$J8 MGDUIVGD"F%L_\+<>]0`G,D>;YJG'^"8(4IZB#5C!YC!$%L7YIR`.!9O-S'T\ MI]D;C_6L;5GI\,&+/!;2+@Z?:#AG@,BB9&'E*:.`@:CGM0`3058N:)?!X4!H MR'40SOOW[UV@&&"9B2#6A;_,I3T^#>9FB<3KSQ_,&HE*FBR=@E-]`@2/<0I4 M^*".8F53SGO>O%OU)_-OM+W@1^73OJ[^D)D0*;,A/ZJ843^D'!+UK8)'USQ" MQUU1:Z)7D_@SZTV^F/4F!`U6L-Q.8RQFB6\C6>`2@"1,`E%-%R#?=-4+I")2!*>#HY-,D&Z\01U+RW3T^_"("(&JOC[K3#^9KR7I]6_ MC_.D^(,CZUF*/Z,]XD4+XQ&J#`E2*:&L5-H#F)?KDRQ<@70<5`SK#5/,?_ZYVWNK!<,*5!(%!B]``TA`5DZ==`XV]B1@U8X/P!$!FP;CJ2-P5;24/+)I$V`M/.D" MP$`&BUPGH"`)<+-`/O2! M22F045K!5,J0W:BSTEM@5#I3+V64;3Q\A3>`@8O:UGX/A"]]DW_T`F1AQ!.^^CK&;U.1 M,PH/H(2&\R912Z$6($Y0WJSK7%S\;(H4J18-NHP@NL;)P:_TL/(=7&>RL``XFXN"('&:RQ/X(OZ5VP/4#VSW/UVNR:9 M+'?+*QH[*[9/^K,PEN)1Y@615+:;5D#YRCA9"BZ`ZS^E`F\`70&%((X0D+>QB)#*@:A!EV*9!*L[RL2(#:KL1_HQ0&/M%4`S"#=BBBB*. M?X`>S&3,1G\!1BSJ5#[9$^,@B^:#EV0UI2ES\_/O47, M5BIC)IB034?$@GJ`/+TR;>21X?DM4[-DYP`/W?3L`:)/28RUV,I;+44&I.]+ M(+Q.A)=F8.Q\KWK&C#4X:^(,RI,6WA@M*ZFM`":220E(Y.;/TND%&[[`>&60 MH=8B_T3`_%:8.$3%')3!)!W-*%(82L-"BI<[9:'4%DN"'_CG@QH-A,EN*7&>D>B5\5!).3XKJ:I?\;3 MR/F7,+%6_;*!Z;28DNE!@JX@ MB67]O.0XECR6VU@U_.!-/0PM<:1E4($(0S6="-F>")BR[XLRH0B>*([.)6;` M;1#C:41((IKQP?,!E9*P2ZSQ!@1/LIO5"/ZA@C_10@*\HQ8;Q?"V$3SX_=\L M?8T`W4O6;-KK#S+ESZ5EZVLBA(LW!&ENN&OJAJ7*2DO1N68+0Q)LU4.@RPB" MJ0>@BA_@IJ44!>#[130:L64-"A'CO.B:$XG[?.9]1T91<$BPXN@ZQE^/Y%VD M>2TBF5"?87$FROR[-8,:Y(%'40Z+CG+_6F3K/]!8\WL.']`&P38R?%X)%0#* M#8HT!&&1?L8V+G`T4L0,%"1;Z12X6'NF*.C8AZ.@\7C*%@^=(O9:P29%DS"^ MI=,@Z!3DVADHH*=8#O8!*F+&N;TBVI/.):K0U*:.'W"UAI00&1BG<^7?"DMW M36R)'T03E1LEH=]W6XX9,B-3.JY+YBKFY\H;"$[87*))AYI.H5N!I*7"`X52 M8])G+-0,^E(4O6DVS?QEMYV+8:)K; MR7``A0.H#^%#>.KRG%EO"$TZ+(.ICU@L!?X2!>P'$]I9>#$8-#H$10G^0==` MT*W'RZZ2B>'LK8-7;XC9*@@72K\4VIJNS@OR7'=8CGE0>Z&&6@NVDW/2JB06 MX_0.J37L-%IE_NGWRN+@_A(K@C69ON\OM+:!<(/`>B`(2F8]6%*Q[.VTFP;D M+'P'%^7-;,6!6XLJW'^)0PF0>TFK=F=@M(1DX%N=QL6NLDI9:`^25UN?U)X. MXF3$59W!I%P:;;J7@P%+I(`&HPB4W"9_/75 MQK##94EU49A5F[X\]Q;%9\?C!"\&2^Y@V=5=1;U25I;E]L5RX/0&&,XK^NUR MS+KR^/W8B>*,Z0ZU7IZD0@4JY56/_*+R[A+VWZ)87A5Y12YV:EZ>@W)6=R(Y MF0OJ6CX"1IMZX83H*%JL`\VXG^H:Z=,4B-?;,HROZ1'!-G'D%MI2X M)W-NZ*J(8C4(PJI)`%VSCGE;&2\8R/4X>W0 M6"1X=V0V8#:N)RE<4/REW);YELCU5E3$W"N"%?!%'4^:JWYK"-W&Z'0AM\W, M"J#VZ/HT[!MDTR#Q MZ;YL8:RB+C;3ZL![6DHN+7+K@6?P+ZE2#J18YXG@:T(\H8H<_2*+'2]I2:!4 M/"51QXE-%8"R-0_H)Q*8Y$`N\L:A:`Z^'E=J0Y2CPT+&N-2YE2A;1I@9[557 M2ZN@*92=98LY$@1HZ&[360@O25\VG#\H'T"FM1H2DLY"90:2H*6+43+NM=5+ M#I8R97,I1.7M1\49"E4@KFFZ="+%=TLDJRB@RG['[Z@T*0_!D021L4,EK]FI M&@][.J6$*V] MUH)HE4L`>(!MP$?SC&3*^G/4M/B-$7V*";8 M7LMXL1_+.ZML)71<6'*S;'M`2MD22#DGA'Q,\5A->58SX!X%X/P;S7/_S_M(W[.0^3D\V:+ MRA?$=*1!TI9JYE2G),XSN`9.,Y(H&V)EQ\3SOZB M]%&5=_Y'XTNCR+1B.3,>HS/I*]=+!DY@^_-0:@M*?1)9-8F_PEQ--J;&=4Z"+OG_YD;]?$IS\90JBC"?:&(D?-B2H^7-^>Q6I@;M91*,!:` M4@F>\C7S,$N70O]DYI6#"4KID"`)9IB#&\3^%D$_@T1FGB^DB*U@CD9^(1B`0_Z/M@%P>Q(' M*L[A%#&.21"R@O_@)6`(M/J,&TZJF]%K-1>H\$A0(5F#HQ37[@SE%^/^WBBF M^014,<8JA>.!_@RTV)L\48.)6%"P3XN.BHIKZO(PJ3H,6026$D;D$C*4IN@Q MI"H@;F9AF/)?8A$M'G`3^`9%9J;,0V)>Y4>[,]K)=V2/R M=[O;Z.UQL%T]4/YE]EJI0#Y*PAS57^LJ!2)U"YJZRILC6H(EPG#Y- MKE5Q$-*1]#D(I@H"9'8U)UK+K&O@I%DJPAL9+6$?&F,F8)'DP[E,.?=.UE'&RGMF8[5(YR9; MI)2S58ZZN2P4JR[SI"6=%H/B$"+ZUMJRAG)H2EI(ZA957^J.%FL3EE"8HO4K MJ]]X93;?,%3)(6^Z#4G-NPV471Q141I`NM5"D4W#[$F,))-W$EUETGD^3T;%)ABN#;0I6@&\6RYKCHE+P M9-3HR2H!*?42(3&%+5F6;4$I3UC4%Y'61$=B?1G]))%-!6[@<<](P``/T&VK MG\L[$>-;JDHG2/QSBO0/-,_U[I#A6@F`B?KO?P=?(('9!#$=F39[D* M7SNZ[S$^ICM]`\C7B3=+7[I2?J%WCM8L=8!E"$*J#<+9H2*1Y<5@Z1%I"7+2XL:N>%7 MQN_+GPJB,C#EQ&8"HBB:,U`\Q\)5E4G+.AA)15L*J/J%.`>-<:Z$-SU$\6EJ M.L+$QNU/I%Q"_>+'^2B;Y*&^I2<8SGCI(MD&G@;ED,4L.0LQ1W>@28"-`5Z: M*JY$;^-8'0+G>U/$F!(!)*DB(/J-VVE<1(0ELF0S;>X")Y%J5'ED*X1[,F*L MSF#RO=18#V64@LNXPB_5GYJ,Y6J3Q4,Z/1<1AO*%0CGG&5#.EFRLT`YE<"L;*F$&K-R3PYZ&8 MR)67SO`/,\Q\]6/QT\,_M[0K.%76&$];?ZU+KZ*2]@4Y>.=+(4""]IE9Y`)A#=^/[HR.T!;#!=-O+1T8R37YWD>G36[@Q=^?\O-^E3 MZ8=VAS]+/2J_COKUE;-?;7M5$2S?[MB5M_SSX8AS>:75X]AV[1>[[:FYM!1U M\MQVK5:KZP[;@QU/\?Y[VU6^6,2M0USSPNT.VA9QIX:X3J?E]@=-B[B30QR( MRDZS;HC;A[[_-@TR<3RG6=V9;S[)0U/?L?CIWO36;;K#[I;D=NC-6&2TW':S M8Y%1"V2TVDVWV;FPV*@'-EI#M[^M"U%_9;B+\WL(O1CXEMXV+M1W6ZU:4)O% M!>"BW1U:7-0"%ZV!VQMN&1"PR#@T,D!YR.CP$]")=SJ(AX[\?HN3[R))_ZMH MK!'$T2]S91+3 M7LW/EQ;ICX?T`4B_+>][+-*?"M+;/;=]T;-8?V98;[D7W=IA_4F$%7ZO'JEG M;>\[TF`Z;G=@;[AK@HU^Q^WU:^$)66R\ZH&T;G9M)DX]L-$=]-W>12TDU;.( M$LBVA!JDC>T)K4WY:#9EN^L.'\61L!>6=/$;$R&*_!M@?M-WA<,L* M5(O]IX;]7L_MMK=T%IY?LH+::1N[!^_;./H:9T95`PY!V2KBH.W>=@1@ATUX=#M;.L[KR&2QQ*'%O\/QW]KV'6;]\W?SW M+CKN1?N>]V@6_Z>/_T[;;6Y;=_XH^%\VB'ZA5O/%KY;^(SR9EOE''0WXJ33[ MX+6'$QYQ]@$!9T>![@G,;WJL$QZSG#96I.(ZWK6'XZ?UB!XY-YYF)V13#\>6 M\Y#?<3S#T29J/`_]'2?_^/E8R+$H28(CLYT;+\QI?$Z:CZ?&]]04T8#!**9* ML=D-[/H?6I;>I^%"ZA$>S5<`S1.$Y#PEGN`BI_54;6.TX)$PV6).8,V]A6`0 M<.@/CG\+A8='$#FMX3D/C@GC^/LYNC%R-`M//./A;XD(Q0U.0)UXXXR&6UV6 M!J/BQ%!CGG7UC`\U.T]-G!G'YWJZ8'F24>K$MT).N>>A6\4X(YSMHAMT`APA MSO*XIIE^7I:)&1`9?9MP5OHFST[2:Q(8>JK7F@7PJ&@J"9`IX9=O:>7DQ(H% MJY_'$3@XL!KI,$U%FM+XIGC"1U$,%),R_5 MPW/E[!4`,8IG"U?.7<3?YDG$.*WV@]FZ`=1#EL,%Q)B.>1<@\;C9#1X*SMFW@!2E_P:T%"Q&,>1 MVUE9]U6/;\1$)#BN^:OWP[D$.LX>88BN-*%PW&HP69S(43\$S/<1Z;D,SARG MST6I4+.4L!]&CMHJ3WG*)0D7'CL7!DJ&S`1(8)]^R<_A5\8T.I$'2HO)!'GG MAM>0<_3^D+/%8!G^@`M\+=$?$$0L&^$-6C0MK1J0_$OS,),S&4$,QXF7+!P_ M@-42024W:@!4@$,]`SW:&F%$B:FF-PJY((-7?D3-MJJ&@4=PST!HY8E0(E=O MPX"=)J"AV0#;#'#R,`H*`-=%J44:G>>XX4K1@MX"ASDA.PAQA.Z!C4.03$G\0_(O&8]:;]!D<6!N@@/Y5.J,4V*EH(("CD"RYUD\IWW(?ZJH M4?$;OE7:G1L_"`_%XR3GRZ0_P,`&4P*."3!6N]T]"(_WP)YSJ&VM#?/5B?*5 M<2>N#Q3&4=<.[<>3O[T MV*!!VT3&=5+#I@L4S'*>!:B3'8'>71)' MP5C-BY7SG3,QGD9Q&%^3KPPOP^>+4>+8:+SAX#S4-)YDMRPA;T08S^6,:M@# M&!-77N3Y'EHG8(D$Z52:#F`=Q*,_E6D,-D(>A#A1&BS:"*V,]+M>"`O*::1O MNDC!UG5@HY\]/V#`WD>P<>F#?N&_GREG?_#J\_LOZA_#5R\+0,'RR?`]&8*` MLYK":8\$F(D>/(#F6\'A#G+W&*^^,>"#*S7`06/S7?X:GH>E%(#P>WW2A+P$ M@S1QGI$5I680\U"=U-5AD$1N*D`-1$`I#-%2&G@R2D>(M^":XG)J>FQA&E=1 M2`/.RJ$X/INF&"\3%+M@VE`/.CK>4)#3+,=X60;*2=K)L-R"PP6^F($%2@:D MC]Z`.K0\U3JO?$A`$Q2>`X*X5H\0!)+P@:8H]A3)!1FW&'`":I[C*N`VJ$[W M;@&M.A:*AP08?7RE,RK.74^<)A#^[B'S M4+#F&KPQ.@4WWB$@WI,H+8%85#^@O<7L:V)E#`[`0$48`M M)0V"03#*R].)*0^*Y41A&`$H+SJ-CC,#1)/;!=AYT6H,]2_\/"'7!H#89GRR MJ^]ASXFL.O^``DZ.12_+C`58S#HUM#*28S!;8XTB6B* M(166J"C&?X!>)"M@]7$0_"A>82&/KZE`]!,$8]!;(.42ELDRPN>CY`9NSM&9 M.[P7Y71:=%'>A.-LPWF>`ML^_!)2F2X>7:B(;*&"B3*NJJ;4%]8;&T\Z<.E[ M9'7B?TFE55RQ^8%W'0&Y@<6JK*F)-]9QR8\1VS6&/89O@?'1("@`/#)=0*IG M,5KH8!\K@%'A!Z`SYUZ2+=BH4_26QF&.4#!]XK44*1AX=R+X-@:4,\;B2I_0 MK]^`'HH3#JHJBTT;289]1SI0FE;$*X(O6^+;2,+#8!0:EU,OG7RNC15\_G8: MX[[@-?A`FH\`LH"BKF`\JZY-'\`XYTJ0"D,Z+5G2'\JFM"_F8;S@XTKU03/J M1@)0$LE;6@Y")V`X@F&0H"4!3Z'ZM9QW`,Y[#<088SA:&D)L0[$)BK^ZS@.? M(M5L;*(%V0$+L@LFD=8\E\7CBDYU5.Q*?1JT\L!GW<`/(4`X9L./3;U;==O+)5',]/B>_7,5?!I9V214N`O.@WNLJ()>[GW;$=3$:RE#,2 M,BT+7[2:`[?9;&+2`C]$2$#NKY(LR'G_]*(E)T.@N=.QP.H MA[Q_4H%`/.A+72>")3'\.PS&:*DHM:7D*S^IM(PR;B@:`;C6"Q$,I<6DM^\[ M2^Y4M]LA^@DBY0$YRMUA$.CJ4T%&$004)@G+$$HT,$7([9+SQM8?+#U7^1B8 MB)!3"H',0^),HH)%-*TR]X#)!LXULI@W`FXD[L"`>"3OU\B_Q5M#>>%%:0C" M1RM"0T!>^PR=]D1*A.KT)3SL#:#@3R-2KW1(_Q%)O'+R!HJ5\,5+LYW7PMC? M$JIZC69)1B@I9YZ#*1[,Z^S-HB)0,KM29FC):"[HQ_"`<9C5FUS"+8&RQ:'6 MSC<]!2EV.$?TM^`O,!H":<$C.5PQ3IW/(@7Z&8OZ>=M/"F,/\\0(T*F'"5[I M5&9ZP0\"D`J,2MXUBH=.O]$J1=:J,BM)CO0N&NWBR:Q2^*&3YR5L&.%RFG2J MUY:B:>.RW6%Y66W5==CVZTJ_"2\1;N.$+@RD\'%&7D@3S;4L;%T884.*(_:& MC<'F7=%S*ZN60X<:!A2(,K'&R[(D&.6<,R[#(N""_2XR%^\,&WA8,_1_LWC\ M'7PV"K@KPQL<.G%G(%/',>FDAH6BX*UU&SW]BU*<4V-E#;1.&=*-@&X3<"7P M^N63USHRC%.FAK;Q`+N*75,EZ)_D29O0%%F>1&/@?=,'VR9J"=F%O5W"=:>4EVGL_7A5$W!L6*6T9O#,NG@7(A%;"XH'[:8:%0^4V$?L[>P&LQ M]G+II9!@GX3QKE"-1AX+#6?F:5"#PXP!P\ M>U!`2N9M,ELBH6#D)\(:C!M!2%]BCY$(`W&CBE$45:T0%=D*^KX;GP.7*[[F M9$7";?'749PD%!&3P5?Z%.8MB"B(\;\`)@!24HK!-$5(R`=:I,*4V)D)P1?Y MH3*,@57`Y>1<".F'%G\SJ9B^IW))D;^7#!57TSYY;_`^?"MUN8!$55/@SJ\% M.+,48DHP]1<`F^?P4RHD%$:)@P9W:2VM_$L?+_/<-+X%5"248)OFE*[!+$M[ MY/J&`.V"B(6(3"J.B_P#UQEA7K1(4Z.@1I8BL$R:H?<.9"#SX-`?%(M8%AC0 M.($X!+$ZH1H7^"M5DDCCA/8FJXZ69,7,6W#>*?V>@$J%^%Z2=TI2\*T`E8%0 M&<0(5\%,/5D&0Z1X6R1>J.7C48:7](7$8T&]FJ>4"PW? M!=%W>,'S<#X^*:'SD=0^QRO4-3[E9!)I>&$:%VG3JMXG`URGWIC)&-.=9$&. MDTZ![-C`E*$-XWJ2J%23.&?EIV:>M:%N)<'[F(R3,6O3I_Z,P3+!ZR'ZE:K7 MP>HULC9*@"%9R]Q_I#QF1)*2.O*%>6`J$P4,>;XADO(B"V8`%,.!1X8/RRPQ ME7YO``R"IX`5'RU!BBFJ<9+I.@)Y\^O,XPSS)%`Z26&&?D.0,43`7\C!(Y7R M@UDE&>7H"YF_7Q@%15C//$78*=@B21`N6,YOUA&%[#>QHG];*`1EWQ5J@^V' M;12%0Z8:7[VAV:2768D`ML+_\@4G(>(C M%"!=R(BNM'$RL-0C(C/"/CPIZ8'HAPDFP(JYX(9CNY&XCC/."<>0+&A^/*/O M(BOQ/I?+""9*K/.AAU'9W`;IH9.2GA]IO2=A(:/6DDS0T.$,$E0?V`6*D";# M2Z`IT!ZI#AZ!!?6BW^XW+G3@@0ID2W(%#06J"F#".<.P"#R51_I&4BH0.4A) M7@$6*7$O70RF?P?Z\3%;`.B%OE9<+7FIO!Y.G3.ZK`?-![2:OOSU5'R?1P6S M:C$VZ<8B#&5OBK_]U/R)_IW.O;'Z-R6M_^TGSOG]::FM!A;8>O,4-JQ^>@6J MS<^F<`+-GU\YVVZCZ+=%@-W1MFM3=Z[#MGT[XE)+VX/S!:P`(EI-C02SJ(#Q M\\K9W/IM+7P$VC8X@G='E&J1:@@KKQ%I*Z/JBY7C'V:XV@KE/D3VI`BI70LZ M>N>-BX:__T(GI7:48Q%%V2)2=UOTU!(]Y?:05RJCH9X<=>QNYM(DZ5S\?/^& M6^\H$_2W`$S4KVCM_@;VZ99-R.7R[9\/1XWEE5H/V.>6?=742IVEI79JH-89 M=MW68,L&FGO8VZX"Q2)NS5IG`[?;W;(+]!ZVMN4`*8NN=7PVZ+N#;<=='HW/ M'J5;\[9;H-#'>XRD8_C!"QV2_YM/\-!4=V!2NW]/^([;W+8K^',=6G-H')SU MV@<>]7R'$'ZN!S]HN]UZ3-FNY8R@;;?X!>_D_?O9UT]IU,-#VAKO8\)#:]C$ MC-9['[P=\'&*6#]KNYUN]Q&0_@Q'PSXVKEN#@=OO/?,A+@]JA\^QMGN=GVV[ M__"V^_W.P&TW[=B%YXK_LU;3[;0>!__WU%<6[7M@^W;?'5[G/!R$8"6.O11G<74J MM!F&65V#NA_"0KZ84&>#D0CC6TMZ!]K.UJ##(SG^L#6^:5?TRH&S)S?N]A#* MN$9J[V/D7,Z3("Q8GJOWEANH4&T"\G6ICPH-*5&-XY8YT3E#7N5SZ'37W%4M MX=SY)R^CWWJIJCR-J4O`P,%/8( MI4YK:T06MM'7RXU96D;C!*P_%;*L1S9@8>WE%6W?9>&I,)/[:UYZ&IYJ3TH- M^7O91+]A]"3[*LE#-=CGZ2R(8NXZ$>U">\1!BEWX0YH3EC^YS$`$18F)"M*$ MSU&U\ZH9411,GGDON=^XCX-[X.&W>1+[F$J.G;(S?*"P-F2/ON7OL1R;AWGJ M=,`J_IGZ!.$,&RIU.1OQ"EC-N_TG'?I?.TU#D MFA4_R>+$*E9,`>U^'@*:9+/(BJ9W.S!EL-)%ZV)(K692%@T\CD+@I>R>VY&GV$EL3,,NJQ0#0+U9=FSTF14 M?`P/EGO65RDI[L@P6E`!?*@;^1ZO='%WU_<@4_">AF?<)0@OT2A1/E:5H"-: MV10%J8?O7#Z/D^D1O*]@3IU$+/CY'ZA)?+LG&VT12-RKVC'Z5*=@X87@P@F> M8%J*`F2W<>'_IU+X<;N$PDQ%=:J['SE^D&#/@2).&(^`^_D!3S7KIHK9PY?( M[K5?]>G[;-313HL:%02NCA\4>UNE&.5"<4(Y)A+8VUV=SPM1'DU&>:BI3IF;$J& M@#K&612AGD+W8_,#\5?.'N=(<@:;@Q0@2UD<+R\;+S->Q=+=RJ6=,T*&.H(U M%@`Z9A(!14#=V(L.FI?7<6@$*P\>QDY[P,9J@&;L8*<>;.W&\2A]U+PX:ZA5 M/#CE()V+YCQ&Y\@^P0$YU]+)+")WV)Y\A9RX8V4YG%?J*E3V98V(7L6YWAW) MJS6KGH;Y_G6%NCC8H>>I23-==\ZWHOZ4PG-KN*@(V[.L:-MSW`NR([1MZJ8VU:$ M4X2K7(<:EB[%H[I\J5/$U'2KLGA",+RX&/2H&310;>53JWWQC1B8OEM)Q,SC M`=:J.0^/Z)A[@8\$J.(T#>>2Y[3KO;,]9>Y?+UZ$XD9X[V-V,J9=S1-QOF3% M4.\_ZAV%4[!XJ(KG)!A9H5=:IB0`$)F-I4U'TF%2:@(KV\2RB5+[<=JGKYBD M;R#4-1YVOT=1EF$[O24>,ES'S;)U39+)UI?/TN8']7:MP/.EK:J[BKM*YIL] M5Q%\V5'/CV>"^OJ6>J91BW;IIO.V<&'N7J*XPP/(/,H^"QTO?"ON2VD["FG8-1)4DP$)?^W:+"\"S$<00\WGZ4*_@QG MG01C/63U2F6FF?+$Z"-N4IW.8G.KU>\\]+#K+-$,-9^-R]V`?3$.:5)S@*Y/ MQ.U"N:4A$Q#^2_4\U`T\J<>^B_IMJ06B?A(;UKD\5)%\7S7#\1IG_")#>*$X M#U%Y8IG)4E_#F?==L&6AA6PQ'CM5GS5\;#S_$?`$-EUU.;Q0NE$`T%_P^0ONZJ_N<);0<'(F7A"B'I8)9BK*;":K@74"M#;W M0M6GF3TQ3_955S-3,YQ/B/T_<^$N?Q;?TB8-T9SL#XJ9#!%-,=525#H:'"?; M(EKR8)-6#2F?X"1TWUND] M+/I]^;*(HUJMX=*-D;R-6\GZ7@]M]?T0LR`S#PQ[&\6)_"=#=-1CBD:3BMQ:`]W;&OD@.&=VANWNLCL^]^X58N6 M>R>BKPKDLI$AK[@&C>9]\LV/.X5VW-R*=?W3,BZ)S`=5O>6I&D/Q&X0&H*+'R9>%$P'**P9?EX!X;83<<&T.;OH!'3;]: M-LPE,:(1$T2\%_)#EXR`FE]5G1BA?2U.>_LT]#62.T@W9IN;V6'M%M^M5.>9 MZS2%-0O=-[?\CGIJ(\?\)@[!`_62A4SPT22-\CT5;":V&ZT.:BHCFS4CQMO2E:N28K+D6+ZTU&O2=2P1'53XCS"+8DT M#O5-B?,8MR1\-Z)+*X]W2_*,>?*^D?(=X^,;^;4Z5JY5SB/&RE7&$";FK,;* MU^C"]>%N9_=0MXSKK`EWI_>(=SMWQKK3BF"WDI);![Q'@L=4KX]Y.SO'NQF( M?<2\-]+C7;%OILR#Q;^=QXI]GXC<<]IM):YWKG/[K'M`2*R_DUT@"-#\*$&> M^\!_&EH%_1/9>TL%Q`FFE4Y@(0@.!]@$R#](I^OSJBFHD4=D0A37CX;X\T8@ M%HF!."V4QV^B_<>!%<-UY;M&TVE:`M59W["LY$>EV5UENP-WR8WBO%7Y=39S M5E=`@>5%;/O`7_,QA\+_(Y(8S4P<-)OQL&O#V1F]5)&`M7GNO@\2">/K91>J M&-W+JQ6F'L!>\@$G*U$`^:OU!X8B#D$%01],@O&J;7,6NR#-;5PQ6:^H_ M(2:MI$5BRA'0>%JHL1'E1*-=I696&QUWBI&COQ(7Y!%%J0H;SL$U!E>1(3E! MY)2@9L#RB"[A&!$8X>!<]J)+1;&MNW>U(2),.UWBFS*=UD"[*>UIIU'[*KD5+N'MYLHRO(M3++FP(A".IY-0N_2+Y> M*255>^B_2C=F9=].8UK[-B)AP/$Q*0U+&=O.UZ6-R]Z8C"AV;,`78C*@)8S* M8XG:Y8-_KQXVBXXI@YZ*B6.I'E92'_0!I+Q^XBZ?#/69PSW+4\/@UU,HK+)&I4"8<%?@AI%4'>@Q!TL8=Y>9CA\\%*$F71#VXH4J+ZL<4'\ELC`5CJK@; M(E=OCO/E"[BXV\L10EW/5=1]$\KHG8.*E^T($Y')D(>JH"@).M"VU634[LIZ M>DY+D8D.0-W4DT)_$P1I:3WF:B#B=&*DM>#,]RGL5AO:FBVE"V,&6$-.LE$I M,N4-K-`]Q;G+-QQ'R,9XKB1FW.!1'U$2"I.)2,SK#=T,92![H4@J04DBJ,.U MX![&^"*%+-4%`WJM8R_EY%>M>]:D;36`BC!T%K%7Q3D'NCNEL02M[X5I7`(" MWL3('XU2&0;Y`JT%>[^'=#^Y:-64K$3CO1/AI4-:[!@O_FG)#"M.&H]&5IE"I%O6BWQAT?M9Y`NOR^SC` MS&8,!PQ(76%+KWG&A7^:!J5`HJ('W$/@JZ9?^!2IQA4ZB?>;80&)*ZOL+OIN)DGJL`F1P@!Z_4;PZ&.BS!@\O+!E\:? MHGQ%?IM)PTPK5V$#7R:2A1X_)Y]7'?4ER$@QY\,9%0@I>.QK*P#0INS$O6L,+L[K=<\(X)0L#8XP+ M`!UY.`_2J9EK3/>Y]':O480MD;J!''"RB(X0<-VKK++'5_`$C]6-;W7NX7(W ML_KFRMYG$X>P1SI[M$?>E@HK)L['N23YS\(7LSDSR+(NKC1:2HIZ#-)*2J7$ M^-#$K$@NFC48"HC@*+$;R@TEK?VRN-_,Q(9Y2UHS4<5NKR;0R#Y87/8M9/O1:H0]V40FJL(-KJFU0+#[H'I$XQED-= M$Z0KKHQ+U];++6XO#%=+:AHP+WE=E^I[(77'@G!V/P@/!0UDSS\(Q7OX=0C]#H^H0^ST&]0 M0@'\X[.8_.VG=V`'8:C\O-F"_\MB_OGBO-/\Z7]JD9YSK-J#M7U''])9EOLJ M:Z00E(`91Z.F=KL[=N6(;R#]T.L[E##X[EKUG/@N,$20>'2Q4)\G7@S$D$B\L:9Z@1:%"/I.OY`T1Q7*,DG*/@,+X!K M-`:Y0R5N[)2CU-!K%87Q-Z5OP MMHA!RRFE0(Q=)DIE&[K,,V,@'BXNI M@IQF.29_91EEB4SY`AP'WF$NH)B!QYHE=#$S*PXM3[7U4#XD3+/$F`H0A#8P M9/8[$3Y&T,;H[LH%&;>!$3$8+0`[?H`$Z!;0JF.A2!MF*E+[HM@1.&T2C![Q M/576-S58S+P?\"XF_"*3:]P2*%%.=\[LGDY,V5TL)\JF)LHDCC)C`.MD4A2CR<]4L/OP".SDRH$2=>UTNV54N'=%,D!8GL][B MV]Y>4Q:>LA$_@Q6(ONB;0H*"C7@%9GH.A_]%LOZC&'U',S-J8"GMWDE`8H9@ M-)`'G(LMSNIF"3[]>F$Z=U5S;\9Y$\EA[.`:F`(-%`%(A6V0Q)@WJ"I=INCH MLERG*VXY":OB<9S>25$C+">1P_QD\0?VWZ%KDD0W!J"Z1RJ!28[1%O,95H/@ MB#YI0'G.#2:<9`OEZ(^E9.4`@F%#L@FG*Q!\C[O0P7])U1GK1I-^X%U',26\ M*)M.9HI2:LO'B*TKPRK$M\`$DI%WP084Z)8L1C\!4V8DP&AV!(DO:R?(M%3T MEL9A7B2U8ND'J;EPP6E\1'89WF&5/J%?OP%M&"=J3@3;C=I4,ZQ,TL32P"-> M$5S9%-]&$AX&H]#[UV`GH5P%/'&3?U##GO]<+('U$&K32$\5?7><#Q M0S9YT8[M@!W;!<-,:Y[+XG%%IUI7^>-)E)\F'I%H*T)%IAK1/S) M&8E3?47-PI=RX("P@'?0]V.^+RL((J_"PU.7K4!B'L?,\VOTD&22E+H-!^`Y MC0V8&B`^[0G,-V77A^"YT_U9F4DW^TOV'O``Q+O:5T\4@T'U`T8_K_>H=A"E" M;I=<2+;^8.FYNO/!O*,<>\EZUUA=P_G\)HMH6F7N`9,MY$L,NHXC[L![F4CV MFR(OFZHL.1%6M[5%YWW'AA+G3'X_6@X$\C4J^9*J-9 M.7D#Q4KXEJY6MET+(Y`KS>N;)1FAI)QY#J9XD,:NOE]9+RH");,K98:6C.:" M?@P/&(=9OB?C%Q<\]W+>2W<\OP5_@4H,L@6^Q[#"1^%8QB*U M3G_=G&*-+9W>)7'F:*35SO,_!1UXE,W(E.FIYZN\4_D#5HJ#T%`E&2\Z?6-. MNLS"XY)IUF/<2XC2EHRDI^JB)4JKQ^(!4ABXG":=ZK6EF-RX;'=87E9;F)V6 M2G8A'PZO56[CA*Y05.R:CF8JF%`XVB+X[M253JB7("P+D4=X9V=6273FIH=+*DK74; M9GFL$?DM\C6KH77*D&X$=)L0M,Q7*)V\UM>,N*WP_01$Q%.4=QR]DDTKE!0@&S8-,,%L&ER# M+1;\$/XYVD18<@6&?2('03CRN?-KRO.4K.%:%[3>3Y?%]+=&*`K[EV-ID#+HQ'UTYS: M5/U-A'[.GLEK,?9RZ3%Q?C_6$7.,K-@TQ]7PMEG&(=)\`IL.I-M%)U@,0#/Z M-9G=3.CD9(!NSO)%%HG):V`N68=OR,M@@)3#+:H$&%N><-@M-2LI5-#PE)IS M',])?W@"ZVM9?,YL:8*E(;H(Q.X<;6B@3%,9(&0WNTEI: M^9<^7N:Y:7R+I;4N1O.-;D1RCY@@&,^",37Y,KJ,X1,J(\,M&H85/12LE!2Z8!]=9"_"]["L($WSA&?3(2G>%JDH:OEX).<%*XG#E$5[E)X1 M22G.%J5$`O5JCD7/$ZJM#L/#"YZ3*N7;1TT\U[]A[$0E-E`!N%DIQZ5/=%46 MYVFY1!,3P.0T06R+F0@V,&68Q;@J)2K5),YM74OU[&8//B9X'].3,F9M^A25 MLN-5%<^3P8H:6%8WZR@!AF0MF\=2'TYB1)*2.@I7%!BEE#Y-MU527F18XW?- M<."1X<,R;TYU,3,`=AT#5GRT!*DC)B#"B@'1JO/[/,X$C5;3PJSHIX&A^0@Y M>*22H##/!MXBQPF%WM@P"HH08ZF3X3P!6R0)U!R1S3JBD/TF5O1O"X6@[+M" M;;#]L(VBX#8F?`V(9I-R/F3W1DS91F(Y@H7QS!C]FVY"R21MCNN*2\,1D7'X M\C:8D02F6E)D(KKG361R6QJ'@G+OL2H;.4!5M%!A9KEM*!=N.U)_*1C,P@ZN M]4H4/T9 MV/>RIE0Z+?B6`B=".!O!K%J,3;JQ",,YVI;1]=]^:OY$_T[GWEC]F]+X__83 M9T'_I.`;48+R^1C;:AUBNV>`C)HI^&OA(]"VP5$H.]A6Z*$D,@WCE5`N^W. M4R[?_OEPU%A>J?6`?;[8:4^MSM)2"59Q;;M69]AU6X/^;BL^8&^["A2+N#5K MG0W<;K=Y-+R]M.AZ&)\-^NZ@4S<^VX<6^#8-,K%)]-]W"]5#IC>?X*&I[L"D M=F_R&G3<9GM+ZCJTZ'ZN.#CKM8>'Q<`=0OBY'OR@[78O#GST];2J5WN4/<6ZQOC^LG[7=3K?["$C? MTK*WN-XCAP\&;K^WI;GV"!Q^%+=@>5_4@GO;?7"L[5[GM],Z^R5=[C+NQ_DH M%(]#O>LAV(F`^YV!VVZV'X"`QU-2%O\/Q_]9J^EV6H^#_WOJ*XOV/;!]N^\. M+^YIF1Z%[9V)&*GQ>UH7QY$A.0I=%WD_B:)\8I<@&U#-+C+S>U7&;7LJS3X)B4BGEX2`$*W'LI3B+ MGA:U<3*QR_T@C8&`--/'DMZ!MK,UZ*$<8+@UOFE7],J!LR-R0&=[IJ[JB6<.__D9?1;+U65 MIVP?J\LV"Z6#NF9@M!+!7P3&.MRI*\1U=`9PJ0_85I"51BZJ@B9GNU>IL"I+ M!&4S\^`_/3"`N\"&7JI:P!8'BMGI8QQS:L(MZ_MDFR53:Q>3VU=F`F/U!\U2 MQ;_J2A;=;&W+75!7%NP15Y23ZV&AX#`X4]0JG3VAJ1A6WT]7*3F);1 M.`'K3X4LZY'-8%A[>7+VH?"-*0M%> MT;QVJ#+78U4,5L8R$QQ1?M\YS>WRYZA_$PV4XJK,,O^Q-*V0*^[F'6)#"8F:9:@'&E4P M[RK3%B6(>AM+H!,$OS')WW+37*I#)699F;YCC!];MZ-:$\6)T>X'+\,*OH4< M/:1#5(J(83GY``VL4K;@EN2:3CTN,%=ZPDM`)E);_W@\SDFBG04OBV'&;!(/ MBT8^9SB^GCOY9O095A([PZ#+"@$::@ODR[)GI+'?QKU)2W)$!!U*/ MQR+4386/5[JXN^LKO2E4&,%D<5I-.P[L&?/(M4LT2I2/527HB%8V14'JX3N7 MS^-D^A7O*YA3)Q&[.IZ00.*^V<;<>B<%"R\$%T[$>8H3SLPH0'8;%_Y_*H4? MMTLHS%14I[K[D>,'"?8<*.*$\0BXGQ_P5.-PJI@]PM3M??;./GV?C3K::5&C M@L#5\8-B;ZL4HUPH[B@D1UK+3Z"<^CL8>%X$.KL07US7O:1GVQ0PXO-1X9^/ M20`[!K)9$7`Z0,1U^^;:[.YX6HCR:FI8+B[569Y93+\KSJ((]12Z'YL?B+]R M]CA'DC/8'*0`F1SHM[SLRM#0BJ6[E4L[9X0,=01K+`!TS"0"BH"ZL1<=-"^O M@[8[5D.K3GO`QA.1R$X^V*D'6[MQ/$H?-2_.&FH5#TXY2.>B.8_1.;)/<&30 MM70RB\@=MDI?(2NPVL$Q%Y";,Y]PVLL278(L=&(6:.[ M_.Z!BC6;E4;97B-NSK&C;<]P1LF.T;>JF-M6A%.$JUR'&I8NQ:.Z?*E3Q-1T MJ[)X0C"\N!CTJ!DT4&WE4ZL]^HT8F+Y;*6:6J^8\/"Z$ADP#`:HX3<.Y!([! M[JIJ[VQ/F?O7BQ>AN!'>^YB=C&E7\T2<+UDQU/N/>D?QY&/*7G$2C*S0*RU3 M$@"(S,;2IB/I,"DU@95M8ME$.<8DK6>NF*1O(-0U'G:_1U&683N])1XR7,?- MLG5-DLG6E\_2Y@?U=JW`\Z6MJKN*NTKFFSU7$7S94<^/9X+Z^I9ZIE&+=NFE MR'>-'FIGRE:60W[5DSR@G:<1B>`Z*GWS)6N#O9\-Q\FKST?[%/I\V!I0C;8P M&HE\-A$T;YA-=G"_XL1HT[8HAM&?&TO?"ON2VD["FG M8-1)4DP$)?^W:+"\"S$<00\WGZ4*_@QGG01C/7;V2F6FF?+$Z"-N4IW.8G.K MU>\\]+#K+-$,-9^-R]V`?3$.:79U@*Y/Q.U"N:4A$Q#^2_4\U`T\J<>^B_IM MJ06B?A(;UKD\X)%\7S5/\AJG'B-#>*$X#U%Y8IG)4E_#F?==L&6AA6PQ,#Q5 MGS5\;#S_$?`$-EUU.;Q0NE$`?3.\Q*Y:Q/#.F49-$QW$> M^M*B9;BHS?"JI5Z.K9L&!1J8JE1#>:^?!;`:K ML&._G'$@$S#%#Y&,`S5CC[ZM=H$X$]CN-KHK0FY<=%O7@)5WZTMW=4M^2I+ M2=T5*00;;^ST39;*XENYS=J8E&#<;=WWLNCWYSVT MU?=#Q.&K&=-K7E3F]1V1@HL3* MEX43`-?UJV3"7Q(A&3!#Q7L@/73("[%757=F< MJYW@EO,[:YFYJ8_N:T$!VZ?&K]$F0;HQ`][,6&NW^+ZG.O==ITZL6>B^^>YW MU'@;>>\W<0A>L9^*PH)4(DOG@L-%LXN>'[ M&EWN>;R;FV?,D_>-WN\8L]_(K]7Q>ZUR'C%^K[*8,%EH-7Z_1A>N#\$[NX?? M9:QI30@^O4<,WKDS_IY6!."5E-PZ"#\2/#I[?1S>V3D&ST#L(PZ_D1[OBLTVXK<;US[=UGW9="8OV=[$Q!@.9'"3S=!_[3T"KHG\A^ M8"I(3S"M="<+07`XP"9`_D$Z79_K38&6/"(3HK@2-<2?-P*Q2`S$J:H\$A3M M/P[V&.XTWW^:3M,2J,[Z)FHE/RK-[BHE'KA+;A3GTLJOLYFSN@(*+"]BVP?^ MFH\Y//\?D<1H9N+PVXP'K3#U`/:2 M#SA9B4S(7ZT_,!1Q""H(^F`2C%=M`_;B*G9%GMFZ`K5:4_$,6DE+1)3CH#& MTT*-C2A/&^TJ-4?;Z`)4C$']E;@@CRAR5MAH7K9U'%LY(!O*,[JK%1]W!JZW M*QYA=B400I%E-!E8D30I\B3FG'/N2I0!*.77"ZXQN(H,R0DBIP0U`Y9'=#'( MB,`(!^?7%YTSBFW=O:L-46K::(/[( M&IOK>?M$TDUJ5(ESX#'LC\6Z,1CZ+]K-4DY`"QSZ7X8_J['0>:3RU2-$':DF M;/>!3..AL&)'XF+8Z`^;/Z^F#N!'")*E>_67#><2(_M&30U[%N:%?I'(:$C% MJ/`37$X2,`H0L`$?6@"T/4IVQ%0`]%.YN&AY4R"AP798+5LHLM57:F_5'OJO MTHUI[+?3F-:^C4A2#? MJX?-*FTJ.:#JZUCJKI5<$7T`*:^?N,LG0XWY<,_RU#$OA0HH"-+A+>@A\9*7B]6.*CV3ZRH(Q55RFD1\Z#Q)A MP,7M<8X0AWNNHNZ;4!;Y'.P/V;\Q$9F,QZB2DY*@`U.@FHS:7=F`@/-X9&8( M4#>*XD9UXO4>)6$PF0B$O/N17>/&SR<9*&;N=I+$'K>V$:EX"`-S$L2;-G MQH',#\9`)UV#E(B4Q!G>`T7DR":<7;W04>QDZ49J7-Q(K7;206!FGB_0:I!W MCW@QA;M67>Q*!,X[$3Z7Q%%9ZJ_`P)\:'T`+(>+_'2??G2LJ*0+<YQVDXBQ@*W[$E19N,AOI,HC4_7OU.O] MHN-V^UVJ+/:NP?VXIF2:PK3A4'FE*50JWKWH-P:=GW5BQ;J$2(Y^LQG#T0Q2 M5]@#;9YQI:2F02F0J$H$]Q#XJDL:/D6J\46+(*^"MX2Y&R\,?+!\%`9UPB<6 M$B*E^HEW&Z$!B>LK[&XZ;N:)*K#)2T/`>OW&<*B#-@R8O!GQI?&G*%^1WV;2 M,/-P5;>5)GFB6YX#\:FZ_'$-`B_,X:4]2;@T7:FP..Y>1@>T+50F+5)/;*#K M[-O0H\?D\^KCOB0Y"88\>..6(P47/BS2F:GB4U6!&H6AF]]2X4-#WK%=Y!>: MMF/D1^,.1R*[%2*ZFQ!D)FZ0E*)I9$X8IV1A8`!T`:`C#^=! M.C63L^FRF=[N-8J8*E(WD`..8M'A"RX4EFT)\!4\P6.U+]PA/:AVR<5UR'%" M>Z2S1WOD;:D29>)\G$N2_RQ\,9LS@RSKXDJCI:2HQR"MI%1*C`]-S!+NHKN% MH8`(CA*[H=Q0TMHOB_O-3&R8MW1/(1MK>"9$*L)>MMT)B"7I;IP'MDTMZ?L_ MYG1]81Y8^8,L[L"?)S5?98[S?2TGMI"[SR*<59_Y;8Z8B+^PT!*.H=7L-5K# M8:4NW\8P6%[X+&;]U&N!.M1=/*3&"J*MODG-`T#W@-0IYIBH.XQTQ95QZ4Y] MN2?PA>%J24T#IH49TEEZI=LA&)'&-JB]?*X5$C=\4%V,E_#;*(2*-N>\3%]B MN2L.G+.#\U9U/I@KQ>?#EDX92\PKJ/T*_!H@'D`)]1O='500Y3HI&?*B.V!Z MJ=(^LF1H2_7SW[\D/@BWWX*_\@"T\>(R\J\X)^RS2$&(C$7Z"?V0Q5<`Z748 MC[__S__^7__]RX]1$@:_XG_"/_]_4$L#!!0````(`.B#:4?E04S,>!(``#3S M```5`!P`&UL550)``.D$$%6I!!!5G5X"P`! M!"4.```$.0$``-U=2W/CN!&^IRK_@7$JM=F#;,N>Q]K924J6Z!EN;%$KRIXD MERV8A"SL4(`'(/W(KP]`D;8DDB`HD0*4.7@L&=WL[J_1:#0>_/D?S_/0>H24 M(8(_'70/CP\LB'T2('S_Z>#&Z_2\ON,<6"P".``AP?#3`28'__C['_]@\7\_ M_ZG3L2X1#(-S:T#\CH.GY&_6$,SAN?498DA!1.C?K%L0QN(;TMQ`&A-V/GE>TLBA[.CXZ>GIX.,7D$3X1^8X<^ M46/GD9CZ\)47!0&&T6_=X^]_.1F<''??'Y^='A\^3[D2`Q#Q!N([_J=NE_\X M/IN<=,]//IQW/_Y'\6D1B&+V^K3CY^/TWX+\YQ#A;^?BQQU@T.+08';^S-"G M@R4=GTX/";T_.CD^[A[]Z_K*\V=P#CH("XA\>)!1"2Y%=-VSL[.CY*]9TUS+ MYSL:9L\X/>7,_XHD[9B<)>)=$1]$B8=5/L8J;2$^=;)F'?%5IWO2 M.>T>/K/@(#-^8D%*0CB&4TO\SSWE]:D+=+EOS(_$GXXX//$H0.C^ESN+4J$I[MZ^1.O8CXWV8D#/BP M87^/>:?;3B,9Q]U@!-CL,B1/VSM9CE,3\@_Y:$6A.[V(&<*0,1[K+@!#_'$C M"AE_L%*DK,>E";DO@8]"CF7/YY`RE/0]_M0!8@\D_5@E=`T6C5@:/O5\G\1\ M),'W7I)LT:!22#E5$W+9@&+.FXT@]68\&%=)5-:^"5D<_`A9)/S=P;\0A".> M"@K/JC13)6$3TB61I"-2DT!$2=Y9E3I'!5DSO0'1).&\AH!QM9.(4>W_$J)& M[!7?,?@]YFSM1Q6!RMKO+LZ->-SU4;6[;<9M=WI,P%W8E!:KO-J(.&K2RJE: MC3YJ`BJ2MQB)U.14(FXM*JG)J$"ZN]XT@!%`(>N,(0]+<>4`N173-K3*'C4D M$>3SK1=AQKI*R'CL'(DAH&*Z]=@L%#FN;>6I=;6HPZ.-^)P^JVZ`7B-K-4)G M[OE[(TFCE-M.]/@&7RX1!MA'(!R`"&RM2AG#76BC[.BU&;4XEF:&(W&45,:Y M9[L/V1SQJQ!$):-M@/<.=!RS>%M5EEFT+[&R1]5DTUK6HQA"56C;EK'&L%2# MB4QJ'X1^'";`7/'/*Q3P.8(X@$'&1XB_5;&??RTXI(LR7:MC953+O_).:2U8 M6"L\6A*\NI"_(O4)%_6U,LA_[[O#@3WT[('XS7.OG$%OPC]<]*YZP[YM>5]L M>^)EZR>9\"'Q5P0.Q0(.H:NHI_(FJS13P.Z2I9J8=>X!>#@2WG`$PXAEWR3^ MT3GNIBLV?TZ__JW'&->E'U-1ZL\>$(([&":/_2UMM];L2)_`HM3*G4C\)TK& MCR`4OMV+^MRM7WBT3MR^7!%%\G4%E]RI1WV+T`#23P?=[#F`^BM.E%\^2UL< ML7B^<-@.XCZ2T4\IF:85+27/S\(KA)==V#$.18XP` MC1!4@$M*I8;6>[UH*>AM'%A5,:]>=&L[@2@;@PK1,((U>1CSI3N8- M/,EY$&DU'S!E@XZ,RHP,H72TJ5;8.)0^$Q(\H3`L1^2MA1E#?HGUUQ4QSM(. MC@"^1SQC7.C!O<)^]L-8U*BJ45"C-F.4+T&HC@&,0R_+31:E7M@GC"M`L+\( MPM*0ID!JQGA?D995JFX<:&]5;^;@WG2*0L1S%29V0Z```<0N MW-]2U!>W8JL&]@==G;0!DQGG"`.8;#QC5>G?>CLUJ#[JZI=%2AEH^Z)9W5L` MJ3NE7:94P^LLI>4MA8]TQ2&1*)JL;!\N8^..KS_U'UBIF$1/>D<8-> M4Z*V<4#UP0.*0'@%`8/N78CN%T?0*M&JHM,]]5.&3,T`QN&VI)]2RFI4^E8" MQ3ZE9[F.7F>:5TQE4+*F'-[V8HZ'H3M=B"OK*LNM#$K32OM*7BOS3$_P_032 M>=&&_P(("EL;E)Z502'1TCA(2H8[E>BE0&I0HE9ON-^#.);LZ%E24`4R&8U! M&5H)5M4:&P=2^44!>7"*VNJ,#&0^)S@1JFIK:JZE[MQ2N*07GQ,A7S:S4*'5G>0J`ZIN".,P MS.O('7"Q)V=$:&+J**+H+HY$`C\A(ML@..)FY*+<.SB"%#()SDWQ-V\LW<9. M:_Y3=9&20?YRC3"AB?95R.=;FC?F-HAAF6&,0W!IZM##09W4O)I2=R]5U:V\ MQ%H/-HW%R#KZ->SX4M/\?+1NF2O^><>'.XNO/EPYZ7FZR4E/ZZ\KG']L\]AJ M[7L15]1[IZ:>-^'_7=M#KII[:;DC>]R;.+R!QB.M7R`(HUF?V]FE]P"C_RYN M?.(_N28>I(_(A^GZ^Q5D;$3)(Q+WX%X2>@%XOG4GV^#7"'.-P;N&_(T807]( M;]`=UJ+B!K8T;C"OH<.K9:8-=Y1BQKJ'2B/\1F;S`E_J:)X+@A"R5'+IB89< M0]U!HD3RS8&K=(G]"`2+8J'X;<-!H8"![HZ]#=:E]C`.SS2_P_?IX75)J"YH MJG7!A$7NM-+=UIKI#B"EYLZME!1H9YSS?`8(BPJRBY>N7':G5:=?*LAT=WQ5 MC)2T-W#TY4Y%7P_8=26C[WI#W0L?JL"4:&A<]QG`!PK%"3=A0!STYJ)&\M^5 MNZX*CXZ5$^E>R5!%2$%SX]!ZU>UMY4QAK%QN;,S@D]=@O0>5Y#Y&%BO5U2IW M3^.B=+)@JY"3K3;3>^U`4KU-A1&SF'*Q"QMK[QY%)L_?+5"FI7$!2^0G3/0& MR%,4^UGX?8S8;/%.%3D^"J3:>[T"6LH6,+3_#PDFJ\$M5;@B($CHM.=P"K"I MZ6X>9EQDM!H?TDNK)F0$:7('*4]*+Z$LH-?AH3W;4\"RODV,BZ-O:86XAVRQ MKGD-HQD)EBZQD(UU2N2Z-V^KC7XU+&%>_Y1.V"43X2HZW7NY58?":MW-PVS5 MY?I$O$4K3FY;S]:E+R"/(NEVQ@EXAFQ]APR?8#;:A5L60G<:K,'B9=.T@@F= MD3-0`TQ6&`*,Z\TC2J8HDI=.EMOH[@MY>:4CXFZ0-S,_XKJE_GW*Y0Z?POJ.E:F=8P5-;;;WKX!*]V=207$ MC2U4T=-VO#ET\_ST:VU]X.^?6MIPA_VQKW%59H&SU$2PI MD>XB7,FIJ4L^JJ-[O+@JPW^94(`9\-,%K>13VM>"W^/%"%YMA[:>ISN>*SA% M43[;FN6-&RG:R8O;B^WU`=V#X5JB5+-GU1I_D,']N\&33RI.MT<^U9H/[4=Z MJ-UG_B_337?))/&F+ZY;LB^<6^OBY89;P<&O9=$>3W8> M%Q>U%12Z=+ZU@+#>.<5CR\$3%I8P#N/C?P?D7T$H#NP*U M[FTR;<5U9<.9%];STB>%US>35)SD4J77_7ZC'4$O,]X^@*_\9@T%4MVO3-H1 MY/ORIH[R."5[3\\F(5_.3\TMSO;=+>H8USA?T74NL7N\7[#OXRG&DD$K?>/# MAN/]&K4BVGM6?:MCN7T:[)>V)FXRX*^0*R*_9[6Z6K8S#_KEN.1.%V_7Y6HG MA^/+$9=3*0*]9T4Z%4L9%]%U7L+1W;/*VYY>V5$>@/HS0.\W"]ROI(I0[UD! M3MEFYL%MPL'M[I[5X?;XJ+?>8XG=/:NZ[>M!QA)C+-9_FM_4HTY(S_\>(RJNL0QB(2^LREX42`W=`E(3\/5M`ZHF,Z\#%(G.U8U>1B'`XA2< M6!9]F$O?J%6'AZ';1IK'7VY$`QV!$A_"(-D((2Z:;>$(=)H;N*-G2%>J; MT;BY:\Z=E?81R:D,W3+2<+_?BUU#.:G?7C*6[;!VL!??,10@0*7K31NP,G1? M2<..H&I2`[TC%\"X!@#?([%@5I7_*=`:NM^DZ:A?9C3S@GW1@*6:[RO0&KK) MI(517C7C-W+&^UI6;WC&J\Q7ZYL,']+X[4ZS%U>+XA1/UM+W;7K0CVG%WHMZ M7`R=!]=T@]R;$.L;TNP1T&$L%E?A555X932&3GFW@[K:2,9%OF61KQ"&XK`: MA8'L3AP)B:&SU^90+321<:`NAQQY%\VW-'1.VEP,-GN%9;0B9Q9$*C9`2(D, MG5MNV2>KS60NMA.27:R6'+U(3T"K%!2*Z0R=/3:#L-Q8!H);!9)3\NY#Q4RCY<<:.F%M(UUK&"KCDH-EK6O&H4I* M0T]2-./^&Y@-C/O-F[`&`WM`]K"/.U- MCMLS3]VZ\1;F:6_BV9YYZ@X_4O/L\@*G(8ABRE.BBYB)N@?CYN$9$&*BL@\9 M-\_J`:*5.XU^LCK6`#$_)(SSX!^ZA]:P-[D9V^+RHHL;SQG:GF?UAN*%\IZ3 M7&DT&MN>/9PD[UMO[;*F2^"+4VTOR:+D8D^>4&QIBU[)+4UGZQJ='%J7O;YS MY4S^;?7ZO]XXGI.\*3Y1:N!X(S?]HC5=AO`I/;Z79)\`!X`&Q>)WC]?%/^6` MV%^YY'WW9CAQAI_%!5/#06\\:$]@&U#,117=*DFABD7MKHOZ[M"R>^,AE]&S M1O;8\K[TQG9K0KYM6'#P+P3AZ);_R@4I,>S)NK3O#RUG>&M[D^0R,F=H_>(Z M_)=;_HF[?WO&3:8?G;O2FQQ6I#Y=E_K#X>+2M`[OCLG-8]^BUW1<1O05A M#*]Y5.5BK&X269'WW;J\'T7O<\;6;>_JQK:N[9['C9O@>,[!K_'7$C[ ML5S2]^N2_L0M>W/AV;_>"'^P;UN542UFCTB(?%3FT1^VC-W67S/^/VK6?H83IH^Z$>- M-VY^@2",9GT>#5QZ#W!Z!'3$?W*K>)`^(A]67HI2BXG&DDZ)G-R;43S?5,LU M:MTEG`T`79MVUK%2@T5*&N`H`>[X[/0X@4U\\]M70K]!RI:C)I_BLL6VS]]C M^E(`F"!4H--=8-H"*D4-#:TD%RN>7"JQ82]J!(/KF&` M_*4)^%IGK,="=^ENRWZYB;U,0A$%6Z,H6.C>*+(S%-_L96ZI-4MMAR2"V=5< MQ?EMKI!3G-\N9;$)3^MAP=20''X(J"B#/Y8HF:O^;)S$OSZHS:E7OL*LIF:N M=%1:8MZE/NMEB/31Q2KD:D?)$ZS'E MKE'+;_`E77\"X0!$H%C17/5(6=%_PA=KFCW`"O@3]"E;T;OJ5YEVV,E*"DZ9 MF4D<,;&^DZP89FM67X58977HTWKUJ.Q![MN#++)XDL4_6D_IL[198,SB$D5S ME2L5144UQ[OY09L^!64%>4C0BGN01%5EAL?5B0R5^!28TE MJ')(TJ12_!"NP;_Y'U!+`P04````"`#H@VE'[=@[@(,9``"FD0$`%0`<`')D M;G0M,C`Q-3`Y,S!?9&5F+GAM;%54"0`#I!!!5J00059U>`L``00E#@``!#D! M``#M75MWZKB2?I^UYC]XM5LO0[!UR;4)O!YU%LX^^__3UY.3EY>78)<_F"Z$_O&.+9&O. M(%-JH45;U+1=Y-_73__Z[[/6V6G]X^G%^>GQZXB!:)D^*\"_8S_5Z^R?TXOA M6?WKV:>O]<__E[$WW_2GWJ*WT]?3\+]9]9\=[/[XRO]Y,#VD,=.XWM=7#W\[ MBF!\.3\F='QR=GI:/_G?FVO#>D03LX9=;B(+'&O7H#DFEBF'Y`Q52(- M+,'_JLV+U?A7M?I9[;Q^_.K91W,[!)@FQ'5OC0=KEGC$2'?2Q,PM6*ETO5-RI3SB'QLF4YA41-; M*4EN&[D>LJ-=\P<9<9MZO5'OB8]SS)99])RWJ:T@X`,R18^L#'Y&'3;\3]#& M4`1M5H^I-S)\8OUX)([-9AC]KRE[Z#9#)&IQ.S8RO<>V0UXV)]E:2V7(WV43 M&T6]T>74PR[R/#;679H>9MWU*?)8QYE&RGRME"%WV[2PPVS9L)A)/1P\>ZS7 M%O:>2/AGFM`YFBA%T^BE85EDRF82=VP$?AFU4X44URI#+MVD+FO;ZR-J/++! M.$TBJ'P9LG3<9^3YG.\=]Q>"79]YC9Q9J6I*K5B&=,%(4N.NBX4B43$*(VMFZ)KDGY?T_+,4IU'8VE9P_$!O;>R:KH5- MIV7ZYL90H`:W@28ST7,W5.%<.E<TM8!QX MTTVA1)NH7N+,C,K93&5>3\8A-$O=JF7,,2WE:$0DM4FMN>!)A:-2`"<'\P,, M?F3P,1#ND35!K>D#JMEXPCBLYI- M)B;.*?1Z[2U('/14FZ#)`Z(YQ8U7K5Y6TW'R21A4J%XNE_B-O*+-ZVR5DVAD M3AV_,"GGU>,RLZ^Q&[BUU^S/F-SHU4>NC>RYY+S!C<[ZV->\A?#XMJ[5M'FM MZ$S?]@7[%RG7N=*W397_K\]>KWG5+'QA_U_3?;CO#/^81#'.<#K%BX!P>0D%HXB@=C*XCTWL( MAMBI5QN;YM,)]\=.D.-[\V\"#ZUV6@]C)OX6?GV_$)]I%'78QP5I'?,!.4'? M]V'AI+(G"H@^C.XY"<0.RZV*O&15@\Z%#Z>HC'[`;%[\:A'79SS4G:`W-K>B M,?\PEVQ$R215GZ'NB!!!5,%,D".-4$;5;T?UTZ4L#F'\_G;DTVD"9!E6FCU( M?!`A+A]0&J\X"]>2JY5JPT2//LUF<5,`]A)A3C"?5$.MR-H*UPF0@8#BI1IF M?=629A6APDD6`)!QSDYWWCKW]00,91EH[L%O.A9N:L$`)&3$<[E&9*).B!MX M%S?ATA8RX%K1^])M%U]C`W81/R4D768U![N&;0=Z,YV^B>V.VS2?L&\Z:581 M5JO@\2K=1.D`0'O)-=B`;Q^ZR)Z?):59*KG\?=(HKIB)!)*#XW#=B>F!-CSO,2Z+(@RT25A/5NO^HL'VRR@]9 MZZ-<:P7Q"EYO>1PK6+&N%KW_(LVK;_+R8(+SEGR>=#QOBNS6E')8B&)BSZ@>_!@& M5.BOB%K86^X8`YS(U=9NV#\_)'`N5='60>A!.::&F]I52Z<@`J=AR:OU/Z>S M\"]O2(`E;$#AM7@>?N(;`@R/=4+8HC5^Z9TI3Y:J,$-T^J3BN#$;!`=L?J/8 M"@X$6;'&BTGM[Y1XPK.*(NTI3XH-8$%V_ZRBW8,AL3RSBYO;5:MG0`49_8N* M1H=9W$5^;]0F=(1P++R[A.=^M>E=)4-.A!`Q+A3AM1DCK(5>LK!7\[,;UYX MW)=H1'C2ZBO,GHHZ5)Y,5>(&N25WG[-/R0C[UT+'0NNB`HJ/;)I^//) M"@K6QP])$:]K%ZO$PC\_%XIS;1A76ONZ]WME@;PY[UR)0?K"@]VQQZ,'61OL MC_JQUFT,;P?6UT`D3]@6XP=$%T-064! MW>FWO,2$/5L5]N.QUNG>Z<8PB-+N=+5?>AWVX8[]Q:A?F6K3+H")"7V^*O2G MXUDP>8T]B<&8<]-GHT_%CZ'H9IB8N!]6Q?W,'[S.0+MK7-_JVHW>,)AJ@V&Q M,O5"U\;$!/VX*N@7IM?;2T/_[9:30;^K4L2"]\7$`'S:<,S6_C%OO[*FICL:Q-JRMA9.8ILM]9$,9RM M3:N"H;1R^;/<:!.3?FVJA4?6RH7?[$J;&*RU23GW$QYVPZJ&'6T-MO`2G!C* MM5D\&64$2]"F]C1K]*=#JM@A56QO4\4>"?6'B$Y:Z,$?LMY24L22BRN>&B;" MJ%J6Q)JP:6E'8`5):6%"9:<81O&$L+)LHW12V.;VJR8=#`BQ;V/JL1$:N5R. M:V*ZPD![H+2D1*\T_I-,@I<]C@&*#HX<.75,A_\8""34-5Q!5M96#GVG"%_Z M*1F@=`.QY]?.3&^HN*P`K$OQ$_5@H. M:/ILV,7321=E-IBPD1VS83H6<"A4R*Q-D](W[([S/7CQ6CMFN`3AP?%1QKG[ MAI]8YXRCQY^*STCFL& MX2&E?R[YY*&<<[4+Y=4MDAS2]86BISQU]<_5Q++#QVIR7:@^)]I3M4F2JK[5[EP*_:Y42@Z%DF]TR5Y3AA>4R2T9@[X)Y5;4V5 MW;9*+:[RAL,L)75V(PX_&0/AI&U!Y&SHOB[I%LX\3VA2]FY.A."L*_G:SCN3 M8CXIS=/4]>`E0`W+Q\_L_Y?(?T'(O>OHBU<,A2'H@KFX<)/W=5DKAZPG)!M" M4W.K)#X#`D?42#%WVZ%FHCD=VSMZ&^F?-B@:PJ]^[':VQQT;U4'VVE MH/KV2108/"*0&UFSW`'@^?E3QBJ#C/P7YE&F7+":5E-],V5#`.YYE'QV^3NA M/WC,R$PHX$`G7DAA%4/"PN-]5\@SNHMYH%N4FFKZ7I=2WR+JTH/+EKHZB@BY"#,U7/)E. M+@FEY&4V]+)?EB_(%ALGK97=,EXV-*!QY:YX@G'!\Z;N.7H+]Q M3`W7#C^EV+)0<^I;>`-8X#&@W!"`.&=O>#(CC]=G^F@ASZ+X*7J'9]HS"U17 MWZXY8(!VC*S(MI=]FG25<+9DTKRKZ1U.*ETDUE`UFN9"FEW16Q( MG5_D^K+?F?0\H+#G+M]:X%V^-9G7/B8TY2*;3)757GKDP*]:W'RBZ!W7F*GR@D]Y]FYU"7G)O$P\(10U>6C&6S8O3UR)R2_'&]GVZ$+R M:03>8"W;<40OOR#JH;=PS=8WJ>^R+\3.I+"2M-L5)-HTBT9`F\J^LV%VMND- M2>B/SSUUY*7$P*;5O*_+NK<[\RM@,R%0!:DHLS2CD%QV@]_HLL@Y8;]-)^S+E(RM\OM2 MGP=5809=I;UA$WB1P78(!G;_OCB7H@9P2W9O:-B<4HIB&7;!C1O;(2'0^?NB MH%`)$`'EYCI7"U\6]]X[[<2,DYM%4";R+<^T[W1FS3B3RLU?J."!FI7L4_1D M8CM,>V;E@S%]FRN(S.*\+UKF5`MXD+DWM`T@=XEK116S'8HF=OV^Z"A0`40] MN?DJWPFQ7["3E/@]W]T-2ZAOR+BD\%;^WCSK'3=4/[K&S_Q/WW3'>%%W.T]] MBA#JTV;KRH`/)/:&F;%IF;6"\#.O*<-7BO3^OK@HU@)(POW9X(\I8/O;8)%^ MWS'Q,FQ^2;X*I$^)A9#MM9GR6I@?.N/XJRC#\^I9&K+7<1NC$0-L"B]MV:!1 M]!#(;I,#A\SX-?7;D(1,@2M`545=^J&2&`MHOL*&XO<5TOC[0C*O&0%\DZOX4 M`52JT$N==MQ?"#/K'?O())JG'-?^C'Z9C.7S*I:/QUJG>Z<;PQN].V0?M5]Z M'?;ACOUU.]"7Z<>UH$?M.6Q='L@?Z*W-IAK7PJ;3,GTS&>>7PCA_16_::-Z! M9K,>I&%-R2&_*(HQFDI>$33#)]:/VH/IS6ZK0ZX7?1%SC4Q]CZUQ>*!7+\CN MYR/_[URJR'`90WM^NHKVT[%F#'O-7VN7#4-O:35_O&O$W,==ZRXXT,NM) M8W]J+V%?AUSZ0R[]WN;2-QC+[?07.:T44SMY)1&3:K%^@4]QN3KX-?B0,T9A M5/JRS/S>&HYL"<^U>31*UYQD>%5C%;W)24!)-N_JNQNKTZYR>26[3R65,T9D MT4WEUU+IDR>'O"$4N'`S[RSM!51@%4FW#U0Z0I#LT'=T=H*4$[KJ$9]Z0!RG M32C_<8-!I5!_LFY:R.XY5@<;XI7B4U5VP-VI>,`IO2MI;*J<))61,J*X_1SG MO@<[!!VWCR@F=DIR506='3BYF>I`CU[RU@ES%/A]PLAN32E//@S$#A!Z$2_" MTU_9RAE[2#2SYF[KW7"JF&9`EWRG!S+]]0G3H,[B*:EN($OH[-V0KB+50:R4 MFW^T.=K@R>-[?56[>VM='1BYB>(@/A9-#H'>,83P^-%'=N,947.,YB-UGV(+ ML:>#(9H0-Q"_\>#YU+224CF"5_OD;DC=Q>4&>""SR4V^*/&1$.EE*VM)D0!; MI]3F3*ELZ9BJ)XBJ4+L/V5+UA5$6[G)&AMK80Y4-G-S MR7$@;WYUB8(;=IO`:PLK:13.)C(XLQ.9YN1@'VG[0EZ@GD M:M$MQVR+Z0'B&N4O&"1NH(VIZ5SC41)Y$K0+U=ZI9;,0!&@6!?;R.#%J#?@3.ZM!>%FT!!_I]I9RA`C7T`5AJ`L_$H8 M=Q11'O@`R,VU*55%D7%:S0>@N("'!V!3Y8$/0,F[W(WQF*(QF[\Z3`CL>MBZ M,YTI-!$#I7?,W&E(=C46-_L.:*JQR]]T58`Q&6Q>V9YS'IHIL$Y<&P7703^D M+S_BH.MYIZTR^MPAHE6''V1:)!9I>]FO*VFIA?H<-@3P-5;B,S*D?OZA[S;%L)>\;`==3\&K;A MH^DFQD-5P,*<$NPO$XLH`O2K]I2-=VQBX+>ERF-C7()WS,8$18`^UYZRL4WH M"&')A%P3XAUS,ED7$"T5".RH1`MPV#UT_EE%EG,58KYC:A?5%D3^'4T!2M43 M\^>?@YEI14N!\]1B9FR;F%9U!%NB=.^8ZCF5!#%<\12,DI8!2M(\IXCOF.M% M-"4Z)=M+QL>7&DHR/J>([YCQ130%,GY?=]W"A0R_&5I)NN>1[QUS/;>:0*(K MDOJO\_*Q0Y%#DGG(%`G#6F'.('3K$#I7Q)IGP$%0<.A0OI7;D4!(BU0[) MLL9IJ!&LDZC19*4K'F533.\J1[;DMDTU(2E`?LG,+>$"@.$EO-QJ,4EA)>*` M$$A0-4>8=QP3JOB)L_*!?(>84$5FJ]VGDLHSYR$FM.+7+Y1O>]6"0\78%=TJ M+"7N]\/>VQ; Q[.@6\"RDM#=:376O(LX7Z.K^R[YNS`H1J[ET*.D&HN75 M;T/BF\ZVDLZS]+Z_=,NK!#774(MY%=%G;*%D;2QB,P+@7H`P^GN3>'Z7^'\@ M?_E6\.CE^QE5W)ORM*D,-,2HHO=[J1Y%M!B0*TLAS2O";G!O:YJ`""DY.%_X M)JU$!:6]*J]@B^K391-@HHB5[0=[+0+1;I#)([8"$H=A6K$5Z?C[5V MHS/0[AK7M[IVHS>,VX%^HW>'QB+`ZQ#6=0CKVMNPKL4C=/FV^'B%$65R/[Y= MHV?DB.,"LM97.V`@GQ94VX=-'`;7<:2=Z^9L1L[9?TY+`6;.HRCE3OMEF%OE M\_GM44+E$_F%S!WW:>I[`>YZVIFMH)*DT+IBCRA@TV14B@_B$:'/BMCO3&Y4 M154&/%,_8"))[/,B)@PKRP[5G!VG\ M32VC!!0>CYGRDG]*2Y)MG@ECV#``;JN-;,'S$=_F,@D=!$<(7[NB3W MJFHSI4$&%S#G)1O+0&R8L:.$$9H**GY?_[R?AA(#!LWT67;J&*$^%[B%'OST MW#V@N-J.LA"C:B&`:\*FYU`!%>0XKV)EIQA&<2^T+-NH[!N68#^Y3EX^'R\< MHV5%6J0\`")W+2(YI.LO)>^`E>FO72BO\13A(:5?E*STTORN4^4U+I8==*%. ME=JKG[]N/?,^_?+][)\4C_<2"@Z91^Z4?4W<\9Q\&>Z,2RPNS3!9]$VRRJ^F MN\L%72ZOVJ:%&A,R=05/#U1CAZPDA@`9*I+ZH49<9,H5>!\*!$A&;\`+T(9( M^3\\X)U]\_]02P,$%`````@`Z(-I1^^U3T7(2@``X"\$`!4`'`!R9&YT+3(P M,34P.3,P7VQA8BYX;6Q55`D``Z0005:D$$%6=7@+``$$)0X```0Y`0``[;U_ M<^,VTB?^_U7=>\#EN;LD579F)I/=YY+=O:=D2Y[1KFUI)7FRN=13*4J$;&PH M4DM2'CNO_O"#I$CB!T&*(EO*<_7][C.QNIO=P`>-!M!H_/D_7C8>>L9A1`+_ M+U^\^^;M%PC[J\`E_N-?OGB87P[FU^/Q%RB*'=]UO,#'?_G"#[[XC__[W_\; MHO_OS__C\A+=$.RY/Z!AL+H<^^O@3^C>V>`?T`?LX]")@_!/Z)/C[=A?@AOB MX1!=!YNMAV-,?Q`?_@%]]\WW2W1Y:2'V$_;=('R8C3.Q3W&\_>'-F\^?/W_C M!\_.YR#\-?IF%=B)FP>[<(4S6:'C^CC^Y=W;?_VO;X??OGWWA[??OW_[SO>._L_;[Q??OOOAVS_^\.[?_Y_EUV(GWD79U]Z^O$W^GV#_ MLT?\7W]@_[-T(HQHU_C1#R\1^\,:Y M)#[KHA7^(N5B4E1\[[[__OLW_->45*)\689>^HWW;U)U,LGT5V*@SVD2D1\B MKMYML')BCK#*SR`M!?NORY3LDOWI\MVWE^_???,2N5^DC<];,`P\/,-KQ,W\ M(7[=4M1&A('NB^1O3R%>JY7QPO`-XW_CXT?:XR[[T/?L0^_^R#[T;\F?;YTE M]KY`C))B46O7]P59"=.;KI6=XI`$[LAOIG69NR?UZ=@)XP,,R/-W;L(BB!VO MD?)YSL[5OL?-6GS/UWU+TRD%-VOI'.=1U(YEE6LWK[I=/?;'6_JO@HKX)::3 M)793)9D(@P?F7^`30R([DQZL"G(]YLV#4&D[%[EVHB67NXLN'QUG^X;-FF^P M%T?I7R[97R[?ODO<][\E?_YEAJ,X)"O:&_,X6/UZAS=+G'V(6_F7+RIHWY2U M9UR#,#7!"5<5[9!0O%D%=!;;QI>>:''!O@Z#3:4*26,%%82_>,M,KFA9^FF- M`06R$$<\;*G5L7DK;%HRT6[C46H6#&+_\F'^Q?]5TO[YS5YL?^`9?'9"=T&_ M,G@AD<;4$DV78%&JEP=)@0`,.%1:E4&1T:"?&=5_PL`#76=L`K_:D2CHNL2% M5LT\-B0B,/C0:5;&B*!#G!`&/MAJ#&^P'X_^M2/Q*UN6T@6N'T<&_U'!TR5N MK-3/8\C(``9/-EJ6L25(T9X6E!\:N"YAJU_'FSK$'?O7SI;0H-[HDRIX.IVW M;-0OS&,F!C`XL]%2FNDQ6)8>`GI]@D?L(AR$3?.Z9J*%E&6)$%I3Q'\B@W M)(SB6X+]!0XWMX'CZ_V*EK0S[U*A;.9C-'2]H\)"N3(:.#5BY(C1(\8`P]G, MGX(P9CH-\3*NV%_4T':Z+V!2M[`?H"+L'3HVVI6QPVDO8P8;1GV!6MR+U+B3 M.:9=X=KY$SUM9PZE2MW,H^@(>\>%C782+CAYR:D<'+(>P:L8(Q11^G M*,AZ1TVU;A6^!/TLJ(_E1VAD'?+M3L=C/_)94.])3-2=^9)JE3-OHB?M'1EV M^I71P:A0C@MQ%A@>98:?`^^9AM+7(79)?..LB$=7;!6;@$:>;O<"+=0O;@D: M&'K'5QTMY4/VA`<))I1RP0!:T1)#-*PB[/1H5:MHX6Q5H@(#'JUJTNEJ$2?' MC7WO?YI-]7-4_M?.YB19I6P.VO_4>[>J]9'V1?!G]%,0_LHVWTC@!8^O:.J$ ML8]#(*'KU2XB/HZBP>I?.Q+Q$S&#$]!2=^D)*E3.NP,-:>_@L=.O#*:4&N7( MC^L=KAV/K(/0)TZ&7[VS,!!WYCLJ%/% M3RLGQ!:@,!!W!HI*A3-0:"EA@*)*O3(H]O3M@:*=:6>TV7K!*\8\A6RR99[, MN+8QT'$!ST9=Z;BRBOFX0;9TMJK.]:N@[>\\6Y'I9R3L'30VVMD<:4.9 M`HGO^"OB>&,_BL,=V\PVN2D==:=^R:QRP1&I27L'D9U^,HP2:K0G!Y7@KIK! MOZT=3WT+)9[ZMEX\]2T0#V6OHSJ>^A8NF-[7!M-[*&!Z7P],[T\`3.\MP/3^ MF'G!F5(5J<$27;?9P1HUBPG"):+>.[Y*,W6:,*,554U@.!&1]RZNYI#?L#L- M@RT.X]^"[+9=ZR>=3H6&I+Z=+9-#0Q[X!JBN@=FX?I+6U,!>OX,]OF M'#*/%7`&=!U$,9`076O5U6M%$JH59Y=8K6%*'I\6;&`P::]K&8K<+0^?U(_$\B[,9`W%GLVNEPMD4JZ7L'3=6ZI6A(N@18SC^B9WC MKX/0'6^<1^(_&@[KE'3=G=,9U-P?T2F(8"#`H)ET,"=(44)[I&Z_OUTZ,'X/0E$]HQ=EE8%/#E'Q@8\'6._[JZUK&88X>+5]1RG'DW$3\ M^:^LD-MKXB;3S#E#OF(%1W2]X\=>1U7^H^!*Y[K6\A\UH!%7 MFUGXK8>)3-,9,'3J95`H$\#H?(U6\I6*MW],+I>SFQ747;`B`XP-QG3%-&'E M>TT+[@))IRMKA7*%)73N]]Y185!*6A33_^)%DX\[6PR#E3A]HPMVBKOXE55K M#C>\6/%@&<6ALXI5T+;CZ\Q!U#$C;'B;" MJV\>@^_X5>M<1)=M\#0J%E$1HD($#34 MFFFPD1`C3HTH>1_H2/T8VPU6F%7\N2LLJ)1*(9#_#43/*Q323A:,IL]>SDKN MLT%7:5 M?N\*#4JU4A04?@31^RJ-I`IX*0UB1'WT]?4N#)F.)%HYWD_8"?7.0$_:%0*J ME$W!H*,#@8L*Y:2[_,E:4\B+!W!^F/@7>SH^=\)6_ MWE7>`C/0=8LAC9I%[)2(`&%&K9D)*QD'XBP]KEF%*YSA;1#&Q'\4KYSI%U\: M\HY7L$:E2PM9)2T@\!@5U&+HRPAE',G3="B1U!^8.);3HT*MP26J;J&C5+&( MF`()(*"H]-)L>R1O-2:T/7J7_?LB\R>'-LED%_/G*"EJ]0/"R-2QI[$PH.1O M#!R`P&2AIFY++?<6S`42S"C'W>?>BPCHQ7+_AOY--9$9:+O>@]&J6]Z'D0A! M(*E*.^U^3++N2K9E.$O_J&&K0#O,Y"C[08RDJAHO&1E`M)1UJ\(*7Z.WCI06 MWI^:K+,KGM,@J>BD/GRNQ]K+:U06QB@?I3+P]8Z]!LK*95`25A2LT?Y&;\J- M?D[Y@=SI'401CJ,*&):).GW41:E@X>66`@48$"G5DG:@Y_/18@X)"LG*T`H1 M$FWWP-"H*^.C1`@,)FKMI,WHA]EL=+]`D%!S[41/`]]E_X5R@M$3S[-:L7_@/3L,0`Y6 M*W8=(IKA%:::+3U\C^-D?.G&H)&EXR?,*I4OO5JFI0<#-@LE%6^3<1849CP7 MR,=`*K`/\1I3[=V%\R+<]XT'V>8/]G'KDH07`4Z(TNGF+-0O@`Y`ST#+@LEY1H#G`5AP1/Q,"W@;WNN$D\'R:,5UCXVZZ,>5YB5*\M.<1.S M2'X#T_LEA8/(1L^,#`JX:RDK?AX3')!(`*A-(]#7&2 MB'G9.O:>MHC9]-&0!5\?.TZ59JAVG;1,8-!GJZFT&9!N-:W%0;'_B%:,EV]U MLKVH57%["@8F<_5>QOX@V\:8[Y81<8D3$AS101BL^%]IJ/C7@`ZN3Y1\1]M= M.WX/DMFM/VW!_**C/4`@F#'0AA7ZRD+4/Z-_,@[TG+#`&`OJ/>?]V*^U59UG MZ_\\0#:B^DA@SP,&EY:*:EWS_A0`ME<>XBW+,8J,.[9EHFY1IE*PB*D\!2`$ M*=22\2*(]CNN,&!AA$,?,-!W?P_=;KF-:MP_A;1)F+I&Y3%ERPO&V=146'J583RX&M^.%^/1G&^[SA>3Z[]] MG-P.1[/YE^BKX>AF?#U>?,VW8Q<_@0.M7?*AB:$G8%JD(>JI(8*O7D)B#G8P M,)7F#TV=5Y8[1(<2_4NXPZYL8D72DI6$/E+$:IBFRABS8`>#R_HZ:_/)MD+$ M!7*$!,51.0P$#W=X$63KZ,HT'Q5MQ_D]>G5+B3TR(1BDF;13I?+$`;A$GG3E M.L//V->F7DM4?6PXE%14[2\D)'``HM1+NWL0"C(8R+@/*$@3'VIV*$K*+A%B M4#6/$@49&*3H=;-(0O49^;K$3X%3!Q@\&:E MI@7H@CTOVODN2T@5DI''1`.)G:Q7AWTO`NW6>CTOZ2IW5ZV7;\5,56_/!@XV M^X,E^TTL%4]/8-*KK\&5S`#&==EH*>V?3NX_7"Y&LSMX6UKRS&]]S*QFZ3<* MLSM>5M&#`9B%DH:%(7OT$?*!\BWQ\60M[-*.L#Q)MRY+5J[HH?:_@\&+0BG) M_U`2C@A.!`0(@?^XP.$FOZ#56:@D[108!F4+`%'0P0&*7CGI$:W\1@%LAZ)9 M2E3.8A9\`)9ZYOFLD@D,]FPUE=*HS0L\V-#D.>#*>%'32B:&SN\%&167K@+;]__X8)G MIGSW[<7_^?8/%W_\]S^FU(2]%^&*M)5]267DQ&A.VY^_Q(K>OV4?>O<'3C7$ MJ^2O[_A?O[M`5,X6K]A#K!Z01\,'KLL+93K>U"'NV$_"45UBD(ZZTX0LL\J% MY"LU*1APF_63+OA3FDM"`R]!!01`J]5NL^,%>7AH2`?B-L1/V(\HRL?^*MA@ M]LSY/8XGZX7SHFN(NE(ZS@!L8F(I"["."#@`;:2W(ALPE9)6Q\G+01X5`0/- M,QP[Q,?NR`E]ZMVCG.9#O"8K[=:L#6.7F+4W)`_3:BXPR+16U01&5U#"P)X< M(%M'TGTO3>R6)+"6M%K]U"O;F>-2+W>!J-/[YLM(!)H)]Y>P<'1'?!K5LM>\ M8TQ;3N>Q9+(N,:13,H^@,@T8WZ-13#XKH!.D'U-Q'ELID(0:R%0GXY]"6U3P MF(J]XD$M]4PP;I9F?%EK22!Q8J+;6MW+SF&SB0\)?;!ILZX23D[YZX?$=LBD/^ MU%?U!IJ>LZ?MR"I3-#N4.C8P`8*]KA7[F-D&)OJ*^&A(G:<31FA+5]!\5_)K M<.`4C\X-LIW5Z@:2.7H"HTYU#0C+Y!#!I]&Q`G32]CA0E/$7G*T1EE+WBJZB MRD9D"5*XJ"KH9X;M4QMZN`BK?O=4#;/@."^>'E+! MCVV49T_5560@:*F[K;IG5+E83T])"@979OWD&GB,&NW?%83V@F!R$[JJA+9, MUNWQ@UK)XF%#D08,8#2*2=M[HP6:C3Z-[A]&,)#Q$3M>_'1-?>`D?'1\\AM/ M#YW2_Z4XGN/PF:RPN4I!+0E=XJF!:7FHU6`'@\+Z.DL)5(((K3%."R/LTX+9 M7AS%]HY55/.\X#,KI"NV/5P2B>(M)X?J:1@\DXC^N@["*\<=XJ6V%-_!4H&B MW]0$#4>$2F0WH^1[,4I\_,BV3TS[?NV8(S_ODY`B2HN6#CLP7I[@N+C%4939 M05(L1&>52)YN((\4D6O'_M4D)E)P]X]X MK4G5J)98@<=!.GW+P$Q^+5R1XC4RG#"D='R)!\2ASQT/1XF^^IJE%Q)TY&`@5ZVCXNT$Z!#[X!"?72R8^$,2\9<>J&J3 MM?%UA0J>3I\*M%&_\'Z@B0':9HN-LE*A%4J/V%&=PUY\$[N,E)7&6=03XO1Q M4QC@FU/W'68/B[W3Q9)EJDX#<;6*A4"\2`+&7ZGUDO>N$RKQ0AL,8$BQGVV, MV'/$;15IPUJIZ=13K]6"E#HK+P\,,/NKS*@P)$4E$[Z M[Z\G=R-T,YOFQZCH.SXP62=JJ7WDN>A7801H=0^*U@"`ZC[2?V&]K.XTW.'XZ?`S;V'JQVD5KS=9UE:FB/G7%8P M0MLWJ*-T&9:"FCU+C),+_VSC`.(3Q<;=$=UF0A43F,TKY5:#F0,:#*VT+>./ M,67[5Q1Y9.,\\O?C,?.V@*`7,=,P-6[TPE9!.Q(]L7$U61M"0`N^K@%H9489 M@T8FB#"T45BWDTK]H/=*P\@\(T/F'/LD"!$O5`P#EGQ910.3H+@T3^(3TUK, MP-3Y\K;2`&F=J^6`!D4K;=6%8('MM^47\#:+_!ZW22JW1X#MJRE4TVS&`@1& M,?2\#NB2QM]1H$^R,_@K3!='24FSA?."HW*1EX'OMK?Z.+(&_:UA.FE:_4KH MJ)\'L\COWF;-WOE7MY/Y_&MT-;J9S$;I9NAB\`\XNZ!)`R2.ZPK[>*VMX:>E M[GXX:566H2^10HLNS&J6D?55X=(%Q9:@1JR5V&X4NYP9,T3#0!C5EFIG.-C+ M$W2)(UFQ/'3VO\**,B2]5)>"9FLI:I')K]84T:7 MB&UD7A['M02`07<3KN;[K_W(ESEXKGLH[U MLNM?`C-FCFI>>?0E`I-GI5>O*-X+04XF!US5BLJU4N8W$UGHX^C^_GXTPBBZS>8=,!1T,%2@:"UZ3'1 M@2+!N.=V[)"R0'$4E5Y1U)\H70(^4C(T3XOO4;7^%2"#JZT7JEK^Q,E,.2V^ M6668IDYTFSI;XBY8`?2\RV^UC]_O3OT6 MAR1P:5^'L6FVL]V6O\*/Q&?'L6CI>.Q2\$7R?DI/NY7@G]_L=I?4MK?;M%DQ_@9&[O6HW9;=J4RX17G.I#8GP,?+-,W!'YAL`?KU0J"#OE+S%C`/R,GOCR:B13!P77Y=W_&F#G''21EXC_N!I4.; M@*WUZ4(_K8::-LUDG6\P37L?Y4M=CI9?E@98'%9W&%R(IL%:.\C@,^^+0V`*ED`\&]GKFV\=;+HM]+^0/`# MBKEJ^P!^GG(3A&M,>"FNMGR++!?`F*C?#`=-#V6AT.YWMV60(M4HH5`-(!@# M1;V=-O97(::!':NKP)X^]KI9I5+37:\M/+L M4V#&XW'MD]*GGMASG*S`[VJWV3'N9\PJ`-EDFT._7_.^TSY]QN$RB+`I9%?H MIJ]1TE<^0+.,C#Y.Z4>^>8&D55*JCIQ@L^5SU<8V;IZ3:L5GG-U5>)'LS\;:&D^5(K94*_MI0$.19Q*3RK>3F@CJN*)50T-+9:]J2@$#XL:J2_'E M8/X1W=Q.?IP77ORZ_X`&UXOQI_%B;"Y:"B&._*[;>Q5T#K.-(K^KC"+15QXE M!')CKW#*/\.LCXB'"R78%D$['N8XG^HMJZ3EQM*FE;3T'3!^[(C&E<=<[E-L MARM,/X;\\F#D&V#TCRLVTV^3#Z/E*_IJQ[)2B/]U[F5-)_O^#S`&<58H^"8( MA\%N&:]WWF"U"G;Z(NQFEH[+\U8J7YH%M/1@0&ZA9!FLA6K/=&'C(AAI#2IYUAX[M#G MD,3L5'C-ENHN7N,PI%/V.I4EGDWGE%[@^,@E$??#,""9UI\M9M":MD\5Q)U? M#]0J+.U(2Y30#@",6IY6IG*:6I$>%].0F1U<[>-F_J[?P'=OB;,D'H]@:=Q= ML6P[6&K';X:TT02EMT4.$0G&U;9CA_JP,F*GE;D%$AV`5?85$?G?Z\ MHJ$'<]4E.O;[;L-776A+6^")*BN..\6Y*I15E]R@:81/5[68/!M*1=BQ]CMP M],:81X?,!RU-LX;.4O"1$+*]A(02*AA%T@)/%XC%V*[G&$JL`+RXTA@+5UW@ M@P]&K<[J=R=%1DB<>%70:"S--0=-5"`0J3&H?OAP(JA4:ZW&)6P\#I-U8NYA M0.NF4/+VBT:#.68P*ACA8U&OM+0QE6X'`'HH3V\/#:;#QP9`S/A@@+!DAAT` M$Z;3`5]182WPPHJL3`BXF^%G[._L%RL2'PS_EF%@9C.6UCL-T"VR0)/IQK6*%=A&\%[P5R M!&OVU/K^3C$,_-OG;JF>L#XX(4PM%&;VGJD!FF7RJ23"*LO;BBVJA#,IG465 MQ`)ZB(@CZ18268V"``P%"T,MX&^0`N8@HK'J58FLX_M/HWF-1-8.$[2^'5*#8I973KZURTCJ3'V=0+Z]KQFPZI4#CV4,`H",`PL#+6`OD$* MF'BDL>I5AQ(WX_O!_37$0XD9WB8SX&1]&_B/"QQNAGC)5J?I\PYXM0M-J1CU M1'0)Z";&Y:%D!N-,*U4T+^J601@&GZG3!1(%Y,>3`4XR M65\.3P>=,@UDQV5"2\XE,=^&;MF];L;P9HY]$H3HGCDJ&."9%BQ*1X.IY("1 MHX_%OT%UU=I?00X-:-6J:O-J2W4%@(`LYW!OB8^I8==466(S\Y7H^YKXE&KK MYKT",2)HW*]V1*GS!Y]:.Z9_\/E)J^^JR\VPK(`HJX]M\4#KD;_9_^JWY>:K7D"W M]$&0(_!85IJ'+ZG[V/*;STX8.CZ4<6V_)7SXV9BU4)B'`@>>C5E*/(FSL7JV M6%W:V2\YH9V/C=9KO(HGZ]'+BM>!FM$0=>*S9N%[S=$3.S!_IM.X/M>AGHA. M2X(V,*Y0$+0&/YAIHX'24I+$SH$F-VCTC^N/@_L/(S0;+$9(_'N.)O>( M'9+!0+#:,O%N9_G2JJ;)ZHGH$L%-C,LCN`X_+.?<0'/)%8\6:'Q_/1L-YB/T MU7`D_O4U_1N'+QK<#\4_1G]_&'\:W([N%WT]FZ"V=D#GIS!\I?,&?[/9OH-+ MC+T\)#6/G3"NW\,ZU96G]*H>O$!+_$A\G\VV[,H`5^8\NQ7@HU'U%*_1J9C5 M`[#IS@XK_^ZV6X\_,>1XZ:M$8W\=A!OQ7F#%BU&VW)W6!JYG4J%8L!TKF#BI MGKY2'>&'Z?1V=$>Q.;A%P_'\^G8R?YB-6,R4Y0_1B>9F,KL;+,:3>QB(32\- M3AWB:IJE2-)MQ159N6(=E?WO8%"D4$IR:GPUR+;E7?ZD/(J?<.+'^$,1L-[I M38<">\V/_G.?*.J[BH7QD$0K+XAV(:[P=H>+[3KL;J,1RE/Z(3+!0+XE0XP> M=7[]<31\N.7^]'YR?\E]:JXZ!`T1CI&6&;I^S`?&V^_?O^7#@OWEE_0**EU4 MI]?W6)5MMO1@IR'C#=OKX5-)=!_$/V'N#6[VPI,&/%!6%P.@%7,9Z@\2U#O4 MV]#>=(\YNP6Z3\5D(A')R62YFNB5)1BPJ8-.%$<"=Y)0>BL6U,MXX+JX'!R8 M"#N#I5'1#'-**AB`,JDF!PV<5F"#OR,%(SR8A(^.G[S=`1UTG>2I_2 MUF+A=.$I&,?+'F*MNF+1DNPN`X56FR,?+;0BN'?8'\,:J59U3O8%*DCGWC4O MG_G>[`MH_PEPCP)?[2*6?A8-<;0*R39IJBLG(A&[^+VW:(%?XBNJR*^:EF\B MJ,L!U-S0_&BI+P7,T&BLNK3;/5@D&Q!7#_/Q_6@^YV'RU6`^GK._3F>C.0NN MX>Q&I*9?!YLE'93\5+5BBC"S]`%>D+#+Q'Z=AX--_KI((R'>35[JRJLN;V7/%W0Z&LR&0&:AD1.RS`F6:,-3BBNF%CUY MIWE^%4H7^J@YF@ZFJ'YQ\%L!`1-RN?NF5O^*RO/]2FISE7EN.I*Z11YS4PLX+&> M"#@H;:2WILJ;$(-R-LG(ST%R] M=1M=Y=NHRO\?+!7D^#$W0:,!I!9Y>B/(:(>49[>87/_M\FHP'PW1]>1N.KJ? M`SH3O'%(R.\([(VOFBW,+%UBV4;Y/%!-]&!0:*&D=.Q"61#G03DF<-Y795F5 M;ZW@Z1MM1K]H9`"-M^ISOO$,?1K3=7@0R*UV\^:.F!0.I"@6E&3(C1X(>G.G-0GQA\ M#P)JCKF0W9*PP\#F#-,)9X=G>!50;7FE+Z;?:Q4L+?BZK7AM:4:Q!'8%$Q@< MVFI:AF#"!P1K'['CQ4_73HCS-RVN')==88J$17;H:R2I2SP>8&H>H0W$@,%L M<]T5I02?2<1VYMDE=RJ!UW<_&-2:6XQI=>^%\R(>GQ-*EJPTDW9VD[%"V>PN MHX:N=[!8**>MOD[)D:"'X=X8*.W0X2SPJIF8-1A[,RWU#(D\S167+VCJ+:J95#M>1%E1ADW M#%4%:<("=_.UB',Z3-U%M(_U&LKJ-_@\PM[@B:""H4S`_ MXW`91/C6N%AH;H2TADVH44[84;WG+?G7CK@D?MT_4#9+FBFR\*&UV#OSI`V, MROQI#5X87K6^PF7091+$':&D?D4F!(:+G:^>L+L3KZ/6%GFP(^2 ME7?E[EY=*9UN\S4SL;#?5T]$[P@^3&_)>R92V+9TA,-GLL)HC3%[W(>Q0P,R M"ZD7[`U'>]2J6/J!J%YY-1YE>H#@TRII0IH74*!"PU;YS@@[KEG1&6)(/!J5 MN#5A5U-:/XAL9+(:K+5$08M'#S/C5"X3L:!8SL_?EV*I`G<-_D[K5]8UJU"H MTI89&F3K*B[=MLBXV-7V?_);0L_)+:$C+9S^AE^S>E1#)W;&?N&:D]'!-A'0 MV>*ID6'9\JD6=^\10&.5RP"D,M*G8NC2R:52V@=BVR&"^N&I_%-322W8UYK1 M0G/!_00.AS:$.H9H*K7W0=&Z*5+PS%\B$P^/I<\J`7EGM/!)'`T^.Z';ZE"I_15(XZ9A$]491#4_<3(CJIE=!'Z;_R=,/K0;;,3[4RV61 MUAM*><.DM:]`6V,13XP MDT8-9:52Y,%FPUYZI4N2L4_QS5Z$/=)RV$;+.^R2%:50+<+J\7>V&&YB5K86 MKL/<.]R::BPG:HB?>\>9]$Y2`WZ`."/RPPEUF$\-9]JWF=*?CX2S'X/P5QQ& M^>A\2_\[\!UO[/]S%RKS4RV8.D.4M0$9C"HY8&#'5LTR8!*^0NF1-].$$PE6 MR#':)'["89,(K-M4X7_J_V(_G(FVB M?O"L8N_X]=K*EXF;J"YM7LIY)1?(QS'+!*"-S^^:[ZA#<3PO^,P";G%=TB41 MOY%F/`6`T>FW.(JR*R`W09A>(3D0##JQ'8.DP5*KD35R<>ZX;D[2,3=Q'0^G M6554,^4F;)$$4#?I-"LW^8+Y`SXV026`,9S0Y7@<[MB!]8VSPH,-V186$_A!G99H>A$;V;G#YO<"ECQ]9"3A3F%)?=0-BT\`#(E[3I^5K M^+\R2W^(5"NOAV"1'J@O5"JI11=:)>207.(G)R3LF"9]WWODQ^QR1'+X>87C MSQC[G\:C@>^*G])+^YH&.D!>E^`\V.P\T>O;#=,-V.4G-QH+%?,OH@Z">R3A?Y10/L@1]L<>CP M$CM82``R!-2K^"8[IX`V36MOR)W&5JEYEU0LX)?$\[#+U_%@+W75'G1C?Q5L M:%/)Z161VU6KH:F']CQI;@ZM'294DX*/"4GW[ M$,8190)9$+_"Y)E]\321GTME;*E%"Q(ACP&%Z8<,A)RXDQT-L@T-AL36>:T: M#T=$P7W@D]1:L;I(WLY8!%,8I.,S-EU0IIF/N?>^]XO4ZJ!$OF45:""H9'F6.?!.%]$&L#XP)%IQM-3>&#I$(V2(,`@RU;3,MYRE%:I M#D<-&GWVW%^(7:+LC/SO'6?365R/5&HGAXT^+WFUXF1HZ7AL+8*"71S%=#5) MO3^,,9\WYL99L;7PZYWS0C:[S540AL%G,9G17^+R18YF(KI=G-0W3H?#*GXP M_J&!TA7@W0ANM$S9D;,!EB@513LVOGC]5Y/?+-)U/BNIU)1FH3P1&%3I-)-> M1$B?(4[*_;$#2)#A3;I#.'-BS-*TC+`QL1?OJ)%#.O!R10BMAKB6MS^'6F&.WJUJ&,$`LXZV2A>[ M25A8P3X@+C9["SX8K/ZU(R&^2AY=Q)%I![R:K4O\V1J1AUX5#QC462HJ[X!' M3^R":$1RR9)^D232KEBH>]^]_!H$2AE'0C ME)(@0EM?`3,ZCF9:>8R)'Y&3"#B_<38-61I^_#KU'!Z# MCR@M?S6H@Y8W?/M41V-E<$N<@`]/MEF:USOPA`7 MLO9X>9@.^D'[Y5,=OQ5->:S1J_GL68Y=LZV*"9@Q(9R.<.32E??O80SWTA7G M-'*['[2_D_%:,517@@%Y>X[S&Z]=QLEG$!=W%@>?=]Q;%>=FOY_QBC7Q1\G+ M\R%FNZ#)10=*SV.)SC:/:NARJB.W=G,?>;JM5N0L1WY=ZZ6#4\%RMFM@W@+W M=&CDVZF#?M%\]U1'N[$9CS6RE1\]RU%LLE1*-\1.A)\"ST5DP^[<8Y%!=KX3 M^]AW\9KX),:WY)G]9TR;@V2\'71/I0:G.JPMF_98`[SB\]!2V;LW75G>FV7P M)<1G.VT7PII95D2A\]B]\.E3'>55C=E)9)[[[EE.X17&2IMBPT,?1PTPLYH\W%@1D4A]L@;Q4) MB8BU/8HY8*_#5LJ;- M+/BZ1+6U&7GL5C*!0:BMIF4<,CX4^!H$LJI$WH[5(:14F(OLJ]04CD5-Q5M- M:GJ!`-`[*&J]5`_/$$Z&OO(HX=?(B>.0+'B_^7*.*-/=Y![-%Y/KOWV7R*:93Z MC$/G$=_O-DL<)@^\1Y-]803>+*I>KB4`7MV(9NI+M8,2*<@18I#/Y8A'U80[ MX@+SI2:0NV,/F!;#VAX76I64QK+[%=>G;LXR]`N$9UV M-O/-D'@[AO1Z,X[$U>>NY)6D)RP35F M'YT(>,ZJJ0'=ST#=.2[J6$-^W.QXUUQWT0R#G!]>!->!SQ[OH%3>*Z^!0O\J MZ#0M?;#4+AU?2TV0'RH'B@3C.-NQ0SHH<5WD!WQ3@`XBME<5DA7[)Y_74;1; M_A.O8A3XWBN+`=*7//B&%Y2R858MDX9$.*UW,0A#VA#8M&'5AF!PH\>J(6H/ M(*/4TQI#-J:HAI'CNH0=CCA>.N>09`2BW99.1/@%ARL2\4TU,;H"7NI"O#3] MV6%?Z>VAZ1YBDO?=OC).UR>M1B3O#XU(=I'815TYWFKGB2>Y7/&U_+HL6Y`! M628G#5)C#0(O^JQ25%I^R-URY.7R46>)[`@@?RPUWRTCXA(G%*>UP8K_=>"[ M?PV('W^BY#MMA'6`P([!(>+]>>R$L0D@[9@D[;G@1^(SX*4E6'M#0'K\P(XO MQ<'0'8Z?`K?B],N*$=!12SU]5==ZXE>$$V?!?#5=,M()_)^LMVD,++J[+[^L MM&9(V"MAOAM-PB&)A$=B,8;27=>2`._)E8;ZR\Y]3\5FZ;2_82QN\HD&]0R> M80I/?[)6/Z9P!/E]I:2TTBRZ!)6#A(-QA&U;I'&5M./VG#Q#X(7PC0(8+A-8 MY-/M`DA$/B/?Z%+;,4A"A]AVM0AZ#G@ZYF_X]8;X]`/$\89.[-P$84$[S?E/ M3=[.GINI:T[V$(TM8^^^J8FV9611=K1.^5D]4`>M@["&M^GP6%+I=N>[S88. MJ]^PFS7#V.>OQ3$?>FUQK;(%N9T>;;;5#-61;`VAO0^&MBV1ZI@6KCR@R[,9 M(JV/C5,9%.V.AC,8!D;\[V__GM\0L"YBU99PZ$/#KBA5.Y)/8U.DH56Z6217 M8^J,QM%Q!M!)C9PC#)DS&RO5@R0WU9SJ.!D\/H:\^=CK2K4:K\39/]Z5IE1C MNL`&/"Q2Z5H&Y2*(Z0*9G5^FX<_IH+&>-P;A96MX3^A!M\[-707!K^C9\78\ MH67FN`Q#[^+0>R7^8WI#[AXWV7$QRND?D19F5F/5(`0XBJLU MEV)=ZDS%$<8*1_P)P64!\6E%J":8__V<<7P'+?6G'7/4TVM'WE!S`,)U8%[Y M$U-CLN8E%/+J3YTP]G&874I7[<O=J!ZFM1FG1C8F* M.$6D;H6XHR.6NN`9IA_=878NK?1$^68PDG>&0@NE,[P9:&$@JUI!U;WT4+#` MB.JLD=ZZ*?I:#3"&Q)WC.^*^ MP@W&43+`-8VBH>T2N$9U\UA4$H*!ETF[,F+VM-F5*O8VN:C](RJM1&B7K5E@ MI$\-/CNANZ!M-W@A2E]1(("7]:]63[K*PZ@0(T,_,\+_A#&F][>2KH,-*T`N MSCSW5Y.N7N6+2\R4B;ADE+NZ,@L\[R8(V8^:ECK6Q[KT*L=ML#SLC_,E,'[M MJ.:51Q^_GH^N!O/1D-W8GX[NYX/%>')_=H-0W"\[?I.GWSG1H5=LIB.-.O$1 MB/>0CF6D\F82"S2NVLG1A3'VE+@72`[ MP`;IBD-*<1Z><_2R)2'GR0!]I%&C_-(I>4Y#4[7I.16?`3>6BN^'\EYA7WL']PC*0Y3BY5\$E#LFE(5IA.)[F*3Z:[H$VD M=';XW-S$[$RZOHC>5VB'Z:TMT)1(0JDHM&6R$!6&A#0TKZJ[=#H31&YZ-+7D M\2=G\]=/:3*IV:1'BNA,GS[S+4T+T\]DHS.JM?=TC`'>I@:@!GG[35MKH+?W M>6C'[=V;WF"?]83&>&IQK\.\IA(G-=(;-7"K@[V6!KV'Y;V:?>H;\-5M(FV& M]C/>:ZIQ8B.^42.W/.9KZ7!.H[Z)X;^+HP"HR\GS/C:P,OUW=IC0PUZ1]==! M337M-NF1CB/`3"Q='U(T#RA[.;J8X8W#MZG8>RYL*WOG>+=D71YQ]5C[.J2H M,D9W,J'CZST":J!LY1E$QH]R`A"3`&A*69;'HLB4&NSBIX`7S.&W['.)4U-J M=%08;#,V=G-S;C)4+5IS@O=4\!LCY,)8=MJ ML=Q4#M#?'*+=R?J;P[OD:/ZFN6KGZ6\.;H]>(^NL.-J8/4W@1V3%BVBH0CHM M:6>1L=?Q;*2==M4VJ4D2-.#V@>:F=[R0C`#KYW2MLEEX#7S1*6K0QBL,=/UL\^DWZ6I\^B:FU06.V,LO6 M^.Y9Y:O6M[L\L&?SP9=1?LZ]0,LZ3XB>P`B7VX;5(UP\.;XR";#M/JK]^9,8 MZ0T;M9717O/;O2]9>S)8/=0?3RIAM7&+?,(1M;*W,5W^_'F,:76C=C.FB]\^ MFWOIS>Q6#^UG3GKN(_LF"->8]#FX%1J&E.=&0BSMU547\O%@&E)N7[`T,:WMPX)#S*V7"KJIV'8ZK? M&=WX(WN]SFJOO/UVT3HB)W%$:\H@#LQ^][OJ\!Q2;?W.PRLU[)8^-NYA^2<( M._M'\4R_RQ,!>/ZHMG[GX8\:=DL?AP[_Y8^:MD@M?_2[.L9@;RW!\T7UE#L/ M1]2D0SH]%['2['?@@AHT1RW_<[*G*[^''8ES.ITY1KO40OI9G>.(8ZS)NGP% MK?4S->UW3F(>K&JF=LY;-1\Y_=FIPC+IK3E.AIR,3KRXB;:4ZL3'FZZP'G\! MO).+:':?/HE1V:`QCU"_Q_C=TQ^[]8W57X,AV4W29S@W24>;K1>\8CP7[_VJ M&RH+*GB;1-SX_._7013?!_%/[-GV5?#H,Z^5?ZA*TRL=?;O+T=QI<^:'N[2V/*`?_#`C1Q&CO^1WYM`J)YL5?:3_/O=!+IPA75TG?V)TNBNJ72MQ M%L/>V,"=C'^E!N?O"$QF&SU",O#1Y[266KJ*%AL#,!S"$*]Q&&JCH1])_#2F M"_UGXNX<3RQ(Q(.4FFXX0%Z7P_1@L_,CKK$P,(/G4`O*XX`/+!2)]2OAE##@ MSG5?5H?_2TWX+TZPBNOX(UVS5W_JE$HPF!JKS>(+JN^`&5I'-$Z=;+\-\3,) M=I'W^CLY#,TF]>,46JC__9/8-&K:K!T?ZO10=Z&?@TFUQ>HAOO-!C6SC*^7* M!N./S^N:N+&X3L?=@4;;/U6OEP5G5!QF@/1DAGCLW^^9'0]5ZX>GJ]Q<_TPR]$V?MVG!V? M75L\GU93[W(G,QY12/$"96SH9\;SGS#\6F;5V-_NXDCS)F\E=9=>J4)E)>R* MI&!1IE13`M5@/$.?!K3 MI8ZP4+*5.L_'ZH=T/W;AO`RB",?1-/#(ZE7J!PT=K'XP*UGNAY0:Q[Q4)"(YF<@/8O1*4;*E8MF%+&51#\RI^J$L8]#NO[! MM!-B>0C7E@`+!$W55V>W+*F@]-61=7($41CWM+.Y.);N+>3UUNO9'L0=+I_E M:HD`]IU:0V7WE$C[:'G3F[Y3'(I3+GXZIEV%U!38D(L#T-^M/RL,N66'D),CHI4N#\%<<1OF#ZRW][\!G5W[^N0OE M';E*#F#=:*FNU(&"#^49WTP33B18^^HPAD)G2^@DH.R=_<_PND+23=7N;)2L M!%4?37Q+:,#KDOB5!M")LK.D/:*JQ7L-7EB=4U]Q^7`GD<"7"8D,E`GIHR<_ M8L>+GZ[I=#D)'QV?_,;-GX9X0W:;9`E\AUVRH2Z;,S87WD[5@AL&H0\122G[B*XIR+9?D[@>>)%;[X/ M;M>'323_\AW@?C_((!NL7*#L$RCYA@2?XF=0^IW^72==6-N-]BH>0&/?6E6# MYQ7)5)R\IT[2K+/H_U)'E)1;2)9;TS!X)A']=1V$5X[+8G_EG'B@2$!=W)8E M900(N8@)1GG)%RB1C1+A*)&.,O$\9XM^@">Q]S5S?W"(?QM$T<0?DF@;1+QL MQF2MC_6-#(`ZW$[/M6[LN, M$J6D?;KM?= M$:9:Q#3#U*C1"P/1CD1/S,M.UFRBU/67D0E8E]GIJNJU2'0;%AU79&=]QP3T MY>589A5=M@1%1Y'X7J7#,W(`ZC-+124WR'/-\GR9/TQ8^W*)7#-C!)`G@-83 MU3,_;_B>9WW1U0OG)='C"OMX393^2T,*J-VK-"SW0()SRI!V`_HJX>D+\RP% M)L1/5!?RC(5^]YCZ7*JCJD\,Y(#ZQ49+1=F./4\Q0KM`+$6>SB.4_P+6EJ;! MTK;V-EO^Q&G`Y"#+&D/KU#9`18FN:$;!$))5G%2`%N\V,$SG7@[2'F`<(A30L&[/%N6Q!1*BD9"-A/`+E`)D M_P$DR/DGLG&>^PRH-Y:T(U>BA-339@658S@I.]$33\]QL7OU^A"QV64?+JQB\BQRG@.?_F%'_Y;\ MJ'GAZS")@/#1DB&JA2DV; M3LOQP8JQA&)MQEB6$@'U+W!1[F>+4+M8NS M.OR`X-!(;>D5HDP(.Y#C5?/CM&K^1>Z_T[O=_"(XFBP]\BCZ_*)0!&/_10!8 MT.6"EFF`]JDQT[/8;SWF=$X+^K+C8%9[@;V^:IQ0%>2`NL%&2^UTFO0'2MD0 MY^L]X+DC?D"'IGC4++F[9@YY5!P`.ZE"45/8H\D@`A;[)&6C6XQ]+"4"ZNR6 M#*D9^V3BP<8^3'D^X4=/;&WU['@,VR(/I[QGJP)('7Y`<&BDMEROAG:\B%[H M/W)R+I)$)J38INXMKHDP)7\:LM?8@K3J,4O$M(E(E,JDJ!"%VG]._B\3C[A\XS-WQTQ?6SUA=^>Q6MA. MR&INLB&0)H*1%6V8(?&H$:[^684#10%"QJ$62!ERB3P6T*42>75:+O,"<:D< M*HE<]#.7#``7+.*\P_$3`$59EP[D#RXN%X$;[VS9ZY?O"=#;N(\1MVV?-W M[)P^*=!(@V@5AFJP`P)'$ZWEA\_8\C\3'Z'&"OBG,`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`;1G0296JF&JS=]Y"H=/='JYL\:3B9%\8ES[_NX"Y MWNK^D)[I=,9@IQ/:,Q_0I;4VW]H9.C'.$B&['07V>IU#='.,YNAOW&3**O9, MN,*(:8SV>:]]ITF/_2T-W`9+:I:S4N:I:D@!N>8J#0U9QX(#_9SR])5+?,N2 M#2?KZQ"[),[L8;FP7L#2HE4=4\4#J(>L596?AZ2,[(:)8+W(C1RT9U=T6OY/ M5,BO],_IG^C_L"%.__+_`5!+`P04````"`#H@VE'LGUGN?$O``!O-@,`%0`< M`')D;G0M,C`Q-3`Y,S!?<')E+GAM;%54"0`#I!!!5J00059U>`L``00E#@`` M!#D!``#M?5MWV[BRYONL-?]!D[-FG7,>G,1.^I*;%L?O7#T!2$D410($D"%#Q?NCMV`"(JJ\`%`IU^<=_/VW^=\__M?96>\*(]?YV!OZ]MG86_G_U9M8&_2Q]PEY*+`B/_BOWA?+C>EO M_"OLHJ`W\#XP>W\_%NV/LH>OCXYLVW M;]]>>_ZC]Q0B&[W:]J*CE/4[__#APYODK]NF1RV?[@)W^XUW;[;3V8U,_HHY[7,S"?'' M,)G>M6];42)APL_TF"WHO\ZVS<[HK\[.+\[>G;]^"IU76^8G'`Q\%\W1JD?_ MGTC*[JLIND0V-F_HG]X0>.(-\J*^YXR\"$?/%*M@DTR53#\9ZSY`JU]>!8X7 MG>WE(73^#=(W>GX@ZR7$5-Q?]=Y4FN/`]T+?Q0Z1/N?2B.U@ M9(7W5Z[_K;Z0'8W4Q/PGY+0*T'1U&8?80V%(]KI+*\3D<[,`A>3#H)U2;I0F MYGUEV=@E6/9M`FF(D[5'OCK$X8.?_5,T:8DA&N$T^M:W;3\F)XFW7B3*5N`( M)\GOU<2\1E;@D;'#&0H6]V0S%LV(U;Z)N8R]1Q1&5-['WJ\^]B*B"E+)$K)) MV+&)V24[R1E531RZ2Y+%"EH<@F[-K`8<)`KG#;)"0G:R8XCEG].I$7[%=R'Z M*R;#CAXA$V*U;V^?FY%]U\9B<:LV6GMT+*T[MRDJ#L=2L>/`9LOOI73W@4T0 MV%WA3@2;)ZBSLET)-D=`U_96TQ!%%G;#LSDBVU(L/"!K#:J"JNVG)GZ$R'WK MF;)1E@C>&*TC,;$">MUZ;!:*HU%5Z:FR5,B,H6)_SKXENT$7NBG=H;?B^:]& ME$;N:*W0\14]7V'/\FQLN4,KLFJ3PAJP#6K`@BX]D,*S=,LX/XX2RSB1[.G# M]H[X.YT(1*-M8.P6:)R'<5U2\D.HGS%8HB2'4:;U`+=02%_5]L]ZV5_Y'LBI[Z1"]_!C9 MO+?8H\V_D5W^FPO-`&R_;U);"^E4@>[!W%`2;S"H6VY?R`KX`H^NS40A!],`D%$N[Z# M]W?DNK]Y_C=O051AWT/..`QC%/`.8&87(#(_FH0,B`OZX/GBNS'A8/"<.*>% M/%B.F@+A^,D\.!A4:U1/T_4[1P]^D#UG1S$7#58/("@_FP<*GP?ZL$ED9$`V MT[4?<"\.A89`)#Z8AT0IQ1H7A[_9^%YBKTJLY^%T;QSD+A%N/_"MSCQ\(`S1 M>>](U9!4#[\BOV-L9)SF4'",NG,+R=>/"54-P8CD&D/Q,/(ZSB"]!(U_O"FU MNBHRR8I]E`_LL1>]L][.Z9'\/)A.AJ/)8C2D/RVFU^-A?TG^<=F_[D\&H][B M\VBT7%0RR^;E;&6%=PEF<7BVMJP'*FP_O$%N%&Y_DQAP-3(6$@G+4 M7)NEE\_A,A@8I)J!!O7')ILU_3_J5_YHN?0!K!\-K"!X)DI*\C;&1@?879N) M&`2$7X4DDT#,G*O#.;(1F?"=BR8HRJCEK"QN+VUVY0J00>@W`ZDA6B$R+6=I M/:4$?@K\,!1")>BFS1A=`2L0!PP!*T97A-0Y-[.""",`5MQ>VDS65:`" MT&\&4K,`/5C8&3U1YQA$=N]I=(^"E%8V4OQ>VDS8%9""T&\&4@=4`;4^C?;K M*H=1&84YYI.YISO@=4HU8%YC^@('J>D;MO<;=ETV!OL6 M^NS<`&[ZC$F;Q.PQ89:WQD3_3XD@BW/T9+LQM;:+@8#UUF?OE@9)AAUF`+B] M'*3V+C3P0S)KW[/3O8![U@"ZZC.-2T,'9H09N.UC'L*QUU^ML(O)E2&DL;#8 MP59`[@V$;-].?DN.S]+HYK(566M8*-[*;!@R2[4!!IHA"^47_+WPREHY\CVA MB"JS=,BO8!$;3`$M21<1BJ[,Q7900)39,V0`*2/1#/:+V"[+;F5&"3B[F6SN MY/WW&EMW-'P5)[OO<38>\54+/@(49&76#CC(LFPQ8[7E9@U^AN3U@0*FS)(A M#0,31:/?*K?//%GD/B&5_":(R4YR1(#XU0LT"!199;:0FLA6X)@94`]CM/1W M>C#DS:6L.?C9V5#XN%PP!*CL,"]D`&$K][N&4'"4&5+J@E-.N1FPY#.<"%=/ M:6,H/,J,)37AX7#`#(CV\N-%`_+_6.RQP>D"A4N9K:.QU<3@AAF@#:P'3"\D MR`K1],[%ZS1AJA`Y43\H?,H,&S7A@_'%#`QEM,4:2N&%,IM'X^K^"=[2]X8V MJ;M=63:*&4OS^!20L1N7]X+"I\R<`N._Z#@TU7)\C3TT7:5S MY"VQ?"LH)&T83,"0E!%J"`2^MUZB8%.6UK`$BM+64$C:L'3`(>$0;@8T#+T( MLJL!NH)]M$T"#U!A[1WK5QH0;CVI4'M%Q4NR@^[*@E%!AEMV=YVP:#6C.P MZ#M.$A%JN3,+.V,O.UXY#V"L#E!DE-USY9^W^+0;`I!MQYLX":%)CM&2VD37 MU#,(1=/5TGKBOES*#00%5-G-M\I[915>F0'TG&:-]9"S32&>(X90]38!9+\G\WHPE17J97O>EL-.\O MQZ2!1M4EM>3MYB[65I@=M)K[$K]O0):-XY::50\!_X^L>.6$FK'U?4:6&]T/ M"-G38&UY^.^T:C'Y+Z%L@8)';"-A<(+4(+I5#R8>?G6:.HKH+/`?<4C^NO*# M2\L9HCM>%&WM@76K,6A-SS+]]B`)1ERC,-PQXZIA:6(/ MKEO):EZB1(SLNHVQG!7IRS/]J>)94S*`[JR>M62#R1`SSIB%Y:(PFQDWK=!1 M0]T)/(&H,`CL^NK+[D3>.DMU"XJ96[0ME%!I!@!#1)A'4T11UGE.?T-?`/\^J!MO(0NR602[-'[G'&6CV%!_ M1E!)1!FDFK'HCHB14!I,2/PIB063W)-1`O<>H0`D\XWU9P*MBN4QR9U'DSKZ M2JCSY/PGFA*&IN1KQ.("(=<,_"8^!X^G&-6 MFF/ISU"0U-DC)^\5XAUL,F.8D=P3B)X\<\P`=;^ATUHKJ6?>#8KN?2>7$UCT M,BKL;D;B4/!"E&!)]Z\'W%L0Y[8@ZF=&'M$FKH)E]X@.@QU20A$A=?1$%888 MA_>IGPO_A`5TU9Z)5!9R$"NZCWK"%G)"^8=J?,8H@;++Z:<]/ZD,WC`FG`C8 M`!/#83/MN4JEH3PUL\*AVC'P/2*C,1'3O1_>)2)Z9!:'NK2>4%@,N^I[3J/Z MG.)):$_!6ETK;`4>DVX(A*",49?(0RM>,#&S@_:)B@:+]YU(M7K3"4]@2Q4K:8JJPR8\,]F#X010/2PE9& MZ%16Z#;-Q#8&[M(*L[I7&1RY))NQFHI3'&(WCGA19,P.VC.YUD&F M0+89V/R.\/J>S*I/7^W7:!)O[E`P71T%30E6DN0PVM._RN!8B45&HYM)HD2@ MH/1`VK/)-H"PB$WF!Q"69,_:3?X@DO"'*I&$@^G-;#[Z3-J-OXQZXPGY]\B, M=`@IJ>2R7\(`J;@N#\*TZ-4.)\@*J^ISN^L1DI48N&&1)70IY8;+B==$89A/Q-?XAW3&0RH7)F'1])MU=R/6: MG:WNX.;RH^3-A5Y<%LOIX+?/T^OA:+[X]][HG[?CY1]F7%RJ)<$'==>:_3.; MX9)?F*;83K3VCQ:!ZAV@0G;.0XKRX3HF`$+6,!J3'SFWQ[*VA@%S(%8L!'+3 MSWO2F(!"*DKTC/`]:KCI/V$((.7=NHA-.26Y:Z;.UXO#N0W]C84YT;2,YH:A MPI.XXC-&.4&YJ&PSTM[=(&JUY6JFQ:;&V#DDX&!2;,9%@U&00P2.H)LQ1@D) MH$"<,`.T8I4&$5JL]L9<_"5@XM-N!CZ`HBC"!08?PI@;M\QBD^5076`#A]!! MX7K[X=W;!"SZFS^7]%X]3ZZZ3$1HPY)VNM,*2;&=08-)BZ;<NM,% M55D:$#Z8@9B$/T(-CP/EV!S=J8NW'H`_@9PU[P$%V*?&LR#2_RYQ8J5>U"LK M0GDQH\*+>4*6YF$?Q@'E1#J[9&DE?YP^)!$AHR<4V#CD>1M6&+N>'-R$@;83IX:2;/^-RMP/@5<[[FJ MX^E.:]G,$2%DF-&@)_M?3G6+G\7&[D?CEM^;R%TK0.0HI,'B-*7V=)76_]O>Q(21GK5&U9[^$RQ( M37#/C)VEF#-@B/8T#'&87K6IWL.Z:G].[^ILF6CN"]I3DH+EHVFNFB$KS?J8 MI^DK6G3YSWU0>T)4L"0IYKD9@J4HKD==]E,P?`WFA7A$P9T?(OVJ0YV7BS\O M#,B26OWQ@DZ_$\B?<='6%/8OPR5LG%?4X2B:WEVYWE!:AA[#/ M#*"U%@%5YH;2(M3?2?U0(VK&*'-6:5E>OI.*,[J+2BES23%E>SFAFE3;S-&' M#K^"1\R2]MK=45J4#3[/NO^FO77=VCKJ$!Y1QXL]HY)%T/><:VS=83=A&6&T MV!A:>V#MKBKM7HR;0,$,=?>8F*UYAS`1X4=^=BA8;^V.,$TA)I(#-NNZ?QXQ M>)BZ=46BZQ&LMW:?F[8$A-NT*BP,]IVBN`PS.G(UXV2D MI;2[]E++;0D+AWFG+"L#HOFOJ\G)KJOVTLQMRTB!::G[<:^\QZINHZ=66P[2!&>196N?[PQ]->(;KM"Q&$O=T7+[CS M55FAW"8\4<8'`A?5]OQN69.Y;V\L4M6OZJ\]H,8Q_9 MAK=91NR_8AP@0HD3TTDCT:T0:\/BRQ)Z*RGQ$ZC[_S#Y@?!'?A=C! M5L#5ABH,I;V`LCJ1@?+Q!$6(<)-LK='SS+6\B*8H(K]]H$WDMA?6&-IK.BO= M9_B<.P%I"7P;(2?,I9^H("XR@VBO'=V=Y:TQO>Y+(WO<5WM9:H7(LCAE"++%PPD41\'OI;T$M;JC^R2#(N#L M:L2B!1X7'&EGO!PUP^$3-6+MX@0:,&)QQX+*4]MAX8W)$X"39IPZ<_20[:S3 MU;7OK9L:-Y, MPC0DBL'@]8'*0]N&3'EY$'/&O%7/Q^VX)12MMFV(]5;O:06^S`[HVDJB('B2 MVPF*>MM&P`IK5,R;$Q"`W$9TC3U$;,S8)M;D79=45]8,"V;;=KOHJYG/HM!:RI"P(>T*EH6U;7[UE#90'0S#= M:XEI6M%;C\QW3'[A)19HSRF/L:/O#^$NAR2LZ(OBST*EJ6U;8U-:?,/XF"&* M<)XU8G`$CPM.^62\,#7#X:X;'$>K%;*CZ6KT9-];WAK-R>DZ]2AC$E-)>$\? M4A\ME__8(3<*5(;:-C+*RU`5[IFQOY3/,2VP4O129>,N-PH4=_/-BU6XU_6= MHISF/N%H$#P3YB4%FF1%Y:@[5$;,-SE*\>LT*I^V(2(2^>7?FV_I!)/K5)+3Q<"O8Y+-`&-+"RU@07[ M/)#M*:WO,?&C/U`BO%?[P7.(T_&J#P>%69E5LS&@_";8H13TS,GA.KV(W$5] MQRDM/TX;,]I"X5)F-E0!%YU!ZY^?>66_/`_*/\]>]27]Y.Q_1&CN7MXOQ9+18]/J38>^ROQ@GE7=F M\]%B-%GVE^/I1&/MG6FPMKPL)^Z^\%":4#]/^"Y?KN7N:Q*)#ZB&AM=X>&_E M88A".\`/V=Q+1&-)Q.V23.0KFQM5QM)?_#/V_%B3+>$=+<8CA>S:?8+ MC9O$%JB!O[DC**?4"M<^OY8P5.^<([?UM<>._(&3WZG:RYP?1VLAQ//M'2>)-A?S[4N=0.2)H% MOD=^M+/=U*/)DKPU"G%U;SSY,EHL:=59\F/OU^F8_/"%_(OMHQZ4F0[.Z`3L*ID M!S*NQE0HI0'+C*%[.5;#&%0UBLDJ3]0C4 M+_-3!ZSQV@-K7OC-R$JQY&@SW-:^.5Q9.$C\&VZ01:DY3!EPL#6\+VX-/U&+ MU7C>^]*_OAWU;D;]!3G&DXKR&G>&'4'[J0+6/;^7QE5=-C'`FA5TT[PB(1@5 MUAN(#]I7$TVIAOZ*R6"C1_9"^J&XD'XF9^SMY6+TSUNJ&(^^:%Y"12H@WD"L M'EI]G`XG!5@VG"Z:EXP(DR-?)0'MVI<*[)EUYKO8QJP;YH\UGUM[_[$=_S]? M7EX-?GD]E@L:6H37'EYAFZ::VYL:,SPACS>U1CWEU]@&V&V&OUU=$6E8&)2% MTJB4AB[BGI6*H.FWR>1WY\@S`')`5W`"^PZB#>:<&4!_1I8;W0\(U_),N;0< MZE86IE,'0U]I,'#NMPX*0PWN*O*HW-:"65I/:9+*]/,,GTIF:W#\;)=`XU)L MTJ*ET@->E*6-@?@I"RE1N>@XW%&TJ&Z011\>5[%[2XNA9,'[8H1H9V!?(&#* M`DJ4+3@IWIFQ_.:$7#*'^R$YZEU_ZRQ/;=AQA(*%OXJ^$99**$R5A@-*A+)H M$[5*5`T.ZRP\Q=@@KO%?,7:HD^LN<2,AT8\#&X6P;4)J!*!H*(M04;995.!C M1\QT2UI/C6&D^ZFVD2X=_<5$9[");F'?(R=."P0DSGZ6NPPL+R3SHM[&V;42 M8G*1'>B$#7$5F6J&FK&?/-5HDR4L!7]9KY.VLP'XI?TT./)1Y.S[1[%PI3ZS M)NSN)^(\NY>@XO3HB6TG44DNT4`=^<4H.:!N3S\YQ]N:?&M883?$I9>WLH]" MUP2.O4:L\>_1PY=ZH1V[JNZ#+`%[@,00NE=](_Z]TBPS\+[^&WK>Z1]#*[+* MEK;HQBXYAF[-K";X%2@V1"-C.'=SMN^+HP!(CHNW"5OWBZ\W1]4K3[";3ZF; M9>=XEM?ZJH]]BA[?S?''(AL8YWFG+!.SA:8@B"[OA668++]]1C@*1 MI5^@LL^0KMF'7AZC#'Z,*O=;(W/?X'A3D!2H&V"QMVX=I'V_OW+^*?))@DSA M!CG8SJ7L*%@PY(8X2:=>>388`FIIKF(Y:B02&7?+.5>>#4I!_=T/OJ(@S%]5 M'LB_?<]RQ]Z_XH#EG`OH=[)NNF">F6$I*)>V:72/@HJGZ6'?4W;GA?/.9*QG MY+^$V`4*'K&-JJI0Y8.,E/B@W!MJ$N8LE@B_9WIJ*]>&L9GO@1"F?6 M,[60EYN'CU+>E9N'0SJH5M<(LF/*E`EBM=>YS+:"M\PC5++*"NU$ MB^Q(+-4\!7,!*"Z=`@GY?<`$!,@"1&/R(T<#*FMK!A+E?,N85%.0>[AQ"0TAO[&PIX$'ML.AB#"DRX1,%M2 M]F_G31J0KW`0DO6(//K):]_R;M#F#K$JGS%;ZWZ0$TA,WOPKH%B1H3XIB9R6 MUZ-_3";!936O@^[G,@ENB^E6Q/`%LGWJS`&4;'9SW<]8$LP6T6S(U2Y/$!.4 M,NHE(5'V-`6$A$>"28#0>8T]HCS'=*%>63;J;VBJ,?Y-IKR']H.`J4Z79'KA M$6TB-+>>M2&RA/]&M,19D@XN>W7FFDBD!M%^ME0#$,2:[AO8#XG>EDB76Z[% M7MH/N&J(EQ-OG"6,ZSDY(318-&=1N6WL*.=[9=?)W8=>7"<-=IWLMC5.J=W[ MQ7BGVV!DKO%N0(YQ'.UJP7(M=V5M.X1"V?3-L-D=SDQDL"MO;080;''B@M&0 MG:ZQ',R^^TBTH\,YBF[;@FZZ?7AX,G:<2EG,`#/N>"]O#P?[V,7+V\-W\O:@ MPR:NS+&K"S;QMA][#."UGM>>MA\?SDUXZNG&Z\,L\!]0$#W/7"M)#$QSUR1) M@B^?Q6D"&0!N!D.9BI MQ9XY<]%]17H@Z'ZJ+-I)0HP+\%9DFAF[[A#ZGZ( M4`9_">O,D(&)[^$M#:F>D>5;7/HS%)"]:F-Y-KI"/,AEQM!NSH4B+,^8[GNA M76.;$AH*U;BCAKKC;,&P,D@T8S'FK`#%NF:?`J(\<-[=A3WU&_>A$$&YH##U M$GU?3F?!L.P7&T&YJ]$_NFS:)@G_`GG8#Y(@8,ZC;+X1E.GZ[_PEM)G!=*&S M-1L*0%Z2EU@>*=TOA44#/UWJS+J*B=P:J`@2/.8[=R6 MK">\B3>7?A#XW]*-F?PE*LON5$;\2A0S/5?J*IPQXRUF&P=81C3ZT"2I%ZP M91XVA2*D_T+$I-,@&'8[^/9>/B?$4:\%$2B\CE"(]%]N@#PP`["R%7\5H+]B MY-G/TU56X('&&*0_"6"L.!SXR5`[N+7X90;DA_)Y0R.JJ+\O84"N%AATI3*[ M0R$U+595P`_M$7`[SWG[KQB'F`X8PN+=?BC&NUW0XB.#\?5X^4>O/_CG[7@Q MIG%M"\,"V[:Q?@-_]A(6`>#5^+Q.BFCH9A@8!XR6ZS#!'1(.CRW:!O/OM MC.\DRNS0(3R8-)@1;%8V/?IC@(2NH("N9N`DD#L`8`6RU`1QW,3D`'[^C%UW M;CG8=_TU.\J,=N"TUYT[!"Q5>5.YD'Y%SP^?+9I"VAEOK#7VUER6ES?5[0A7 MB=L\JE4Q.G'AH@5:8`+.::_;=:D:RT7T*^+[P'(QP=K#%HSOG/:ZW44J\5U( MOR*^3_Z8S[B,SC?0_9Y?B;/'%)IA]OA$YDM]_Z9>KHCVY?.`Z&MK/Q`D-@!U M-D.S`6F@('K,"!DNG>K8L]W8H8>4%7Q%$:5T0:M&)KY=?2]?)_TSC!PDX6NTG:)WMWFQ<%B>ET M)BI6*URG)[$)D1/?L_.L:$B M.Z&^1:K,X'63HC7V'+3"'H[0-7ZD_XPL;XUW?=M9Z$):'\KTK+L@=AT/_10 MV:E-1D'XD?;4H5,=?%W[`YE^':H$C=/;4`\H;M\T=O#=[B0@:`IM/HR'#L]56>&$.S= M%1:62^9/S1\T$]_.W0#B=<7LVIU<"F`^:`\O'%F!A[UU.$/!XI[P((L$W,WO M(*+PQV)$X?O7O5%_/AE//BUZL]&\M_C0P,9/*[4V\#?;'POI;4?10&^BQ-'^*4_\+V(4$U:N<])YBSJ M'I^T8PM.[8%U.S=4$Z2&^&G&+@(B9KN!HFV^IGX06(0X@7&BB;%U>QLH%!$0 M5\V0$EUGS9\7^E_Y6SEM**$USYN(AAWI/VT8[)+6)`UP#:B&O(`!#>L3[=H] M][;8L?>KC[WH"_DQ)L-GMLNS?^5_66X._:EH#OWA=6\\^3):+&]&DR7YL??K M=$Q^^$+^=3L?[?.LG25?[#UFHVNUDR:6Z1L4W?OYN,&^YQQP!7"-DAU(JZJ0 MBZ7FNW9;#.2)\]:8K=HF4$F^"FI_0;N=N M1-8:Y[D9&Y")6HS$-5>=O5R_(M/`)3A5949><<\R[)KT%3U?8<_R"!_EGRO?E'Y#S[W5]@,]AWSAY;8$)IJ1*N>W`F97?@"=/NT/[][M&XT/77 MZR"9(4V/*"M"A<[:[KS*Q*24.R:?4-*[@,YT-\I@ZX0R<>L1MKK/V%MO`V,F MJ.+-@SN4-J\L9?`".&<&\"8:)S5ZX#0@$'I?5AOP`658HY9^9+F7OO_UB^7& M:+I*8EOSD\\2#^_"'QEFJ0KCZ//+J2,/%8EM9G=@9M^.YN@1>3&BCRRBQ9RF ME^;TT)<9HRXP`$:8LD$#7MP)-=333_9)NXFQ]666:&2O;HJYV@.$12]`@B*D M'ZJ^_)A1B[1C#S[-$'UC>5;JO'V%4)AM9VS2&,V[_?C#I\V0M;F(?/OKV1UU MO!_X&YK#+QET^W;J[[VRITE18TK][W19Y>^)^>7Z[FUQN?[XNK=83@>_G5WV M%Z-A;S"]F8TFBSZM&[Q_I,VY?_?\]$L]\L_>M^Q;.E?PGIKI*L^D.7*I<8I: M-\+$N_DN%[\`6-!UQS6A$FXG*Q(W`^A+S>+V$.MZS>(^V<><)?D*OV9%^8N1E5B?=!9?E5GH\LNWP^#CRCE.S)\1Q:PV!B;82%C-5\S0P9*)7?XO)3 M0G_-PFT-Z?";!]=_1BC1EE)%B%D4;*L\LKOHSJVC`C5:42AU67/I^0&/_9F"5&":HI*/J8[PJU3TLR!RY"=E2H3-(\(`3 MT:8E+%B*PA&ZIE"_6*P89A`]<@Z>@+[2FD9)N21@7;!FS1%U]"++EI9SH*R+ M+?<:K\J$K@0*=F^HQ*A[I*IBN!)QPZ#S]2BZ(RO`$$?W?I+%(PD)S[WE4M>^ M\$!.YU3LIT?!(`">+%&PN1#L2R9,4%^IURK"5;)9F<#$DQ7]W'9NINC7F:"^ MHKB&B7Y]E!7%QN\RZ8S)9[$78CL)VF>[93'3+H3WV@.F70N>\0U\TVH@*HQIU004*6\ M[WB2<$$8^CR,&='FYU6BS4FS^>+VWU^"RE^"RE^"RE^"RE^"R@WE_4M0^4M0 MN1+ZC0@JGR.:K,NF%5"I]B,**&JNMOD[(24N.$ M?6T$7DA]7;O$*8\RKP#&=^+WR>+8,:-H-M'EO>65.A8J$&'I&6B/"58NQA5! MZ?A.*J3Z"SE&D*-3%(LST!Y0K%\4RT'YCL,NA1R[\H,5PIHEN602VD..]0LS M$YKO6)X[H^`:$6QLDHK[XHD)6_5LQU:6VX"*-#AJIFE^;*F9?/L^-&JRF3PF M^EN!,2/%77J*^H(-S1'WBKB>NKAGEWU:"<1(69>;G[X@17,$O0JBIR[E MIZ+BRP3BGK*]78YCWX&/*;\(V;N+2GZF1A0@>_$T??$T??$T-=_;T6!/TZU[ M%M_1]+!5ASA_.'$SW$RA#J)FNG:6"0R#Z0WY9#(B)U-%B'Z+Z5])VQTWT^WE MQO>(+)^S25>1[]0Y_>+%.?W%.?T$G-.U5#S35W_ENZMXUFKP@;ZD_"_!!R!G MH,3/9[HJILU0X8C%_)1NA:L%GRL!FSLN1:QTJDL_LMRV,EK`OJ[]/&JK4*(, M&&:(W^[\1,$CME$Y`W;6ZX36,"$J_W=J`IOXT1\HFB/;7WMTE>5K50&4&+6? M[XS'?ZMPG+@$IBOPR@^R7]%VG.0I;<^C,X[[>@`R0SB'V;L;XSCX'4?W8\_! MC]B)+3=5--+B?9QWG.I#:M?_H2)3FVUFH%\WCU#JPG.HAPITL<:_IKW\E93N MI8C9!HF36O<"91$]\E-XB6%@P6*(-'(KS9;R1%1+NO*('7)OKLFU$NS;=S:B_N)V/;D:3Y6+G MBJ/3`6='X7[2`/<:?B\37#(ZZ3P#`>/%-<:PMU:#76-V\G3YO/OQ,T8!8<+] M\S5Z1"[_`1S:OT-H04DRP]&F]/PYGK?H+5QR&#/@E!->%LPPBHUXUMY-;^P] MQ%&8D'@N>OSD=M+];%5)?%E(LKEBQA6A;*(75>"[,,4S015\%UV![UT5^-Y) MPJ?L'445?.^:A8_A')D8Q7,DQ9GHWIH^W6K"-0 M*%D=S%`Y8!HDBP8SO"R7@>6%*Q2$?<])'Z%HL:15R:Q#ZF(4EO])I%$V^Q4S MT!=(!^VE"E6#).:6(I@6R/8])R\>7)#8S:$0_=Q5B$2<,D-M M6=S[040G.$1WD3@,A-'M7-=)B>$N@=?.,/YE'3AF);AN,+*%6".\^@PZ=0MF)(D M'IF+'8#H:'=_$%!<.67)(PKN_!#I3TMX[7OKK9`"VH^VBHX($&YT?!IQUZVV5_H?ZCW,_G-_P=02P,$%``` M``@`Z(-I1T&HBR`!"P``?UP``!$`'`!R9&YT+3(P,34P.3,P+GAS9%54"0`# MI!!!5J00059U>`L``00E#@``!#D!``#M7-USXC@2?[ZKNO_!1]75[CT`(9DD MDVRR6P1,XAF^#I-D9UZVA"U`&R,QDIS`_O77\D<`VRB&R12I)?.0,5)WJ[M_ M[E9+MGSQVVSB&8^8"\+H9:%2.B@8F#K,)71T6;BUBU6[9ED%X[=?__5/`_Y= M_+M8-!H$>^ZY46=.T:)#]HO11A-\;EQCBCF2C/]BW"'/5RVL03S,C1J;3#TL M,72$(YT;'TIG`Z-8S"'V#E.7\=N>]2QV+.7TO%Q^>GHJ4?:(GAA_$"6'Y1-G M,Y\[^%D61R[%\H_*P;?_'-8/#RK'!V='!Z79$(RH(PD$J@VZ*A7X^7WLTX]^[2MUG7MT M73UQ.N[L:Z_\[:MW):YGIX/^`SJ=._*S=4"$1=5;H7?G,L$Q\7`X[5TA))NE)2$IB4A5F-P7Q1%"TV>6(1*#0'34H5B.4RR<>5AD\@0]&4R4 M4>I/LKWC2EZ6\RDN`U$1J#`GSC/?RTRK#*"#:L[6+NC)T(Z[=`%$&$D0AY-R M'$>02SP\P50V&)_4\1#Y'M!_\Y%'A@2[!4,B/L)2W>MBBARLE16'"Z*4051! M%HE:5-MT2B!LH.$?%^K^.E?^[(/6AKJ`W)$E6765(>)\I6&5NB:51,Y5^/%) M(+]@$/>RH*50(\+XP9@N'A)*`L6B(*\812-F7[Y$U#5"6<:2L(MR4LR2<%]@ MMT-_#:ZG'`L0$S`UH2%BC$C6,#G(K^`Q2JM'IBC;8`Q?EX9XK_["92+*0A<1N'9 MD:(S[$Q5Z04*+"(G-X,>L@_Y(+/[\%_+;`-PTKY7Y3#' M8Z`AC]B":GN"<$L%(RO?@Q2F+?H8`Y2'4HW.61.>P9#2J-:L) MBF78_*)JLMO&I8\'%'?R"26`?[^N@-"VJ[5E7K36@$EJ:=-=UZKU^ ME/3Z22DL3HLPJ0;E4*L+A='^SJB$!QO\+8R4@X(R,YY#L[KTWOZ0]/:IFC6M MGG%7;=Z:1LNLVG!K!P7G'CK;]@<"?_/!&/-QX>=4J][%QTD7?X0;^O;*AC66 M2B/FW9XZ-U]-WH5%E4/B5+XACQZ8D^^LYXV?XX'V<8\Q'Q1]-/`V`R_BT$-W M^MW0AC!2Z^+,NG2?7;ZV`EWV_4M$>A!2R]\7BM5]AF-- M8;H,AIY$"\5A:BVLJ6#W&8;,>G49!!V!'H+44GE]6;O/".2;D>M8(N*)8@]# MN>OC32;S)*L>M=2">^-9/1H/6*,1WU$5(@:AS2067317MWLVB)F4>LQ2R_5L MS):0"80;TU#Z.SXOA$X;N%,/06K_8,VZ)Y*VCUY?NZ:)9YH_-]BNS^;1 M8Y3:*'AQ612/$@QM/$;#O(.7`<0#GC<(1=0AR*LCB7+BEV+30YC:7L@-X6<\ M-X;Q2(8+0[W#F,8C,3?E)]?#MOF&Q/L\M7YO(KZEF2_5\09UWJ8SC=^2N%<. M6SR>^!X)6DR/-MO9B$?L+$8T6#AD\$K[4S3H.\PID'K"SX=F0*@'+;47D@&L%ARG-UYNZR((@Z.5N(VL8<#R\+ZM1= M,3X6]P>85II-O)A$B=83KU`@QG7!HT=5TDRX"TTW46+AALV4B/FV4$)[X'J-%ID\ZJ*X8,X[ MOO;TMF[\3,8R]J2(6XH+4=MHDSYYO;TZ@:PM],EQZ#S/G;+,V0X9U:URIFZ5 MRLEW*K.=(B]I$9U>#\H=E:S^Z$-L>U>,/02%3V?8D6/,ES=5NHA+BKE%)8;9 M3ZW@E0F7A6T8B>>I)VJ7!6Q!/%#)[R!P(RG*_\=,V9/XU)"9#H?-#&,GH6V^!LDG@] M.[163_*B7:[/H[>.$X8Y'+L_T+)[QA\('=70E$AU[#DT)M7Z1G'I^MP90_[M M#-69PFGTR8(F%.=8G36T)C#5/895>IO)+UAV$7$;C,=V?@?_]HC^6)?`U(TY MW#-]-*L*H;8=U,_$F4+5N@@0-1%1N\(<_?P'9UDFI3VP.>-VM["R/U*'KH>[="'=F' M3O*(PTR3"M^\Q&\A;)L$I@E7O?1`W6AR[&$1?%U+K#%O,Y:W8&10M_6"3;(6 MG@PP7RGH$AW;*NRR"2+T%;1M$"YDDV#:QWS29(BNZKR^>^>:V]AA4&RL55W3 MOW/=(4[#W4_DJ<55X.55[;44.]>__:777=5WI67G^M74Y\(8IP1!O!'FL=%\ M55T=P_2+5S M.]KXZ1,LAO`\\G"TH92(UQ>I=FY'^$&DKI>L`#+:=ZZK[M.059#)D2.?-QMR MT:+H*K9I+,[W^I^4')WI,%6]F!% M$K/\]&\.MWM,1F.)W>HCYFB$S1GF#A&XRXF#NYC7V`3\&KP;G31Z&\ZW;GX/ MJXA7N[B,!HKZ<->2(5YC\WKR-V=H=33B>(0DMJ@2*8@35#2Q86N[=VC(13E\ M2@.7_P=02P$"'@,4````"`#H@VE'P&Q@D?C0```90@D`$0`8```````!```` MI($``````L``00E#@``!#D! M``!02P$"'@,4````"`#H@VE'Y4%,S'@2```T\P``%0`8```````!````I(%# MT0``&UL550%``.D$$%6=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`Z(-I1^W8.X"#&0``II$!`!4`&````````0```*2! M"N0``')D;G0M,C`Q-3`Y,S!?9&5F+GAM;%54!0`#I!!!5G5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`.B#:4?OM4]%R$H``.`O!``5`!@```````$```"D M@=S]``!R9&YT+3(P,34P.3,P7VQA8BYX;6Q55`4``Z00059U>`L``00E#@`` M!#D!``!02P$"'@,4````"`#H@VE'LGUGN?$O``!O-@,`%0`8```````!```` MI('S2`$`&UL550%``.D$$%6=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`Z(-I1T&HBR`!"P``?UP``!$`&````````0`` M`*2!,WD!`')D;G0M,C`Q-3`Y,S`N>'-D550%``.D$$%6=7@+``$$)0X```0Y 9`0``4$L%!@`````&``8`&@(``'^$`0`````` ` end XML 48 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

Beginning balance $ 32,123

Equity earnings in these joint ventures $ 1,992 $ 2,009 6,301 $ 4,722

Distribution of earnings (6,255) $ (7,358)

Equity contributions in existing joint ventures 265

Ending balance $ 32,434 $ 32,434

X

- Definition
This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Cash dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations that are returns of capital. Excludes dividends or distributions from equity method investments classified as operating activities.
+ References
No definition available.
+ Details

Name: us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 80 234 1 false 29 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://radnet.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://radnet.com/role/ConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://radnet.com/role/ConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://radnet.com/role/CondensedConsolidatedStatementOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentation 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION Notes 8 false false R9.htm 00000009 - Disclosure - 2. FACILITY ACQUISITIONS AND DISPOSITIONS Sheet http://radnet.com/role/FacilityAcquisitionsAndDispositions 2. FACILITY ACQUISITIONS AND DISPOSITIONS Notes 9 false false R10.htm 00000010 - Disclosure - 3. NEW ACCOUNTING STANDARDS Sheet http://radnet.com/role/NewAccountingStandards 3. NEW ACCOUNTING STANDARDS Notes 10 false false R11.htm 00000011 - Disclosure - 4. EARNINGS PER SHARE Sheet http://radnet.com/role/EarningsPerShare 4. EARNINGS PER SHARE Notes 11 false false R12.htm 00000012 - Disclosure - 5. INVESTMENT IN JOINT VENTURES Sheet http://radnet.com/role/InvestmentInJointVentures 5. INVESTMENT IN JOINT VENTURES Notes 12 false false R13.htm 00000013 - Disclosure - 6. STOCK-BASED COMPENSATION Sheet http://radnet.com/role/Stock-basedCompensation 6. STOCK-BASED COMPENSATION Notes 13 false false R14.htm 00000014 - Disclosure - 7. FAIR VALUE MEASUREMENTS Sheet http://radnet.com/role/FairValueMeasurements 7. FAIR VALUE MEASUREMENTS Notes 14 false false R15.htm 00000015 - Disclosure - 8. SUBSEQUENT EVENTS Sheet http://radnet.com/role/SubsequentEvents 8. SUBSEQUENT EVENTS Notes 15 false false R16.htm 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationPolicies 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) Tables http://radnet.com/role/NatureOfBusinessAndBasisOfPresentation 17 false false R18.htm 00000018 - Disclosure - 4. EARNINGS PER SHARE (Tables) Sheet http://radnet.com/role/EarningsPerShareTables 4. EARNINGS PER SHARE (Tables) Tables http://radnet.com/role/EarningsPerShare 18 false false R19.htm 00000019 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Tables) Sheet http://radnet.com/role/InvestmentInJointVenturesTables 5. INVESTMENT IN JOINT VENTURES (Tables) Tables http://radnet.com/role/InvestmentInJointVentures 19 false false R20.htm 00000020 - Disclosure - 6. STOCK-BASED COMPENSATION (Tables) Sheet http://radnet.com/role/Stock-basedCompensationTables 6. STOCK-BASED COMPENSATION (Tables) Tables http://radnet.com/role/Stock-basedCompensation 20 false false R21.htm 00000021 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Tables) Sheet http://radnet.com/role/FairValueMeasurementsTables 7. FAIR VALUE MEASUREMENTS (Tables) Tables http://radnet.com/role/FairValueMeasurements 21 false false R22.htm 00000022 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetails-Revenue 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue) Details http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 22 false false R23.htm 00000023 - Disclosure - 1. NATURE OF BUSINESS (Details - Notes payable) Notes http://radnet.com/role/NatureOfBusinessDetails-NotesPayable 1. NATURE OF BUSINESS (Details - Notes payable) Details http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 23 false false R24.htm 00000024 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Details http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 24 false false R25.htm 00000025 - Disclosure - 2. FACILITY ACQUISITIONS (Details Narrative) Sheet http://radnet.com/role/FacilityAcquisitionsDetailsNarrative 2. FACILITY ACQUISITIONS (Details Narrative) Details http://radnet.com/role/FacilityAcquisitionsAndDispositions 25 false false R26.htm 00000026 - Disclosure - 4. EARNINGS PER SHARE (Details) Sheet http://radnet.com/role/EarningsPerShareDetails 4. EARNINGS PER SHARE (Details) Details http://radnet.com/role/EarningsPerShareTables 26 false false R27.htm 00000027 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-jointVentures 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) Details http://radnet.com/role/InvestmentInJointVenturesTables 27 false false R28.htm 00000028 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-keyFinancialData 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) Details http://radnet.com/role/InvestmentInJointVenturesTables 28 false false R29.htm 00000029 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details Narrative) Sheet http://radnet.com/role/InvestmentInJointVenturesDetailsNarrative 5. INVESTMENT IN JOINT VENTURES (Details Narrative) Details http://radnet.com/role/InvestmentInJointVenturesTables 29 false false R30.htm 00000030 - Disclosure - 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) Sheet http://radnet.com/role/Stock-basedCompensationDetails-outstandingOptionsAndWarrants 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) Details http://radnet.com/role/Stock-basedCompensationTables 30 false false R31.htm 00000031 - Disclosure - 6. STOCK-BASED COMPENSATION (Details - RSU's) Sheet http://radnet.com/role/Stock-basedCompensationDetails-Rsus 6. STOCK-BASED COMPENSATION (Details - RSU's) Details http://radnet.com/role/Stock-basedCompensationTables 31 false false R32.htm 00000032 - Disclosure - 6. STOCK-BASED COMPENSATION (Details Narrative) Sheet http://radnet.com/role/Stock-basedCompensationDetailsNarrative 6. STOCK-BASED COMPENSATION (Details Narrative) Details http://radnet.com/role/Stock-basedCompensationTables 32 false false R33.htm 00000033 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details) Sheet http://radnet.com/role/FairValueMeasurementsDetails 7. FAIR VALUE MEASUREMENTS (Details) Details http://radnet.com/role/FairValueMeasurementsTables 33 false false R34.htm 00000034 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://radnet.com/role/FairValueMeasurementsDetailsNarrative 7. FAIR VALUE MEASUREMENTS (Details Narrative) Details http://radnet.com/role/FairValueMeasurementsTables 34 false false All Reports Book All Reports In ''CONDENSED CONSOLIDATED BALANCE SHEETS'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. rdnt-20150930.xml rdnt-20150930_cal.xml rdnt-20150930_def.xml rdnt-20150930_lab.xml rdnt-20150930_pre.xml rdnt-20150930.xsd true true XML 50 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. STOCK-BASED COMPENSATION (Tables)
9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock option activity

Weighted Average Weighted Average Remaining

Exercise price Contractual Aggregate

Outstanding Options Per Common Life Intrinsic

Under the 2006 Plan Shares Share (in years) Value

Balance, December 31, 2014 2,092,509 $ 3.58

Granted – –

Exercised (1,102,500 ) 2.69

Canceled, forfeited or expired (25,000 ) 2.22

Balance, September 30, 2015 965,009 4.62 1.07 $ 1,783,778

Exercisable at September 30, 2015 921,676 4.74 0.98 1,631,678

Restricted Stock Awards activity

Weighted-

Average

Remaining Weighted-

Contractual Average

RSA’s Term (Years) Fair Value

RSA's outstanding at December 31, 2014 942,023 $ 1.96

Changes during the period

Granted 744,423 $ 8.60

Vested (848,552 ) $ 4.55

Forfeited (29,526 ) $ 5.59

RSA's unvested at September 30, 2015 808,369 0.71 $ 5.22

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

7. FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
First Lien Term Loan
FAIR VALUE MEASUREMENTS
Term loans face value	$ 384,176	$ 399,750
2015 Incremental First
FAIR VALUE MEASUREMENTS
Term loans face value	73,026
Second Lien Term Loans
FAIR VALUE MEASUREMENTS
Term loans face value	180,000	180,000
Level 1 \| First Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0	0
Level 1 \| 2015 Incremental First
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0
Level 1 \| Second Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0	0
Level 2 \| First Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	383,216	394,753
Level 2 \| 2015 Incremental First
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	72,843
Level 2 \| Second Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	172,800	178,200
Level 3 \| First Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0	0
Level 3 \| 2015 Incremental First
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0
Level 3 \| Second Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	0	0
Total Fair Value \| First Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	383,216	394,753
Total Fair Value \| 2015 Incremental First
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	72,843
Total Fair Value \| Second Lien Term Loans
FAIR VALUE MEASUREMENTS
Long-Term Debt fair value	$ 172,800	$ 178,200

2. FACILITY ACQUISITIONS (Details Narrative) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Goodwill	$ 201,450	$ 200,304
Baltimore County Radiology
Proceeds from sale of imaging center	5,000
Gain on sale of imaging center included in equity	3,700
New Jersey Imaging Partners
Proceeds from sale of imaging center	35,500
Gain on sale of imaging center included in equity	4,800
Murray Hill Radiology
Cash consideration paid	5,800
Fixed assets	1,600
Prepaid assets	95
Goodwill	4,100
Hanford Imaging
Cash consideration paid	1,000
Fixed assets	345
Goodwill	655
Healthcare Radiology
Cash consideration paid	425
Fixed assets	134
Leasehold improvements acquired	290
California Radiology
Cash consideration paid	4,200
Equipment acquired	217
Leasehold improvements acquired	1,700
Goodwill	2,100
Other intangible assets	100
Other assets	34
New York Radiology Partners
Cash consideration paid	29,800
Note issued	1,500
Assets acquired	34,500
Assumed equipment debt	2,300
Assumed current liabilities	891
Equipment acquired	4,600
Leasehold improvements acquired	12,000
Goodwill	12,900
Other intangible assets	600
Accounts receivable and other current assets	$ 4,400

5. INVESTMENT IN JOINT VENTURES (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Equity Method Investments and Joint Ventures [Abstract]
Management service fees from centers underlying joint ventures	$ 2,600	$ 2,300	$ 6,400	$ 6,900

6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Stock Options	9 Months Ended
	Sep. 30, 2015 USD ($) $ / shares shares
STOCK BASED COMPENSATION
Begining Balance \| shares	2,092,509
Granted \| shares	0
Exercised \| shares	(1,102,500)
Canceled or expired \| shares	(25,000)
Ending Balance \| shares	965,009
Exercisable at the end \| shares	921,676
Weighted Average Exercise price Per Common Share
Begining Balance	$ 3.58
Granted
Exercised	$ 2.69
Canceled or expired	2.22
Ending Balance	4.62
Exercisable at the end	$ 4.74
Weighted Average Remaining Contractual Life
Ending Balance	1 year 25 days
Exercisable at the end	11 months 23 days
Aggregate Intrinsic Value
Aggregate value outstanding \| $	$ 1,783,778
Aggregate value exercisable \| $	$ 1,631,678

6. STOCK-BASED COMPENSATION (Details - RSU's) - RestrictedStockMember	9 Months Ended
	Sep. 30, 2015 $ / shares shares
RSA's outstanding, beginning balance \| shares	942,023
RSA's granted \| shares	744,423
RSA's vested \| shares	(848,552)
RSA's forfeited \| shares	(29,526)
RSA's outstanding, ending balance \| shares	808,369
Weighted-Average Remaining Contractual Term	8 months 16 days
Weighted-average fair value, beginning balance	$ 1.96
Weighted-average fair value, granted	8.60
Weighted-average fair value, vested	4.55
Weighted-average fair value, forfeited	5.59
Weighted-average fair value, ending balance	$ 5.22

6. STOCK-BASED COMPENSATION (Details Narrative) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Common stock issued upon exercise of options and other awards	3,678,741
Stock Options
Aggregate intrinsic value	$ 6,100	$ 5,900
Unrecognized stock-based compensation expense	$ 21
Unrecognized expense weighted average period	1 year 1 month 6 days
RestrictedStockMember
Total shares issued	3,461,208
RSA's previously vested	2,623,314
RSA's unvested	808,369
2006 Equity Incentive Plan
Shares authorized under plan	12,000,000

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$ 36,054	$ 307
Accounts receivable, net	159,205	148,235
Current portion of deferred tax assets	17,246	17,246
Due from affiliates	2,604	1,561
Prepaid expenses and other current assets	41,194	24,671
Total current assets	256,303	192,020
PROPERTY AND EQUIPMENT, NET	232,477	223,127
OTHER ASSETS
Goodwill	201,450	200,304
Other intangible assets	45,225	47,624
Deferred financing costs, net of current portion	4,294	6,122
Investment in joint ventures	32,434	32,123
Deferred tax assets, net of current portion	32,584	35,334
Deposits and other	4,108	4,026
Total assets	808,875	740,680
CURRENT LIABILITIES
Accounts payable, accrued expenses and other	95,058	97,816
Due to affiliates	5,664	6,289
Deferred revenue	1,323	1,964
Current portion of notes payable	23,391	19,468
Current portion of deferred rent	2,299	2,100
Current portion of obligations under capital leases	8,761	5,637
Total current liabilities	136,496	133,274
LONG-TERM LIABILITIES
Deferred rent, net of current portion	26,299	20,965
Line of credit	0	15,300
Notes payable, net of current portion	606,744	551,059
Obligations under capital lease, net of current portion	7,422	6,143
Other non-current liabilities	5,577	6,241
Total liabilities	782,538	732,982
STOCKHOLDERS' (DEFICIT) EQUITY
Common stock - $.0001 par value, 200,000,000 shares authorized; 44,495,235, and 42,825,676 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	4	4
Paid-in-capital	188,310	177,750
Accumulated other comprehensive loss	(146)	(112)
Accumulated deficit	(165,452)	(172,280)
Total RadNet, Inc.'s stockholders' deficit	22,716	5,362
Noncontrolling interests	3,621	2,336
Total equity	26,337	7,698
Total liabilities and equity	$ 808,875	$ 740,680

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 9 months ended Sep. 30, 2015 - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income / Loss	Total Radnet Inc Equity	Noncontrolling Interest	Total
Beginning balance, shares at Dec. 31, 2014	42,825,676
Beginning balance, value at Dec. 31, 2014	$ 4	$ 177,750	$ (172,280)	$ (112)	$ 5,362	$ 2,336	$ 7,698
Issuance of common stock upon exercise of options, shares issued	814,662
Issuance of common stock upon exercise of options, value		594			594		594
Stock-based compensation		6,309			6,309		6,309
Issuance of restricted stock and other awards, shares	884,423
Forfeiture of restricted stock	(29,526)
Sale of noncontrolling interest		3,657			3,657	1,348	5,005
Distributions paid to noncontrolling interest						(613)	(613)
Change in cumulative foreign currency translation adjustment				(34)	(34)		(34)
Net income			6,828		6,828	550	7,378
Ending balance, shares at Sep. 30, 2015	44,495,235
Ending balance, value at Sep. 30, 2015	$ 4	$ 188,310	$ (165,452)	$ (146)	$ 22,716	$ 3,621	$ 26,337

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 7,378	$ (2,610)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	43,836	45,193
Provision for bad debts	25,295	21,945
Equity in earnings of joint ventures	(6,301)	(4,722)
Distributions from joint ventures	6,255	7,358
Amortization and write off of deferred financing costs and loan discount	4,000	4,444
Loss on sale and disposal of equipment	774	1,581
Loss on early extinguishment of Senior Notes	0	15,927
Gain on sale of imaging centers	(4,823)	0
Stock-based compensation	6,477	2,069
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable	(32,485)	(42,887)
Other current assets	(15,628)	(4,754)
Other assets	(1,254)	(72)
Deferred taxes	2,750	(2,461)
Deferred rent	6,034	653
Deferred revenue	(641)	604
Accounts payable, accrued expenses and other	(1,603)	(8,225)
Net cash provided by operating activities	40,065	34,043
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities	(41,237)	(9,428)
Purchase of noncontrolling interests	0	(196)
Purchase of property and equipment	(38,736)	(33,895)
Proceeds from sale of equipment	648	766
Proceeds from sale of imaging facilities	35,500	0
Proceeds from sale of internal use software	443	0
Equity contributions in existing and purchase of interest in joint ventures	(265)	(1,161)
Net cash used in investing activities	(43,647)	(43,914)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on notes and leases payable	(6,645)	(16,733)
Proceeds from borrowings	74,401	210,000
Payments on Term Loan Debt/Senior Notes	(17,548)	(211,344)
Deferred financing costs	(531)	(6,650)
Net proceeds on revolving credit facility	(15,300)	25,100
Distributions paid to noncontrolling interests	(613)	(148)
Proceeds from sale of non-controlling interests	5,005	0
Proceeds from issuance of common stock upon exercise of options/warrants	594	1,546
Net cash provided by financing activities	39,363	1,771
EFFECT OF EXCHANGE RATE CHANGES ON CASH	(34)	(38)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	35,747	(8,138)
CASH AND CASH EQUIVALENTS, beginning of period	307	8,412
CASH AND CASH EQUIVALENTS, end of period	36,054	274
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	26,543	32,389
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Purchase of equipment and leasehold improvements not yet paid for	$ 15,700	$ 16,600

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common stock - par value (in Dollars per share)	$ 0.0001	$ .0001
Common stock - shares authorized	200,000,000	200,000,000
Common stock - shares issued	44,495,235	42,825,676
Common stock - shares outstanding	44,495,235	42,825,676

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Nov. 05, 2015
Document and Entity Information
Entity Registrant Name	RadNet, Inc.
Entity Central Index Key	0000790526
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		46,120,671
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

7. FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Line of credit	$ 0	$ 15,300